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Harnessing site selectivity in C–H functionalisation remains one of the greatest challenges 
in modern catalysis. In order to differentiate electronically and sterically similar C–H bonds, 
a variety of pioneering methods have been developed in recent years. One of the key 
developments is the use of Lewis basic directing groups to selectively direct a metal centre. 
The results herein report the manipulation of directing group chemistry to allow selective 
ortho, meta and para C–H functionalisation of arenes. 
Chapter 1 reports the developments in moving beyond ortho-selectivity in transition metal 
catalysed C–H functionalisation chemistry. 
Chapter 2 reports the use of the biologically relevant oxazolidinone and hydantoin 
heterocycles as weakly coordinating directing groups in ruthenium catalysed ortho-C–H 
alkenylation methodology. 
Chapter 3 reports the application of ruthenium catalysed σ-activation to the remote C–H 
functionalisation of indoles at the C6 position and carbazoles at the C4 position. 
Chapter 4 reports the manipulation of site selective cyclometalation and its application in 
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Chapter 1: Site Selectivity in Transition-Metal Catalysed C–H 












“Controlling the regioselectivity of C–H bond functionalization is imperative to harness its 






1.1: ortho: The Birth of Directed C–H Functionalisation 
 
 The ability to transform seemingly inert C–H bonds into reactive functional groups 
has become one of the greatest tasks in recent modern catalytic development. This is 
because one of the greatest assets of C–H functionalisation methodology is its potential 
use in late stage functionalisation for inter alia drug discovery and natural product 
synthesis.2 This power to access untapped chemical space using modern transition metal 
catalysis is of great interest to both industry and academia. C–H functionalisation has its 
principle advantages over traditional cross coupling methodologies, such as the Suzuki, 
Negishi, and Stille reactions, in that at least one of the substrates do not need to be pre-
functionalised with functional groups (B(OR)2, ZnR, and SnR3 respectively) that will 
eventually become atomic waste.  
 
The major challenge in C–H functionalisation is the ability to selectively transform 
certain C–H bonds. This has been combatted by many through two clear methods. The first 
is direct C–H functionalisation where a highly active metal centre exploits the careful 
manipulation of steric and electronic effects to enable selective C–H activation. This C–H 
cleavage will take place at the most/least electron dense, most acidic or least hindered C–
H bond, depending on the catalyst system employed (Scheme 1-1a).3 The second is 
directed C–H activation, here a Lewis basic directing group can coordinate a metal centre 
and facilitate selective insertion ortho to the directing group (Scheme 1-1b). The latter of 




Scheme 1-1: Direct vs Directed C–H Activation 
 
There are multiple pathways in which a metal centre/complex can enable C–H 
activation to form a cyclometalated intermediate. These include oxidative addition, 
electrophilic addition to a metal centre, σ-bond metathesis, and concerted metalation 
deprotonation (CMD, also known as AMLA). The first and last of these have become the 
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most widely used in C–H activation methodology (Scheme 1-2). A pure organometallic 
oxidative addition can be carried out with low-valent electron rich complexes of rare earth 
transition metals. This also leads to a net +2 change in the oxidation state. CMD, first 
proposed by McGregor4 and Fagnou5 relies on the use of its coordinated carboxylate ligand 
to act as a proton shuttle to enable C–H activation, and due to this there is no net oxidation 
state change in the metal. This allows CMD to be more widespread, especially to base 
metals. CMD was first applied to ruthenium catalysis by Dixneuf6 and Ackermann.7 It must 
be noted that both CMD and oxidative addition are also used in direct C–H activation. 
     
 
 
Scheme 1-2: Methods of C–H Activation where X = Oxidation State of Metal (M) 
 
This cyclometalate can then coordinate a coupling partner and then cross couple this in a 
C-R bond forming reaction to create the ortho-substituted arene (Scheme 1-3). In the case 
of Scheme 1-3, a standard oxidative addition / reductive elimination pathway for the cross 
coupling is shown, however there are multiple ways in which a cyclometalated species can 
facilitate C–H functionalisation including (but not limited to) transmetalation, migratory 




Scheme 1-3: Overcoming Site Selectivity using Directing Groups 
 
 The use of directing groups that strongly coordinate a metal centre, predominately 
based on N-based directing groups, has evolved rapidly to enable the use of a multitude of 
different metal-coordinating directing groups. Among these are the heteroaromatics: 
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pyrazole, pyrimidine, triazole, tetrazole, oxazoline and then acyclic derivatives such as 
ketimines (Scheme 1-4).9 Through an influx of research output, a large variety of C-C and 
C-X bond forming reactions have also entered the synthetic toolkit including (but certainly 
not limited to) those shown below (Scheme 1-4c).9 It also must be noted that despite C–H 
functionalisation’s roots in rare earth metal catalysis such as palladium,10 rhodium,11 and 
ruthenium,12 a variety of transformations are now available using first row transition metals 
such as cobalt,13 manganese,14 and iron.15 
 
Scheme 1-4: Strongly Coordinating Directing Groups in C–H Functionalisation 
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 Whilst the use of strongly coordinating directing groups has enabled efficient and 
selective C–H functionalisation, these structural motifs are not often ubiquitous in organic 
molecules. Therefore, there has been a large interest in the use of weakly coordinating 
directing groups (which generally coordinate metal centres through a carbonyl) which are 
more commonly found as organic functional groups, these include: carboxylic acids, 
aldehydes, esters, anilides, and carbamates (Scheme 1-5).  Due to the weaker 
cyclometalated species formed as an intermediate in these reactions, these structures are 
less amenable to the widespread toolkit developed for strongly coordinating directing 





Scheme 1-5: Examples of Weakly Coordinating Directing Groups in C–H Functionalisation 
 
Directed C–H activation has enabled a plethora of transformations, of which a huge majority 
enable selective C–H functionalisation ortho to the directing group. In order to gain access 
to the more remote meta and para C–H bonds, different techniques are necessary. The 
next section will explore in much greater detail how directed C–H functionalisation under 






1.2: meta: Beyond ortho-Selectivity 
 
1.2.1: Direct meta C–H Activation 
 
The power of selectively accessing remote C–H bonds will heavily contribute to 
future research programmes in all arms of synthetic development.18 The first reports of 
transition metal-catalysed process to overcome the cage of ortho-selectivity made use of 
direct C–H functionalisation, where steric and electronic properties of an arene can dictate 
selectivity.  
 
Sterics were exploited in a report in 2002 by Smith and co-workers. Here they 
utilised iridium catalysis in the presence of phosphine ligands to selectively C–H borylate 
the least hindered site on steric grounds.19 Therefore, on the use of a di-meta-substituted 
arene, C–H borylation takes place meta to the substituents already in place (Scheme 1-6). 
In this methodology, the arene is often used in vast excess as solvent, and for solid arenes, 




Scheme 1-6: Site Selective Iridium-Catalysed C–H Borylation 
 
Hartwig and co-workers have applied this selective C–H borylation methodology to 
subsequent palladium-catalysed alkylation and allylation chemistry to give a wide range of 
structurally diverse building blocks.21 
  
 In 2009, Yu and co-workers disclosed the exploitation of the inherent electronic 
properties of an arene to exhibit meta selectivity. Here, they demonstrated that electron 
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deficient arenes could undergo selective direct C–H activation at the meta position 
employing palladium catalysis and a specialised sterically encumbered pyridine based 
ligand (Scheme 1-7). They showed that despite overall preference for direct C–H activation 
at the meta position, competing para C–H functionalisation was also observed in a majority 
of examples.21 A full experimental and computational mechanistic paper on a similar 
methodology has been reported by Wu and Zeng.22 A similar concept has also been 
explored by Sanford in the C–H acetoxylation of electronically biased arenes, where the 




Scheme 1-7: Palladium Catalysed meta C–H alkenylation of Electronically Biased Arenes 
 
 Both methodologies shown above were shown to utilise a vast excess of arene in 
the reaction mixture, using them as solvent. Ritter and co-workers described the C–H 
imidation of electronically biased arenes employing dual palladium / silver catalysis and 
using the arene as the limiting reagent (Scheme 1-8).24  
 
 
Scheme 1-8: Palladium / Silver Catalysed C–H Imidation at the meta Position of Electronically 
Biased Arenes  
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They demonstrated that a mixture of electron withdrawing meta directing and electron 
donating ortho / para substituents was necessary to elicit the greatest selectivity. It was also 
shown to undergo C–H functionalisation via a radical mechanism whereby the silver salt 
engages in a single electron transfer (SET) process which then interacts with the palladium. 
 
1.2.2: Template Assisted meta-C–H Functionalisation 
 
1.2.2.1: Covalent Templates 
 
 One of the most well-known and key methodologies that has been developed to 
enable the meta-selective activation of C–H bonds is the work pioneered by Yu and co-
workers on the design of templated directing groups (Scheme 1-9).25 These directing groups 
have been shown to form macrocyclic cyclometalates which have been meticulously 




Scheme 1-9: Template Assisted meta-Selective C–H Functionalisation 
 
The seminal example of this work was reported in 2012 on the meta-alkenylation of benzyl 
alcohol derivatives (Scheme 1-10).26 The templated directing group that was disclosed is 
an incredibly sterically encumbered phenol derivative, which coordinates a palladium centre 
through a nitrile functional group. This mechanistic pathway has also been investigated from 






Scheme 1-10: Palladium Catalysed Template Assisted meta-Alkenylation 
 
One of the major disadvantages to the methodology above is that a method of cleaving this 
high atomic weight template was not disclosed. To this end, at the end of the report they 
proposed a removable ‘U’ shaped template which could be furnished to a hydrocinnamic 
acid derivative (Scheme 1-11a).26 This could direct functionalisation to the meta-C–H bond 
and was then readily cleaved via saponification, including recovery of the amine parent of 
the template which can then recycled. Yu reported that this U-shaped template could also 
be used to facilitate meta-C–H arylation chemistry (Scheme 1-12b).29 Another report also 









 In late 2013, Tan reported the meta-alkenylation of benzyl alcohol derivatives using 
a silyl-based template (Scheme 1-12). This has benefits over the previous methodologies 
described as a simple in situ treatment with TBAF at the end of the reaction reveals the free 





Scheme 1-12: Readily Cleaved Silyl Based Templates for meta-Functionalisation 
 
Following these seminal reports Yu reported the meta-C–H functionalisation of amine 
derivatives using this template concept. A modified template was used to enable effective 
meta-alkenylation and acetoxylation of a wide range of amines, focussing on aniline 
derivatives (Scheme 1-13a).32 This work was expanded into indoline derivatives which were 
furnished with a sulfonamide template linker. It was shown that the all of the previously 
developed alkenylation, arylation and acetoxylation methodologies were amenable to this 






Scheme 1-13: Template Assisted meta-Functionalisation of Aniline and Indoline Derivatives 
 
 From this point on, this research area has received a colossal influx of reaction 
systems with further developments from Yu and vast contributions by Maiti and co-workers 
amongst others. A summary of the templates constructed and the transformations available 
with them is shown in Scheme 1-15. Firstly, Maiti and co-workers reported the meta-
alkenylation phenylacetic acid derivatives (Scheme 1-14a).34 Li and co-workers then 
showed that an in situ created phthalimide (from phenylethylamides derivatives) enabled 
meta selective alkenylation chemistry (Scheme 1-14b).35 Yu then reported that his U-
shaped template was also amenable to the meta-alkenylation of phenylacetic acid 
derivatives (Scheme 1-14c).36 Maiti and co-workers demonstrated that sulfonates could be 
used as linkers for this methodology, and were shown to be able to undergo a Julia reaction 
give the di-vinylated benzene (Scheme 1-14d).37 Yu and co-workers then reported that the 
use of a pyridine template enabled meta-alkenylation and iodination of benzyl alcohol 
derivatives. This was an important step as can potentially unlock other chemistry that pyridyl 
directing groups can carry out in palladium catalysis (Scheme 1-14e).38 Li showed that 
amide linked templates could be used in meta-alkenylation reactions (Scheme 1-14g).39 
Maiti and co-workers demonstrated that their sulfonate template from before was amenable 
to meta-hydroxylation methodology (Scheme 1-14g)40 and that increasing the linker size 
maintained reactivity in remote functionalisation (Scheme 1-14h).41 The same group then 
 12 
 
demonstrated that a biaryl system (Scheme 1-14i)42 and phosphonate linkers (Scheme 1-
14j)43 were tolerated in catalysis. They also demonstrated that sulfonates furnished with 





Scheme 1-14: Summary of Templates and Transformations used in Template-Assisted Remote 
meta-Functionalisation 
 
 All of the examples above have employed palladium catalysis to afford macrocyclic 
cyclometalates that can carry out C–H functionalisation chemistry. There have been two 
recent examples to date that have utilised rhodium catalysis in template-assisted chemistry. 
Both Lu, Sun and Yu,46 and Maiti47 have reported meta-alkenylation reaction methodologies 
(Scheme 1-15). Whilst this is inherently iterative of previous work, the importance of these 
findings is in the potential they hold to open up a vast field of potential chemistry of rhodium 




Scheme 1-15: Rhodium Catalysed meta-Alkenylation of Template Furnished Arenes 
 
1.2.2.2: Non-Covalent Templates 
 
 Template-assisted meta-selective C–H functionalisation has become a widely-
researched area in the past five years. Despite all the improvements and template 
developments, there is still a fundamental issue with this kind of chemistry. This is the high 
amount of atomic waste of the template, which is not found in the final product, and in 
separate pre-installation and removal steps. Due to this there has been efforts to create 
non-covalent templates that are in the reaction as part of the catalytic system (catalyst or 
ligand) than can direct cyclometalation at the meta-position and therefore subsequent meta-
functionalisation. The power of non-covalent interactions in transition metal catalysis has 
also been explored in a recent review.49 
 
 The first example of this proposal was reported by Kanai and co-workers in 2015. 
Here they demonstrate the conceptually elegant iridium catalysed meta-borylation of 
benzamide derivatives (Scheme 1-16).50 The regioselectivity was controlled by the 
meticulously designed ligand additive, which was shown to proposed to form a hydrogen 
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bond between the urea (ligand) and carbonyl (substrate), which templates the bipyridyl 
ligand proximal to the meta-C–H bond. This example highlights the power of non-covalent 
templates as the ligand is used in quantities as low as 1.5 mol%. Low amounts of competing 




Scheme 1-16: Iridium Catalysed meta-Borylation using Non-Covalent Template 
 
 In 2016 Chattopadhyay reported the iridium catalysed meta-borylation of aldehydes 
(Scheme 1-17).51 In this methodology, methylamine or tert-butylamine is reacted in situ to 
form an imine, and then they propose that one of two mechanisms are at play. Either (a) a 
hydrogen bond between the H on the imine and the oxygen on the boronate ligand enables 
templating of the octahedral iridium centre to the meta-C–H bond or (b) the imine can 
coordinate the boronate itself in a Lewis basic fashion. In this report, competing 






Scheme 1-17: Iridium Catalysed meta-Borylation of Aldehydes using Non-Covalent Template 
  
The first two examples shown above have (or potentially have) made use of 
hydrogen bonding interactions to elicit meta-selectivity. In 2016, Phipps and co-workers 
described the meta-borylation of quaternary ammonium salts utilising electrostatic 
interactions between substrate and ligand to facilitate selective C–H iridation at the meta 








 In early 2017, Yu and co-workers reported the meta-alkenylation of 3-phenylpyridine 




Scheme 1-19: Palladium Catalysed Remote Alkenylation using Non-Covalent Pyridyl and Nitrile 
Templates 
 
They proposed that a metal centre (palladium or copper) can form a cyclometalate with the 
bidentate sulfonamide ligand. This cyclometalate can then coordinate the pyridine directing 
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group on the organic substrate. From this point, they propose that the pyridyl sections on 
the ligand can coordinate a palladium centre. Using their model, this palladium would then 
be proximal to the meta-C–H bond of 3-phenylpyridine. To this end, they propose that 
directed cyclometalation and C–H functionalisation affords the meta-alkenylated structure. 
In this same report, they looked to expand the scope of heteroaromatics to enable the 
remote C–H functionalisation of quinoline. They found that in this case, a drastically different 
scaffold was required to enable precise recognition of distance and geometry. They also 
found that preforming the template cyclometalate was more fruitful, therefore a variety of 
palladium bound templates were synthesised, with Pd2 being the most efficient. 
Unfortunately using catalytic quantities of this co-catalyst low conversion to product, 
however they found that using stoichiometric amounts of this cyclometalate they could 
access C5 alkenylation of quinoline derivatives (Scheme 1-19b). 
1.2.3: Transient Mediator 
  In 2009, Gaunt and co-workers disclosed the meta arylation of anilides. Here, they 
employed copper catalysis and hypervalent iodines as coupling partners (Scheme 1-20).54 
A mechanism was also proposed which builds on their work using a similar system in the 
C3 arylation of indoles.55 They suggest that a conjugate addition style carbocupration which 
causes dearomatisation, subsequent rearomatisation leaves the organocuprate in the meta 
position to the anilide directing group. This organometallic can then reductively eliminate to 
form the aryl-aryl bond in the product. This work was expanded to utilise α-aryl carbonyl 
compounds as structural motifs.56 
 
 
Scheme 1-20: Copper Catalysed Remote meta-Arylation of Anilides  
 18 
 
   The above report introduces the concept of the use of a transient mediator in meta-
selective C–H functionalisation. In this method of accessing remote C–H bonds, one utilises 
an ortho / ortho C–H functionalisation pathway, which gives the net meta-substituted 
products (Scheme 1-21). This methodology enables the insertion at the ortho position, 
which is labelled ‘X’ as this could be a metal centre or an organic structure (such as part of 
the directing group shown above). This insertion of ‘X’ then enables the C–H 
functionalisation of ‘Y’ at the ortho position. Again, this Y could be a metal centre or the 
coupling partner installed (Y = R). This can be seen to carried out with or without ‘X’ still in 
places at the ortho position. Finally, cross coupling chemistry allows the functionalisation of 




Scheme 1-21: Remote meta-Functionalisation via Transient Mediator Chemistry 
 
 Larrosa and co-workers described the use of the formal meta-selective arylation of 
arenes. Here they utilised the benzoic acid directing group neighbouring an ‘R’ group 
(Scheme 1-22). With respect to Scheme 1-11, the ‘X’ group is already furnished in place, 
then removed in situ. They carried out an ortho-C–H arylation of the acid and in situ 
protodecarboxylation to afford net meta-substituted arene.57 Larrosa expanded on this in a 
report applying similar methodology using salicylic acids as readily available feedstocks.58 
 
 
Scheme 1-22: Palladium-Catalysed meta-Arylation of Arenes 
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This concept has also been applied by Ackermann and co-workers, where they employ 
ruthenium-catalysed C–H alkenylation and hydroarylation reactions including an in situ 
decarboxylation to give meta-substituted arenes (Scheme 1-23).59 In the case of 
unsymmetrical alkynes used in the hydroarylation methodology the larger substituent is 
located at R4. In the hydroarylation work para-substituted benzoic acids were also employed 





Scheme 1-23: Ruthenium-Catalysed meta-Alkenylation and Hydroarylation of Arenes 
 
 The drawbacks of the chemistry discussed above is necessity of a pre-installed acid 
in your structure to direct C–H functionalisation and then protodecarboxylate. Larrosa and 
co-workers provided a follow up to their previous report exploring the use of in situ methods 
to install, use and then remove the directing group in a “traceless directing group” strategy.60 
They employ phenol as a substrate for investigation in the hope to override the innate ortho-
/para-directing nature of a phenol (Scheme 1-24). They showed that a one-pot process of 
ortho-carboxylation of phenol followed by a palladium-catalysed C–H arylation and 
subsequent decarboxylation gave the meta-arylated phenol. The reaction was shown to be 







Scheme 1-24: Relay Palladium-Catalysed meta-C–H Arylation of Phenols   
 
 In 2015, Wang and co-workers reported the meta-functionalisation of O-naphthyl 
carbamates applying methodology similar to that proposed to Gaunt (Scheme 1-25). Here 
they employ palladium catalysis to enable C–H arylation at the meta-position.61 Here they 
propose a carbopalladation taking place via an electrophilic palladium leaving a carbocation 








  Njardarson and co-workers reported the meta-C–H alkylation of catechol ethers in 
2016 by a careful study on dearomatisation, functionalisation and subsequent 
rearomatisation (Scheme 1-26).62 Initially they carry out oxidative dearomatisation using 
lead tetra-acetate. Pinacol is then added to sequester the remaining lead in the mixture and 
forces it out of solution, therefore a filtration allows a telescoped process to the alkyl 
addition. Radical alkylation then takes place in a 1,4-type addition to the intermediate 
enone. On addition of TFA rearomatisation gives the meta-substituted catechol. This 
methodology was shown to primarily restricted by the availability of different boronic ethers 




Scheme 1-26: Transition-Metal Free meta-C–H Alkylation of Catechols 
  
In 2015, Yu and co-workers reported one of the pioneering contributions to this 
method of meta-functionalisation.63 They took inspiration from one of the first ground-
breaking pieces of transition metal C–H activation chemistry, the Catellani reaction 
(Scheme 1-27).64 This methodology centres on the ability of cyclopalladated norbornene to 
‘walk’ from one M-C bond to the neighbouring C–H bond. In this catalytic cycle norbornene 
is then reproduced in the cycle to reform the arene-palladium bond. This renders the 
reaction catalytic in both palladium and norbornene. The power of norbornene in transition 






Scheme 1-27: Palladium Catalysed Catellani Reaction 
 
Yu applied this to the meta-functionalisation of phenylacetic amides.63 They 
demonstrated that both alkyl and aryl iodides were viable coupling partners enabling a wide 
scope of transformations (Scheme 1-28). With regards to mechanism they used directed 
cyclopalladation ortho to the acetamide directing group, which then allowed norbornene 
coordination and migratory insertion, to give the Catellani-type intermediate. This then 
enabled cyclopalladation in the meta C–H bond, and subsequent oxidative addition / 
reductive elimination gives the C–H functionalised intermediate. Instead of a further 
insertion (as in the Catellani) protodemetalation is suggested to take place to give the meta 
substituted structure. Even though the mechanism is catalytic in norbornene, they employ 






Scheme 1-28: Norbornene Mediated meta-Functionalisation of Phenylacetic Amides 
 
 Almost simultaneously with Yu’s report, Dong and co-workers demonstrated the 
meta arylation of benzylamine derivatives using the same norbornene strategy. Here they 
made use of a triphenylarsine ligand and what they refer to as an ‘acetate cocktail’ to enable 
selective meta-C–H functionalisation (Scheme 1-29).66 They also showed, like in Yu’s report 
above, that aryl iodides containing coordinating groups ortho to the C-I bond were the most 




Scheme 1-29: Palladium Catalysed meta-Arylation of Benzylamines using Norbornene Chemistry 
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Since these first examples of using norbornene in this kind of chemistry, multiple 
developments have been made by the Yu group in order to expand the scope of C-C and 
C-X bond forming reactions available and structural templates amenable to this reaction 
methodology. These developments are summarised in Scheme 1-30. In the first of these, 
they investigated modification of the norbornene additive to improve the scope of coupling 
partners and versatility of their initial meta-arylation and alkylation methodology discussed 
above. These developments enabled the use of alkyl iodide substrates with more delicate 
functionality and also allowed arylation with aryl iodides without an ortho-coordinating 
substituent (Scheme 1-30b).67 They then demonstrated the ligand-promoted meta-arylation 
of a vast array of aniline and phenol derivatives containing a multitude of different directing 
groups (in the interest of lack of generality and space this has not been included in Scheme 
1-30)68. This was followed with the meta-amination and alkynylation of aniline derivatives 
(Scheme 1-30c)69 and then the meta-chlorination of aniline derivatives (Scheme 1-30d).70 
They then reported the meta-arylation of nosyl protected phenethylamines, benzylamines, 
and 2-arylanilines. This was also the first demonstration of the use of catalytic norbornene 
in these kinds of transformations (Scheme 1-30e).71 In 2017, they also reported the meta-
arylation benzylamine derivatives,72 the meta-arylation of auxiliary-free phenylacetic acids 
(Scheme 1-30f),73 and the meta-arylation and alkylation of sulfonamide derivatives.74 
Amongst these contributions from Yu’s laboratory, other groups have also entered the 
field.75 Since the first report in 2015, there has been a continuous stream of publications 
using this concept and if there is a sustained influx of reaction systems this methodology 
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ABSTRACT: The search for selective C–H functionalisation has enabled some of the most 
elegant techniques in modern catalysis. Herein, we review the rapidly expanding field of 





The ability to transform inert C–H bonds into reactive functional groups has come to the 
forefront of modern synthetic developments in recent years. A range of elegant methods 
have been developed using a multitude of transition metal catalysts to enable the formation 
of a variety of C-X and C-C bonds.1-2 One of the major assets of C–H functionalisation is in 
the potential it holds for late stage functionalisation of bioactive structures in inter alia drug 
discovery.3 
 
The major challenge in C–H functionalisation is the ubiquity and similarity of many C–H 
bonds in a complex organic molecule vis-à-vis steric and electronic influences. To this end, 
the utilisation of a Lewis basic directing group has become commonplace in the C–H 
activation toolbox. Here a directing group (DG) coordinates a metal centre, which then 
facilitates C–H activation selectively in the ortho position to the directing group (Scheme 
1a). This reduces the thermodynamic cost of C–H activation and enables the specific 
activation of certain C–H bonds and, most importantly, with predictability. This 
cyclometalated species can subsequently enable coordination of a coupling partner and 
reductive elimination to give the C–H functionalised product and regenerate the metal 






Scheme 1: Directed C–H Functionalisation Methodology 
 
This has led to an influx of catalytic systems utilising a plethora of different Lewis basic 
directing groups, covered in depth in a recent review by Liu and Zhang.4 However, in order 
to access more remote C–H bonds in an arene (meta and para-selective C–H 
functionalisation)5-6 specialised techniques have been developed.7-8 In the arena of meta-
selective C–H functionalisation three primary techniques have been established. The first 
of these is the use of meticulously designed templated directing groups, pioneered by Yu 
(Scheme 2a).9-10 Here an organic linker “template” places a directing group proximal to the 
meta C–H bond. Traditional metal coordination, cyclometalation and functionalisation then 
occurs at the meta position. The second is the use of a transient mediator (Scheme 2b) 
where an ortho / ortho functionalisation pattern where the first insertion is then removed in 
situ.11-12 The final of these is ruthenium-catalysed σ-activation. σ-Activation benefits from 
the use of strong cyclometalated species as described in Scheme 1, however instead of 
partaking in standard oxidative addition / reductive elimination chemistry, it uses the 
cyclometalate to influence the ring electronically enabling para functionalisation to the metal 
centre. This ortho / para relationship gives a net meta-selective C–H functionalisation with 
respect to the directing group (Scheme 2c). This functionalization can only take place in an 
ortho / ortho fashion under sterically biased substrates, however the meta-substituted 




This tutorial review is based on the last of these techniques, and hopes to educate 
and excite readers about σ-activation, from its genesis at the stoichiometric organometallic 
level, the transfer to synthetically viable catalysis, and the possibilities available for the 
future of this chemistry in site-selective synthesis. 
 
 
Scheme 2: Techniques for meta-Selective C–H Functionalization 
 
II: Stoichiometric Work 
 
The concept of utilising a ruthenium metal centre in this kind of methodology was 
first investigated by Roper in 1994, where benzene and toluene complexes of ruthenium 
were shown to undergo nitration para to the ruthenium centre (Scheme 3).13 The reaction 
methodology was shown to give rise to multiple products based on the ruthenium core, 
however only the most relevant structure is shown. This shows that the location of the 
ruthenium centre was actively dictating the regioselectivity of C–H functionalisation via 
electronic influence on the aromatic ring. 
 
 




In 1998 Coudret reported that phenylpyridine complexes of ruthenium underwent 
electrophilic C–H halogenations at the para position to the metal-carbon σ-bond in 
impressive yields.14 In this case N-bromosuccinimide (NBS) and iodine were used as the 
halogenating agents (Scheme 4).  
 
 
Scheme 4: C–H Halogenation of Cyclometalated Ruthenium Complexes 
 
They then used these aryl halide structures in palladium catalysed cross coupling 
methodology. This was followed the subsequent year by the work carried out by Roper and 
Wright. Here they found, again, that cyclometalated phenylpyridine complexes of ruthenium 
(and osmium) underwent electrophilic aromatic substitution (SEAr) on the phenylpyridine 
ligand (Scheme 5).15 They showed that under nitration conditions that the di-nitrated 
substrate ortho and para to the metal centre was isolated in low yields (Scheme 4a). They 
also demonstrated that electrophilic bromination took place in much higher yields and with 





Scheme 5. Electrophilic Substitution of Cyclometalated Ruthenium Species 
These two products indicate that the selectivity has been dictated by the metal centre acting 
as a Friedel-Crafts type ortho / para directing group, through the Ru-C σ-bond. It is this 
activation through a σ-bond which has since given its name to this field of catalysis. 
 
III: From Organometallic to Catalytic 
 
This initial organometallic work and concept that σ-activation could be used as a tool in 
selective synthesis then lay dormant until 2011. In a report  on the ortho-C–H alkylation of 
ketimine derivatives using primary alkyl bromides as coupling partners, Ackermann 
disclosed meta-substituted by-products in yields up to 7% (Scheme 6). Whilst this was not 
ratified as σ-activation mechanistically at the time, it has been noted as the first example of 
this methodology reported in the literature.16 
 
 




 Later that year, Frost disclosed the first catalytic process to enable the selective 
ruthenium catalysed meta-sulfonation of phenylpyridine (Scheme 7a).17 Here yields of up 
to 80% were reported with no ortho-selective impurities which would take place via 
traditional pathways. The report also contained key information about the potential 
mechanism at play. The ortho-cyclometalated phenylpyridine species was synthesised and 
submitted to the reaction conditions enabling quantitative access to the meta-sulfonated 
product (Scheme 7b). This ruthenacycle was also shown to be a catalytically competent 
organometallic in the reaction methodology. These findings, along with the initial 
stoichiometric work led the authors to propose that the cyclometalated species could direct 
SEAr C–H sulfonation para to the metal centre giving the net meta-sulfonated 
phenylpyridine. This presented the first synthetically useful catalytic development in σ-









This was followed in 2013 with a report from Ackermann on the meta-alkylation of 
phenylpyridine.18 Moving on from his previous report (Scheme 6), here he established that 
employing secondary alkyl halides enabled solely meta-selective C–H functionalisation in 
synthetically useful yields (Scheme 8a). In this report, they detailed the vital use of the 
sterically demanding benzoic acid, 1,4,6-trimethyl (mesityl) benzoic acid (MesCO2H). The 
authors also present a much wider scope of this methodology, using pyrazole, pyrimidine, 
benzimidazole and imidazole directing groups. This methodology was also reported to 
proceed via a cyclometalation, σ-activation, SEAr-type pathway and a full plausible 
mechanism was proposed (Scheme 8b). They also observed complete racemization of a 
enantiomerically enriched coupling partner which reinforced up this electrophilic proposal. 
In a footnote, the authors did note that the interesting find that the addition of radical 




Scheme 8: Ruthenium Catalysed meta-Alkylation of Phenylpyridine using Secondary Alkyl 
Halides 
 
IV: The Radical Revolution 
 
The development of methodologies slowed as other classic electrophiles were 
explored with little success.19 It wasn’t until 2015 that a full alternative radical mechanism 
was proposed resulting in a flood of new methodologies to the area. The groups of Frost 
and Ackermann simultaneously reported the meta-selective alkylation using tertiary alkyl 
halides (Scheme 9a).20-21 Whilst the transformation itself was inherently iterative of the 
meta-alkylation methodology above, the two new reports contained game-changing insights 
into the mechanistic nature of the functionalisation. The two groups suggested that the 
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coupling partner interaction with the cyclometalated arene were through a radical addition 
rather than SEAr proposed beforehand (Scheme 9b).22  
 
 
Scheme 9: Ruthenium Catalysed meta-Alkylation of Phenylpyridine using Tertiary Alkyl 
Halides and Radical Proposal 
 
Frost evidenced this radical functionalisation using radical trapping experiments (TEMPO), 
by using coupling partners with a strongly disfavoured carbocation such as 1-
bromoadamantane and tertiary α-halo carbonyls, and also by the isolation and 
characterisation of polymeric by-products. Ackermann explored radical clock experiments, 
racemisation, and SEAr precursor studies. Between the two reports on the same 
transformation, one could argue there was now unequivocal proof of a radical 
functionalisation. Both of the mechanisms proposed suggest a dual role ruthenium which 
enables both the traditional cyclometalation but also as a redox catalyst (Scheme 10). This 
secondary role is capable of donating an electron to the coupling partner via single electron 
transfer (SET), facilitating homolytic cleavage, leaving the stabilised tertiary alkyl radical. 
This radical then interacts with the para position of the cyclometalate. Redox 
rearomatisation, proton abstraction and protodemetalation gives the meta-substituted 
product. Both groups did not specify the nature of this “Ru(II)” species, however kinetic 
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investigations by Ackermann suggest the reaction is second order in catalyst, suggesting a 
secondary outer sphere ruthenium species.23 
 
 
Scheme 10: Mechanism for meta-Alkylation of Phenylpyridine 
 
Later in 2015, both the Greaney and Huang groups proposed, again almost 
simultaneously, the meta-bromination of phenylpyridine derivatives.24-25 Greaney and 
Huang utilised tetrabutylammonium tribromide and N-bromosuccinimide as the bromine 
source respectively (Scheme 11). Huang suggested an SET process similar to those shown 
above. However, here involving a second C–H activation and with a defined inner sphere 
ruthenium catalyst generating bromine radicals. Despite the necessity for an air atmosphere 
(uncommon in σ-activation), this is not commented on with regards to the mechanism. Both 
reports made great use of the key benefit of installing aryl bromides, where subsequent 
palladium catalysed cross coupling enabled the formation of meta-arylated, borylated, 





Scheme 11: Ruthenium Catalysed meta-Bromination of Phenylpyridine 
 
Despite a C–H nitration reaction being the first example of stoichiometric ruthenium σ-
activation, it took until 2016 for ruthenium catalysed meta-selective C–H nitration to be 
developed.26 Here, Zhang employed [Ru3(CO)]12 as the ruthenium catalyst, as well as a 
silver salt (silver trifluoroacetate, AgTFA), oxidant (oxone), base (tetrabutylammonium 
acetate, NBu4OAc), and nitro source (copper nitrate trihydrate). Despite the cocktail of 
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reagents, this has enabled efficient and selective meta-nitration of an array of arenes 
(Scheme 12). Zhang also proposed a mechanism involving two C–H activated 
phenylpyridine structures. In this instance this bi-pyridyl complex was isolated from the 
mixture, characterised via single crystal x-ray diffraction and proven to be catalytically 
competent in the reaction mixture. They also propose a dual copper/silver oxidation 
cascade which enables the formation of the nitro radical. The meta-nitrated arenes were 









Following these mechanistic insights, Frost also reported a revised radical 
mechanism in 2016 for the initial meta-sulfonation methodology. This was proposed to 
undergo a similar mechanism where SET enables formation of the tosyl radical, after similar 
mechanistic results were discovered with that methodology.27 
 
V: Recent Advances 
 
The mechanistic foundations had now been set for σ-activation methodology, and 
these insights inspired a catalogue of different applications building on the established 
transformations. The following part of this review is split into three subsections entailing the 
expansion of this technique: structural template expansion, new C-X bond formations, and 
catalyst development.  
 
V.I: Structural Template Expansion 
 
One of the key drawbacks in σ-activation, which the reader may have identified, is 
the over reliance on phenylpyridine. Despite being an excellent model substrate employed 
by multiple groups, phenylpyridine has limited biological activity and limited scope for further 
derivation. To expand the scope of this synthetic technique, an auxiliary approach can be 
used. Here one can furnish a motif with a directing group, carry out the remote 
functionalisation, and then cleave the directing group to reveal the more useful functionality. 
 
This technique was first employed by Ackermann in his 2015 tertiary alkylation 
report. Here they use N-pyrimidinyl aniline as a model substrate in the meta-alkylation 
methodology (Scheme 13a).21 After acidic cleavage of this directing group in aqueous 
media, this now led to the meta-functionalised aniline. It should be noted that the 
regioselectivity of functionalisation is complementary to the natural ortho / para directing 
selectivity of an aniline. The same group also expanded on this in a recent report using 
ketimine directing groups, which when treated with aqueous acid after functionalisation, 
reveals the acetophenone (Scheme 13b).28 They reported a vast scope of 40 examples of 
different structures utilising both secondary and tertiary alkyl halide coupling partners. They 
also demonstrated a vast array of post-synthetic modifications of the ketimine group to give 
anilines, phenols, indoles and benzylamines, as well as in situ ortho-C–H functionalisation 
to give di-substituted arenes.  
 
 




Scheme 13: Use of Cleavable Auxiliaries in meta- Selective C–H Functionalisation. TMP = 
3,4,5-trimethoxyphenyl. X = Cl, Br or I 
 
Following a similar concept of creating the meta substituted aniline building block, Li has 
reported the meta-alkylation and sulfonation of diazobenzenes (Scheme 14a).29-30 Both 
methodologies were shown to be selective for functionalisation on only one of the aryl rings 
and using catalytic iron powder in acetic acid, the diazo could be transformed into the free 
aniline. The same group have also demonstrated the meta-alkylation of phenol furnished 
with a pyridine directing group (Scheme 14b). This can subsequently be removed under 




Scheme 14: Ruthenium Catalysed meta-Functionalisation of Aniline and Phenol Auxiliaries 
 
C–H activation is a powerful tool that can be employed to derivatise biologically 
relevant structures32 such as indoles. Frost reported the remote C–H alkylation of indole 
derivatives in 2017 (Scheme 15).33 The difficulty of selectively accessing the benzenoid ring 
(C4-7) of an indole has been highlighted in a recent review.34 This functionalisation was 
shown to utilise a primary directing group at N1 and an ancillary directing group at C3 to 
enable remote C6 alkylation on the benzenoid ring. This methodology also benefited from 
the first input from computational chemistry in σ-activation, where calculated Fukui indices 
on organic and inorganic structures helped elucidate that cyclometalation at C2 would in 




Scheme 15: Remote C6-Selective Ruthenium Catalysed C–H Alkylation of Indole 
Derivatives 
 
As a follow up to their work on the meta-nitration of phenylpyridines (and related 
heteroaromatics), Zhang reported a further iteration of this methodology in 2017.35 Here, 
they focused on the use of the oxime directing group as a removal auxiliary. In this process, 
they also reported a variation on their catalytic system to utilise silver nitrate as the nitro 
source and O2 as a co-oxidant (Scheme 16).  
 
 




V.II: New C-X Bond Formations 
 
One of the other avenues which is necessary to develop σ-activation is the search 
for new C-X or C-C bond formation reactions to expand the arsenal of transformations 
available. In early 2017, both Ackermann and Wang reported the meta-selective C–H 
difluoroalkylation and monofluoroalkylation of heteroarenes (Scheme 17).36-37 Ackermann 
proposed a triarylphosphine additive as a co-catalyst, along with a wide scope of arenes, 
directed by pyridine, pyrimidine, pyrazole, and purine directing groups (Scheme 17a). A 
radical process was also suggested although the exact role of the nature of phosphine in 
the mechanism was not presented. Despite this, they did demonstrate both carboxylic acid 
(MesCO2H) and phosphine co-catalysts were vital to catalysis. Wang’s report employs a 
palladium(0) co-catalyst (Pd(PPh3)4) in the same transformation. They propose a 
Pd(0)/Pd(I) redox cycle for the generation of the difluoroalkyl radicals (Scheme 17b). Zhao 
has also since proposed a ruthenium catalysed meta-difluoroalkylation of similar substrates 
with an alternative additive of silver triflimide (AgNTf2) and, surprisingly, in many cases 
without an additive at all.38 
 
 




 Since Ackermann’s first observation of a meta-C–H alkylation using primary alkyl 
halides in small quantities, σ-activation methodology has utilised secondary and tertiary 
alkyl halides much more frequently as they are less likely to undergo tradition oxidative 
addition / reductive elimination pathways. In 2017, Frost reported the meta-alkylation of 
phenylpyridine derivatives utilising primary α-halocarbonyls. They found that similar co-
catalysts as above (triarylphosphines and Pd(PPh3)4) drive the reaction towards meta-
selectivity over competing ortho-selectivity (Scheme 18). A majority of the examples led to 




Scheme 18: Ruthenium Catalysed Alkylation of Phenylpyridine with Primary Alkyl Halides 
 
 In early 2017, Shi and Zhao reported the meta-benzylation of phenylpyridine.40 This 
was achieved using RuCl3 as the ruthenium source, ferrocene and ditertbutyl peroxide 
(DTBP) in radical generation, toluenes as benzyl precursors, and a binol derived phosphate 
ligand (L1, Scheme 19a). The use of bulky phosphate was shown to suppress competing 
ortho-functionalisation. Through in-depth investigation into the role of the additives they 
proposed a mechanism (Scheme 19b), they proposed the formation of a di-phenylpyridine 
structure similar to that reported by Zhang,26 however with the bulky phosphate ligand 
bound. They then suggest that through SET from ferrocene and hydrogen abstraction from 
DTBP give the tolyl radical. This radical then interacts with the cyclometalated 
phenylpyridine at the para position to the metal, redox rearomatisation with Fe(III) and 
proton abstraction, and finally protodemetalation gives the meta-benzylated substrate.41 
The methodologies described in this subsection not only permit the introduction of different 
C-C bonds but also allow the use of varying redox active metals, such as iron and silver, 
and more importantly show they are compatible with the σ-activation system. These 










V.III: Catalyst Development 
 
As shown throughout this tutorial review, catalytic σ-activation relies on the use of 
the platinum-group transition metal, ruthenium. The use of high loadings (<30 mol% Ru by 
weight) is also a common feature of many processes. Due to this there will be should be a 
focus in the coming years on performing these methodologies in a more sustainable 
manner.  
 In early 2017, Ackermann was the first (and to date, only) to tackle this problem.42 
Here they adapted the meta-bromination methodology developed by Huang and set out to 
investigate the use of a recyclable heterogeneous ruthenium catalyst (Scheme 20). They 
showed that the use of a user-friendly silica-derived catalysts Ru@SiO2 outperformed its 
homogeneous counterparts. The substrate of focus of this report also demonstrated the first 
use of a purine directing in σ-activation methodology. The catalyst was shown to be 
amenable to recycling, and was used as many as seven times with an impressive yield drop 
of less than 20%. 
 
 




Ruthenium catalysed σ-activation has been shown as a key tool in accessing remote 
meta-selective functionalisation, moving from an organometallic to catalytic synthetic 
methodology. We have seen the radical revolution which has enabled the development of 
many new methodologies seen post-2015 in this field. We have seen that either sterically 
crowded coupling partners or ligand sets have suppressed traditional ortho-functionalization 
pathways and promoted complementary meta-functionalization. These insights will only 
lead to a stronger influx of reports in this field.  As there have already been as many 
methodologies published in 2017 as the previous six years combined, the stage is now set 
for ruthenium-catalyzed σ-activation to move from proof of concept research to a broadly 
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applicable methodology in the synthetic toolbox. We now stare into the horizon of ruthenium 
catalysed σ-activation where we expect to see the continuing rapid expansion in scaffolds, 
new C-C/C-X bond forming processes and well-defined bespoke catalysts. These will no 
doubt be applied in the late stage functionalization of biologically relevant molecules, in drug 
development, and in the creation of novel building blocks.  
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1.3: para: Beyond meta-Selectivity 
 
The search for para-selective C–H functionalisation methodology has received a 
smaller influx of generality in their reaction systems cf. meta-selectivity. This is as the C–H 
bond lies even more remote from any functionality that can impart selectivity of 
functionalisation. This has led to these methodologies focusing less on the use of Lewis 
basic directing groups and more on utilising steric and electronic influences in direct C–H 
functionalisation.76 Despite this, there have been methods that utilise the directing group 
strategies using expansions of the template chemistry above. 
 
1.3.1: Template-Assisted para-C–H Functionalisation 
 
 In 2015, Maiti reported the development of a template that via appreciation of 
geometry and distance, they enabled selective para-C–H alkenylation reaction 
methodology (Scheme 1-31a).77 They proposed that the template made use of the Thorpe-
Ingold effect, and a longer chain length to enact selectivity for the para position over the 
ortho and meta positions. Despite this, regioselectivity of functionalisation were found to be 
between 5:1 and 20:1 for para:others. The same report also reported the para-acetoxylation 
of the same templated structure. As with the template chemistry discussed previously, the 
ability to remove and recover these templates is a vital concept to recover atom economy 
of this transformation. On treatment of the silyl linker with TBAF, the Si-Cbenzyl bond is 
cleaved to leave access to the para-substituted toluene in excellent yields and with near 
quantitative recovery of the Si-O cleaved phenol derivative which can be used to reform the 







Scheme 1-31: para-C–H Functionalisation of Toluene Derivatives via Template Assistance 
 
 In 2016, the same group proposed the template-assisted para-C–H alkenylation of 
phenol derivatives (Scheme 1-32).78 This methodology was realised via a switch in atom 
connectivity with their previous report.77 They then demonstrated cleavage of this template 
using p-TSA which produced the para-substituted phenol and the silanol-based template 






Scheme 1-32: para-C–H Alkenylation of Phenol Derivatives via Template Assistance 
 
 As discussed above, the use of catalytic non-covalent templates can be an 
incredibly powerful methodology in template-assisted remote C–H functionalisation. In 
2017, Chattopadhyay reported the iridium catalysed para-C–H borylation of benzoates 
using a salt / Lewis basic chelate-type model to enact para-selectivity (Scheme 1-33).79 This 
chemistry enabled highly selective C–H borylation with regioselectivities ranging from 9:1 
to 99:1 with most results considerably higher than 20:1. They proposed this mechanism 
based on insights of using the preformed potassium alkoxide (OK) salt and comparing it to 
the OMe substituted ligand (cannot form the non-covalent interaction). Here, high 
conversions were observed in both cases however the salt gave selectivity of para:meta of 






Scheme 1-33: Iridium Catalysed para-C–H Borylation of Benzoates using a Salt-Templated Non-
Covalent Interaction 
 
1.3.2: Sterics-Induced para-C–H Functionalisation 
 
 The use of sterics to influence the regioselectivity of C–H functionalisation tends to 
rely on pre-existing sterically demanding functionality, especially in the case of para-C–H 
functionalisation where the site of potential reactivity lies distal from those steric influences, 
which could lead to major regioselectivity issues.80-81 
This has combatted in two ways in recent years, the first reported by Itami where 
the steric influence is enacted by the ligand on the metal (Figure 1-1), and the second 
pioneered by Nakao by using bulky Lewis acids to enable selective direct C–H 
functionalisation at the para position. 
 
 
Figure 1-1: Techniques for Sterics-Induced para-Selective C–H Functionalisation 
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 In 2015, Itami and co-workers reported the iridium catalysed para-C–H borylation of 
alkylbenzene and silylbenzene derivatives (Scheme 1-34).82 Here they utilised an incredibly 
sterically demanding bidentate phosphine ligand (L8) to disfavour competing meta-
functionalisation. This concept has also been studied computationally in modelling reactivity 




Scheme 1-34: Iridium Catalysed para-C–H Borylation using a Bulky Iridium Catalyst 
 
 After preliminary work on the selective C4-alkylation of pyridines using a bulky 
aluminium Lewis acid to enable site selective C4-metalation and functionalisation,84 the 
Nakao group looked to apply this concept to the para-C–H functionalisation of arenes. Here 
they employed a dual aluminium / nickel system to enable the para-C–H alkylation of 
benzamides and aromatic ketones (Scheme 1-35).85 The demonstrated that coordination of 
the carbonyl to a bulky Lewis acidic aluminium centre, coupled with a bulky nickel system 
enabled steric clash between the two, leading to selective para-selective C–H 
functionalisation.  Following this the same group then reported the use of sulfones as 
substrates for the same reaction methodology.86 
  
In 2017, the Nakao group coupled this chemistry to an iridium C–H borylation system 
to produce the para-C–H borylation of benzamides (Scheme 1-36).87 Here they employed 
the same aluminium centre (Al1), however this time with an iridium precatalyst and bipyridyl 
based ligand. This concept led to a wide scope of para-borylation reactions, and it was also 

















1.3.3: Electronics-Defined para-C–H Functionalisation 
 
 A majority of the examples of para-C–H functionalisation to this date have 
electronics to thank for the selectivity dictated in the reaction methodology. Here, 
substituents which place electron density on the para position of an arene can enable 
interaction with electrophilic metal centres or substrates. With regards to modern transition 
metal catalysis, the first example of selective para-C–H functionalisation came from the 
Gaunt group in 2011. They adapted the reaction systems they’d developed for the copper 
catalysed C–H arylation of indoles55 (and subsequently the meta-arylation of acetanilides)56 
to electron rich aromatics such as anisoles, anilines, and steroid derivatives (Scheme 1-
37).88 Selectivity issues were only shown to take place in arenes with one or more electron 
rich substituent (such as 2-methylanisole). Interestingly, they also demonstrated that, 




Scheme 1-37: Copper Catalysed para-C–H Arylation of Electron Rich Arenes 
 
 In 2011, Yu and co-workers reported the para-selective C–H arylation of mono-
substituted arenes using palladium catalysis. They demonstrated that oxidative C–H/C–H 
cross coupling could take place between benzamides and para-directing arenes (alkyl, 
alkoxy and halo-substituted arenes) in great para selectivity (Scheme 1-38a).89 In the same 
year, Cheng and co-workers also reported the ortho-arylation of N-methoxybenzamides 
where coupling partner functionalisation took place para to the directing functionality with 
no regioselectivity issues. They also showed that the benzamide then forms an in situ N-





Scheme 1-38: Palladium Catalysed para Oxidative C–H Functionalisation of para-Directing Arenes 
 
 In 2012, Lloyd-Jones and Russell reported the gold-catalysed direct cross coupling 
between aryl silanes and electron rich arenes. They demonstrated that substrates such as 
anisole can be coupled at the para C–H bond to the alkoxy substituent. (Scheme 1-39).91 
The reaction was shown to be most efficient using 1,2-substitued arenes, and selectivity 
issues were only sparingly observed. A supplementary in depth kinetic and computational 




Scheme 1-39: Gold Catalysed para-C–H Arylation of Electron Rich Arenes 
 
 In 2013, Ackermann and co-workers demonstrated that under ruthenium catalysis, 
anisoles can be oxygenated at the para position with complete selectivity. Brief mechanistic 
studies detailed that radical scavengers such as TEMPO reduced reaction efficacy, 
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suggesting a single electron oxidation mechanism however a full catalytic cycle was not 




Scheme 1-40: Ruthenium Catalysed para-C–H Oxygenation of Anisoles 
 
 In 2015, Nicewicz reported a pioneering study in remote C–H functionalisation on 
the para-selective amination of electron rich arenes using photoredox catalysis. (Scheme 
1-41a).94 Here they employed an organic acridinium photocatalyst (PC1) and catalytic 
TEMPO in an oxygen atmosphere to facilitate the coupling of anisole and pyrazole. As with 
previous methodologies, regioselectivity issues with the ortho position were observed 
throughout (with exception). They also reported the late stage functionalisation of 
representative drug-like structures and investigated the use of ammonia equivalents to 




Scheme 1-41: Photoredox Catalysed para-C–H Amination of Electron Rich Arenes 
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 In 2016, Ritter and co-workers disclosed the para-C–H amination using dual 
palladium and ruthenium catalysis. They used selectfluor as the aminating source which 
they demonstrated could be interconverted to the piperazine motif in aqueous sodium 
bisulfite. (Scheme 1-42).95 They proposed that the selectivity was dictated by a “Charge-
Transfer Radical Addition” where transition state interactions between the SOMO of the 
coupling partner and the LUMO of the arene enable electron shuttling.96-97 They 
demonstrated that the greater electron affinity of the coupling partner (more positive), the 
higher selectivity of functionalisation. This was rationalised as the higher electron affinity, 
the more readily the coupling partner will accept an electron from the arene to enable the 
charge transfer complex, responsible for selective C–H functionalisation. The selectivity of 
different substrates was also predicted and then experimentally validated by the use of 




Scheme 1-42: Palladium / Ruthenium Catalysed para-C–H Amination of Electron Rich Arenes  
 
 In 2015, Suna and co-workers proposed the para-C–H amination of electron rich 
arenes. This was achieved by an electrophilic para-iodonation with a hypervalent iodine 
source, followed by a one-pot copper catalysed amination to give the para-aminated product 
(Scheme 1-43).98 In 2016, this same methodology was applied to copper catalysed C-O 





Scheme 1-43: Copper Catalysed para-C–H Amination of Electron Rich Arenes via Electrophilic 
Iodonation 
  
Zhang and co-workers reported the gold catalysed para-C–H alkylation of electron 
rich arenes using activated diazo compounds as alkyl surrogates (Scheme 1-44).100 This 
chemistry was demonstrated to be incredibly high yielding in as little as 3 minutes of reaction 
time. They also applied the reaction system to the late stage modification of biologically 
relevant steroid and menthol derivatives.  
 
 
Scheme 1-44: Gold Catalysed para-C–H Alkylation of Electron Rich Arenes 
 
 In 2017 Ye demonstrated that using a palladium/NFSI system, one could access 
para-C–H arylation of simple arenes using aryl boronic acids. They disclosed that the use 
of dimethylformamide (DMF) as a ligand was critical to reactivity at the para-position 
(Scheme 1-45).101 Like the gold catalysed para-C–H arylation proposed by Lloyd-Jones and 








Scheme 1-45: Palladium Catalysed para-C–H Arylation of Arenes 
 
 Deng and co-workers reported the para-C–H acylation of aniline derivatives utilising 
copper redox catalysis (Scheme 1-46a).102 They proposed that on removing a proton (via a 
CuII species generated in situ) and an electron from an aniline, one can access a highly 
activated anilino radical which can then couple to an enol (Scheme 1-46b). Single electron 
oxidation (using another equivalent of CuII) and loss of a proton then enables formation of 
the ketone. They then suggest that oxidation of the benzylic position using the copper 
enables formation of the 1,2-diketone structure. The oxygen is also proposed to 




Scheme 1-46: Copper Catalysed para-C–H Acylation of Anilines 
 
 The aminoquinoline directing group (also known as ‘Q’ or ‘AQ’) has become a widely 
used directing group in C–H functionalisation methodology.103 It can form an incredibly 
stable tridentate cyclometalate it can form with a metal centre, which has led to its use in 






Figure 1-2: The 8-Aminoquinoline Directing Group in C–H Functionalisation 
 
The cyclometalate above is most often formed and therefore enables C–H functionalisation 
of C(sp2)/C(sp3)-H bonds on a structure. However, if C–H activation does not take place (or 
even in small amounts in an equilibrium) competing functionalisation can take place on the 
aminoquinoline directing group itself. This has almost exclusively been shown to take place 
at the 5-position (Figure 1-2), which is the para position the amine. 
  
 The first attempt to render this a catalytic process in its own right, was achieved in 
2015 by Wei, where the copper catalysed C5-sulfonation of aminoquinoline derivatives was 
reported (Scheme 1-47).104 The same transformation using similar systems was then 
published later that year by Yang, Wu, and Wu,105 and in 2016 by Lin and Zheng,106 Xia and 




Scheme 1-47: Copper Catalysed C5-Sulfonation of 8-Aminoquinoline Derivatives 
 
 This concept was adapted via Manolikakes and co-workers in 2017, where the 
quinoline section (green, Scheme 1-48) of the structure was swapped with the aryl section 
(blue).110 This then enabled a benzoylquinoline auxiliary to be furnished to an aniline 
structure, which could then enable para-C–H sulfonation in the same manner to above. 







Scheme 1-48: Copper Catalysed para-C–H Sulfonation of Aniline Derivatives 
 
 This concept was also taken on by Weng and Lu, who instead of swapping the whole 
structure around, moved the basic nitrogen to the arene, creating a pyridine and a 
naphthalene (Scheme 1-49).111 They then applied this structure to a copper catalysed para-
C–H sulfonation reaction as a model, however in the report, they also show unoptimised 
conditions for the para-acetoxylation, halogenation, tifluoromethylation and amidation of the 
aminonaphthalene derivatives. More detail on the mechanism of this transformation will be 
given in Chapter 4. 
 
 




1.4: Aims and Objectives 
 
  At the outset of the following research, the major aims were to develop techniques 
which can enable the control of site selectivity in C–H functionalisation, with a large focus 
on the manipulation of ruthenium catalysis to enable this chemistry.  To this end, this thesis 
will be split into three distinct chapters which will focus on the regioselectivity of the C–H 




 We planned to expand the ongoing project in our group on the synthesis and 
modification of biologically relevant heterocycles. This was to be done on using these 
heterocycles as weakly coordinating directing groups in C–H functionalisation. 
 
 We also planned to investigate and develop further our previous efforts into 
ruthenium catalysed σ-activation methodology.  This was to be done with a primary focus 
to expand the structural template scope away from privileged motifs such as phenylpyridine, 
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Chapter 2: ortho - The Use of Biologically Relevant Directing Groups in 







2.1: Chapter Introduction - Ruthenium-Catalysed ortho-C–H Alkenylation Reactions 
via Weak Assistance 
 
 The ortho-C–H alkenylation of an aromatic compound has been well documented 
with a wide number of weakly coordinating directing groups since Miura and co-workers 
reported the C–H alkenylation of benzothiophenes, indoles and benzofurans (Scheme 2-
1).1 This was reported to take place through chelation assisted cycloruthenation aided by 
the acetate additive. Following this alkene coordination, migratory insertion and β-hydride 
elimination afford the C–H alkenylated motif. Copper acetate is then used to re-oxidise the 
Ru(0) to Ru(II) to re-enter the cycle. The C–H alkenylated structures were isolated as the 




Scheme 2-1: Ruthenium-catalysed ortho-alkenylations of arenes  
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Since then, the methodology has been expanded primarily by the Jeganmohan and 
Ackermann groups to include benzoic acids,2 ketones,3 aldehydes,4 esters,5 anilides,6 and 
carbamates.7 (Scheme 2-2). Benzoic acids were shown to carry out an in situ intramolecular 








The use of weakly coordinating groups in C–H functionalisation is becoming more and more 
well established and a multitude of techniques are now available to use oxygen directing 
groups in C-X and C-C bond forming reactions.8 The ability to use these weakly coordinating 
directing groups is attractive as these functional groups are ubiquitous in organic molecules, 
unlike strongly coordinating directing groups.9 These groups often possess potential for 
quick and simple further derivation as well (Figure 2-1).10 The research described in this 
first chapter is based around the concept of using weakly coordinating directing groups with 
intrinsic biological relevance, not just a common functional group nor a tool for further 
derivation. This C–H alkenylation reaction was used as a model proof of concept of 
cycloruthenation and potential C–H functionalisation. Two families of biologically relevant 
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2.2: Ruthenium(II)-Catalyzed C–H Functionalization Using the Oxazolidinone 
Heterocycle as a Weakly Coordinating Directing Group: Experimental and 
Computational Insights 
 
2.2.1: Introduction and Commentary 
 
The oxazolidinones heterocycle is classically derived from amino alcohols (which in 
turn are derived from their corresponding amino acids) and a carbonyl equivalent. This has 
been shown to be introduced using diethyl carbonate, carbonyl diimidazole (CDI) and 
phosgene (Scheme). A bulk of the methods to produce N-aryloxazolidinones involve the 





Scheme 2-3: Streamlined synthesis of N-aryloxazolidinones 
 
A multitude of methods have been developed for this cross coupling, primarily using copper 
and palladium chemistry, a select few are displayed below (Scheme 2-4).1 There is also 
literature precedent to access the N-aryloxazolidinone structure from the commercially 
available N-phenylethanolamine using phosgene,2 through a carboxylation and in situ 









Scheme 2-5: Synthesis of N-aryloxazolidinones 
 
 The Frost group has been interested in the oxazolidinone heterocycle for a number 
of years. Due to this,  expedient in–house methods for their synthesis have been developed, 
with emphasis on the ability create diverse oxazolidinones quickly and efficiently (Scheme 
2-6).5 A one-pot cyclisation-arylation methodology was reported in 2014, where the 
synthesis of decorated oxazolidinones was developed from readily available starting 
materials. This method has also been employed as the key step in the synthesis of three 







Scheme 2-6: Copper-catalysed one-pot cyclisation-arylation synthesis of N-aryloxazolidinones 
 
The modification of N-aryloxazolidinones could provide a novel route into new 
biologically active molecules. The post-synthetic modification of biologically interesting 
compounds can be a vital tool to access untapped chemical space. This could lead to 
improved activity against wild or resistant strains, or hold a completely different biological 
activity. The Frost group has used this concept and developed a method to synthesise 2-
thiazolidinones from oxazolidinones (Scheme 2-7).7 The use of Lawesson’s reagent creates 
the oxazolidinthione which then undergoes a pseudo-reversible Barton-McCombie type 
rearrangement to incorporate sulphur into the ring. This reaction was deduced to function 
via a radical mechanism through investigations into scrambling of enantiomeric purity and 




Scheme 2-7: Ruthenium-catalysed oxazolidinthione rearrangement 
 
 As mentioned previously C–H functionalisation is a powerful tool in the modification 
of arenes. The N-aryloxazolidinone motif has been subject to some investigation into its use 
as a C–H functionalisation template. In 2015, Suna and co-workers reported the para-C–H 






Scheme 2-8: Copper catalysed C–H amination of N-aryloxazolidinones 
 
They achieved this by electronically installing the iodonium para- to the electron donating 
group and then using an in situ Ullman coupling to afford the para-C–H aminated product. 
They applied this methodology to the synthesis of linezolid using the oxazolidinone as the 
electron donating group. 
  
As the N-aryloxazolidinone structure bears a Lewis basic site neighbouring an sp2 
carbon hydrogen bond, one could envisage the heterocycle could be utilised as a directing 
group in chelation assisted C–H functionalisation. This was first realised by Sanford utilising 
hypervalent iodine salts as the coupling partner (Scheme 2-9).9 This methodology was 
expanded by Dong and co-workers to introduce cross dehydrogenative coupling of arenes 





Scheme 2-9: Palladium-Catalysed ortho-arylation of N-aryloxazolidinones  
 
The aim of the following project was to utilise ruthenium catalysis in the derivation of 
biologically relevant motifs using the oxazolidinone heterocycle as a weakly coordinating 
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ABSTRACT: Herein reports the ruthenium-catalyzed ortho-C–H alkenylation of a wide 
range of N-aryloxazolidinone scaffolds. Alkenylation was achieved with complete mono-
selectivity with a scope of 27 examples in 2-MeTHF. Yields ranged from 23-94% creating 
highly decorated oxazolidinone scaffolds. A kinetically relevant C–H cleavage was also 
observed with a KIE ~ 2. DFT calculations elucidated information on mechanism, detailing 
the β-hydride elimination as the most energetically challenging step of +13.5 kcalmol-1. In-
depth computational kinetic studies also predicted a KIE of 2.17 for C–H cleavage and an 




The oxazolidinone heterocycle is prevalent in pharmaceutically active compounds 
with widespread bioactivity for example Linezolid1, Tedizolid2 (antibacterial, Figure 1), 
Rivaroxaban3 (anti-coagulant) and Toloxatone4 (antidepressant). For these reasons the 
synthesis of these heterocycles and their modification has received great attention in recent 
years.5 These biologically active structures contain the oxazolidinone heterocycle 
neighboring an aromatic ring. This makes these structures prime for investigation as 





Figure 1: Pharmacologically active compounds containing the oxazolidinone heterocycle.   
 
Transition metal catalyzed C–H functionalization has become a vital synthetic tool 
to facilitate the formation of useful C-C and C-X bonds.6 This methodology transforms latent 
C–H bonds into potentially reactive functional groups. Harnessing this concept to allow 
derivatization of biologically active compounds such as the oxazolidinones is a very 
attractive strategy to enable the synthesis of drug analogues through expedient late-stage 
modification.7 
 
Ruthenium catalyzed C–H bond functionalization has seen widespread application 
into the modern synthetic world due to pioneering developments from Oi and Inoue, 
Ackermann, and Bruneau and Dixneuf8. Methodology has evolved rapidly to utilize weakly 
coordinating carbonyl directing groups to install diverse functionality.9 This functionality is 
often ubiquitous in chemical structures; however, if necessary, an auxiliary approach can 
be used which involves separate installation and removal steps.9k The presented study is 
focused on the utility of directing groups with intrinsic biological activity and how they 
facilitate C–H insertion via chelation assistance (Scheme 1). Despite early work reporting 
palladium catalyzed ortho-arylation of the 3-aryl-2-oxazolidinone structure, the motif has not 
been widely used as a directing group and there have been no such examples employing 




Scheme 1: Ruthenium Catalyzed Alkenylation of Arenes 
 
 
RESULTS & DISCUSSION 
 
Optimization 
The envisioned reaction methodology was probed using 3-phenyl-2-oxazolidinone 
(1a) and ethyl acrylate (2a). The electron deficient nature of acrylates has shown them to 
be excellent coupling partners in ruthenium, palladium and rhodium catalyzed C–H 
functionalization reactions.9a,11 A summary of the optimization is displayed in Table 1. 
 
Starting conditions were obtained from literature precedent for the use of ruthenium, 
silver and copper in cooperative catalysis for similar transformations (full optimization 
information is available in the supporting information).9f,h,i,k  Alkenylation was observed in 
DCE in low conversions (entry 1). Much more substantial formation of product was observed 
with higher boiling polar aprotic etheric solvents (1,4-dioxane, DME and 2-MeTHF, entries 
2-4). A 2-MeTHF/AcOH mixture was interestingly shown to completely nullify reactivity 
(entry 5) as AcOH is a proposed by-product in the reaction. 2-MeTHF was carried forward 
as solvent as choice as is a more sustainably sourced alternative to DME.12 Multiple silver(I) 
oxidants were investigated with none showing superior activity to Cu(OAc)2 (entries 6-9). 
However, the monO–Hydrate complex was not only tolerated but shown to accelerate 
catalysis (entry 10). Only oxidants containing carboxylate counter ions promoted the 
reaction. This is in line with literature precedent for a concerted metalation-deprotonation 





















aGeneral Reaction Conditions: 1a – 1 mmol, 2a – 3 mmol, [RuCl2(p-cymene)] (2.5 mol%), AgSbF6 (20 mol%), 
Solvent (4 mL). b 1H NMR conversion. cIsolated Yields after purification. dAgOAc (2 eq). eWithout [RuCl2(p-
cymene)]2. fWithout AgSbF6. gReaction performed at 100 °C hAgSbF6 (10 mol%). iSolvent (1 mL) 
   
It must be noted that reaction efficacy was not maintained in the absence of either ruthenium 
catalyst or silver co-catalyst (entries 11-12), however it was possible to decrease silver co-
catalyst loading without detriment to the reaction (entry 14). Finally, the reaction was shown 
to proceed with equal if not superior reactivity at higher concentration and proceeding with 
excellent catalytic efficiency under air (entry 15). Here oxygen in the atmosphere aids 
oxidant recycling.8a Also noteworthy was that throughout this optimization there was no 
observation of o-,o-di-alkenylated product either by NMR or TLC. This high level of 
selectivity is an attractive feature.6b, 8a 
 
Entry Solvent Oxidant 3ab 
1 DCE Cu(OAc)2 15 
2 1,4-dioxane Cu(OAc)2 56 
3 DME Cu(OAc)2 72 (68)c 
4 2-MeTHF Cu(OAc)2 70 (67)c 
5 2-MeTHF/AcOH 3:1 Cu(OAc)2 - 
6 2-MeTHF Ag2CO3 13 
7 2-MeTHF AgOAc 48 
8 2-MeTHF AgOAcd 64 
9 2-MeTHF AgO2CCF3 Trace 
10 2-MeTHF Cu(OAc)2·H2O 77 
11e 2-MeTHF Cu(OAc)2·H2O - 
12f 2-MeTHF Cu(OAc)2·H2O - 
13g 2-MeTHF Cu(OAc)2·H2O 68 
14h 2-MeTHF Cu(OAc)2·H2O 78 




With optimized conditions in hand, 3-phenyl-2-oxazolidinone (1a) was reacted with 
a variety of electron deficient and electron rich alkenes to explore the scope of this catalytic 
transformation (Scheme 2). 
 
Scheme 2: Acrylate Scope of Oxazolidinone Directed C–H Alkenylation 
 
 
Excellent catalytic activity was maintained using methyl, n-butyl and benzyl acrylates 
showing yields up to 94%. Unfortunately the reaction did not proceed with other electron 
deficient alkenes and electron rich alkenes due to lack of reactivity or high volatility of 
substrates in open atmosphere (see supporting information). Despite this, similar structures 
can be accessed from 3a-d through functional group interconversions. The use of methyl 
acrylate enabled more facile purification via standard chromatographic methods (cf. benzyl) 
as well as superior isolated yields (cf. ethyl). Due to this, methyl acrylate was carried forward 
as the acrylate of choice for expansion of the scope with aryl oxazolidinones (Scheme 3). 
 
The reaction was shown to tolerate a wide variety of functionality on the aryl ring 
including fluoro-, chloro-, bromo-, alkoxy-, aryl, and alkyl. Highest yields were achieved 
using electron rich substituents (3ab, 3ac, 3ai, 3aj). Yields were reduced when using highly 
electron deficient arenes with substituents such as CF3 or m-p-Cl (3ag & 3an). These 
patterns in reaction efficiency are consistent with similar reported methodology.8k 
Unsymmetrical examples such as 3-methyl and 3-chloro (3ai-3an) gave major isomers 
based on the least sterically hindered site with excellent selectivity. An ortho-substituted 
example (3ao) was also tolerated however in reduced yield. Heteroaromatics could also be 




Scheme 3: Arene Scope of Oxazolidinone Directed C–H Alkenylation 
 
 
Structures bearing a fluoro substituent meta- to the oxazolidinone directing group 
(3aq & 3ar) gave a mixture of regioisomers (Scheme 4), separable via column 
chromatography. Regioisomers of structure 3aq gave an impressive combined yield of 91% 
and were further characterized by single crystal X-ray crystallography to confirm 
regiochemistry.13 These validated that the electronics of the system dictate the selectivity in 
these structures. This insight in selectivity is mirrored in a previous report in a benzamide 
assisted C–H cyanation reaction.14 3ar gave a similar distribution of C–H alkenylated 








Functionalization of the heterocycle itself was then varied using structures 
synthesized from natural amino acids valine and leucine (Scheme 5a). These substrates 
performed with good efficiency for such highly functionalized motifs. Yields were reduced 
with larger alkyl derivatives due to potential disruption of directing group C–H alignment, 
highlighted with 3bd.  
 
Methanol derivative (1ca) bearing functionality in the 5-position was reacted under the 
catalytic conditions (Scheme 5b). The reaction conditions led to some undesired removal 
of the silyl protecting group. Due to this, the crude mixture was submitted to an in situ 
deprotection to afford the primary alcohol structure. One pot methodology was pleasingly 
shown to manifest comparable efficiency to sequential isolation and separate deprotection. 
This allows for more expedient synthesis and reduced waste from work-up and purification. 









Scheme 5: Heterocycle Scope of Oxazolidinone Directed C–H Alkenylation 
 
This methodology was shown to be scalable affording over 2 grams’ worth of 
alkenylated product (Scheme 6). On a gram scale the lowering of ruthenium and silver 
loadings afforded a 77% yield along with a 22% yield of recovered starting material. 
Interestingly there was still no observed presence of a di-alkenylated structure, which was 
also not observed throughout the scope of the reaction. Complete mono-substitution 
selectivity in C–H functionalization methodology is highly sought after. To investigate this 
further, mono-alkenylated product 3b was re-exposed to the optimized reaction conditions 
in an attempt to force formation of the di-alkenylated product 3bdi (Scheme 7). Despite this, 
no sign of this product was observed via TLC or crude NMR where only starting material 
was present. This highlighted the absolute selectivity of the oxazolidinone directing group 




Scheme 6: Gram Scale Ruthenium Catalyzed C–H Alkenylation 
 
 
Scheme 7: Attempted Di-Alkenylation of Mono-Substituted Structure 3b   
 
 
The introduction of ester and alkene functionality to the compound allows further 
derivation to form more complex and decorated structures. Heterogeneous hydrogenation 
allowed access to the ortho-alkylated motif in quantitative yield (4a, Scheme 8). Selective 
mild saponification allowed hydrolysis of the ester (4b) without interaction with the 
oxazolidinone heterocycle. Amidation conditions also afforded the amide in good yields (4c). 
These functional group interconversions allowed access to cinnamic acids and cinnanamide 
structures which are known to possess antimicrobial activity.15 
 
The reaction conditions were now employed with analogous derivatives of the 
oxazolidinone heterocycle core to explore electronic effects on efficiency of catalysis 
(Scheme 9). The pyrrolidinone (6a), 2-thiazolidinone (6b) and 4-thiazolidinone (6c) 
structures gave modest-good yields in the C–H alkenylation reaction. These results 
manifest how subtle changes in heterocycle electronics can affect C–H functionalisation 






There have been multiple other examples of weak directing groups directing C–H 
alkenylation reactions such as carboxylic acids8c ketones8i, aldehydes8f and esters8h. As 
reported reaction conditions for these protocols are similar, it was of mechanistic interest to 
perform intermolecular competition experiments to create a reactivity order of directing 
groups. One equivalent of further weakly coordinating directing groups: ketone, acid, ester 
and aldehyde (7a-d) were reacted under the optimized conditions from this report with one 
equivalent of 3-phenyl-2-oxazolidinone (1a) to compete with one equivalent of methyl 
acrylate (2b) (Scheme 10). 
 




Scheme 9: Ruthenium Catalyzed Alkenylation of 5-Membered Heterocycles 
 
 
These experimental insights show that the ketone directing group (7a) competes 
preferentially over the oxazolidinone whereas acids, aldehydes and esters give rise to a 
larger majority of alkenylated aryloxazolidinone. This also allows understanding into 
potential functional group tolerance of this methodology, where aromatic acyl derivatives of 
the aryloxazolidinone would give rise to a large mixture of products which was observed 
experimentally when para-acetyl-N-aryloxazolidinone was submitted to the reaction 
conditions. 
 
Silver hexafluoroantimonate (AgSbF6) is a ubiquitous catalytic partner to ruthenium 
para-cymene dimer.8c,8f It was of interest to investigate whether it only acts as a catalyst 
activator or plays a further part in the reaction. Due to this, a proposed catalytically active 
monomeric species [Ru(p-cymene)(OAc)2] was subjected to the reaction conditions with 
and without the co-catalyst (Scheme 11). Interestingly no conversion to product was 
observed without the additive, highlighting its further importance as a source of SbF6  anion 












Replacement of the aromatic C–H bonds with deuterium atoms gave the isotopically 
labelled structure [D]5-1a. This was submitted to the reaction conditions in order to 
investigate the potential hydrogen incorporation into the final product. This would be 
indicative of a reversible cyclometalation. The resulting reaction gave rise to an 8% 
hydrogen incorporation into the ortho-C-D bond (Scheme 12), also affording the isotopically 






Scheme 12: Ru(II)-Catalyzed Alkenylation of Isotopically Labelled Substrate 
 
 
The kinetic isotope effect (KIE) of a substrate can give great insight into mechanism 
and give information about the rate limiting sections of the catalytic cycle (Scheme 13).  
 




This allows greater in-depth understanding of reaction tuning and optimization.17 Kinetic 
isotope analysis was carried out experimentally using two methods: initial rates by parallel 
reactions (Scheme 13a) and through intermolecular competition between 1a and [D]5-1a 
(Scheme 13b). Both methods showed that the reaction had a kinetically relevant isotope 
effect, signifying that C–H cleavage is in or near the rate limiting step. 
 
Computational Mechanistic Studies 
Density functional theory (DFT) calculations were undertaken to establish the 
mechanism and energetics of the reaction for 3-phenyl-2-oxazolidinone 1a and methyl 
acrylate 2b.18 Previous studies have shown the importance of using corrections for 
dispersion, solvation and extended basis sets when treating large organometallic reaction 
systems that involve charged species. A similar approach was adopted in this work, with 
geometries initially optimized in the gas phase with the BP86 functional and a medium sized 
basis set (SDD for Ru and 6-31G** on all other atoms). The resultant free energies were 
then corrected for solvation (2-Me-THF), dispersion (Grimme’s D3-BJ parameter set) and 
an extended basis-set (cc-pVTZ for Ru and 6-311++G** for all other atoms) giving rise to 
composite free energy differences ΔGMeTHF (1 atm, 25 °C) relative to complex A and 
separate species 1a and 2b.  
 
Under the catalytic conditions, acetate from the copper complex (Cu(OAc)2·H2O) 
breaks up the dimer [RuCl2(p-cymene)]2 to form the in situ catalytically active intermediate 
A, [Ru(p-cymene)(OAc)(1a)]+, with the silver compound (AgSbF6) removing chloride anions 
from the solution. The cationic complex A has the oxazolidinone coordinated through the 
carbonyl oxygen, one κ2-acetate and an η6 para-cymene ligand around the ruthenium 
center. Concerted metalation-deprotonation (CMD), also known as ambiphilic metal-ligand 
activation (AMLA), occurs as a two-step reversible process (see Figure 2). The first step, 
via TS(A-B)1, involves κ2- κ1 displacement of acetate, by the approaching ortho C–H bond 
of 1a, to form an agostic intermediate INT(A-B), where the pendant oxygen of the acetate 
is directed towards the ortho H (O···H = 1.686 Å), thereby elongating the C–H bond from 
1.091 Å to 1.148 Å. The second step, via TS(A-B)2, involves endergonic C–H bond 
cleavage to form a six-membered cyclometalate B (+4.0 kcal mol-1). Formation of the 
agostic intermediate, which involves breaking a strong Ru-O bond, determines the overall 





Figure 2: DFT calculated free energies (kcal mol-1) relative to A for the C–H activation of 
N-aryloxazolidinone 1a at [Ru(OAc)(p-cymene)]+ in Me-THF.  
 
Ligand substitution of acetic acid in B for methyl acrylate 2b forms four isomers of 
C, which differ with respect to the orientation of the alkene at the ruthenium center. Despite 
the pre-1,2-insertion intermediates C11,2 and C21,2 being more stable than the equivalent 
pre-2,1-insertion intermediates, the free energy barriers for 1,2-insertion (TS(C1-D1)1,2 and 
TS(C2-D2)1,2) are respectively 20.0 and 19.9 kcal mol-1, approximately 5 kcal mol-1 higher 
than 2,1-insertion (see Figure 3 and Figure S1 in the supporting information). Therefore, 
2,1-insertion of 2b into the Ru-C bond is regiosterically favored via TS(C1-D1)2,1 (13.8 kcal 
mol-1) and TS(C2-D2)2,1 (14.9 kcal mol-1 ), placing the methyl ester substituent next to the 
ruthenium in the exergonic eight-membered metallacycles either below (D12,1; -1.7 kcal mol-
1) or above (D22,1; -1.3 kcal mol-1) the plane of the ruthenacycle (when looking at the 
complex from the position of the para-cymene ligand). 
 
 
Figure 3: DFT calculated free energies (kcal mol-1) relative to A and the free substrates, for 
the 2,1-insertion of methyl acrylate 2b into adduct C.  
 
Unlike in previous functionalization studies with methyl acrylate (by Davies and 
Macgregor19, who used 3-phenyl-pyrazole to form a seven-membered rhodacycle) for this 
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2,1-insertion no interaction is observed between Ru and the ester substituent in the eight-
membered ruthenacycle. In fact, the increased size of the metallacycle restricts its ability to 
interconvert between conformers D12,1 and D22,1, as the preference for the boat-chair 
conformation reduces the flexibility of the metallacycle ring; this contrasts with the behavior 
that has been reported for similar, yet smaller, equivalent seven-membered intermediates.19 
The stereochemistry of the 1,2-disubstituted alkene product 3b is determined exclusively 
by which β-hydrogen is transferred to the ruthenium center; from either above (Ha, Figure 
4) or below (Hb) the plane of the ruthenacycle. 
 
 
Figure 4: Ruthenacycle D2,1 showing the position of Ha (above) and Hb (below) the plane of 
the metallacycle. D12,1 has the CO2Me substituent cis to Hb whilst D22,1 has the ester group 
cis to Ha 
 
The β-hydrogen transfer process involves two steps: formation of an agostic 
intermediate followed by C–H cleavage, as the β-H moves to the Ru center. Figure 5 shows 
the transfer of Ha, which lies above the plane of the ruthenacycle, for both D2,1 isomers. In 
the case of D12,1, where the transferring hydrogen is trans to the ester group, formation of 
the agostic interaction between Ha and Ru proceeds via TS(D1-E1)1a (19.1 kcal mol-1) to 
give intermediate INT(D1-E1)a (+13.1 kcal mol-1), and C–H cleavage occurs via TS(D1-
E1)2a (13.9 kcal mol-1) to form the cis product E1cis (+10.4 kcal mol-1). For D22,1, with Ha cis 
to the ester group, formation of the agostic interaction proceeds via TS(D2-E2)1a (13.5 kcal 
mol-1), decreasing the Ru···Ha distance from 3.701 to 2.716 Å in INT(D2-E2)a (+5.8 kcal 
mol-1) before C–H cleavage via TS(D2-E2)2a (7.8 kcal mol-1) and formation of the 





Figure 5: DFT calculated free energies (kcal mol-1) relative to A and the free substrates, for 
the β-Ha transfer from 2,1-insertion ruthenacycles (D2,1) in Me-THF.  
 
The process of β-H transfer is more complicated for the “bottom” hydrogen, Hb 
shown in Figure 6, as the formation of the agostic interaction between Hb and Ru (Ru···Hb 
decreasing to 2.4 Å) forces dissociation of the oxazolidinone group at the ruthenium center 
(Ru···O increasing to 3.4 Å). This raises the barriers for the first step from D12,1 via TS(D1-
E1)1b (17.5 kcal mol-1) and from D22,1  via TS(D2-E2)1b (31.9 kcal mol-1). The C–Hb bond is 
elongating by ~ 0.03 Å as the Ru-Hb distance decreases; this is a greater distortion than C–
Ha (~ 0.01 Å) when the agostic intermediate is formed for the top β-H transfer. C–Hb 
cleavage occurs via TS(D1-E1)2b (13.6 kcal mol-1) and TS(D2-E2)2b (20.4 kcal mol-1) for 
D1 and D2 respectively to give intermediates E1ʹtrans (+9.7 kcal mol-1) and E2ʹcis (+14.1 kcal 
mol-1). Reassociation of the oxazolidinone oxygen occurs via TS(E1ʹ-E1)trans (12.8 kcal mol-
1) and TS(E2ʹ-E2)cis (16.8 kcal mol-1) to form the equivalent E1trans (+11.3 kcal mol-1) and 





Figure 6: DFT calculated free energies (kcal mol-1) relative to A and the free substrates, for 
the β-Hb transfer from 2,1-insertion ruthenacycles (D2,1) in Me-THF.  
 
Based on the assumption that the energy difference of 0.4 kcal mol-1 between the 
two 2,1-insertion ruthenacycle complexes (D12,1 and D22,1) is small enough that both 
species are populated during the catalytic cycle, it is comforting to note that both 
ruthenacycle isomers preferentially form the trans 1,2-disubstituted alkene product over the 
cis stereoisomer. This agrees with experiment that only trans 3b is observed, and is due to 
H transfer of different β-hydrogens (Ha or Hb). The free-energy difference between TS(D1-
E1)1a and TS(D2-E2)1a suggests a preference of about 104 for formation of the trans 
product over the cis isomer. 
 
The absence of a di-alkenylated product (3bdi) formed during the reaction was 
investigated, with the subsequent C–H activation of 3b at the remaining ortho C–H position 
modelled. The barrier for this activation was 15.4 kcal mol-1 (see Supporting Information, 
Table S2), 3 kcal mol-1 higher than activation of the initial C–H site in substrate 1b (TS(A-
B)1 = +12.4 kcal mol-1), hence 3b does not undergo a second C–H activation. The unusual 
isomeric preference 1ar / 1aq substrates were likewise studied. Here, the major and minor 
C–H activation pathways were modelled for 1ar (see Supporting Information, Table S3) and 
unsurprisingly the barrier for the major isomer pathway was lower in free energy, by 0.9 kcal 
mol-1. This small difference, and similar energies for 1arA and 1arAʹ, the major and minor 
isomers of [Ru(p-cymene)(OAc)(1ar)]+ respectively, (ΔG = 0.4 kcal mol-1) agree with the 
experimental observation of both isomers, showing a slight energetic preference for the 
formation of the major isomer. 
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In order to estimate the Gibbs energy change for the uncatalyzed coupling of 1a to 
2b to give 3b, the oxidation process also needs to be included (equation 1). The overall 
reaction may be considered as: 
1a  +  2b  +  ½O2    3b  +  H2O (1) 
 
for which the exergonic Gibbs energy change (at 25 °C) is -49 kcal mol-1. This is the amount 
by which all the Gibbs energies relative to A must be reduced between one turnover of the 
catalytic cycle and the next. (Note that the reaction path for the conversion from E2trans to A 
in the next cycle has not been investigated computationally.) The significance of this 
consideration is that it allows the turnover-dependent intermediate and the turnover-
dependent transition state to be identified as D22,1 and TS(D2-E2)1a, respectively, which 
occur sequentially within the same turnover cycle (Figure 7); the possibility of the turnover-
dependent transition state occurring in the subsequent cycle can be discounted in this 
case.20 Thus the computational modelling predicts the rate-determining step (as commonly 
understood) to be formation of the agostic intermediate immediately prior to β-hydride 
transfer. Under the experimental conditions the oxidation step is undoubtedly mediated by 
Cu(OAc)2, although the detailed mechanism is unknown.21 However, for the present 
purpose it is necessary only to consider overall stoichiometry and thermochemistry, not 
kinetics and mechanism for this stage of the turnover cycle. The calculated free energy 
changes ΔGMeTHF reported above (Figures 2 – 6) refer to a standard state of 1 atm for all 
species, but detailed considerations of the rate-determining step (or, in general, of the 
turnover-dependent intermediate and transition state within a steady-state catalytic cycle)20 
depend upon actual concentrations under experimental conditions. The relative Gibbs 
energies shown in Figure 7 are corrected for the change from 1 atm (concentration c1) to 
the standard reaction conditions (Table 1; concentration c2) by the term RTln(c1/c2) at 
temperature T = 120 °C. The ligand exchange step B  C (for which a transition structure 
has not been determined) becomes exergonic due to the larger relative concentration of 
alkene 2b, with the consequence that the free energies of the transition structures for the 
alkene insertion and -hydride transfer sections of the cycle are lowered with respect to 
those in the C–H activation section. The resulting profile (Figure 7) shows four transition 








Kinetic Isotope Effects 
Relative to A, the computational modelling predicts an intrinsic KIE kH5/kD5 = 2.2 for 
the C–H activation step. Since the preceding transition structure TS(A-B)1 for formation of 
the agostic intermediate is calculated to be slightly higher in energy, the intrinsic KIE would 
be partially masked, leading to a reduced value for the observed isotope effect. The 
experimental KIE by direct comparison of initial reaction rates for 1a and [D]5-1a has a value 
of about 2, which seems to suggest that most of the intrinsic KIE is being expressed. The 
KIEs calculated for the individual agostic formation, migratory insertion, and β-hydride 
elimination steps are all essentially unity as expected (Scheme 14). 
 
The KIE determined by the method of intermolecular competition expresses the isotopic 
discrimination up to the first irreversible step of the cycle, relative to free starting material. 
It is known that cyclometallation is reversible (Scheme 12), leading to loss of deuterium 
from the ortho position of 1a. The product ratio determined in the competition experiment 
therefore reflects the isotope effect on cyclometallation. However, the interpretation of the 
experimental isotope effect is complicated by at least two factors.  
 
Figure 7: DFT calculated free energies (kcal mol-1 relative to A) for the coupling of 1a and 
2b to form 3b using a ruthenium catalyst at 120 °C in Me-THF and at concentrations 
corresponding to the standard experimental conditions (Table 1).  
 
First, the isotopic product ratio observed depends upon the degree of conversion, since 
starting from a 1:1 mixture of isotopologues, a product ratio of 1:1 must be obtained for 
100% conversion: the observed isotope effect should be corrected for the fractional degree 
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of conversion, which leads to a greater value for the KIE.22 Second, the fact that isotopic 
exchange at the ortho position is seen to take place during cyclometallation means that the 
proportion of deuterated 1a in the reaction mixture is reduced, leading to an increase in the 
apparent value of the KIE. Numerical simulation shows that only a small percentage of 
isotopic exchange due to B  A reversibility is required to account for an apparent KIE of 
about 2.6 as observed for the intermolecular competition experiment. 
 
Scheme 14: Full Mechanism of Ruthenium-Catalyzed C–H Alkenylation including Kinetic 
and Energetic (kcal mol-1) DFT Contributions 
 
Conclusion 
We have reported the first use of the oxazolidinone directing group in ruthenium 
catalyzed C–H functionalization. This proof of concept of cyclometalation and subsequent 
functionalization was modeled on an alkenylation reaction. This led to the synthesis of over 
25 novel substituted N-aryloxazolidinone motifs with up to 94% yields with absolute mono-
selectivity. This methodology granted access to biologically relevant derivatives of 
oxazolidinone pharmaceuticals and could be applied to late stage drug modification.  
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  DFT calculations for most sections of the catalytic cycle suggest why trans-3b is the only 
product isomer obtained, but yield very similar free energies for the transition states of 
several steps in the proposed mechanism using relative concentrations corresponding to 
the experimental conditions. The C–H activation step involves a KIE of kH/kD5  2 in apparent 
agreement with the observed value, but several reasons are noted why a direct comparison 
between calculation and experiment may not be warranted.  
 
ASSOCIATED CONTENT  
Supporting Information. Full characterization, NMR spectra, computational data and 
crystallographic information is attached. This material is available free of charge via the 




* Christopher G. Frost: C.G.Frost@bath.ac.uk (Synthetic) 
* Ian H. Williams: I.H.Williams@bath.ac.uk (Physical Organic Computational) 
* Claire L. McMullin: C.McMullin@bath.ac.uk (Inorganic Computational)  
 
Notes 
The authors declare no competing financial interest. 
 
ACKNOWLEDGMENT  
The authors gratefully acknowledge the University of Bath, Syngenta (JL) and the EPSRC 
(PW) for financial support. JL would also like to thank Christina Gulacsy and Dr. David 
Carbery for use and help with HPLC work, and John Lowe for NMR expertise. We thank the 
University of Bath for access to its High Performance Computing Facility. 
  
REFERENCES 
(1) For reading on linezolid see: (a) Barbachyn, M. R.; Ford, C. W. Angew. Chem. Int. Ed., 
2003, 42, 2010-2023. (b) Gregory, W, A.; D. Brittelli, R.; Wang, C. L. J.; Wuonola, M. A.; 
McRipley, R. J.; Eustice, D. C.; Eberly, V. S.; Bartholomew, P. T.; Slee, A. M.; Forbes, M. 
J. Med. Chem. 1989, 32, 1673-1681. (c) Brickner, S. J.; Hutchinson, D. K.; Barbachyn, M. 
R.; Manninen, P. R.; Ulanowicz, D. A.; Garmon S. A.; Grega, K. C.; Hendges, S. K.; Toops, 
D. S.; Ford, C. W.; Zurenko, G. E. J. Med. Chem. 1996, 39, 673-679. (d) Evans, D. A.; 




(2) For reading on tedizolid see: (a) Locke, J. B.; Finn, J.; Hilgers, M.; Morales, G.; Rahawi, 
S.; Kedar, G. C.; Picazo, J. J.; Im, W. B.; Shaw, K. J., Stein, J. L. Antimicrob. Agents 
Chemother. 2010, 54, 5337-5343. (b) Im, W. B.; Choi, S. H., Park, J. Y.; Finn, J.; Yoon, S. 
H. Eur. J. Med. Chem. 2011, 46, 1027-1039 
(3) For reading on rivaroxaban see: (a) Roehrig, S.; Straub, A.; Pohlmann, J.; Lampe, T.; 
Pernerstorfer, J.; Schlemmer, K. H.; Reinemer, P.; Perzborn, E. J. Med. Chem. 2005, 48, 
5900-5908. (b) Perzborn, E.; Roehrig, S.; Straub, A.; Kubitza, D.; Misselwitz, F. Nature 
Reviews Drug Discovery. 2011, 10, 61-75. (c) Yuan, J.; Liu, K.; Li, L.; Yuan, Y.; Liu, X.; Li, 
Y. Molecules, 2014, 19, 14999-15004, d) Rafecas, J. L.; Comely, A. C.; Ferrali, A.; Amelia 
Cortes, C.; Pasto Aguila, M. WO2011080341A1, 2011. 
(4) Moureau, F.; Wouters, J.; Vercauteren, D. P.; Collin, S.; Evrard, G.; Durant, F.; Ducrey, 
F.; Koenig, J. J.; Jarreau, F. X. Eur. J. Med. Chem. 1992, 27, 939-948. 
(5) For reading on the synthesis and modification of N-aryloxazolidinones see: (a) Ghosh, 
A.; Sieser, J. E.; Riou, M.; Cai, W.; Rivera-Ruiz, L. Org. Lett., 2003, 5, 2207–2210. (b) Mahy, 
W.; Plucinski, P.; Frost, C. G. Org. Lett., 2014, 16, 5020-5023. (c) Mallesham, B.; Rajesh, 
B. M.; Rajamohan Reddy, P.; Srinivas, D.; Trehan, S. Org. Lett., 2003, 5, 963-965. (d) Mahy, 
W.; Plucinski, P.; Jover, J.; Frost, C. G. Angew. Chem. Int. Ed. 2015, 127, 11094-11098. 
(e) Mahy, W.; Leitch, J. A.; Frost, C. G. Eur. J. Org. Chem. 2016, 7, 1305-1313. 
(6)  For reviews on   transition metal catalyzed C–H functionalization see: (a) Ackermann, 
L. Chem. Rev. 2011, 13, 3075-3078, (b) Arockiam, P. B.; Bruneau, C.; Dixneuf, P. Chem. 
Rev. 2012, 112, 5879−5918. (c)  Chen, X.; Engle, K. M.; Wang, D-H.; Yu, J-Q. Angew. 
Chem. Int. Ed. 2009, 48, 5094–5115. (d) Engle, K. M., Mei, T-S.; Wasa, M.; Yu, J-Q. Acc. 
Chem. Res. 2012, 45, 788-802. (e) Rao, Y. Shan, G. Yang, X-L. Sci. China Chem. 2014, 
57, 930-944. (f) Thirunavukkarasu, V. S.; Kozhushkov, S. I.; Ackermann, L. Chem. 
Commun, 2014, 50, 29-39. 
(7) (a) Yamaguchi, J.; Yamaguchi, A. D.; Itami, K. Angew. Chem. Int. Ed. 2012, 51, 8960-
9009 (b) Mahy, W.; Plucinski, P.; Jover, J.; Frost, C. G. Angew. Chem. Int. Ed. 2015, 54, 
10944-10948. (c) Liu, P. M.; Frost, C. G. Org. Lett. 2013, 15, 5862-5865. (d) Brown, J. A.; 
Cochrane, A. R.; Irvine, S.; Kerr, W. J.; Mondal, B.; Parkinson, J. A.; Paterson, L. C.; Reid, 
M.; Tuttle, T.; Andersson, S.; Nilsson, G. N. Adv. Synth. Catal. 2014, 356, 3551-3562.  
(8) For key seminal publications on directed ruthenium catalyzed C–H functionalization see: 
(a) Murai, S.; Kakiuchi, F. Sekine, S.; Tanaka, Y.; Kamatani, A.; Sonoda, M.; Chatani, N. 
Nature, 1993, 366, 529-531 (b) Oi, S.; Fukita, S.; Hirata, N.; Watanuki, N.; Miyano, S.; Inoue, 
Y. Org. Lett. 2001, 3, 2579-2581. (c) Oi, S.; Ogino, Y.; Fukita, S.; Inoue, Y. Org. Lett. 2002, 
4, 1783-1785. (d) Ackermann, L. Org. Lett. 2005, 7 , 3123-3125. (e) Ackermann, L.; 
Althammer, A.; Born, R. Angew. Chem. Int. Ed. 2006, 45, 2619-2622, (f) Ackermann, L.; 
Vicente, R.; Althammer, A. Org. Lett. 2008, 10, 2299-2302. (g) Ozdemir, I.; Demir, S.; 
 102 
 
Cetinkaya, B.; Gourlaouen, C.; Maseras, F.; Bruneau, C.; Dixneuf, P. H., J. Am. Chem. Soc. 
2008, 130, 1156-1157. 
(9) For key examples of ruthenium catalyzed C–H functionalization using weakly 
coordinating directing groups see: (a) De Sarkar S.; Liu, W.; Kozhushkov, S. I.; Ackermann, 
L. Adv. Synth. Catal. 2014, 356, 1461-1479. (b) Ueyama, T.; Mochida, S.; Fukutani, T.; 
Hirano, K.; Satoh, T.; Miura, M. Org. Lett. 2011, 13, 706-708. (c) Ackermann, L.; Pospech, 
J. Org. Lett. 2011, 13, 4153-4155. (d) Kakiuchi, F.; Kan, S.; Igi, K.; Chatani, N.; Murai, S. J. 
Am. Chem. Soc. 2003, 125, 1698-1699. (e) Bhanuchandra, M.; Yadav, M. R.; Rit, R. K.; 
Kuram, M. R.; Sahoo, A. K. Chem. Commun. 2013, 49, 5225-5227. (f) Padala, K.; 
Jeganmohan, M. Org. Lett. 2012, 14, 1134-1137. (g) Ackermann, L.; Lygin, A. V.; Hofmann, 
N. Angew. Chem. Int. Ed. 2011, 50, 6379-6382. (h) Graczyk, K.; Ma, W.; Ackermann, L. 
Org. Lett. 2012, 14, 4110-4113. (i) Padala, K.; Jeganmohan, M. Org. Lett. 2011, 13, 6144-
6147. (j) Reddy, M. C.; Jeganmohan, M. Chem. Commun. 2014, 51, 10738-10741. (k) Li, 
J.; Kornhaass, C.; Ackermann, L. Chem. Commun., 2012, 48, 11343-11345. 
(10) (a) Kalyani, D.; Deprez, N. R.; Desai, L. V.; Sanford, M. S. J. Am. Chem Soc. 2005, 
127, 7330-7331. (b) Yeung, C. S.; Dong, V. M. Synlett, 2011, 7, 974-978 
(11) For palladium see: Leow, D.; Li, G.; Mei, T-S.; Yu, J-Q, Nature, 2012, 486, 518-522. 
For rhodium see: Colby, D. A.; Bergman, R. G.; Ellman, J. A. Chem Rev, 2010, 110, 624-
655. 
(12) (a) Pace, V.; Hoyos, Fernandez, M.; P.;Sinisterra, J. V.; Alcantara, A. R. Green Chem. 
2010, 12, 1380-1382. (b) Pace, V.; Hoyos, P.; Castoldi, L.; De Maria, P. D.; Alcantara, A. 
R. Chemsuschem, 2012, 5, 1369-1379  
(13) (a) Crystal Data for C14H14FNO4 (compound 3aq1): M =279.26 g mol–1, triclinic, space 
group P-1 (no. 2), a = 6.8220(2), b = 10.6058(3), c = 19.5239(7) Å, α = 105.484(3), β = 
90.601(3), γ = 102.910(2)°, U = 1323.22(7) Å3, Z = 4, T = 150.00(10) K, μ(Cu-Kα) = 0.954 
mm–1, Dc = 1.402 g cm–3, 13114 reflections measured (8.9° ≤ 2θ ≤ 143.942°), 5164 unique 
(Rint = 0.0248, Rsigma = 0.0279) which were used in all calculations. The final R1 was 0.0379 
(I > 2σ(I)) and wR2 was 0.0994 (all data). (b) Crystal Data for C14H14FNO4 (compound 3aq2): 
M =279.26 g mol–1, tetragonal, space group P43212, a = 9.43321(9), c = 29.5288(4) Å, U = 
2627.64(6) Å3, Z = 8, T = 150.00(10) K, μ(Cu-Kα) = 0.960 mm–1, Dc = 1.412 g cm–3, 23288 
reflections measured (9.844° ≤ 2θ ≤ 143.71°), 2586 unique (Rint = 0.0317, Rsigma = 0.0148) 
which were used in all calculations. The final R1 was 0.0283 (I > 2σ(I)) and wR2 was 0.0720 
(all data). CCDC 1479666-1479667 (for 3aq1 and 3aq2, respectively) contain the 
supplementary crystallographic data for this paper. These data can be obtained free of 
charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html, or from the Cambridge 
Crystallographic Data Centre, CCDC, 12 Union Road, Cambridge CB2 1EZ, UK. 
(14) Liu, W.; Ackermann, L. Chem. Commun. 2014, 50, 1878-1881 
 103 
 
(15) (a) Sova, M. Mini. Rev. Mec. Chem., 2012, 12, 749-767 (b) Seelolla, G.; Cheera, P.; 
Ponneri, V. Med. Chem., 2014, 4, 778-783 
(16) For previous use of the pyrolidinone directing group in palladium catalyzed C–H 
functionalization see: (a) Giri, R.; Lam, J. K.; Yu, J-Q. J. Am. Chem. Soc, 2010, 132, 686-
693. (b) Bedford, R. B.; Mitchell, C. J.; Webster, R. L. Chem. Commun. 2010, 46, 3095-
3097. (c) Desai, L. V.; Malik, H. A.; Sanford, M. S. Org. Lett. 2006, 8, 1141-1144. (d) 
Prakash, G. K. S.; Mathew, T.; Hoole, D.; Esteves, P. M.; Wang, Q.; Rasul, G.; Olah, G. A. 
J. Am. Chem. Soc. 2004, 126, 15770-15776. 
(17) Simmons, E. M.; Hartwig, J. F. Angew. Chem. Int. Ed., 2012, 51,  
3066-3072. 
(18) DFT calculations were run with Gaussian 09 (Revision D.01). Ru centers were 
described with the Stuttgart RECPs and associated basis sets, and 6-31G** basis sets were 
used for all other atoms. Full details and references for all computational methods can be 
found in SI. 
(19) Algarra, A. G.; Davies, D. L.; Khamker, Q.; Macgregor, S.; McMullin, C. L.; Singh, K.; 
Villa-Marcos, B. Chem. Eur. J., 2015, 21, 3087-3096. 
(20) (a) Kozuch, S.; Shaik, S. Acc. Chem. Res. 2010, 44, 101-110. (b) Kozuch, S.; Martin, 
J. M. L. ACS Catal. 2012, 2, 2787-2794. 
(21) Funes-Ardoiz, A.; Maseras, F. Angew. Chem. Int. Ed., 2016, 55, 2764-2767 
(22) Melander, L.; Saunders, W. H. Reaction Rates of Isotopic Molecules, Wiley, New York, 
1980, 56-129 
  
2.3: Use of the Hydantoin Directing Group in Ruthenium(II)-Catalyzed C–H 
Functionalization 
 
2.3.1: Introduction and Commentary 
 
 With the success of the oxazolidinone project, it was of interest to investigate further 
biologically relevant directing groups in ruthenium catalysed C–H activation. The hydantoin 
heterocycle bears both urea and amide functionality and has been used in a variety of 
biological applications. Hydantoins are classically synthesised by two methods. The first of 
these is the Bucherer-Bergs reaction which involves the condensation a ketone, potassium 
cyanide and ammonium carbonate (Scheme 2-10a).1 This takes place via an isocyanate 
intermediate after reaction of the cyanohydrin with CO2. The identical product will also be 
formed by submitting the cyanohydrin to ammonium carbonate. This reaction has since 





Scheme 2-10: Bucherer-Bergs Reaction in the Formation of Hydantoins 
 
 The second method is the treatment of isocyanates with amino acids followed by a 
cyclisation via condensation. This enables a wide range of readily available synthetic 
feedstocks. The glycine derivative can be synthesized using an aqueous protocol (Scheme 
2-11a)3 however other derivatives can be accessed using sequential addition and ring 





Scheme 2-11: Synthesis of N-arylhydantoins from Amino Acids 
 
 The arylation of dimethylhydantoin has also been reported using copper catalysis 
and aryl iodides. Forcing conditions are generally used in high boiling polar aprotic solvents 




Scheme 2-12: Synthesis of N-arylhydantoin via Ullmann Condensation 
  
In 2013, Krische and co-workers reported the ruthenium-catalysed prenylation of 
hydantoins (Scheme 2-13). This was shown to take place through a hydroaminoalkylation 





Scheme 2-13: Ruthenium-Catalysed Allylation of the Hydantoin Heterocycle 
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As shown above the hydantoin heterocycle can be formed from amino acids, they 
can also reform the corresponding amino acid. Due to this hydantoins have been used as 
intermediates in the synthesis of unnatural amino acids, and in the derivatisation of 
hydantoins themselves. In 2015, Clayden and co-workers reported the palladium catalysed 




Scheme 2-14: Palladium-Catalysed C–H arylation of the Hydantoin Heterocycle 
 
 The hydantoin heterocycle has been used as a directing group in transition metal 
catalysed C–H activation. Kerr and co-workers elegantly employed iridium catalysis in the 





Scheme 2-15: Iridium-Catalysed ortho-Deuteration of Nilutamide 
 
This acted as proof as concept that one could utilise the hydantoin heterocycle as a directing 
group to enable cyclometalation. The aim for this project was to apply previously developed 
methodology from the oxazolidinone project to this new scaffold. The results achieved in 
this project are presented in the form of the Note that was published in The Journal of 
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ABSTRACT: Ruthenium(II)-Catalyzed C–H Functionalization of N-arylhydantoins is herein 
described. The biologically relevant hydantoin (imidazolidinedione) heterocycle functions as 
a weakly coordinating directing group in a C–H alkenylation reaction. The reaction gave a 
wide scope of 23 examples with yields up to 94% in green solvent 2-MeTHF. 
Functionalization of API nilutamide (anti-androgen) is also reported. The use of the 
succinimide heterocycle as a directing group is also demonstrated in modest yields. 
 
The hydantoin (imidazolidinedione) heterocycle (and sulfur anaologues) is prevalent 
in numerous medicinally and agrochemically active scaffolds. These include the hydantoin 
class of anticonvulsants (phenytoin, fosphenytoin, Figure 1), non-steroidal androgen 
antagonists (nilutamide, enzalutamide) and fungicides (iprodione).1 
 
 
Figure 1: Biologically Relevant Compounds Containing the Hydantoin Heterocycle 
 
Using biologically active heterocycles as directing groups in transition-metal 
catalyzed C–H functionalization is a powerful synthetic tool as this can grant access to a 
novel library of derivatives inaccessible through other synthetic methods.2 Direct palladium-
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catalyzed C–H arylation of the hydantoin heterocycle itself has been recently reported by 
Clayden and co-workers.3 The hydantoin heterocycle has also been shown to form a six-
membered metallacycle in elegant deuteration studies carried out by Kerr and co-workers 
(Scheme 1) using iridium catalysis on the anti-androgen nilutamide.2d This work acted as 
proof of concept that this heterocycle could potentially be utilized in transition metal 
catalyzed C–H functionalization, allowing the creation of novel analogues of biologically 
relevant motifs. 
 
Scheme 1: C–H functionalization of N-arylhydantoins 
 
 
Ruthenium(II) catalysis has emerged as a powerful method of the formation of 
metallacycles and subsequent functionalization.4 The ability of weakly coordinating directing 
groups to facilitate this functionalization has been brought to the forefront of C–H 
functionalization methodology through important contributions from Ackermann5 and 
Jeganmohan6 amongst others. 
 
Preliminary reaction conditions were identified from previous work within the group 
and literature precedent on related alkenylation reactions.2a,5,6 Electron deficient alkenes 
are commonly used coupling partners due to their high efficiency in cross dehydrogenative 
coupling reactions.2a Initial optimization was carried out using nilutamide test motif (1a) 
containing the gem-dimethyl substituent on the hydantoin heterocycle, methyl acrylate as 
the coupling partner (Table 1), [RuCl2(p-cymene)]2 as the ruthenium source, AgSbF6 as the 
co-catalyst and Cu(OAc)2.H2O as the oxidant. Selected results will be discussed further. 
The reaction was shown to not tolerate aqueous or acidic solvent media (entries 1-2) 
however polar aprotic etheric solvents afforded the alkenylated product in high conversions 
(entries 3-5). A number of silver(I) oxidants were employed in the reaction methodology 
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(entries 6-7) however none gave superior yields to Cu(OAc)2.H2O. Pleasingly the reaction 
performed more efficiently at lower temperatures (entry 8) giving a 95% conversion and 
94% isolated yield. Despite this, when the catalyst and co-catalyst loadings were reduced 
the reaction conversions dropped (entry 9). 
 
Table 1: Optimization of ruthenium(II)-catalyzed C–H alkenylation of N-arylhydantoina 
 
Entry Solvent Oxidant (1 eq) Temp (°C) 3a (%)b 
1 H2O Cu(OAc)2·H2O 120 0 
2 AcOH Cu(OAc)2·H2O 120 0 
3 2-MeTHF Cu(OAc)2·H2O 120 85 
4 THF Cu(OAc)2·H2O 120 74 
5 DME Cu(OAc)2·H2O 120 81 
6 2-MeTHF AgOAc 120 39 
7 2-MeTHF AgO2CCF3 120 0 
8c 2-MeTHF Cu(OAc)2·H2O 100 95 (94)d 
9c,e 2-MeTHF Cu(OAc)2·H2O 100 70 
aStandard Reaction Conditions: 1a – 0.25 mmol, methyl acrylate – 0.75 mmol, [RuCl2(p-cymene)]2 – 0.0125 
mmol, AgSbF6 – 0.05 mmol), Oxidant – 0.25 mmol, Solvent – 1 mL. b 1H NMR Conversions taken after silica 
filtration compared to 1,1,2,2-tetrachloroethane as internal standard. cReaction performed at 100 °C. d Isolated 
Yield. eReaction performed using [RuCl2(p-cymene)]2 – 2.5 mol% and AgSbF6 – 10 mol%. 
 
Armed with optimal C–H alkenylation conditions the scope of this methodology was 
expanded allowing access to a large number of potentially active 
pharmaceutical/agrochemical analogues.   The nature of the coupling partners and of 
aromatic functionality was initially investigated (Scheme 2). Three different electron 
deficient alkenes were employed in the alkenylation reaction giving ethyl, n-butyl and benzyl 
derivatives (3ab-ac). Despite high yields, n-butyl example (3ac) was inseparable via 
standard chromatographic techniques from the starting material and was obtained in a yield 
of 94% as a 5:1 mixture giving a 78% NMR yield. Various aryl functionality was then 
introduced in order to examine electronic and steric effects on the efficiency and selectivity 
of the reaction. A wide range of alkoxy, alkyl and halogen functionality was tolerated (3b-
3f) with highest yields obtained with electron rich aromatics. Trifluoromethyl derivative (3g) 
was synthesized in reduced yield, however allowed efficient functionalization of electron 
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poor aromatics. Compounds containing both meta- and para- functionality (3h-i) were 
obtained in high yields with excellent selectivity of functionalization in the least hindered 
ortho-position.  
 
Scheme 2: Ruthenium(II) catalyzed C–H alkenylation of N-arylhydantoin derivatives 
 
a = Isolated as an inseparable 5:1 mixture of 3ac:1a. 78% depicts contribution from 3ac (94% total yield)  
 
A heteroaromatic variant was investigated under the conditions in order to expand the scope 
of sp2 sites that are available for functionalization. Thiophene example (1j) was shown to 
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be alkenylated under the optimized conditions in excellent yields with both methyl and butyl 
acrylate coupling partners with no chromatographic separation issues. 
The hydantoin heterocycle is commonly synthesized from naturally occurring amino 
acids which are a very attractive synthetic feedstock. Six examples were synthesized from 
natural and unnatural amino acids: glycine, valine, leucine, proline, homocycloleucine and 
sarcosine (Scheme 3).3,7 This showed that multiple hydantoin heterocycles were tolerated 
as directing groups however the bare glycine derivative (1k) only afforded alkenylated 
product in reduced yields. Bicyclic and spirocyclic directing groups derived from proline (1n) 
and cyclohomoleucine (1o) gave rise to good to excellent yields of C–H alkenylated 
products (3n-ob), granting access to highly decorated structures. Sarcosine derived 
hydantoin (1p) showed that compounds containing NH-functionalization were also tolerated 
well. 
 
Scheme 3: Ruthenium(II) Catalyzed C–H Alkenylation of Hydantoin Derivatives 
 
 
It was now of paramount interest to submit the drug structure nilutamide (Nilandron) 
to the reaction conditions in order to probe reactivity (Scheme 4). Despite the highly electron 
poor nature of the ring (containing both CF3 and NO2 substituents) formation of product was 
observed, albeit in low isolated yield. This manifests that this methodology can be used to 







Scheme 4: Nilutamide Functionalization 
 
 
Intermolecular competition experiments were performed using electron-rich (1b) 
and an electron poor (1e) substrates. It was shown that the C–H alkenylation of electron 
rich substituents is preferred as a ratio of ~6:4 was observed (Scheme 5). This can be 
rationalized by the C–H activation occurring via an electrophilic-type activation mode by a 
cationic ruthenium catalyst. It is also proposed that the more electron rich and less sterically 
hindered urea directs the C–H functionalization (see supporting information, Scheme S1).8    
 
Scheme 5: Intermolecular Competition Studies 
 
 
Our previous work depicts the functionalization of the biologically active 
oxazolidinone scaffold which bears a similar directing heterocyclic motif.2a Due to this, a 
competition experiment was carried out between the groups reacting them in equimolar 
quantities with one equivalent of methyl acrylate to probe how the directing groups compete 
for the coupling partner (Scheme 6). The investigation showed that the oxazolidinone 
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heterocycle competed more favorably for the acrylate as a 1:4 mixture of 
Hydantoin:Oxazolidinone was observed in NMR spectra. 
 
Scheme 6: Competition Experiment with Oxazolidinone Directing Group 
 
 
The succinimide group is also structurally similar to the hydantoin heterocycle. Due 
to this, it was of interest to explore whether this could also act as an efficient directing group 
in directed transition metal-catalyzed C–H functionalization, as to our knowledge its utility 
has not yet been investigated. Our previous reports have also indicated how such subtle 
electronic differences can strongly affect reaction efficiency.2a 
  Four N-arylsuccinimide derivatives were synthesized and submitted to the optimized 
reactions conditions (Scheme 7). However, in this case, it was found that slightly higher 
temperatures were necessary to allow the reaction to proceed efficiently. The yields are 
modest to poor, however this provides the first example of the use of the succinimide 




Scheme 7: Succinimide Directed Ruthenium-Catalyzed C–H Alkenylation 
 
 
In conclusion we have utilized ruthenium(II)-catalyzed ortho-C–H alkenylation to 
derivate a large scope of biologically relevant N-arylhydantoins with yields of 14-94%. The 
reaction methodology also favorably takes place in the green solvent 2-MeTHF and 
absolute mono-selectivity was observed throughout the project. This report includes the 
application of this methodology to hydantoin directed C–H derivation of an anti-androgen 
API, nilutamide. We have also reported the first use of the succinimide directing group in 
directed C–H functionalization with limited but varied scope.  
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Chapter 3: meta – Ruthenium Catalysed Remote C–H Functionalisation 









3.1: Chapter Introduction - Breaking the Phenylpyridine Monopoly 
 
 Still in its infancy, the technique of σ-activation for remote meta-functionalisation has 
relied heavily on the use of phenylpyridine as a template thus far. Phenylpyridine forms an 
incredibly strong and planar ruthenacycle making it the perfect candidate for investigation 
into these types of reactions. Unfortunately, the utility (and more importantly lack of utility) 
of the phenylpyridine structure has brought into question the broad synthetic value of this 
methodology. There has been effort towards expanding the scope of these transformations 
away from privileged motifs. Other strongly coordinating directing groups such as pyrazoles, 
benzimidazoles, imidazoles, pyrimidine, pyrazine, purines and ketimines have been 
employed in a few examples, although this is often at the expense of increased catalyst 
loading and/or lower yields. Ackermann and co-workers however have reported a large-
scale investigation into the use of N-pyrimidinyl anilines as auxiliaries for meta-






Scheme 3-1: Meta-Functionalisation of Heteroaromatics via α-Activation 
 
At the start of this project, only Ackermann’s report was present in the literature on 
removable auxiliaries however since then, as discussed in Chapter 1, there has been efforts 
to expand this methodology in diazo2 and oxygen3 bridged biaryls primarily by Li and co-




Scheme 3-2: Ruthenium-Catalysed meta-C–H Functionalisation of Cleavable Auxiliaries  
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The work carried out in this chapter revolves around the developments of scaffolds for 
remote σ-activation. This began with the investigation into different sulphur-linked biaryls 
and continued into the remote functionalisation of indole and carbazole derivatives. This 
chapter will initially be introduced using a perspective that was written for ACS Catalysis in 
2017 on techniques for the C–H functionalisation of indole on the benzenoid ring. This 
review will underline the strategic importance and key developments in the synthetic toolkit 
for selective and effective C–H functionalisation of biologically relevant structures such as 
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ABSTRACT:  The indole scaffold will continue to play a vital part in the future of drug 
discovery and agrochemical development. Due to this the necessity for elegant techniques 
to enable the selective C–H functionalization is vast. Early developments have led to 
primarily C2 and C3 functionalization due to the inherent reactivity of the pyrrole ring. 
Despite this, elegant methods have been developed to enable selective C–H 
functionalization on the benzen moiety at C4, C5, C6 & C7. This review focuses on the 
contributions made in benzenoid C–H functionalization of indoles and other related 




The indole heteroaromatic and has become one of the most widely studied organic 
templates over the past century.1 This is due to their wide prevalence in the natural world 
and biologically active structures (Figure 1a).2 The indole alkaloid motif itself is a bacterial 
intercellular signal molecule, and is also present in the natural amino acid tryptophan, the 
neurotransmitter serotonin, the plant growth hormone auxin, a number of marketed drugs 
sumatriptan (migraine), indomethacin (anti-inflammatory) and ondansetron (nausea) and 
bioactive hallucinogens such as dimethyltryptamine and LSD. From the review “Rings in 
Drugs” by Taylor, it is reported that the indole ring is present in 24 current marketed 
pharmaceuticals, where it lies as the 4th most prevalent heteroaromatic.3 
 
The biological relevance of the indole scaffold has pushed it through to the forefront 
of synthetic developments. Classical syntheses such as the Fischer,4 Bartoli,5 and Larock6 
have become universally used, amongst a multitude of other synthetic protocols.7 The 
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indole scaffold has also been a key substrate in the development of C–H functionalization 
methodologies for its synthesis and modification (Figure 1b).8 Whilst these methods 
effectively grant access to the bicyclic system, they require the requisite functionality of the 
indole ring to be pre-installed on the organic reagents.  
 
Transition metal-catalyzed C–H functionalization has emerged as a powerful tool for 
the late stage modification of biologically relevant structures such as indoles.9 The synthetic 
toolbox has expanded to utilize a variety of metal catalysts using multiple different 
techniques to install a huge selection C-C and C-X bonds.10 Effective C–H activation is 




Figure 1: (a) Biologically Relevant Motifs Containing the Indole Heteroaromatic (b) Site 




The indole scaffold has been widely used in both direct and directed C–H 
functionalization at C2 and C3, as covered in depth in an excellent review by Sandtorv.12 
There have also been a few elegant examples of systems that allow a reaction condition 
dependent switch between C2 and C3 functionalization.12c-d,13 
 
Due to the inherent reactivity of the pyrrole-type ring, the development of 
methodologies to enable site selective C–H functionalization on the benzenoid ring has 
remained a great challenge in catalysis.14 Despite this there have been a variety of elegant 
methods developed that will be discussed in detail herein, where this review will focus on 
accessing reactivity in less activated positions, at C4, C5, C6 & C7. These will be herein 
colour coded as in Figure 1b. The benzenoid C–H functionalization of related 
heteroaromatics such as carbazoles and benzothiophenes will also be discussed when 
relevant.   
 
FUNCTIONALIZATION AT C4 
The C4 position of an indole has been accessed almost exclusively through blocking 
the C3 position. This would then deem the C4 position the next most electron rich carbon 
centre on the indole structure. Jia and co-workers reported the direct C4 alkenylation of 
tryptophan derivatives employing palladium catalysis (Scheme 1). This reaction 
methodology gave complete selectivity for C4 however relatively high catalyst loadings and 
long reaction times were needed for more challenging substrates.15 
 
Scheme 1. Palladium-Catalyzed C4 Alkenylation of Tryptophan Derivatives 
 
 
Following on from this seminal example of C4 functionalization, Prabhu and co-
workers reported the complementary ruthenium-catalyzed alkenylation. This was proposed 
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to take place by the furnishing of C3 with an aldehyde directing group. It was shown that 
this directing group favoured forming a 6-membered transition state at C4 over a five 
membered metalacycle at C2 (Scheme 2). This alkenylation reaction was shown to be 
tolerant of a wide range of alkene coupling partners including acrylates, acrylonitrile, 
styrenes, and vinyl ketones.16 
 




In 2017, Prabhu reported the use of a C3-aldehyde directing group in selective C4 
amidation of free indoles. This reinforces the concept that the aldehyde directing group 
preferentially assist in C4 metalation (Scheme 3). This methodology permitted access to 





Scheme 3. Iridium-Catalyzed C4-Sulfonamidation of Indole Derivatives 
 
 
Prabhu and co-workers succeeded this with further insight into C4 vs C2 selectivity 
by developing complementary ketone directing groups at C3 where the methyl derivative 
selectively facilitated C–H functionalization at C2 under ruthenium catalysis, where the 
trifluoromethyl derivative exclusively gave C4 selectivity under complementary rhodium 
catalysis (Scheme 4). This along with the above investigation allowed the elucidation that 
stronger directing groups (COMe) carry out directed C–H insertion, giving C2 selectivity, 
and weaker directing groups (CHO, COCF3) assist in the stabilisation of direct electrophilic 
metalation.18 
 




This work has been expanded upon by Zhang and co-workers where a carboxylic 
acid directing groups enables double C2 and C4 alkenylation using rhodium catalysis. This 
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di-alkenylated product then undergoes an in-situ decarboxylation to afford a free C3 position 
(Scheme 5).19 
 
Scheme 5. Rhodium-Catalyzed C4 and C2 Di-alkenylation and in situ Decarboxylation 
 
 
In 2017, Shi and co-workers have utilized this directing group strategy to enable the 
palladium catalyzed C4 selective C–H arylation of indole derivatives. Here the bulky pivaloyl 
directing group preferentially cyclopalladates at C4 and subsequent oxidative addition of 
the aryl iodide and reductive elimination gives the C4-arylated indole (Scheme 6). The 
pivalate directing group can also be readily cleaved to the proton using glycolic acid.20 
 
Scheme 6. Palladium Catalyzed C4 Arylation of Indole Derivatives 
 
 
The same group also published the C4 alkylation of indoles in 2017, using 
hypervalent fluoroalkyl iodine reagents as coupling partners. Here, complementary to 
Prabhu’s work,18 they employed acetyl assistance to afford the relevant palladacycle to give 
the C4-substituted product (Scheme 7). The methodology was shown to be incredibly 
functional group tolerant, including boronate esters and benzothiophene. The directing 




Scheme 7. Palladium-Catalyzed C4 Alkylation of Indole Derivatives 
 
 
FUNCTIONALIZATION AT C7 
The first report to access the C7 position came from Iwao and co-workers in 1999. 
Here they employed a specialized sterically demanding directing group to facilitate directed 
ortho-lithiation at the C7 position. they then showed they could quench this organolithium 
species with a variety of electrophiles including silanes, CO2, DMF and alkyl groups 
(Scheme 8). Despite preferential selectivity for C7, C2 by-products were still observed in 
yields up to 13%.22 This work was improved on in 2003 by Snieckus and co-workers. Here 
they detailed the use of a phosphonate directing group which was proposed to enact 
regioselectivity in a similar manner to above, however here the directing group was 
completely selective for C7.23 
 





Shi and co-workers have recently devised a manner in which to apply Snieckus’ 
directing group to transition metal catalysed C–H functionalization rather than directed 
ortho-lithiation. Here they use a pyridine ligand to enable palladium-catalyzed selective C–
H arylation at C7 (Scheme 9). In this methodology competing direct C3 arylation was the 
main by-product observed although consistently in low quantities (with exception).24 
 
Scheme 9. Palladium-Catalyzed C7 Arylation of Indoles 
 
 
Ma and co-workers have also applied to the use of a sterically demanding directing 
group at N1 to afford C7 selectivity. Here the pivaloyl (COtBu) group acts as a weakly 
coordinating directing group for rhodium catalysis allowing C–H alkenylation (Scheme 10). 
The reaction methodology was shown to be widespread with 30 examples and yields up to 
98%. Despite this the catalysis was not tolerant of C6 substitution and occasional competing 




Scheme 10. Piv Directed C7 Selective Rhodium-Catalyzed C–H Alkenylation of Indoles 
 
 
Pan and co-workers have also described the C7-selective rhodium catalyzed C–H 
alkenylation of indazole derivatives. Here a urea directing group is employed in the reaction 
methodology (Scheme 11). The catalysis was also shown to be amenable to both electron 
poor (acrylate) and electron rich (styrene) coupling partners.26 
 
Scheme 11. Rhodium-Catalyzed C7-Selective C–H Alkenylation of Indole Derivatives 
 
 
Shortly after the work from Ma, Antonchick applied the pivaloyl directing group to 
the C7 selective C–H sulfonamidation on indoles, this time employing iridium catalysis 
(Scheme 12). This methodology was shown to be applicable to aryl, heteroaryl and alkyl 
sulfonylazides and to be tolerant of C6 functionalization. Indole structures synthesized in 
this report were also shown to inhibit HeLa cell proliferation. This manifests the biological 




Scheme 12. Piv Directed Iridium Catalyzed C–H Sulfonamidation of Indoles 
 
 
C7 functionalized indoles have been shown by multiple groups to be accessed via 
the indoline intermediate (Scheme 13). Here reduction of indoles, followed be directed C–
H functionalisation and subsequent re-oxidation to the indole structure gave the desired 
product (Scheme 13). The C7 functionalization of indolines has been widely explored and 
has been applied to alkenylation,28 alkylation,29 arylation,30 amidation,31 acylation,32 
cyanation,33 and chalcogenation34 reactions using a variety of metal systems.  
 
Scheme 13. C7 Functionalisation of Indolines to Access Indoles 
 
 
The above methodology functions via nullifying the reactivity of the C2 position 
towards directed metalation. This has also been used successfully by Smith and co-workers 
by using C2-substituted indoles in a C7 selective C–H borylation reaction (Scheme 14). 
Here the N–H is proposed to act as the directing group by coordinating the boronate ligand 
to enable site selective C–H iridation.35 Interestingly the same group have also reported the 




Scheme 14. C7 Iridium Catalysed C–H Borylation of 2-Substituted Indoles 
 
 
Movassaghi and co-workers expanded on this methodology by using Smith’s reaction 
conditions on C2 free substrates, allowing C2 and C7 diborylation followed by a C2 selective 
acid promoted deborylation, affording solely the C7 borylated structure.37 This methodology 
has also been applied under forcing conditions to afford the C2/5/7 triborylated indole.38 
   
One of the most important examples of C7 C–H functionalisation of free indole came 
from the Hartwig group in 2010. They reported the iridium-catalysed C–H borylation on free 
indole with no other tricks to give the C7 functionalized product. Here they used a transient 
bulky silyl directing group to direct cycloiridation at C7 (Scheme 15). This methodology was 
shown to be incredibly selective and applicable to various substituted indoles as well as 




Scheme 15. Iridium-Catalysed Silyl-Directed C–H Borylation at C7 
 
 
The C1-selective C–H functionalization of Carbazoles has also been explored via 
the furnishing of the NH with a directing group. A summary of the transformations, transition 
metal used and references is displayed in Scheme 16. This selectivity has been achieved 
in a wide number of systems as there is no competing direct selectivity observed at C2/C3 




Scheme 16. Transition-Metal Catalyzed C–H Functionalization of Carbazole Derivatives 
 
 
FUNCTIONALIZATION AT C6 
It has been demonstrated that the use of carefully tailored directing groups or 
reaction systems allow functionalization at C7. Unfortunately, the C6 position lies even more 
remote from a directing group, therefore other strategies have been employed to access 
this regioselectivity. These strategies have been more sparingly observed and more closely 
mimic those used for remote meta-functionalization.  
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The first to be discussed is the work by Baran and co-workers in 2015. They reported 
the remote C6 selective C–H borylation of tryptophan derivatives utilizing iridium chemistry. 
This selectivity was controlled by a bulky ligand to access the less hindered C–H bonds and 
selectivity issues were observed between C6 and C5 C–H borylation (Scheme 17). This 
was developed as the key step in the total synthesis of Verruculogen and Fumitremorgin 
natural products.41 
 
Scheme 17. Iridium-Catalysed Ligand-Controlled C6 C–H Borylation 
 
 
Yu and co-workers have pioneered the developments in remote functionalization via 
the use of a meticulously designed templated directing group.42 From this, they have 
developed the remote C6 olefination, arylation and acetoxylation of indolines. Among the 
scope of this reaction there were two indole motifs which were functionalised in a C–H 
alkenylation reaction in good selectivity at C6 (Scheme 18). In both examples C2 and C3 
are already functionalised. The template has been shown to be removable on the indole 








Shi and co-workers now applied established meta-selective C–H functionalization 
techniques to this N-phosphonate substituted indole. They successfully developed Gaunt’s 
copper-catalyzed meta-arylation technique on this structure to afford C6 functionalized 
material in absolute selectivity, a feature which the previous two techniques have not 
provided (Scheme 19).14h A very wide scope with varying indole and coupling partner 
functionality was shown to be amenable to the reaction conditions. The reported mechanism 
entails coordination of a copper(III) species to the phosphonate directing group which on 
steric grounds preferentially positions itself towards the C7 proton. Here Cu-Ph across the 
double bond, followed by rearomatization gives the C6-arylated indole. The group also 
reported the C6-alkenylation using the corresponding hypervalent iodine salt.44 
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Scheme 19. Copper Catalyzed C6 Selective C–H Arylation of Indoles 
 
 
In 2014 You and Zheng developed the catalytic C6 functionalization C2/C3-
disubstituted indoles using scandium triflate as catalyst. The reaction showed the indoles 
reacting with an aziridine in ring opening chemistry to afford C6 alkylated indoles after a 
reversible [3+2] annulation at the C2/C3 bridge (Scheme 20). DFT calculations elucidated 
a reversible annulation process that allowed the formation of the more thermodynamically 
stable C6 alkylated product. Again, with some of the above methods issues with C5 




Scheme 20. Scandium Triflate Catalysed C6 Alkylation of Indoles 
 
 
Ruthenium-catalyzed σ-activation has become a more widely used technique for the 
meta-functionalization of arenes.14j-k,46 Here a strong metalacycle enables radical 
functionalization para-to the cyclometalation. This concept was applied to the indole 
structure by Frost and co-workers in 2017 (Scheme 21). This methodology used a strongly 
coordinating directing group at N1 and a weakly coordinating directing group at C3 to enable 
remote C6 selectivity. The reported mechanism shows a C–H activation at C2 with 
interaction from both N1 (strong) and C3 (weak) directing groups. Redox radical generation 
from a ruthenium centre then enables remote radical addition to the most electronically 
activated benzenoid position. Computational Fukui indices were shown to validate the shift 
in electron density in the proposed cyclometalation at C2 to the remote C6 position.47 
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Scheme 21. Remote C6 Selective C–H Alkylation of Indole Derivatives via σ-Activation 
 
 
In 2016, Morandi reported the iron-catalyzed C–H amination of arenes. Here they 
employ the protonated hydroxylamine as a new amination reagent and iron sulphate as 
catalyst. Electronic bias and sterics were shown to affect the regioselectivity of 
functionalization in non-biased substrates. In the case of indoles (Scheme 22) the major C–
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H aminated product observed was with functionalization taking place at the C6. The 
methodology was also applied to dibenzofurans where a higher yield was observed 
although the selectivity issues remained.48 
 
Scheme 22. Iron Catalyzed C–H Amination of Indole and Dibenzofuran 
 
 
FUNCTIONALIZATION AT C5 
The most sparingly observed selectivity in direct indole functionalization has been 
accessing chemistry at C5. Despite selectivity issues in some methods discussed above 
between C6 and C5 there have been incredibly limited reports showing conditions that 
preferentially go for the C5 position.  
 
There have been reports of non-catalyzed Friedel-Crafts type acylation of the free 
indole structure using AlCl3 as a Lewis acid by Demopoulos. This was shown to lead to a 
mixture of C5 and C6 substituted indoles with ratios of generally ~3:1 in favour of C5 
(Scheme 23).49 The product was also shown to undergo heterogeneous palladium 
catalysed deformylation to give the solely C5 substituted product mixtures.  
 





The sole example of selective transition-metal catalyzed direct C5 functionalization 
of the indole benzenoid ring came out from the Shi lab in 2017. Here they used a 
combination of the pivaloyl directing group at C3 (which directs to C4) and the remote 
copper catalysed process (which enabled C6 functionalization) to permit access to the C5 
C–H bond (Scheme 24). The reaction pathway was proposed to follow the same 
mechanism as their work with the C6 arylation. As with the above methodology, the 
functionality at C3 (in this case the directing group) can be removed to give solely the C5 
substituted indole. In this case the directing group is removed cleanly using pTSA in glycol.20 
This report also completed Shi’s clean sweep of benzenoid indole functionalization having 
developed methods to access C4,5,6 & 7. 
 
Scheme 24. Copper-Catalyzed C5 Arylation of Indole Derivatives 
 
 
A clear majority of the examples that have been discussed above utilise a directing 
group on the pyrrole-type ring to enable positional selective catalysis on the benzenoid ring. 
However, there have been examples where a directing group on the benzene ring enables 
indole functionalization without reactivity at C2 or C3. The position of these directing groups 
enables a wide breadth of potential products. 
 
In 2017, Larrosa and co-workers reported the regioselective C–H functionalization 
of indole-carboxylic acids. When using indole-7-carboxylic acids, C6 arylation was the only 




Scheme 25. Ruthenium-Catalyzed C–H arylation of indole derivatives.  
 
 
When using indole-5-carboxylic acid the C6/C4 disubstituted structure was observed on 
using heightened catalyst loading. When using indole-6-carboxylic acid or 4-carboxy 
derivative C5 arylation was observed. On increasing the catalyst loading using certain 
substrates the C5/C7 difunctionalized motif is also observed. This showed that depending 
on the functionality present on the benzenoid ring, any regiochemistry could be accessed 
using their ruthenium catalysis.50 
 
Pedro and co-workers have also reported the organocatalyzed enantioselective 
Friedel-Crafts aminoalkylation of indoles on the carbocyclic ring directed by a hydroxy group 
already present on the benzenoid moiety of the indole heteroaromatic.51 
 
CONCLUSION 
The indole scaffold has become one of the most widely studied organic structure 
due to its prevalence throughout the natural product, pharmaceutical and agrochemical 
worlds. The ability to access site selective C–H functionalization on the benzenoid ring has 
remained a challenge due to the inherent reactivity of C2 and C3. In spite of this, elegant 
methods have come to the forefront of modern transition-metal catalysis. This review has 
covered the techniques to access the C4, C5, C6 and C7 positions of the benzenoid ring 
utilizing a vast number of remote functionalization techniques and selective directing group 
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chemistry. The development of site selective C–H functionalization will continue to be an 
integral part to synthetic development in the derivation of biologically relevant structures 
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3.3: Remote C6-Selective Ruthenium-Catalyzed C–H Alkylation of Indoles via σ-
Activation 
 
3.3.1: Introduction, Commentary and Preliminary Results 
 
The use of cleavable auxiliaries in meta-functionalisation is very attractive as one 
can install the strongly coordinating directing group onto a useful motif and then remove it 
to reveal the functionalised structure/building block.1 The goal of this project was to diversify 
the structures amenable to σ-activation by investigating different auxiliary templates and 
exploring the known meta-functionalisation reactions with these structures. The review 
perspective above will serve as the introduction to this chapter however preliminary results 
will be discussed herein.  
 
The investigation was initiated by synthesising a variety of S-linked arylpyrimidines, 
in the sulfide, sulfoxide and sulfone oxidation states and applying them to σ-activation 
methodology. Four test reactions were chosen for each oxidation state: Frost sulfonation,2 








Unfortunately, no meta-functionalisation was observed for any starting material. Only the 
sulfoxide showed conversion in sulfonation and tert-alkylation reactions, although this was 
only to the sulfide. This was proposed to take place through O-tosylation/alkylation on the 
charge separated sulfoxide and subsequent loss to form the naked sulfide.  
 
Following this, it was decided to investigate the use of N-substituted indoles in σ-
activation reactions. N-pyrimidinylindole was synthesized and submitted to the Frost 3° 
alkylation conditions using tert-butyl bromide as coupling partner. Interestingly tert-




Scheme 3-4: Ruthenium-Catalysed Functionalisation of N-pyrimidinylindole 
 
This is proposed have taken place through a radical functionalisation or through a Friedel-
Crafts-type mechanism. This suggested that a redox catalyst with an appropriate oxidation 
potential to form these tertiary radicals could have been formed using the reagents present. 
Our previous reports highlight the use of tertiary α-halocarbonyls as more efficient and 
reliable coupling partners in remote meta-functionalisation than tert-butyl bromide. Due to 
this, ethyl α-bromoisobutyrate was reacted with N-pyrimidinylindole under the alkylation 
conditions (Scheme 3-5). Under these conditions the C3 functionalised material was again 
observed, however the C3/C6 di-functionalised material was also isolated from the reaction 
mixture. Pleasingly the addition of acetic acid to create a “pH buffer” with the potassium 






Scheme 3-5: Ruthenium-Catalysed C3/C6 C–H Alkylation of N-pyrimidinylindole 
 
These two structures were further characterised by SCXRD to confirm regioselectivity of 
functionalisation. Both of these structures show functionalisation remote from the directing 
group, both in the equivalent “meta” positions of an indole. Despite this observation, it is 
well documented that the most inherent reactivity of an indole takes place at the 3 position, 
however the 6-position is notoriously unreactive. 
 
As discussed above the ability to access C6 functionalised indoles is not readily 
observed.5 Due to this we moved our investigation forward by other N-substituted indoles 
in this reaction, with strongly coordinating directing groups, weakly coordinating directing 
groups and non-coordinating (Scheme 3-6). Surprisingly the only substitution pattern that 
worked here was the structurally similar pyridyl unit, and boc, acyl, tosyl and benzyl 
derivatives were not tolerated in this reaction to either C3 or C6. The results from this point 
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ABSTRACT: The site-selective functionalization of an indole template offers exciting 
possibilities for the derivatization of molecules with useful biological properties. Herein, we 
report the remote C6 selective C–H alkylation of indole derivatives enabled by ruthenium(II) 
catalysis. Remote alkylation was achieved using N-pyrimidinyl indoles with an ancillary 
ester directing group at the C3 position. This ancillary directing group proved pivotal to 
reactivity at C6, with yields up to 92% achieved. A one-pot procedure to install this directing 
group followed by remote C6 functionalization has also been reported, both shown to 
proceed via ruthenium redox catalysis. Computationally calculated Fukui indices elucidated 
that the C6 position to be the most reactive vacant C–H site towards potential 
functionalization. When coupled with deuterium incorporation studies, a C2 
cyclometalation/remote σ-activation pathway was deduced. 
 
INTRODUCTION 
The development of transition metal catalyzed C–H functionalization has emerged 
as a very powerful tool to synthesize and derivate biologically interesting molecules.1 The 
indole heteroaromatic has received great attention over the past century due to their 
prevalence in a large number of natural products, pharmaceuticals and agrochemicals.2 
Because of this, the development of elegant methods for the synthesis of highly decorated 
indoles has received huge efforts in recent years.3 Due to the high potential of these motifs, 
indoles have been widely used as C–H activation templates. The C3 position has been 
shown to be the C–H bond with the most intrinsic reactivity in direct transition metal 
catalyzed C–H functionalization (Figure 1).4 C2 functionalization has been achieved using 
a variety of metal systems, primarily through functionalization of the NH bond with a 
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directing group. Here cyclometalation is facilitated via chelation assistance to afford C–H 
insertion and subsequent functionalization at C2.5 
 
 
Figure 1: Current sites of C–H functionalization of indoles. 
 
Additionally, carefully designed phosphonate directing groups have also granted access to 
C7 functionalized indoles in selected examples.6 
 
Remote reactivity at C6 of an indole has only been sparingly observed. Selected 
examples include the use of ligand controlled iridium catalysis by Baran,7 templated C–H 
insertion by Yu,8 and elegant studies by Shi and co-workers combining the phosphonate 
directing group and other remote functionalization techniques (Scheme 1).9 The ability to 
access remote unreactive C–H bonds has been a great challenge to catalytic chemists in 
recent years.10 Despite this, a few methods have prevailed: meticulous template design,11 
metal-directed σ-activation,12 the use of a transient mediator,13 and the careful manipulation 
of steric/electronic effects (albeit sparingly). 14 The use of σ-activation lends itself as the 
most atom-economical versus the other two methods which often lead to high quantities of 
waste product streams. This is especially the case in the templated work where often 
templates are pre-synthesized, installed and then removed.11   
 
Our previous work in the area depicts the remote meta-alkylation of 2-phenylpyridine 
using the α-bromo ester coupling partner.12c This was postulated to proceed via an ortho-
cyclometalation which promotes a remote σ-activation para- to metal insertion to afford net 
meta-substituted products. Herein, we report the expansion of this methodology away from 
privileged structures such as 2-phenylpyridine to biologically relevant structures such as 
indoles. Ackermann and co-workers have recently explored the use of pyrimidinyl-
substituted anilines in meta-functionalization12d and the expansion of motifs for remote 
activation is pivotal in moving towards broadly useful synthetic methodology. Here we have 
developed the remote C6 selective ruthenium-catalyzed C–H alkylation of pyrimidinyl-indole 
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derivatives. It is proposed to proceed via a C2 cyclometalation σ-activation pathway utilizing 
an ancillary directing group present at the C3 position 
 




RESULTS & DISCUSSION 
The investigation into the remote functionalization of indole derivatives began by 
applying our previous meta-alkylation conditions with 1-(pyrimidin-2-yl)-indole (1a, Scheme 
2a).12c This gave rise to two products, primarily C3 alkylated indole motif (3a) and 
interestingly the C3/C6 di-alkylated structure was also observed (4a).   Pleasingly, 
quantitative conversion of starting material 1a to 3a and 4a was observed on addition of 
acetic acid to the reaction mixture. The regioselectivity of functionalization was further 
confirmed via single crystal X-ray crystallography (Figure 2).15 
 
In the absence of the ruthenium catalyst no reactivity to either 3a nor 4a was 
maintained, despite the innate reactivity of the C3 position. The use of 1H-indole (1b, 
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Scheme 2b) in the reaction gave solely the C3 functionalized motif (3b) in excellent yields, 
however showed no selectivity to the C6 position (4b). This was also shown not to require 
the addition of AcOH, however still proceeded by a ruthenium-catalyzed mechanistic 
pathway. Interestingly, neither tert-butoxycarbonyl nor benzyl N-substituted indoles gave 
conversion to either product. This showed that an aromatic nitrogen or NH were vital to any 
catalytic functionalization, and a strongly coordinating directing group was key to granting 
access to C6 functionalized motifs. It should be noted that this initial C3 selectivity is 
complementary to the C2 selectivity that Stephenson and co-workers observed using 
ruthenium photocatalysis with similar coupling partners.16 
 
Scheme 2. Ruthenium(II)-catalyzed C–H alkylation of indolesa 
 
a Isolated yields after silica gel column chromatography 
 
 
Figure 2: X-ray crystallographic structures of 3a and 4a which confirm the functionalization 
regioselectivity. Ellipsoids as depicted at 30% probability and hydrogen atoms have been 
omitted for clarity. Atom colors: N, blue; O, red; C, grey.  
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As there was no observation of indole structures solely functionalized in the C6 
position, it was postulated that the C3 structure was an intermediate. This was investigated 
by resubmitting the C3 product (3a) to the reaction conditions. Pleasingly high conversions 
to di-substituted structure (4a) were observed via crude NMR analysis (entry 1, Table 1), 
leading to excellent isolated yields for remote σ-activation reactions.12 Reaction efficiency 
was maintained when using THF and 2-MeTHF as solvent (entries 2-3). The reaction was 
also shown to proceed with modest efficiency without AcOH (entry 5). It is proposed that 
the added AcOH facilitates protodemetalation at the end of the reaction cycle. However, it’s 
is not vital to reactivity as 2 equivalents are formed in the reaction mixture. Removal of 
KOAc nullified reactivity (entry 6) however increased loading (4 eq, entry 7) of potassium 
acetate showed some increased reactivity cf. without AcOH (entry 5). The reaction did not 
proceed in the absence of ruthenium catalyst (entry 8). This indicates that both C3 and C6 
functionalizations are driven by ruthenium catalysis. The synthesis of 3a was shown to be 
scalable, affording up to two grams of material (see Scheme S1 in supporting information). 
 
Table 1. Remote ruthenium(II)-catalyzed C6 C–H alkylation of indole derivative 
 
Entry Alteration from Standard Conditionsa 4a (%)b 
1 None 96 (80)c 
2 THF used as solvent 95 
3 2-MeTHF used as solvent 89 
4 DME used as solvent 56 
5 No AcOH 60 
6 No KOAc - 
7 4 eq KOAc, No AcOH 70 
8 No [RuCl2(p-cymene)]2 - 
9 Reaction carried out under air 9 
a Standard Conditions: 3a (0.25 mmol), 2a (0.75 mmol), [RuCl2(p-cymene)]2 (0.0125 mmol), KOAc (0.5 mmol), 
AcOH (0.5 mmol), 1,4-dioxane (1 mL), at 120 °C for 16 h under an argon atmosphere. b Direct conversion 
between 3a and 4a observed via crude NMR analysis. c Isolated Yield. 
 
To investigate whether the C3 functionalization solely functioned as a positional 
block, permitting access to C6 functionalization on steric grounds as the next most reactive 
site or if the ester group had some ancillary directing group effect, a pyrimidinyl indole 
bearing a methyl group in the C3 position was submitted to the reaction conditions (1c, 
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Scheme 3a). No conversion to any product was observed, which signifies the importance 
of the nature of the C3 functionality in activating the remote C6 position. A C2-Me blocked 
substrate was also submitted to the reaction conditions (1d, Scheme 3b), giving rise to 
neither the C3 mono-functionalized nor C3/C6 di-functionalized products. This shows that 
the C2 cyclometalation site is also necessary for the reaction to proceed. 
 
Scheme 3. Remote C6 functionalization of C3-Me and C2-Me indole derivatives 
 
 
Using this knowledge further indole derivatives with proposed ancillary directing 
groups (A) were synthesized (Scheme 4a). Firstly, an auxin derivative, without the gem-
dimethyl substituents, was shown to lead to conversion to product (4e) albeit in lower 
quantities. An inseparable, uncharacterisable polymeric byproduct was also obtained with 
this example, this could be due to the potential radical formed on the benzylic position of 
the ancillary directing group. Neither acetoxy (4f) nor formyl (4g) derivatives gave formation 








Further to this, a small screen of primary directing groups (P, Scheme 4b) was 
investigated. Pyridine (4h) and chloro-pyrimidine (4i) derivatives gave rise to good yields 
and the lack of primary directing group (4b) gave no conversion to product. This, along with 
the previous results, highlight the necessity for both the primary and ancillary directing 
groups for effective catalysis at C6 to take place. Various tertiary alkyl halides were 
submitted to the reaction conditions in order to create highly decorated indole structures 
(Scheme 5). The use of methyl α-bromoisobutyrate granted access to orthogonally 
functionalized positions with difficult to construct quaternary centers (4j). α-Bromo ketones 
have previously been used in ruthenium redox catalysis17 and were also shown to be 
amenable to this reaction methodology (4k). Fluorinated and cyclohexyl variants of the 
esters were tolerated (4l-m), although in poor yields Unfortunately, secondary esters were 
shown to give trace formation of C6 alkylated product (4n). Primary esters, tertiary acids, 
tertiary amides and tertiary nitriles were not tolerated in this methodology under these 






Scheme 5. Remote C6 functionalization of indole derivatives 
 
 
Despite its use in previous remote functionalizations,12c.d the use of tert-butyl bromide as 
coupling partner also afforded no C6 alkylated motif (4o) under these conditions.18 This 
shows the unique reactivity of these α-ester radicals through captodative stabilization.19 
Indole structures bearing electron donating groups gave excellent yields (4p), whereas 
electron poor arenes gave poorer yields (4r), consistent with our previous reports.12c The 
ortho-/para- directing character of alkoxy and halogen substituents could have contributed 
to the improved yields observed by further activation of the C6 position towards radical 
attack. C4-F substituted indole was shown to react in poor yields, exclusively at C7 (para- 
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to the fluorine see supporting information, Scheme S3). This was interpreted to take place 
via radical attack to the organic non-cyclometalated species which was also confirmed in 
silico to be the most reactive vacant site (Figure S1). 
   
It is possible to access the C3/C6 di functionalized motif (4a) directly from the 
unsubstituted indole derivative (1a). This allows one-pot ruthenium(II)-catalyzed C3 C–H 
alkylation and subsequent C3 enabled remote C6 selective C–H alkylation. Conditions were 
explored to drive the reaction methodology to the di-substituted motif (4a, Table 2). 
 
Table 2. Optimization of ruthenium(II)-catalyzed C3 C–H alkylation of indole derivatives 
 
Entry Solvent Base Acid Acid Eq 4a (%)b 3a (%)b 
1c 1,4-dioxane KOAc - - 8 21 
2c 1,4-dioxane KOAc AcOH 2 33 66 
3 2-MeTHF KOAc AcOH 2 34 62 
4 DME KOAc AcOH 2 45 48 
5 THF KOAc AcOH 2 57 39 
6 THF - AcOH 2 0 26 
7 THF NaOAc AcOH 2 9 35 
8 THF K2CO3 AcOH 2 3 6 
9 THF K2CO3d AcOH 2 43 46 
10 THF KOPiv AcOH 2 9 17 
11 THF KOAc PivOH 2 32 65 
12 THF KOAc TFA 2 3 31 
13 THF KOAc AcOH 3 46 56 
14 THF KOAc AcOH 10 31 69 
15 THF KOAc AcOH 33e 5 91 
a General Conditions: 1-(pyrimin-2-yl)-1H-indole (1a, 0.25 mmol), ethyl α-bromoisobutyrate (0.75 mmol), 
[RuCl2(p-cymene)]2 (0.0125 mmol, 5 mol%), Base (2 eq), Additive (x eq), Solvent (1 mL), 120 °C, 16 h under 
argon atmosphere. b Direct 1H NMR conversion. c From Scheme 2 for comparison. d + KOAc (30 mol%). e AcOH 
used as solvent instead of THF. 
   
A solvent screen showed that the use of THF led to more favorable formation of di-
functionalized product (entry 5). Several different bases (entries 7 -10) and acids (entries 
11-12) were used in the reaction however none gave superior conversion to the 
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KOAc/AcOH couple. The reaction system using K2CO3 as base (entry 8) was however 
shown to be reactivated on addition of catalytic quantities of KOAc (entry 9). This clearly 
demonstrates the need for a carboxylate partner for C–H metalation to take place at start 
the reaction.1a Interestingly it was shown increasing addition of AcOH correlated to 
increased selectivity towards mono-functionalized product 3a. This was exemplified by use 
of AcOH as solvent (entry 15) which led to almost exclusive formation of 3a. This highlights 
the importance of AcOH in the C3 functionalization of the pyrimidinyl substituted indole (1a), 
but is then detrimental to C6 functionalization in high quantities. This demonstrates that it is 
a careful balance of acid and base that drives to di-functionalization (4a). 
 
The scope of the one-pot C3 and subsequent C6 functionalization was then explored 
(Scheme 6). 5-substituted indoles (4n-p) gave one-pot reactivity parallel to the C6 
functionalization shown previously with the electron rich structure performing most 
efficiently. The pyridine directing group (4h) was shown to be amenable to this reaction 
albeit in slightly lower yields with respect to the pyrimidine counterpart. The use of the 5-
chloropyrimidine directing group (4i) led to the highest yield of one-pot C3 and subsequent 
C6 alkylation. This ability to carry out this double C–H functionalization allows simple quick 
diversification to create highly decorated complex structures.20 The mono-functionalized 
structures have also been shown to be amenable to resubmission to the reaction conditions 
to drive formation of the di-functionalized motif or reacted with a different coupling partner 








In order to determine reaction mechanism, experimental and computational 
mechanistic studies were undertaken. Our previous investigations in remote σ-activation 
methodology proposed a dual cyclometalation and radical pathway.12c Here, the presence 
of a radical mechanism was investigated by the use of a radical trapping agent (Scheme 7). 
Neither remote C6 functionalization nor one-pot C3/C6 di-functionalization were observed 
in the presence of stoichiometric TEMPO. One catalytic turnover was also observed using 
catalytic quantities of TEMPO, suggesting that a redox catalyst is unable to turn over in the 
presence of the radical trapping agent. As both reactions (Scheme 7a & 7b) were affected 
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by these investigations, it can be postulated that both C3 and C6 alkylation proceed via a 
radical pathway.21 
 
Scheme 7. TEMPO studies on remote alkylation of indole derivatives 
 
 
Deuterium incorporation studies using isotopically labelled AcOD were then 
performed to determine whether formation of C6 and C3 functionalized products are 
obtained via C2 insertion or C7 insertion (Scheme 8).  
 




Deuterium was incorporated into the C2 position in significant quantities (33%, Scheme 8a) 
and only in negligible amounts at C7 (<5%). This highlights that the C6 functionalization is 
most likely not accessed through C7 insertion as observed in Shi’s work but through a C2 
cyclometalation σ-activation pathway.9 Also seeing that similar D-incorporation is observed 
in 3a and 4a in the one-pot methodology (Scheme 9b), it could be suggested that these are 
formed through the same linear mechanistic pathway. 
 
The cyclometalated complex of 1a was synthesized and exposed to the reaction 
conditions (Scheme 9).5e Comparable efficiency to both mono and di-functionalization found 
previously was observed. This implies that such a cyclometalated species could be part of 
the catalytic cycle, either as a redox catalyst in radical generation or through a ortho-σ-
activation catalyst, activating the C3 position for initial radical attack.22 
 
Scheme 9. Remote functionalization using a well-define cyclometalated monomer 
 
 
In order to elucidate the reasoning behind the exclusive C6 functionalization we 
employed computational methods. Ritter and co-workers used nucleophilic Fukui indices as 
a simple method to predict selectivity in aromatic radical reactions in a recent report.23 We 
looked to apply this computational approach to the organic structures synthesized in this 
study as well as the equivalent cyclometalated complexes. In order to do this, the relative 
Fukui indices were calculated from NBO calculations for carbon atoms in both the organic 
(non-cyclometalated substrates) and a range of inorganic (cyclometalated at either the C2 
or C7 position) structures, shown in Figure 3 (additional structures in the SI).24 Our relative 
Fukui indices show the reactivity of carbons towards electrophilic attack with the most 
reactive carbon site for functionalization highlighted in red.24 
  
The inherent reactivity of the organic indole reagent, 1a, is unsurprisingly held at the 
C3 position according to the relative Fukui indices. Cyclometalation at C2 (1aB-C2) shows 
that C3 is still the most reactive carbon, however, an increase in relative reactivity of the C6 
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position is observed. As both these organic and inorganic structures are shown to activate 
the C3 position, it is still possible for initial C3 radical addition (to form 3a) to be achieved 
through an inner sphere or outer sphere mechanism. Cyclometalation at C7 (1aB-C7) shows 
a huge increase in reactivity at the C4 position. As this regioselectivity is not observed 
experimentally, alongside deuterium incorporation experiment results, it is concluded that 
this cyclometalated species is not involved in the formation of the C-6 functionalized product 
(4a). A computed free energy difference of 6.3 kcal mol-1 between the more stable 1aB-C2 
and 1aB-C7, also confirms the experimental regioselectivity.  
   
Relative Fukui indices were also calculated for the C3 functionalized material (3a), 
again cyclometalated at either the C2 or C7 position. Values for the organic 3a show that 
the most reactive site for C–H functionalization is the C4 position. Therefore, a radical 
addition mechanism to a non-cyclometalated species can be dismissed and consequently 
this demonstrates that the metal center and cyclometalation are directly responsible for the 
observed regioselectivity of the reaction. Two conformers of the C2 cyclometalated 
structure, 3aB-C2 have been optimized and are shown in Figure 4. The most stable 
conformer, 3aB-C2*, involves coordination of the ester group to the Ru center through the 
carbonyl oxygen, forcing ring-slippage of the para-cymene to η2 to accommodate this 
additional binding to 3a, whilst the acetate coordinates through both oxygen atoms (κ2). This 
additional binding of the ester group at the C3 position to the ruthenium stabilizes the 
organometallic structure by 3.4 kcal mol-1, when compared to 3aB-C2.  
    
The ability of 3a to access this more stable planar tridentate binding motif through 
the ester group could explain the improved remote functionalization via σ-activation 
observed for this substrate.  Previously, remote functionalization via this method has been 
primarily limited primarily to 2-phenylpyridine due to its strong planar ruthenacycle. 
Identification of this ancillary stabilization provided by the ester group at C3 presents the 





Figure 3. Relative nucleophilicity Fukui indices for organic and inorganic computed 
structures. Calculations were performed at the BP86/6-31G**&SDD(Ru) level of theory. 
Fukui indices were calculated with NBO total atomic charges from the optimized neutral 




Figure 4. Free energies of optimized conformers 3aB-C2 and 3aB-C2* using BP86/6-
31G**&SDD(Ru) in kcal mol-1 showing the impact of ester binding.  The ball-and-stick 
structure is of 3aB-C2* with the η2-para-cymene omitted for clarity. 
 
Based on results from both computational and experimental investigations, a 
plausible mechanism is proposed for the remote radical functionalization of 3a (Scheme 
10). The [RuCl2(p-cymene)]2 dimer is first broken apart using KOAc to form the proposed 
catalytically active monomer [Ru(OAc)2(p-cymene)] (which is competent in the reaction, see 
supporting information Scheme S2). Carboxylate assisted cyclometalation at C2 then 
occurs, including a proposed ring slip of the para-cymene to accommodate the primary and 
ancillary directing groups. A ruthenium(II) catalyst then most likely creates the tertiary alkyl 
radical via single electron transfer.12c The alkyl radical then attacks the cyclometalated 
species at the most activated vacant position, confirmed to be C6 in silico. Redox 
rearomatization then takes place using the ruthenium(III) generated previously and an 
equivalent of potassium acetate. Protodemetalation then occurs using AcOH to give the C6 
C–H alkylated product (4a) and reforms the catalytically active monomer. 
 
Conclusion 
In conclusion we have developed the first remote functionalization of indole 
derivatives via σ-activation. This was achieved using a cyclometalated ruthenium species 
at the C2 position of the indole. It has been reported that an ester ancillary directing group 
at C3 was essential for remote C–H alkylation at C6 to occur and yields of up to 92% were 
achieved applying this methodology. We also reported the one-pot installation of the ester 
at C3 via ruthenium catalysis followed by ruthenium-catalyzed remote C6 functionalization. 
Initial C3 functionalisation has been shown to proceed via a redox ruthenium-catalyzed 
pathway, as well as remote C6 functionalization via radical trapping experiments. Computed 
Fukui indices were applied to organic and cyclometallated inorganic structures to explain 
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the C6 position as the most reactive C–H site for functionalization. Work is ongoing to apply 
this template to other remote meta-functionalization reactions.  
 
Scheme 10. Plausible mechanism for remote C6 C–H alkylation of 3a 
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3.4: Ruthenium-Catalyzed Remote C4-Selective C–H Functionalization of 
Carbazoles via σ-Activation 
 
3.4.1: Introduction and Commentary 
 
 On the back of the success of the indole project, we were intrigued to see whether 
blocking the C2 and C3 positions of an indole could in turn enable selective cyclometalation 
at C7. This proposed cyclometalate (Scheme 3-7) could then potentially activate the remote 
C4 positions of the indole structure. This would grant access to a substrate-dependent 
complementary selectivity which could be an attractive strategy for accessing new chemical 




Scheme 3-7: Proposal for C4-Selective C–H Functionalisation of Indole Structures 
 
In order to investigate this theory, three test motifs based on the indole structure 
were synthesised. These substrates were the indoline, 2,3-diethylindole and carbazole 
heteroaromatics furnished with a pyrimidinyl directing group. All three substrates would not 
permit cyclometalation at C2, hopefully prompting the regioselectivity switch. These test 






Scheme 3-8: Ruthenium-Catalysed C–H Alkylation of Indole-Cored Variants 
 
These initial studies showed one of the structures was by far the most amenable to this 
remote functionalisation methodology, the carbazole derivative. The success of this 
derivative could be rationalised by looking at factors which have been previously suggested 
to be vital the reactivity of a σ-activation complex: stability and planarity.1 Whilst the 
carbazole motif may not necessarily provide a more stable metallocycle than the other 
structures, it does however possess planarity across the whole arene system. This could 
be crucial to its proposed reactivity. As discussed previously, there have been multiple 
systems that enable the selective C1 cyclometalation and subsequent functionalisation of 
carbazoles at C1.2 To this date there have been no reported methods to selective 
functionalise the C4 position. As carbazoles found widespread application in sensing3 and 
OLED4 applications, the ability to derivate these positions could prove to be a transformation 
of synthetic utility. From this point, it was decided to carry forward this project on C4 
carbazole derivation in reaction optimisation and development. The results from this point 
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ABSTRACT: The selective C–H functionalization of the carbazole heteroaromatic offers 
potential utility in drug discovery, sensing, and in organic electronics chemistry. Herein, we 
report the C4-selective C–H alkylation of carbazole derivatives furnished with a pyrimidine 
directing group at N9. This was realized using ruthenium σ-activation methodology, whereby 
C–H activation at C1 enables the interaction of this ruthenacycle, at the para position to the 
metal center, with tertiary alkyl radicals. This transformation was shown to be tolerant of a 
variety of α-halocarbonyl coupling partners and aryl substitution patterns with yields up to 
92% with complete selectivity for the C4 position of the carbazole structure. 
 
Transition metal catalyzed C–H functionalization has emerged as a powerful asset 
to the synthetic toolkit in the synthesis and derivation of organic structures, especially 
biologically relevant motifs.1 The inherent challenge in C–H functionalization of arenes is 
the differentiation of electronically similar C–H bonds. To overcome this, a directing group 
(DG) strategy is often employed to enable site selective cyclometalation via chelation 
assistance.2 Subsequent coordination of a coupling partner and reductive elimination 
pathways lead to ortho-C–H functionalized products. To move away from ortho-selectivity, 
elegant remote C–H functionalization techniques have come to the forefront of modern 





Carbazoles are a fused tricylic heteroaromatic with important applications in drug 
discovery,6 sensing,7 and organic functional materials such as OLEDs.8 For these reasons, 
studies into the modification of this heterocycle have allowed selective C–H functionalization 
of carbazoles and their derivatives. A majority of these techniques have been applied 
through furnishing the NH with a directing group. This enables directed C–H 
functionalization at the C1 position (Scheme 1a). This research has permitted the formation 
of a number of C-C and C-X bonds utilizing a multitude of catalytic systems.9 Limited remote 
functionalization techniques studied on the related indole heteroaromatic have also granted 
access to C2 substituted carbazoles, with notable contributions from Baran.10 C3-
substitution has been widely studied due to the nucleophilic nature of this carbon enabling 
SEAr chemistry.11 To our knowledge, selective C–H functionalization of the C4 position has 
yet to be reported. 
   
Ruthenium-catalyzed σ-activation has become a vital technique in the meta-
functionalization of arenes,12 enabling the sulfonation,12,13 alkylation,14 bromination,15 
nitration,16 and benzylation17 of aromatic systems. In this methodology, formation of a strong 
and stable ruthenacycle, allows para-functionalization to the metal center, via the electronic 
influence of the Ru-C σ-bond, instead of traditional oxidative addition/reductive elimination 
pathways. This gives net meta-C–H functionalization to the directing group. The ruthenium 
center has also been shown to act as a dual role catalyst, facilitating the redox formation of 
a radical which interacts with the para position of the arene. After our success in applying 
this technique to indole structures to enable selective C6 functionalization,18 we sought to 
use this methodology on carbazole structures to give complementary C4 C–H 
functionalization (Scheme 1b). 
 





   From ours and others previous contributions to meta-alkylation methodology,14,18 we 
began our investigations by applying previously reported conditions for catalytic σ-activation 
to N-pyriminidylcarbazole (1a), using ethyl α-bromoisobutyrate as a coupling partner (2a) 
(Table 1, entries 1-4). To our delight we found that when using potassium acetate as base 
(entries 1-2), efficient C–H functionalization was shown to take place. As with our previous 
report, the addition of acetic acid into the reaction mixture was also shown to be beneficial 
(entry 2).18 
 
Table 1. Ruthenium-Catalyzed C4 Selective C–H Alkylation of Carbazole Derivativesa 
 
Entry Base Acid Acid (eq) 3a %b 
1 KOAc - - 53 
2 KOAc AcOH 2 68 (48)c 
3 K2CO3  
(+MesCO2H 30 mol%) 
- - 7 
4 K2CO3  
(+ Piv-Val-OH 30 mol%) 
- - 7 
5 K2CO3  - - - 
6 K3Citrate AcOH 2 45 
7 K2Tartrate AcOH 2 56 
8 AdCO2Na AcOH 2 58 
9 MesCO2K AcOH 2 80 (61)c 
10 MesCO2K MesCO2H 2 64 
11 MesCO2K AdCO2H 2 66 
12 MesCO2K TFA 2 15 
13 MesCO2K AcOH 0.5 80 
14 MesCO2K AcOH 1 84 (68) 
15 MesCO2K AcOH 4 68 
16d MesCO2K AcOH 1 61 
17e MesCO2K AcOH 1 - 
18f MesCO2K AcOH 1 90 (76) 
a General Conditions: 9-(pyrimidin-2-yl)-9H-carbazole (1a, 0.25 mmol), ethyl α-bromoisobutyrate (2a, 0.75 
mmol), [RuCl2(p-cymene)]2 (5 mol%, 0.0125 mmol), Base (2 eq), Acid (x eq), 1,4-dioxane, 120 °C, 16 h, under 
argon atmosphere. b Direct conversion between starting material and product, as dictated by crude 1H NMR. c 
Isolated yields given in brackets. d Reaction carried out at 100 °C. e Reaction carried out without [RuCl2(p-
cymene)]2. f [Ru(O2CMes)2(p-cymene)] (10 mol%) used as catalyst. 
 
On screening different bases, we found that the sterically demanding potassium 2,4,6-
trimethylbenzoate (MesCO2K) was the most amenable to these reaction conditions (entries 
6-9). MesCO2H and AdCO2H were shown to be reactive acids in this methodology however 
neither superior to AcOH (entries 10-11). We then found that reducing the quantity of acid 
to 1 equivalent led to the highest formation of product (entries 13-15). Reaction efficiency 
 182 
 
was also shown to reduce in an air atmosphere (entry 16) and was completely nullified in 
the absence of ruthenium catalyst (entry 17). The use of the pre-synthesized 
[Ru(O2CMes)(p-cymene)] monomer was shown to lead to the highest formation of product 
thus far (entry 18) In order to confirm regioselectivity, 3a was characterized via single crystal 
X-ray diffraction (Figure 1).19 
 
 
Figure 1. SCXRD Structure of 3a confirming regioselectivity of functionalization.19 CCDC 
1574475. 
 
   With optimal conditions in hand to enable efficient and selective C4 alkylation, we were 
intrigued to employ a number of coupling partners to the reaction conditions to explore their 
respective reactivity in this chemistry (Scheme 2). The reaction methodology was explored 
using both the commercially available dimer (Conditions A) and the pre-synthesized 
monomer (Conditions B). A variety of ester substituents were shown to be very well 
tolerated in the remote functionalization methodology (3aa-3ad) with impressive yields up 
to 92% for the tert-butyl ester variant. It is noteworthy to find that tert-butyl bromide was not 
amenable to this methodology (3ae) despite its use in several previous reports in σ-
activation methodology.13 When the difluoro ester was reacted under the optimized 
conditions (3ag), unfortunately no product was observed, even with the addition of 
triarylphosphine co-catalysts, which has been shown to be vital in meta-difluoroalkylation 
strategies.14e-f Perfluorobenzyl ester derivative (3ah) was also tolerated in the chemistry. It 
has been demonstrated that generally the preformed monomer outperforms the dimer 
however in not all cases. 
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Following this, the variation of the aryl functionality was then studied. Mono-substituted 
bromo (3b) and chloro (3c) carbazole derivatives were shown to effective substrates for this 
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chemistry with exclusive selectivity for the non-substituted ring.18 Trichloro-substituted 
structure (3d) was shown to proceed in reduced yields but exclusively at C4, truly 
highlighting the remote nature of the functionalization, as this enables the C–H derivation 
between two substitution patterns. For further experiments and further unsuccessful 
coupling partners, see supporting information. 
 
At this point, we were intrigued to see how the influence of the N-substitution pattern 
affected the efficiency of C4-functionalisation (Scheme 3a). To this end, we investigated 
non-coordinating (1e) and weakly metal-coordinating (1f) substituents. Unfortunately, 
neither of these structures were shown to give conversion to any regioselectivity of product. 
Interestingly, when we submitted unsubstituted carbazole (1g) to the reaction conditions we 
observed selective C3-alkylation in low yields (Scheme 3b). This manifests that without the 
directing group the C3 position is the most activated to interact with a radical. This shows 
that this σ-activation methodology not only produces a highly selective and efficient C–H 
functionalization of carbazole, we also observe a complete switch in regioselectivity to the 
innate reactivity. It is also noteworthy that cf. 1f-g (Scheme 3a), the presence of the NH is 
critical to any reactivity. We then looked to apply this methodology to two other substrates 
to expand the scope beyond carbazole structures. To this end, 2,3-diethylindole and 
indoline derivatives were synthesized and submitted to the reaction conditions (Scheme 
3c).   




To our surprise neither substrate showed any reactivity towards the remote functionalization 
methodology (5a-b). This could be due to the indole substituent at C2 interfering with stable 
and planar cyclometalation or the ethyl at C3 blocking tert-alkylation on steric grounds (4a). 
In the case of the indoline, the cyclometalate formed on the benzenoid section of the 
structure may not be stable enough to permit remote σ-activation (4b). 
 
We were intrigued to run radical trapping experiments to inform whether this reaction 
followed previous trends in σ-activation. We employed TEMPO trapping studies, where 
catalytic quantities (30 mol%) of the radical trapping agent gave a reduced conversion of 
66% to product, and the use of stoichiometric quantities of TEMPO (1 eq) led to a sharp 
drop to 15% conversion. These findings suggest that a radical single electron transfer 
mechanism may be at play. It was then of interest to run H/D scrambling experiments using 
isotopically labelled acetic acid. This showed that there is deuterium incorporation in the C1 
and C8 positions in both the starting material (10% each, see supporting information) and 
product (19% each). This suggests a reversible C–H activation at the ortho-positions. It 
must be noted that lack of scrambling at C5 in the product and at C4/C5 in the starting 
material rules out a readily reversible direct C–H metalation at these positions and lends 
itself to a C1 σ-activation protocol. 
 
From these mechanistic investigations and from previous insights into this 
methodology, a plausible mechanism for the remote C4-alkylation of carbazole derivatives 
is proposed (Scheme 4). It is suggested that the ruthenium para-cymene dimer is broken 
apart using the MesCO2K base to form the catalytically active ruthenium bis-
mesitylcarboxylate monomer ([Ru(p-cm)(O2CMes)2]). This monomer can then facilitate C–
H activation at the C1 position ortho to the pyrimidine directing group. A single electron 
transfer process with an inner sphere or outer sphere ruthenium complex can then form the 
tertiary α-halocarbonyl radical. This radical then interacts with the sterically encumbered 
ruthenacycle at the para position to the metal center via a σ-activation process (likely due 
to a shift in electron density to the C4 position). Redox electron shuttling and proton 
abstraction enables rearomatization of the arene. Protodemetalation using either the 
MesCO2H formed previously or the stoichiometric AcOH releases the C4-alkylated structure 
and reforms the catalytically active monomer. 
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In conclusion, we have presented the remote C4-selective C–H alkylation of 
carbazole derivatives. As far as we are aware, there are no known selective methods to 
directly functionalize the carbazole at this position. We have demonstrated that furnishing 
the carbazole heteroaromatic with a pyrimidine directing group enabled a σ-activation 
process whereby a stable and planar ruthenacycle at C1 enabled interaction of the para 
position (C4) with a tertiary alkyl radical. We also demonstrate the unique reactivity of α-
halocarbonyl coupling partners cf. aliphatic alkyl halides. 
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4.1: Ruthenium-Catalyzed para-Selective C–H Alkylation of Aniline Derivatives 
 
4.1.1: Introduction and Commentary 
 
 Covered in depth in the excellent and aptly named review “Reaching the South” by 
Maiti,1 the search for para-selective C–H functionalisation entails accessing an even more 
remote position on an aromatic ring vis-à-vis ortho- and meta-selective C–H 
functionalisation. For these reasons, as discussed in Chapter 1, most of the techniques do 
not utilize chelation assistance and rely more heavily on electronic and steric influences to 
enable selective C–H functionalisation. 
 
 For a number of years, we have been incredibly interested in the complete control 
of site selectivity in C–H functionalisation. Over the course of previous investigations of 
meta-alkylation methodology, we had observed para-substituted motifs as by-products 
(Scheme 4-1). Under conditions from our previous report,2 using aniline furnished with a 
pyrimidine directing group and an α-halocarbonyl as a coupling partner, despite repetition 
of the reaction to reaffirm our findings, we only observed exclusively the para-C–H alkylated 






Scheme 4-1: Ruthenium-Catalysed C–H Alkylation of N-pyrimidinylaniline 
 
Due to Ackermann’s report on the meta-selective C–H alkylation of the same aniline 
substrate, under very similar conditions,3 expanding this methodology could provide a 
complementary selectivity, and potentially a complementary mechanism, to that already 
known. (Scheme 4-2). This stark contrast of selectivity under almost identical conditions 




Scheme 4-2: Ruthenium-Catalysed meta-Alkylation of N-pyrimidinylaniline 
 
During the investigation into this work, two papers were published which eluded to 
a potential mechanism at work here. The first from Weng and Lu4 displayed the copper 
catalysed C–H sulfonation of aminonaphthalene derivatives, and the second from 
Manolikakes5 again depicts the C–H sulfonation of aniline derivatives, here utilising 






Scheme 4-3: Copper Catalysed para-C–H Sulfonation of Arenes 
 
The mechanism proposed by Weng & Lu was of incredible interest to us as it presents a 
fundamentally similar process to σ-activation, where the copper metal centre is capable of 
cyclometalation (in this case at N–H) and redox radical generation (Scheme 4-4).4 
 
From this point, these mechanistic insights were combined with our knowledge on 
ruthenium-catalysed σ-activation, to optimise and develop our para-selective C–H 
functionalisation into a useful synthetic methodology. The results herein are presented from 
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Ruthenium-Catalyzed para-Selective C–H Alkylation of 
Aniline Derivatives 
Jamie A. Leitch,[a] Claire L. McMullin,[a] Andrew J. Paterson,[a], Mary F. Mahon,[a] 
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ABSTRACT:  The para-selective C–H alkylation of aniline derivatives furnished with a 
pyrimidine auxiliary is herein reported. This is proposed to take place via a N–H activated 
cyclometalate formed in situ. Experimental and DFT mechanistic studies elucidate a dual 
role ruthenium catalyst. Here the ruthenium catalyst can undergo cyclometalation via N–H 
metalation (as opposed to C–H metalation in meta-selective processes) and form a redox 
active ruthenium species, to enable site selective radical addition at the para position. 
 
Transition-metal catalyzed C–H functionalization has evolved into a widespread and 
effective technique to derivate (hetero)arenes and especially biologically relevant motifs.[1] 
The innate hurdle in C–H functionalization is the differentiation of electronically and 
sterically similar C–H bonds in an organic structure. To overcome this, a directing group 
strategy is often employed to enable selective ortho-C–H functionalization via chelation 
assistance with respect to the directing group.[2] Recent developments have allowed 
carefully tailored catalytic systems to permit meta-selective C–H functionalization.[3] These 
methods utilize three primary techniques; templated directing group design,[4] the use of a 
transient mediator,[5] and σ-activation by a metal center.[6] Accessing complementary para-
selective methodologies typically takes advantage of electronic effects to permit C–H 
functionalization at the para position of an electron rich arene, with pioneering reports from 
Gaunt,[7] Nicewicz,[8] and Ritter[9] (Scheme 1a). There have been examples of the use of 
extended templates by Maiti,[10] and the careful manipulation of steric effects by Itami[11] and 
Nakao.[12],[13] In a recent report Weng and Lu described the use of 5-membered 
aminopyridine-based bidentate cyclometalates in the para-C–H functionalization of 
aminonaphthalene derivatives.[14] ,[15] 
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Herein, we demonstrate that certain aniline derivatives can undergo para-selective 
C–H alkylation reactions catalyzed by ruthenium complexes.  σ-Activation focuses on the 
use of strongly bound ruthenacycles which can activate remote positions via electronic 
effects.[6] Ackermann applied this concept to aniline derivatives furnished with a pyrimidine 
directing groups to enable meta-selective alkylations (Scheme 1b). 
 
 
Scheme 1. Previous Reports on Site Selective Catalytic C–H Functionalization in the 
Context of this Work. 
 
We were intrigued to investigate whether complementary Ru-N cyclometalation of 
anilines (as opposed to Ru-C in in meta-selective sigma activation strategies), could lead 
to an active catalyst which may permit complementary para-C–H functionalization (Scheme 
1c). Anilines have been widely used as templates for C–H functionalization development,[16] 
due to their ubiquity in active pharmaceuticals[17] and agrochemicals.[18] This concept was 
initially investigated by submitting aniline to slightly modified conditions from our previous 





Scheme 2. Ruthenium Catalysed para-C–H Alkylation of Aniline  
 
This led to primarily the ortho/para-substituted aniline (3a), whereby an in situ lactamization 
can take place on at the ortho position, amongst multiple other products. No C–H alkylation 
products were observed in the absence of ruthenium catalyst or in the presence of radical 
scavenger TEMPO. This suggests a redox catalyst is formed in situ enabling radical arene 
functionalization. Encouraged by this, we endeavored to promote a solely para-selective 
transformation by using a bespoke N-substituted auxiliary (Table 1). 
 
Despite its use in other meta-alkylation methodologies a pyrimidine auxiliary (1b) 
gave the para-substituted structure in modest conversions (entry 1).[6d],[19] No meta-
functionalization was observed, however competing di-C–H alkylation occurred on the 
auxiliary (4b), albeit in low amounts. It is worth noting throughout the auxiliary optimization, 
there was no observation of the ortho/para-disubstituted structure. Pleasingly the use of 5-
chloropyrimidine as the auxiliary (1c) led to completely selective para-functionalization 
(entry 2). Pyridyl (1e) and Acetanilide (1f) did not lead to any C–H functionalized products 
(entries 4-5), and pyridoyl derivative (1g) was also unsuccessful (entry 6). A screen of 
solvents identified TBME (tert-butyl methyl ether) as the optimal reaction medium (entries 
6-8). A ligand screen manifested that removal of the ligand entirely was of benefit to the 
reaction (entries 10-13), and could be due to a reduction in undesired ortho-cyclometalation. 
Unfortunately, isolated yields in this methodology were found to be substantially lower than 
NMR yields, primarily due to polymeric byproducts formed which were indistinguishable via 
proton NMR (see ESI, Scheme S3). Interestingly on increasing the temperature to 140 °C, 
we observed formation of competing meta-selectivity (entry 13), and importantly no 
























Aux = auxiliary [a] Standard Conditions: aniline derivative (0.25 mmol), methyl α-bromoisobutyrate (0.75 mmol), 
[RuCl2(p-cymene)]2 (0.0125 mmol), ligand (0.075 mmol), K2CO3 (0.5 mmol), solvent (1 mL) under a N2 
atmosphere. [b] 1H NMR Yield. [c] * denotes position of di-functionalization. [d] isolated yield. [e] at 140 °C. [f] 
under an air atmosphere. [g] no ruthenium catalyst 
 
With suitable conditions in hand to access para-substituted structures, we applied 
this methodology to a range of coupling partners and substituted arenes (Scheme 3).[20] 
 
Entry[a] Aux Ligand Solvent 3 %[b] 4 %[b] 5 %[b] 
1 1b NaOAc 1,4-dioxane 35 6[c] - 
2 1c NaOAc 1,4-dioxane 39 - - 
3 1d NaOAc 1,4-dioxane 16 10[c] - 
4 1e NaOAc 1,4-dioxane - - - 
5 1f NaOAc 1,4-dioxane - - - 
6 1g NaOAc 1,4-dioxane - - - 
7 1c NaOAc PhMe 56 - - 
8 1c NaOAc DCE 56 - - 
9 1c NaOAc TBME 81 - - 
10 1c MesCO2H TBME 77 - - 
11 1c Piv-Val-OH TBME 70 - - 
12 1c DMEDA TBME 85 - - 
13 1c - TBME 86 
(55)[d] 
- - 
14[e] 1c - TBME 55 - 38 
15[f] 1c - TBME 71   




Scheme 3. Scope of Ruthenium-Catalyzed para-Selective C–H Alkylation of Aniline 
Derivatives 
 
This scope showed that a variety of tertiary alkyl esters could be applied in modest 
yields (3c-3ce). A cyclohexyl derivative was also shown to be amenable to the reaction 
(3cf), and must be noted that all of these examples proceeded with absolute selectivity for 
the para position. On varying the ring electronics, it was found that 3-substitution was 
tolerated well (3h-m) and that the none of the electronic influences of these substituents 
overrode the selectivity dictated by the N-substitution pattern. The quinazoline heterocycle 
was also shown to be applicable to this methodology, again in modest yields (3na-3nd).  
We anticipated that under certain conditions, the regioselectivity of functionalization 
could be switched to a meta-selective protocol using identical an starting material and 
coupling partner (Scheme 4).[21] With carboxylate assistance as well as a change of solvent 
from 1,4-dioxane to DME, the meta-selective reaction was strongly favored and led to 
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corresponding meta-C–H alkylated product with very high selectivity (99:1 m/p) (Scheme 
4). It must be noted removal of the AcOH still favors meta-selectivity, however is less 
pronounced. This suggests that in a proposed equilibrium between N–H and C–H 
cyclometalated complexes, the use of a carbonate base (K2CO3) could favor an N–H 
cyclometalation to form para-substituted products, whereas acetate bases (KOAc) could 
favor an ortho-C–H cyclometalation to form meta-substituted products. 
 
 
Scheme 4. Ruthenium-Catalyzed meta-C–H Alkylation of Aniline Derivative 
 
As we were observing a definitive shift in selectivity from meta to para, it was of 
interest to perform experimental and computational mechanistic studies to provide rationale 
to a proposed Ru-N cyclometalation/activation pathway.  Initially we carried out radical 
scavenger studies using TEMPO where the use of stoichiometric amounts led to complete 
suppression of reactivity. The isolation of polymeric byproducts, and the unique reactivity of 
α-halocarbonyls are also indicative of a radical mechanism.  
 
The proposed mechanism for the remote para C–H alkylation does not involve 
cyclometalation on the aromatic ring via ortho-C–H cyclometalation. In order to explore this 
an isotopically labelled derivative 1c-d5 was submitted to the reaction conditions (Scheme 
5a). This showed that under the para conditions there was negligible H/D scrambling (~2%) 
in either the unreacted starting material or the product. This suggests readily reversible 
ortho-C–H cyclometalation is not possible. The complementary meta-selective conditions 
did however give rise to substantial scrambling in both recovered starting material and 
meta-alkylated product. Despite this, Huang and co-workers did not observe deuterium 
scrambling in their report.[6f] It must be noted there was no substantial hydrogen 
incorporation at either meta or para positions in either investigation, which demonstrates 




Scheme 5. Mechanistic Studies on para Alkylation Methodology 
 
Acetanilide was chosen as a model comparison for a crossover study due to similar 
electronic influence on the ring, pKa of the N–H, and that it contains a metal coordinating 
group (Scheme 5b). If the pyrimidine is only generating a redox active species capable of 
forming the tertiary radicals, which can then interact with an electron rich organic structure, 
one would expect to see a mixture of para-C–H alkylated pyrimidine (3c) and acetanilide 
(3f). No presence of 3f was observed and 3c was isolated in equable yields. This strongly 
suggests that the C–H functionalization taking place at the para position is directly 
influenced by electronic effects of a coordinated ruthenium species. This result along with 
the previous insights suggest a σ-activation/redox pathway analogous to previous meta-






Density Functional Theory (DFT) calculations of the competing N–H and C–H 
activation of 
1c have been computed for acetate or carbonate as the base (see Figure 1 and ESI for 
discussion).[22] A change in preferred activation and hence mechanism occurs, with acetate 
favoring C–H activation and hence a meta-selective mechanism, whilst carbonate has a 
lower barrier to N–H activation and a para-selective product. 
 
 
Figure 1: Summary of DFT calculated free energies (kcal mol-1) relative to the most stable 
intermediate, for the competing C–H and N–H activations of 1c at [Ru(p-cymene)(O2CR)]+ 
in dioxane, when R = Me (acetate) or OH (carbonate).[22] 
 
In summary, we have reported the selective para-C–H alkylation of aniline 
derivatives, making use of pyrimidine and quinazoline auxiliaries. Experimental and 
computational mechanistic studies suggest that the addition takes place via a radical 
process to a ruthenium species cyclometalated at N–H rather than C–H (previously seen). 
This positional cyclometalation has been proposed to dictate the selectivity, which permits 
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The following work has been moved from the supporting information. A proposed viable 
mechanism based on experimental and computational mechanistic findings (see 6.1.9: DFT 
Discussion), is proposed as below. The ruthenium dimer is broken apart using potassium 
carbonate and solvent to produce a catalytically active monomer. This monomer then forms 
a 4-membered cyclometalate as a bidentate aminopyrimidine ligand, shown to be a feasible 
in silico. Redox radical generation via single electron transfer (SET) from a ruthenium(II) 
species (which could be the inner sphere or outer sphere catalytic species) gives the tertiary 
alkyl radical. This radical then interacts para to the location of the metal centre, at the para 
position of the aniline. Redox rearomatization and proton abstraction gives the C–H 
alkylated arene and subsequent protodemetalation with potassium bicarbonate or from the 
coupling partner gives the product and reforms the ruthenium monomer. Despite these 
understandings a mechanism involving a coordinated ruthenium-assisted deprotonation 
(without formal formation of a Ru-N bond) cannot be ruled out. This anionic nitrogen could 













The development of catalytic C–H functionalisation chemistry will continue to see a rapid 
influx of reaction systems in years to come. The ability of this technique to bypass pre-
functionalisation necessary in traditional cross coupling methodology will make it a major 
player in discovery and, in time, industrial kilo scale processes.  
 
One of the key problems in C–H functionalisation is the differentiation of sterically and 
electronically similar C–H bonds in a chemical structure. The use of metal-chelating 
directing groups has enabled pioneering developments in selective ortho-functionalisation 
of arenes. This chemistry was rapidly evolved to enable the use of weakly coordinating 
directing groups and base metals to facilitate catalysis. 
 
Chapter 2 of this thesis focused on the use of biologically relevant weakly coordinating 
directing groups in ortho-C–H functionalisation. At the outset of this work, this area had 
focused on ubiquitous functional groups, which could be further transformed or removed, 
rather than utilizing directing groups with intrinsic biological relevance. We sought to use 
the oxazolidinone heterocycle as a proof of concept of this methodology. As N-
aryloxazolidinones are the core of a family of antibacterials and anticoagulants, the ability 
to access untapped chemical space on these structures could lead to biologically interesting 
structures. We developed the ortho-C–H alkenylation of N-phenyloxazolidinone as a model 
reaction, and expanded it into using heterocyclic variants derives from amino acids as well 
as a variety of arenes. We were then intrigued to apply this to other heterocycles, which led 
to the C–H alkenylation of N-arylhydantoins (the core of antiandrogens). Both 
methodologies were shown to be tolerant of widespread functionality and both were shown 




Moving beyond ortho-selective C–H functionalisation has seen elegant catalytic methods to 
enable meta-selective chemistries. These have relied on a variety of techniques including 
meticulously designed templates, using a transient mediator at the ortho-position, and 
ruthenium-catalysed σ-activation. The latter of these entails the use of strongly bound ortho 
cyclometalates which can electronically activate the remote para position to the metal. This 
brings about a net meta-functionalisation protocol. σ-Activation also forms the basis of 
Chapter 3. 
 
At the outset of this project, ruthenium-catalysed σ-activation had relied heavily on the use 
of model substrates such as 2-phenylpyridine. Here, an incredibly strongly bound, planar, 
ruthenacycle creates an excellent σ-activation complex. The focus of my endeavours in this 
catalysis was in expanding the scope of structural templates amenable to this chemistry. 
This led to the use of indole derivatives in the remote C6-functionalisation of indoles 
furnished with a strongly coordinating directing group at N1 and a weakly coordinating 
directing group at C3. This enabled the first use of indoles in σ-activation, and also accessed 
a notoriously benign position to C–H functionalisation (C6). This concept was also applied 
to carbazole derivatives where a shift in the site of cyclometalation to the benzenoid ring 
(cf. pyrrole type ring in indole) led to a shift in the regioselectivity of functionalisation to C4. 
 
Moving further beyond meta into para-C–H functionalisation, we are more-so at the mercy 
of steric and electronic control, rather than proximal chelating groups. Due to our interest in 
radical reactions, stemming from our previous work on σ-activation, we were intrigued to 
see whether altering a position of cyclometalation to N–H instead of C–H could still generate 
a redox active ruthenium catalyst, and still enable selective C–H functionalisation. However, 
in this case on using aniline derivatives the site of functionalisation would be shifted to a 
para-selective methodology. This was achieved using anilines furnished with a 5-
chloropyrimidine auxiliary, whereby a complementary N–H cyclometalation promoted 
selective para-C–H functionalisation. 
 
The revolution of replacing platinum group metals with base metals has already begun. The 
synthetic toolkit has already expanded to enable almost pretty much any C-C and C-X bond 
forming transformation imaginable. 
 
With regards to the future of σ-activation, despite a rapid increase in the number of reaction 
methodologies available, structural templates amenable, and now potential shifts in 
regioselectivity in C–H functionalisation, one section of the process is still ambiguous. Since 
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the discovery in 2015 that in fact radicals are the primary active functionalisation reagent, 
an influx of systems based on this knowledge has come through to the forefront of catalytic 
development. However, there has been limited information on the true nature of the radical 
formation, the redox potential of these redox active co-catalysts, and there is even less 
knowledge on the nature of the interaction of the radical and the arene. Is the ruthenium 
dictating selectivity via induction of electron density to the aromatic ring? Is this a charge-
transfer radical addition? Is there direct interaction of the molecular orbitals on the 
ruthenium and incoming radical? Is there a second inner sphere metal centre? 
 
We have begun to utilise computational methods in aiding our understanding of this 
chemistry. Thus far, this has mostly focused on the use of Fukui indices, which demonstrate 
that the ruthenium centre places most electron density at a certain position of an arene with 
respect to the location of cyclometalation and, to this date, this computational method has 
not failed us in predicting/validating regioselectivities. Despite this, more in silico and 
electrochemical understanding is absolutely paramount to the development of this 
technique, to take us from elegant proof of concept methodology to a broadly synthetically 
useful technique, in the meta-functionalisation of arenes via rapid and rational catalyst 
design and reaction development. 




Chapter 6: Experimental 
 
6.1: Data and Supporting Information for “Ruthenium(II)-Catalyzed C–H 
Functionalization using the Oxazolidinone Directing Group as a Weakly 
Coordinating Directing Group: Experimental and Computational Insights” 
 
In the interest of presentation in a thesis, NMR spectra, crystallography data and 
computational data have not been included. However, in the interest of the reader these are 
available online at: 
http://pubs.acs.org/doi/suppl/10.1021/acscatal.6b01370/suppl_file/cs6b01370_si_001.pdf 
The supporting information has also been submitted to formatting and colour changes, 




Proton, carbon and fluorine NMR spectra were recorded on Bruker 300 MHz or Agilent 
Technologies 500 MHz spectrometer (1H NMR at 300 MHz or 500 MHz, 13C{1H} NMR at 
126 MHz or 75 MHz and 19F NMR at 470 MHz). Chemical shifts for protons are reported in 
parts per million downfield from Si(CH3)4 and are referenced to residual protium in the 
deuterated solvent (CHCl3 at 7.26 ppm, D2O at 4.79 and CD3OD at 3.31). Chemical shifts 
for fluorines are reported in parts per million downfield from CFCl3. NMR data are presented 
in the following format: chemical shift (number of equivalent nuclei by integration, multiplicity 
[app = apparent, br = broad, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, dt 
= doublet of triplets, dq = doublet of quartets, ddd = doublet of doublet of doublets, m = 
multiplet], coupling constant [in Hz], assignment). Electrospray ionisation ultrahigh 
resolution time-of-flight mass spectrometry (ESI–UHR–TOF–MS) was performed on a 
Bruker maXis mass spectrometer. Electrospray ionisation high resolution time-of-flight 
mass spectrometry (ESI–HR–TOF–MS) was performed on a Bruker micrOTOF 
spectrometer. Infrared (IR) spectra were recorded on a Perkin–Elmer 1600 FT (Fourier 
transform) IR spectrophotometer, with absorbencies quoted as wavelength (ν [in cm−1]). 
Melting points were obtained on a Bibby Sterilin SMP10 melting point machine and are 
uncorrected. 
 
Analytical thin-layer chromatography (TLC) was performed on aluminium-backed plates 
coated with Alugram® SIL G/UV254 purchased from Macherey–Nagel and visualised with 
UV light (254 or 365 nm) and/or KMnO4, 2,4-DNPH or I2/Silica staining. Silica gel column 
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chromatography was performed using 60 Å, 200-400 mesh particle size silica gel purchased 
from Sigma–Aldrich. Samples were loaded as saturated solutions in an appropriate solvent 
system. 
 
All reactions were performed using reagents obtained from Sigma-Aldrich, Acros Organics, 
Alfa Aesar, Fluorochem chemicals without further purification unless stated. [RuCl2(p-
cymene)]2 was purchased from STREM chemicals. All water used was purified through a 
Merck Millipore reverse osmosis purification system prior to use. Anhydrous acetonitrile 
(MeCN), anhydrous dichloromethane (CH2Cl2), anhydrous tetrahydrofuran (THF) and 
anhydrous toluene (PhMe) were dried and degassed by passing through anhydrous 
alumina columns using an Innovative Technology Inc. PS-400-7 solvent purification system 
(SPS) and stored under an atmosphere of N2 prior to use. 
 
Reactions were performed in oven-dried glassware and under a blanket of N2 if not stated. 





6.1.2: Optimisation of Ruthenium Catalysed C–H Alkenylation 
 
Proton NMR conversions were taken from the labelled diagnostic protons. Only one product 
formed from reaction (complete mono-selectivity) and no observed starting material 
















Entry Solvent Conversion (Yield) 
1 Xylene 0 
2 Trifluorotoluene 0 
3 Dioxane 56 
4 THF 30 
5 NMP 0 
6 CH3CN 15 
7 DMF 0 
8 No Solvent 47 
9 Ethyl Acrylate 36 
10 H2O 0 
11 DME 72 (68) 
12 AcOH Trace 
13 2-MeTHF 70 (66) 
14 tBuOMe 36 
15 CPME 30 
16 Diglyme 46 







Entry Component Excluded Conversion 
1 [RuCl2(p-cymene)]2 0 
2 AgSbF6 0 
3 Cu(OAc)2 0 
4 CuCl2 (No Acetate) 0 








Entry Additive - 20 mol% Conversion 
1 KPF6 10 
2 AgPF6 28 










Entry Bifunctional Oxidant/Base Conversion 
1 Cu(OAc)2.H2O 77 
2 Ag2CO3 13 
3 AgOAc 48 
4 AgOAc – 2 eq 64 










Entry Oxidant – 1 eq Conversion 
1 K2S2O8 0 
2 Oxone 0 
3 AgxO 0 
4 TBHP 0 
5 Cu(OAc)2.H2O
a Trace 










Entry Oxidant Conversion 




3 FeCl3 14 
4 Benzoquinone 39 
5 Na2S2O8 32 
6 O2 – 1 atm 56 






Entry Temperature / °C Conversion 
1 80 15 
2 100 68 

















Entry Time / h Conversion 
1 4 40 
2 8 64 
3 12 71 
4 24 78 
 
  
Entry Atmosphere Conversion 
1 Closeda 72 
2 Argon 66 







Entry AgSbF6 mol% Cu(OAc)2.H2O eq  Acrylate eq Conversion 
1 5 1 3 65 
2 10 1 3 78 
3 10 2 3 70 
4 10 3 3 68 
5 10 1 1 71 








Entry Solvent / mL Solvent / M Conversion (Yield) 
1 1 1 M 80 (76) 
2 2 0.5 M 75 









Previous work in the field has been shown to use two equivalents of Cu(OAc)2.H2O in similar 
transformations. Despite only using one equivalent in this work, it is still necessary to 
attempt to reduce this loading and instead use air as the environmentally benign terminal 
oxidant. The reaction was run with co-catalytic Cu(OAc)2.H2O which was shown to afford 
the C–H alkenylated scaffold in moderate isolated yield (Scheme 7). This allows only the 









6.1.3: Synthesis of Starting Materials  
 




To a solution of N-(2-hydroxyethyl)aniline (6.27 mL, 6.86 g, 50 mmol), triethylamine (13.95 
mL, 10.12 g, 100 mmol) and CH2Cl2 (100 mL) at 0 °C was slowly added phosgene (20% wt 
in toluene) (24.73 mL, 4.95 g, 50 mmol) in CH2Cl2 (50 mL) using a dropping funnel. After 
addition was complete the mixture was stirred at room temperature for 1 hour. To the 
mixture was added 150 mL saturated NaHCO3 solution at 0 °C and was left to stir for a 
further 15 mins. The organic layer was removed and the aqueous layer was extracted with 
2 x 150 mL EtOAc. The combined organics were washed with 3 x 150 mL 1M HCl solution 
then 1 x 150 mL brine. The organic layer was dried over MgSO4 and concentrated in vacuo. 
The crude mixture was recrystallized from hot EtOH to give white crystalline solid, 1a, 67% 
(4.58 g). 1H NMR (500 MHz, CDCl3) δ 7.54 (2H, d, J = 8.7 Hz, ArH), 7.40–7.35 (2H, m, ArH), 
7.14 (1H, td, J = 7.4, 1.1 Hz, ArH), 4.50–4.44 (2H, m, OCH2), 4.08–4.02 (2H, m, NCH2). 13C 
NMR (126 MHz, CDCl3) δ 155.42 (NC(O)O), 138.42 (ArC), 129.21 (ArC), 124.23 (ArC), 






Synthesis of ethylcarbamate protected amino alcohols 
 




To a solution of ethanolamine (3.02 mL, 3.05 g, 50 mmol), triethylamine (8.32 mL, 6.07 g, 
60 mmol) in CH2Cl2 (100 mL) at 0 °C was added dropwise ethyl chloroformate (5.71 mL, 
6.51 g, 60 mmol). The solution was allowed to stir for 30 mins before allowing the solution 
to return to room temperature and allowed to stir overnight. The solvent was removed in 
vacuo and re-diluted in EtOAc. The resulting slurry was filtered using a silica plug eluting 
with EtOAc. The solvent was again removed in vacuo and the crude oil was purified using 
silica gel chromatography (EtOAc:Hexanes 90:10) to give pure compound, isolated as a 
clear off-white oil, 70% (4.65 g). 1H NMR (500 MHz, CDCl3) δ 5.52 (1H, s, NH), 4.04 (2H, 
q, J = 7.1 Hz, NCH2), 3.64–3.58 (2H, m, OCH2), 3.26–3.21 (2H, m, OCH2), 1.17 (3H, t, J = 
7.1 Hz, OCH2CH3). 13C NMR (126 MHz, CDCl3) δ 157.55 (NC(O)O), 61.79 (OCH2), 61.08 








To a solution of valine (4.68 g, 40 mmol) in MeOH (100 mL) at 0 °C was added dropwise 
thionyl chloride (4.3 mL, 60 mmol). The mixture was then heated to reflux overnight. The 
resulting solution was concentrated in vacuo. This material was re-dissolved in dry THF 
(150 mL) and at -5 °C was added lithium aluminium hydride (4.56 g, 120 mmol) in four 
portions. The resulting mixture was stirred for 30 mins and then allowed to return to room 
temperature and stir for a further 1 hour. The reaction mixture was cooled to 0 °C and in 
subsequent portions was added, 4.56 mL H2O, 4.56 mL NaOH (15% in H2O) and 13.68 mL 
H2O. The reaction was left to stir for 1 hour at room temperature. The resulting slurry was 
filtered and the filtrate was dried over MgSO4 and concentrated in vacuo to give a crude 
amorphous solid (3.2 g, 31 mmol). This solid was suspended in H2O (30 mL) and was added 
sodium bicarbonate (5.21 g, 62 mmol) and CH2Cl2 (90 mL) to form a biphasic mixture. Ethyl 
chloroformate (3.23 mL, 3.68 g, 34.1 mmol) in CH2Cl2 (5 mL) was added dropwise and after 
addition was complete the reaction was allowed to stir at room temperature overnight. The 
reaction mixture was concentrated in vacuo to give a slurry which was re-diluted in EtOAc 
and filtered using a silica plug eluting with EtOAc. The solvent was again removed in vacuo 
and the crude oil was purified using column chromatography (EtOAc:Hexanes 80:20) to 
give clear off-white oil, 20% (1.37 g). 1H NMR (500 MHz, CDCl3) δ 5.02 (1H, s, NH), 4.08 
(2H, q, J = 7.0 Hz, OCH2), 3.69–3.55 (2H, m, OCH2), 3.43 (1H, app s, NCH), 3.08 (1H, s, 
OH), 1.82 (1H, td, J = 13.3, 6.6 Hz, CH(CH3)2, 1.21 (3H, t, J = 7.1 Hz, OCH2CH3), 0.95–
0.87 (6H, m, CH(CH3)2). 13C NMR (126 MHz, CDCl3) δ 157.62 (NC(O)O), 63.76 (OCH2), 
61.10 (OCH2), 58.54 (NCH), 29.36 (CH(CH3)2), 19.62 (CH(CH3)2), 18.61 (CH(CH3)2), 14.68 









To a solution of leucine (5.25 g, 40 mmol) in MeOH (100 mL) at 0 °C was added dropwise 
thionyl chloride (4.3 mL, 60 mmol). The mixture was then heated to reflux overnight. The 
resulting solution was concentrated in vacuo. This material was re-dissolved in dry THF 
(150 mL) and at -5 °C was added lithium aluminium hydride (4.56 g, 120 mmol) in four 
portions. The resulting mixture was stirred for 30 mins and then allowed to return to room 
temperature and stir for a further 1 hour. The reaction mixture was cooled to 0 °C and in 
subsequent portions was added, 4.56 mL H2O, 4.56 mL NaOH (15% in H2O) and 13.68 mL 
H2O. The reaction was left to stir for 1 hour at room temperature. The resulting slurry was 
filtered and the filtrate was dried over MgSO4 and concentrated in vacuo to give a crude 
amorphous solid (3.8 g, 32 mmol). This solid was suspended in H2O (30 mL) and was added 
sodium bicarbonate (5.38 g, 64 mmol) and CH2Cl2 (90 mL) to form a biphasic mixture. Ethyl 
chloroformate (3.33 mL, 3.80 g, 35.2 mmol) in CH2Cl2 (5 mL) was added dropwise and after 
addition was complete the reaction was allowed to stir at room temperature overnight. The 
reaction mixture was concentrated in vacuo to give a slurry which was re-diluted in EtOAc 
and filtered using a silica plug eluting with EtOAc. The solvent was again removed in vacuo 
and the crude oil was purified using column chromatography (EtOAc:Hexanes 80:20) to 
give clear off-white oil, 27% (2.05 g). FT-IR (thin film): νmax (cm-1) = 3329.4, 2956.2, 1688.4, 
1581.6. 1H NMR (500 MHz, CDCl3) δ 5.17 (1H, s, NH), 4.11–3.95 (2H, m, OCH2), 3.66 (1H, 
s, OH), 3.54 (1H, dd, J = 11.0, 2.9 Hz, NCH), 3.43 (2H, d, J = 3.8 Hz, OCH2), 1.66–1.52 
(1H, m, CH(CH3)2), 1.34–1.20 (3H, m, OCH2CH3), 1.21–1.03 (2H, m, CH2), 0.84 (6H, d, J = 
6.6 Hz, CH(CH3)2). 13C NMR (126 MHz, CDCl3) δ 157.15 (NC(O)O), 65.56 (OCH2), 60.83 
(OCH2), 51.16 (NCH), 40.54, 24.76 (CH2), 23.08 (CH(CH3)2), 22.17 (CH(CH3)2), 14.56 










3-Amino-2-hydroxypropanol (3.101 mL, 40 mmol) was suspended in CH2Cl2 (110 mL) and 
H2O (35 mL). To the biphasic mixture was added sodium bicarbonate (6.72 g, 80 mmol) 
followed by dropwise addition of ethyl chloroformate (4.00 mL, 42 mmol) at 0 °C. The 
reaction was left to return to room temperature and stir overnight. The solvent was removed 
in vacuo. The resulting slurry was dissolved in EtOAc and was filtered using a silica plug 
eluting with EtOAc. The solvent was again removed in vacuo to give a thick pale yellow oil, 
91% (5.943 g). 1H NMR (300MHz, CDCl3): δ 5.43 (1H, s, NH), 4.11 (2H, q, J = 7.9 Hz 
(OCH2), 3.77 (1H, app dt, J = 10.2, 5.2 Hz, CHOH), 3.58 (2H, ddd, J = 17.2, 11.6, 4.8 Hz, 
OCH2), 3.38 (2H, m, NCH2), 3.31 (1H, s, OH), 3.26 (1H, s, OH), 1.24 (3H, t, J = 7.1 Hz, 
OCH2CH3). 13C NMR (75MHz, CDCl3): δ 158.2 (NC(O)O), 71.4 (OCH2), 64.0 (CHOH), 61.6 
(OCH2), 43.4 (NCH2), 14.8 (OCH2CH3). Data is in line with literature precedent1 
 




To a solution of the above compound (3.26 g, 20 mmol), triethylamine (1.12 mL, 0.81 g, 11 
mmol), dimethylaminopyridine (4.48 g, 36.7 mmol) in 50 mL CH2Cl2 was added tert-butyl-
dimethylsilyl chloride (3.014 g, 20 mmol),. The reaction was stirred overnight at room 
temperature. The solvent was then removed in vacuo. The crude mixture was purified using 
column chromatography (EtOAc:Hexanes 70:30) to yield a thick pale yellow oil, 3.155g, 
57%. 1H NMR (300MHz, CDCl3): δ 5.17 (1H, s, NH), 4.10 (2H, q, J = 7.1 Hz, OCH2), 3.73 
(1H, m, CHOH), 3.67-3.34 (4H, m, OCH2 + NCH2), 2.95 (1H, s, OH), 1.22 (3H, t, J = 7.1 Hz, 
OCH2CH3), 0.88 (9H, s, SiC(CH3)3), 0.06 (6H, s, SiCH3). 13C NMR (75MHz, CDCl3): δ 157.6 
(NC(O)O), 71.4 (OCH2), 65.0 (CHOH), 61.3 (OCH2), 43.9 (NCH2), 18.5 (OCH2CH3), 14.9 
(SiC(CH3)3, 5.16 (SiC), 4.46 (SiC). Data is in line with literature precedent1 
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Synthesis of N-phenyloxazolidinones 1aa-ca 
 




The procedure was adapted from literature method.1 In an oven dried carousel tube, to a 
solution of ethyl carbamate protected amino alcohol (1 eq), 2,2,6,6-tetramethyl-3,5-
heptanedione (Ligand A, 20 mol%) and aryl iodide (2 eq) in CH3CN (0.25-0.5 M) was added 
caesium carbonate (2 eq) and copper iodide (10 mol%). The carousel tube was sealed with 
a Teflon cap closing the tap. The reaction was heated to 100 °C for 20 h. The mixture was 
diluted in EtOAc and filtered using a silica plug, eluting with EtOAc. The solvent was 
removed in vacuo and the crude mixture was purified using column chromatography 
(EtOAc:Hexanes 50:50 unless otherwise stated) to yield N-aryloxazolidinone.     
 




The procedure was adapted from a literature method.2 In an oven dried carousel tube, to a 
solution of 2-oxazolidinone (1 eq), (±)-trans-1,2-diaminocyclohexane (Ligand B, 10 mol%) 
and aryl bromide in 1,4-dioxane (2 M) was added potassium carbonate (2 eq) and copper 
iodide (5 mol%). The carousel tube was sealed with a Teflon cap and the tube was purged 
with Argon for 10 minutes before closing the tap. The reaction mixture was heated to 120 
°C for 18 h. The mixture was diluted in EtOAc and filtered using a celite plug, eluting with 
EtOAc. The solvent was removed in vacuo and the crude mixture was purified using column 
chromatography (EtOAc:Hexanes 50:50 unless otherwise stated) or via recrystallization 
from hot EtOH to yield N-aryloxazolidinone. 






General Procedure A was followed using the following compounds: ethyl 2-hydroxy-
ethylcarbamate (0.67 g, 5 mmol), copper iodide (0.095 g, 0.5 mmol), 2,2,6,6-tetramethyl-
3,5-heptanedione (0.21 mL, 0.18 g, 1 mmol), caesium carbonate (3.26 g, 10 mmol), 4-
iodoanisole (2.34 g, 10 mmol) and CH3CN (20 mL). Column chromatography gave an off-
white solid, 1aa, 21% (0.20 g). 1H NMR (500 MHz, CDCl3): δ 7.44 (2H, d, J = 8.9 Hz, ArH), 
6.91 (2H, d, J = 8.9 Hz, ArH), 4.47 (2H, t, J = 7.9 Hz, OCH2), 4.05–4.00 (2H, m, NCH2), 3.80 
(3H, s, ArOCH3). 13C NMR (126 MHz, CDCl3) δ 156.41 (NC(O)O), 131.53 (ArC), 120.32 
(ArC), 114.31 (ArC), 61.38 (OCH2), 55.56 (ArOCH3), 45.75 (NCH2). Data is in line with 
literature precedent1 
 




General Procedure A was followed using the following compounds: ethyl 2-hydroxy-
ethylcarbamate (0.13 g, 1 mmol), copper iodide (0.019 g, 0.1 mmol), 2,2,6,6-tetramethyl-
3,5-heptanedione (0.042 mL, 0.037 g, 0.2 mmol), caesium carbonate (0.65 g, 2 mmol), 4-
iodotoluene (0.44 g, 2 mmol) and CH3CN (4 mL). Column chromatography gave an off-
white solid, 1ab, 81% (0.14 g). 1H NMR (500 MHz, CDCl3) δ 7.43–7.38 (2H, m, ArH), 7.16 
(2H, d, J = 8.2 Hz, ArH), 4.43 (2H, dd, J = 8.8, 7.2 Hz, OCH2), 4.00 (2H, dd, J = 8.8, 7.2 Hz, 
NCH2), 2.32 (3H, s, ArCH3). 13C NMR (126 MHz, CDCl3) δ 155.49 (NC(O)O), 135.88 (ArC), 
133.84 (ArC), 129.67 (ArC), 118.47 (ArC), 61.41 (OCH2), 45.45 (NCH2), 20.85 (ArCH3). 








General Procedure B was followed using the following compounds: 2-oxazolidinone (0.17 
g, 2 mmol), copper iodide (0.019 g, 0.1 mmol), (±)-trans-1,2-diaminocyclohexane (0.024 
mL, 0.023 g, 0.2 mmol), potassium carbonate (0.55 g, 4 mmol), 1-bromo-4-tert-
butylbenzene (0.35 mL, 0.43 g, 2 mmol) and dioxane (1 mL) Column chromatography gave 
a white crystalline solid, 1ac, 60%, (0.26 g). 1H NMR (500 MHz, CDCl3) δ 7.48–7.43 (2H, 
m, ArH), 7.41–7.37 (2H, m, ArH), 4.50–4.41 (2H, m, OCH2), 4.07–4.00 (2H, m, NCH2), 1.31 
(9H, s, J = 2.1 Hz, C(CH3)3). 13C NMR (126 MHz, CDCl3) δ 155.58 (NC(O)O), 147.32 (ArC), 
135.86 (ArC), 126.10 (ArC), 118.35 (ArC), 61.51 (OCH2), 45.52 (NCH2), 34.52 (C(CH3)3), 
31.52 (C(CH3)3. Data is in line with literature precedent.3  
 
 




General Procedure B was followed using the following compounds: 2-oxazolidinone (0.17 
g, 2 mmol), copper iodide (0.019 g, 0.1 mmol), (±)-trans-1,2-diaminocyclohexane (0.024 
mL, 0.023 g, 0.2 mmol), potassium carbonate (0.55 g, 4 mmol), 1-fluoro-4-iodobenzene 
(0.12 mL, 0.22 g, 2 mmol) and dioxane (1 mL) Column chromatography gave an off-white 
solid, 1ad, 34%, (0.12 g). 1H NMR (500 MHz, CDCl3) δ 7.52–7.44 (2H, m, ArH), 7.09–7.00 
(2H, m, ArH), 4.46 (2H, dd, J = 8.7, 7.3 Hz, OCH2), 4.02 (2H, dd, J = 8.7, 7.3 Hz, NCH2). 
13C NMR (126 MHz, CDCl3) δ 159.40 (d, J = 243.8 Hz, ArCF), 155.50 (NC(O)O), 134.51 (d, 
J = 2.8 Hz, ArC), 120.18 (d, J = 7.9 Hz, ArC), 115.86 (d, J = 22.5 Hz, ArC), 61.40 (OCH2), 
45.59 (NCH2). Data is in line with literature precedent.3  
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General Procedure B was followed using the following compounds: 2-oxazolidinone (0.17 
g, 2 mmol), copper iodide (0.019 g, 0.1 mmol), (±)-trans-1,2-diaminocyclohexane (0.024 
mL, 0.023 g, 0.2 mmol), potassium carbonate (0.55 g, 4 mmol), 1-fluoro-4-iodobenzene 
(0.12 mL, 0.22 g, 2 mmol) and dioxane (1 mL) Column chromatography gave an off-white 
solid, 1ae, 34%, (0.12 g). 1H NMR (500 MHz, CDCl3) δ 7.52–7.44 (2H, m, ArH), 7.09–7.00 
(2H, m, ArH), 4.46 (2H, dd, J = 8.7, 7.3 Hz, OCH2), 4.02 (2H, dd, J = 8.7, 7.3 Hz, NCH2). 
13C NMR (126 MHz, CDCl3) δ 159.40 (d, J = 243.8 Hz, ArCF), 155.50 (NC(O)O), 134.51 (d, 
J = 2.8 Hz, ArC), 120.18 (d, J = 7.9 Hz, ArC), 115.86 (d, J = 22.5 Hz, ArC), 61.40 (OCH2), 
45.59 (NCH2). Data is in line with literature precedent.3  
 
 




General Procedure A was followed using the following compounds: ethyl 2-hydroxy-
ethylcarbamate (0.13 g, 1 mmol), copper iodide (0.019 g, 0.1 mmol), 2,2,6,6-tetramethyl-
3,5-heptanedione (0.042 mL, 0.037 g, 0.2 mmol), caesium carbonate (0.65 g, 2 mmol), 1-
bromo-4-iodobenzene (0.57 g, 2 mmol) and CH3CN (4 mL). Column chromatography gave 
an off-white solid, 1af, 71% (0.17 g). 1H NMR (500 MHz, CDCl3) δ 7.46 (2H, app d, J = 8.0, 
0.9 Hz, ArH), 7.42 (2H, app d, J = 7.3, 1.7 Hz, ArH), 4.46 (2H, t, J = 7.5 Hz, OCH2), 4.06–
3.96 (2H, m, NCH2). 13C NMR (126 MHz, CDCl3) δ 155.14 (NC(O)O), 137.50 (ArC), 132.07 








General Procedure A was followed using the following compounds: ethyl 2-hydroxy-
ethylcarbamate (0.67 g, 5 mmol), copper iodide (0.095 g, 0.5 mmol), 2,2,6,6-tetramethyl-
3,5-heptanedione (0.21 mL, 0.18 g, 1 mmol), caesium carbonate (3.26 g, 10 mmol), 4-
iodobenzotrifluoride (1.47 mL, 2.72 g, 10 mmol) and CH3CN (20 mL). Column 
chromatography gave a white solid, 1ag, 55% (0.63 g). 1H NMR (500 MHz, CDCl3) δ 7.62 
(2H, d, J = 7.4 Hz, ArH), 7.56 (2H, d, J = 7.2 Hz, ArH), 4.46 (2H, t, J = 7.1 Hz, OCH2), 4.07–
3.96 (2H, m, NCH2). 13C NMR (126 MHz, CDCl3) δ 155.02 (NC(O)O), 141.34 (ArC), 126.16 
(q, J = 3.8 Hz, ArC), 125.49 (d, J = 32.8 Hz ArC), 124.14 (app d, J = 271.4 Hz, ArCF3), 
117.63 (ArC), 61.47 (OCH2), 44.86 (NCH2). Data is in line with literature precedent1 
 




General Procedure B was followed using the following compounds: 2-oxazolidinone (0.17 
g, 2 mmol), copper iodide (0.019 g, 0.1 mmol), (±)-trans-1,2-diaminocyclohexane (0.024 
mL, 0.023 g, 0.2 mmol), potassium carbonate (0.55 g, 4 mmol), 4-bromobiphenyl (0.47 g, 2 
mmol) and dioxane (1 mL) Column chromatography (EtOAc:Hexanes 30:70) gave an off-
white solid, 1ah, 34%, (0.16 g). 1H NMR (500 MHz, CDCl3) δ 7.62 (4H, s, ArH), 7.58 (2H, 
dt, J = 7.9, 1.5 Hz, ArH), 7.46–7.42 (2H, m, ArH), 7.36–7.32 (1H, m, ArH), 4.53–4.48 (2H, 
m, OCH2), 4.13–4.08 (2H, m, NCH2). 13C NMR (126 MHz, CDCl3) δ 155.44 (NC(O)O), 
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140.48 (ArC), 137.73 (ArC), 137.16 (ArC), 129.04 (ArC), 127.88 (ArC), 127.44 (ArC), 127.07 
(ArC), 118.72 (ArC), 61.53 (OCH2), 45.45 (NCH2). Data is in line with literature precedent4  
 




General Procedure A was followed using the following compounds: ethyl 2-hydroxy-
ethylcarbamate (0.27 g, 2 mmol), copper iodide (0.038 g, 0.2 mmol), 2,2,6,6-tetramethyl-
3,5-heptanedione (0.083 mL, 0.074 g, 0.4 mmol), caesium carbonate (1.30 g, 4 mmol), 3-
iodoanisole (0.48 mL, 0.94 g, 4 mmol) and CH3CN (4 mL). Column chromatography gave a 
white solid, 1ai, 75% (0.29 g). 1H NMR (500 MHz, CDCl3) δ 7.28–7.20 (2H, m, ArH), 7.01 
(1H, ddd, J = 8.1, 2.2, 0.8 Hz, ArH), 6.67 (1H, ddd, J = 8.3, 2.5, 0.8 Hz, ArH), 4.45–4.38 
(2H, m, OCH2), 4.01–3.96 (2H, m, NCH2), 3.79 (3H, s, ArOCH3). 13C NMR (126 MHz, CDCl3) 
δ 160.23 (ArC), 155.23 (NC(O)O), 139.59 (ArC), 129.78 (ArC), 110.35 (ArC), 109.51 (ArC), 
104.53 (ArC), 61.34 (OCH2), 55.40 (ArOCH3), 45.31 (NCH2). Data is in line with literature 
precedent1 
 




General Procedure A was followed using the following compounds: ethyl 2-hydroxy-
ethylcarbamate (0.67 g, 5 mmol), copper iodide (0.095 g, 0.5 mmol), 2,2,6,6-tetramethyl-
3,5-heptanedione (0.21 mL, 0.18 g, 1 mmol), caesium carbonate (3.26 g, 10 mmol), 3-
iodotoluene (1.28 mL, 2.18 g, 10 mmol) and CH3CN (20 mL). Column chromatography gave 
an off-white solid, 1aj, 48% (0.43 g). 1H NMR (500 MHz, CDCl3) δ 7.36 (1H, s, ArH), 7.29 
(1H, d, J = 8.4 Hz, ArH), 7.27–7.21 (m, ArH), 6.94 (1H, d, J = 7.4 Hz, ArH), 4.41 (2H, dd, J 
= 8.7, 7.3 Hz, OCH2), 3.99 (2H, dd, J = 8.7, 7.3 Hz, NCH2), 2.35 (3H, s, ArCH3). 13C NMR 
(126 MHz, CDCl3) δ 155.36 (NC(O)O), 139.02 (ArC), 138.28 (ArC), 128.88 (ArC), 124.93 
 231 
 
(ArC), 119.04 (ArC), 115.43 (ArC), 61.37 (OCH2), 45.34 (NCH2), 21.67 (ArCH3). Data is in 
line with literature precedent1 
 




General Procedure B was followed using the following compounds: 2-oxazolidinone (0.17 
g, 2 mmol), copper iodide (0.019 g, 0.1 mmol), (±)-trans-1,2-diaminocyclohexane (0.024 
mL, 0.023 g, 0.2 mmol), potassium carbonate (0.55 g, 4 mmol), 1-bromo-3-chorobenzene 
(0.23 mL, 0.38 g, 2 mmol) and dioxane (1 mL). Column chromatography gave an off-white 
powdery solid, 1ak, 98%, (0.39 g). 1H NMR (500 MHz, CDCl3) δ 7.54 (1H, t, J = 2.1 Hz, 
ArH), 7.28 (1H, ddd, J = 8.3, 2.2, 0.9 Hz, ArH), 7.20 (1H, t, J = 8.1 Hz, ArH), 7.01 (1H, ddd, 
J = 8.0, 1.9, 0.9 Hz, ArH), 4.40–4.35 (2H, m, OCH2), 3.91 (2H, dd, J = 8.8, 7.2 Hz, NCH2). 
13C NMR (126 MHz, CDCl3) δ 154.92 (NC(O)O), 139.38 (ArC), 134.51 (ArC), 129.95 (ArC), 
123.69 (ArC), 117.95 (ArC), 115.84 (ArC), 61.37 (OCH2), 44.86 (NCH2). Data is in line with 
literature precedent5 
 




General Procedure B was followed using the following compounds: 2-oxazolidinone (0.17 
g, 2 mmol), copper iodide (0.019 g, 0.1 mmol), (±)-trans-1,2-diaminocyclohexane (0.024 
mL, 0.023 g, 0.2 mmol), potassium carbonate (0.55 g, 4 mmol), 4-bromo-1,2-
dimethylbenzene (0.27 mL, 0.37 g, 2 mmol) and dioxane (1 mL) Recrystallization from 
EtOH/Water gave a white crystalline solid, 1al, 39%, (0.147 g) 1H NMR (500 MHz, CDCl3) 
δ 7.28 (1H, d, J = 2.4 Hz, ArH), 7.19 (1H, dd, J = 8.2, 2.5 Hz, ArH), 7.07 (1H, d, J = 8.3 Hz, 
ArH), 4.37–4.32 (2H, m, OCH2), 3.93–3.88 (2H, m, NCH2), 2.23 (3H, s, ArCH3), 2.20 (3H, 
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s, ArCH3). 13C NMR (126 MHz, CDCl3) δ 155.31 (NC(O)O), 137.15 (ArC), 135.98 (ArC), 
132.22 (ArC), 129.83 (ArC), 119.56 (ArC), 115.71 (ArC), 61.26 (OCH2), 45.23 (NCH2), 19.90 
(ArCH3), 18.94 (ArCH3). Data is in line with literature precedent6 
 




General Procedure B was followed using the following compounds: 2-oxazolidinone (0.17 
g, 2 mmol), copper iodide (0.019 g, 0.1 mmol), (±)-trans-1,2-diaminocyclohexane (0.024 
mL, 0.023 g, 0.2 mmol), potassium carbonate (0.55 g, 4 mmol), 4-bromo-2-chlorotoluene 
(0.27 mL, 0.41 g, 2 mmol) and dioxane (1 mL) Column chromatography gave an off-white 
powdery solid, 1am, 72%, (0.32 g). mp (from CHCl3) = 86-88 °C. FT-IR (thin film): νmax (cm-
1) = 1742.3. 1H NMR (500 MHz, CDCl3) δ 7.53 (1H, d, J = 2.4 Hz, ArH), 7.35 (1H, dd, J = 
8.4, 2.4 Hz, ArH), 7.20 (1H, d, J = 8.3 Hz, ArH), 4.50–4.44 (2H, m, OCH2), 4.03–3.97 (2H, 
m, NCH2), 2.33 (3H, s, ArCH3). 13C NMR (126 MHz, CDCl3) δ 155.21 (NC(O)O), 137.28 
(ArC), 134.85 (ArC), 131.77 (ArC), 131.27 (ArC), 118.85 (ArC), 116.59 (ArC), 61.47 (OCH2), 
45.30 (NCH2), 19.52 (ArCH3). HRMS (ESI): m/z calculated for C10H10N1O2Cl1 requires 
234.0400 for [M+Na]+, found 234.0300. 
 




General Procedure B was followed using the following compounds: 2-oxazolidinone (0.17 
g, 2 mmol), copper iodide (0.019 g, 0.1 mmol), (±)-trans-1,2-diaminocyclohexane (0.024 
mL, 0.023 g, 0.2 mmol), potassium carbonate (0.55 g, 4 mmol), 4-bromo-1,2-
dichlorobenzenee (0.26 mL, 0.45 g, 2 mmol) and dioxane (1 mL) Recrystallization from 
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EtOH/Water gave an amorphous solid, 1an, 32%, (0.15 g). FTIR (thin film): νmax (cm-1) = 
1738.7. 1H NMR (500 MHz, CDCl3) δ 7.63 (1H, d, J = 2.4 Hz, ArH), 7.35–7.27 (2H, m, ArH), 
4.44 (2H, dd, J = 8.7, 7.3 Hz, OCH2), 3.99–3.94 (2H, m, NCH2). 13C NMR (126 MHz, CDCl3) 
δ 154.95 (NC(O)O), 137.78 (ArC), 132.80 (ArC), 130.50 (ArC), 127.21 (ArC), 119.62 (ArC), 
117.21 (ArC), 61.45 (OCH2), 44.96 (NCH2). HRMS (ESI): m/z calculated for C9H7N1O2Cl2 
requires 253.9900 for [M+Na]+, found 253.9720 
 




General Procedure B was followed using the following compounds: 2-oxazolidinone (0.17 
g, 2 mmol), copper iodide (0.019 g, 0.1 mmol), (±)-trans-1,2-diaminocyclohexane (0.024 
mL, 0.023 g, 0.2 mmol), potassium carbonate (0.55 g, 4 mmol), 2-bromoanisole (0.25 mL, 
0.37 g, 2 mmol) and dioxane (1 mL) Column chromatography gave a white powdery solid, 
1ao, 95%, (0.37 g). 1H NMR (500 MHz, CDCl3) δ 7.32 (1H, dd, J = 7.7, 1.7 Hz, ArH), 7.28–
7.22 (1H, m, ArH), 6.98–6.91 (2H, m, ArH), 4.44–4.40 (2H, m, OCH2), 3.96–3.90 (2H, m, 
NCH2), 3.82 (3H, s, ArOCH3). 13C NMR (126 MHz, CDCl3) δ 157.40 (ArC), 154.90 (NC(O)O), 
128.81 (ArC), 128.32 (ArC), 126.04 (ArC), 120.85 (ArC), 112.00 (ArC), 62.46 (OCH2), 55.60 
(ArOCH3), 46.94 (NCH2). Data is in line with literature precedent2 
 




General Procedure A was followed using the following compounds: ethyl 2-hydroxy-
ethylcarbamate (0.27 g, 2 mmol), copper iodide (0.038 g, 0.2 mmol), 2,2,6,6-tetramethyl-
3,5-heptanedione (0.083 mL, 0.074 g, 0.4 mmol), caesium carbonate (1.30 g, 4 mmol), 2-
iodothiophene (0.44 mL, 0.84 g, 4 mmol) and CH3CN (4 mL). Column chromatography gave 
a yellow solid, 1ap, 73% (0.25 g). 1H NMR (500 MHz, CDCl3) δ 6.88 (1H, dd, J = 5.5, 1.4 
Hz, ArH), 6.83 (1H, dd, J = 5.5, 3.7 Hz, ArH), 6.44 (1H, dd, J = 3.8, 1.4 Hz, ArH), 4.51–4.46 
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(2H, m, OCH2), 4.05–3.95 (2H, m, NCH2). 13C NMR (126 MHz, CDCl3j) δ 154.67 (NC(O)O), 
140.30 (ArC), 124.69 (ArC), 117.98 (ArC), 110.91 (ArC), 62.34 (OCH2), 46.01 (NCH2). Data 
is in line with literature precedent1 
 




General Procedure B was followed using the following compounds: 2-oxazolidinone (0.17 
g, 2 mmol), copper iodide (0.019 g, 0.1 mmol), (±)-trans-1,2-diaminocyclohexane (0.024 
mL, 0.023 g, 0.2 mmol), potassium carbonate (0.55 g, 4 mmol), 4-bromo-2-fluorotoluene 
(0.25 mL, 0.38 g, 2 mmol) and dioxane (1 mL) Column chromatography gave a white 
crystalline solid, 1aq, 58%, (0.21 g). mp (from CHCl3) = 116-117 °C. FT-IR (thin film): νmax 
(cm-1) = 1730.6. 1H NMR (500 MHz, CDCl3) δ 7.36 (1H, dd, J = 11.9, 2.1 Hz, ArH), 7.19–
7.09 (2H, m, ArH), 4.50–4.45 (2H, m, OCH2), 4.05–3.99 (2H, m, NCH2), 2.24 (3H, d, J = 1.8 
Hz, ArCH3). 13C NMR (126 MHz, CDCl3) δ 161.44 (d, J = 244.1 Hz, ArCF), 155.21 (NC(O)O), 
131.68 (d, J = 6.3 Hz, ArC), 120.51 (d, J = 17.6 Hz, ArC), 113.37 (d, J = 3.4 Hz, ArC), 105.82 
(d, J = 27.9 Hz, ArC), 61.43 (OCH2), 45.38 (NCH2), 14.18 (d, J = 3.1 Hz ArCH3). 19F NMR 
(470 MHz, CDCl3) δ -114.96– -115.07 (m, ArF). HRMS (ESI): m/z calculated for 
C10H10N1O2F1 requires 196.0774 for [M+H]+, found 196.0784 
 




General Procedure B was followed using the following compounds: 2-oxazolidinone (0.17 
g, 2 mmol), copper iodide (0.019 g, 0.1 mmol), (±)-trans-1,2-diaminocyclohexane (0.024 
mL, 0.023 g, 0.2 mmol), potassium carbonate (0.55 g, 4 mmol), 4-bromo-1,2-
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difluorobenzene (0.23 mL, 0.38 g, 2 mmol) and dioxane (1 mL) Recrystallization from 
EtOH/Water gave a white crystalline solid, 1ar, 58%, (0.21 g). FT-IR (thin film): νmax (cm-1) 
= 1733.3. 1H NMR (500 MHz, CDCl3) δ 7.61–7.54 (1H, m, ArH), 7.16–7.06 (2H, m, ArH), 
4.50–4.44 (2H, m, OCH2), 4.03–3.99 (2H, m, NCH2). 13C NMR (126 MHz, CDCl3) δ 155.17 
(NC(O)O), 150.29 (dd, J = 247.3, 13.3 Hz, ArCF), 146.93 (dd, J = 245.6, 12.8 Hz, ArCF), 
135.02 (dd, J = 8.6, 2.9 Hz, ArC), 117.41 (dd, J = 18.2, 1.4 Hz, ArC), 113.67 (dd, J = 5.9, 
3.7 Hz, ArC), 108.15 (d, J = 22.3 Hz, ArC), 61.39 (OCH2), 45.32 (NCH2). 19F NMR (470 
MHz, CDCl3) δ -135.22 (ddd, J = 20.3, 12.4, 7.4 Hz, ArF), -143.28 (dddd, J = 10.8, 9.6, 7.2, 
4.3 Hz, ArF). HRMS (ESI): m/z calculated for C9H7N1O2F2 requires 200.0523 for [M+H]+, 
found 200.0532 
 




General Procedure A was followed using the following compounds: (S)-ethyl (1-hydroxy‐3-
methylbutan-2-yl)carbamate (0.35 g, 2 mmol), copper iodide (0.038 g, 0.2 mmol), 2,2,6,6-
tetramethyl-3,5-heptanedione (0.083 mL, 0.074 g, 0.4 mmol), caesium carbonate (1.30 g, 
4 mmol), iodobenzene (0.45 mL, 0.82 g, 4 mmol) and CH3CN (4 mL). Column 
chromatography (EtOAc:Hexanes 30:70) gave an off-white solid, 1ba, 19% (0.077 g). 1H 
NMR (500 MHz, CDCl3) δ 7.44 (2H, ddd, J = 4.1, 3.2, 1.6 Hz, ArH), 7.40–7.35 (2H, m, ArH), 
7.17 (1H, ddd, J = 7.6, 2.4, 1.2 Hz, ArH), 4.48–4.36 (2H, m, OCH2), 4.25–4.19 (1H, m, 
NCH), 2.17–2.05 (1H, m, CH(CH3)2), 0.89 (3H, app d, J = 7.1 Hz, CH(CH3)2), 0.83 (3H, app 
d, J = 6.8 Hz, CH(CH3)2). 13C NMR (126 MHz, CDCl3) δ 156.15 (NC(O)O), 136.89 (ArC), 
129.27 (ArC), 125.39 (ArC), 122.38 (ArC), 62.61 (OCH2), 60.62 (NCH), 27.73 (CH(CH3)2), 









General Procedure A was followed using the following compounds: (S)-ethyl (1-hydroxy‐3-
methylbutan-2-yl)carbamate (0.35 g, 2 mmol), copper iodide (0.038 g, 0.2 mmol), 2,2,6,6-
tetramethyl-3,5-heptanedione (0.083 mL, 0.074 g, 0.4 mmol), caesium carbonate (1.30 g, 
4 mmol), 1-chloro-4-iodobenzene (0.96 g, 4 mmol) and CH3CN (4 mL). Column 
chromatography (EtOAc:Hexanes 30:70) gave an off-white solid, 1bb, 94% (0.44 g). FT-IR 
(thin film): νmax (cm-1) = 2964.1, 1740.6. 1H NMR (500 MHz, CDCl3) δ 7.45–7.38 (2H, m, 
ArH), 7.37–7.33 (2H, m, ArH), 4.46–4.36 (2H, m, OCH2), 4.27–4.21 (1H, m, NCH), 2.11 
(1H, dtd, J = 13.9, 6.9, 3.2 Hz, CH(CH3)2), 0.91 (3H, d, J = 7.1 Hz, CH(CH3)2), 0.83 (3H, d, 
J = 6.8 Hz, CH(CH3)2). 13C NMR (126 MHz, CDCl3) δ 156.01 (NC(O)O), 135.64 (ArC), 
130.78 (ArC), 129.51 (ArC), 123.48 (ArC), 62.73 (OCH2), 60.66 (NCH), 27.81 (CH(CH3)2, 
17.91 (CH(CH3)2), 14.45 (CH(CH3)2). HRMS (ESI): m/z calculated for C12H14N1O2Cl1 for 
[M+H]+ requires 240.0791, found 240.0803. 
 




General Procedure A was followed using the following compounds: (S)-ethyl (1-hydroxy‐4-
methylpentan-2-yl)carbamate (0.38 g, 2 mmol), copper iodide (0.038 g, 0.2 mmol), 2,2,6,6-
tetramethyl-3,5-heptanedione (0.083 mL, 0.074 g, 0.4 mmol), caesium carbonate (1.30 g, 
4 mmol), 1-chloro-4-iodobenzene (0.96 g, 4 mmol) and CH3CN (4 mL). Column 
chromatography (EtOAc:Hexanes 30:70) gave an off-white solid, 1bc, 42% (0.23 g). [α]D: 
(c 1, CHCl3) = +45. mp (from CHCl3) = 99-102 °C. FT-IR (thin film): νmax (cm-1) = 2959.6, 
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1753.9. 1H NMR (500 MHz, CDCl3) δ 7.35–7.28 (4H, m, ArH), 4.51 (1H, t, J = 8.3 Hz, OCH2), 
4.37 (1H, dddd, J = 10.9, 8.2, 5.4, 2.6 Hz, OCH2), 4.08 (1H, dd, J = 8.5, 5.4 Hz, NCH), 1.64–
1.52 (2H, m, CH2), 1.46–1.37 (1H, m, CH(CH3)2), 0.91 (3H, dd, J = 9.8, 3.9 Hz, CH(CH3)2), 
0.87 (3H, d, J = 6.4 Hz, CH(CH3)2). 13C NMR (126 MHz, CDCl3) δ 155.51 (NC(O)O), 135.48 
(ArC), 130.33 (ArC), 129.22 (ArC), 122.95 (ArC), 67.64 (OCH2), 54.96 (NCH), 41.02 (CH2), 
24.64 (CH(CH3)2), 23.51 (CH(CH3)2), 21.72 (CH(CH3)2). HRMS (ESI): m/z calculated for 
C13H16N1O2Cl1 requires 254.0948 for [M+H]+, found 254.0932 
 




General Procedure A was followed using the following compounds: (S)-ethyl (1-hydroxy‐4-
methylpentan-2-yl)carbamate (0.38 g, 2 mmol), copper iodide (0.038 g, 0.2 mmol), 2,2,6,6-
tetramethyl-3,5-heptanedione (0.083 mL, 0.074 g, 0.4 mmol), caesium carbonate (1.30 g, 
4 mmol), 4-tert-butyliodobenzene (0.71 mL, 1.04 g, 4 mmol) and CH3CN (4 mL). Column 
chromatography (EtOAc:Hexanes 30:70) gave an off-white solid, 1bd, 15% (0.08 g). [α]D: 
(c 1, CHCl3) = +23. FT-IR (thin film): νmax (cm-1) = 1749.2. 1H NMR (500 MHz, CDCl3) δ 
7.41–7.37 (2H, m, ArH), 7.32–7.29 (2H, m, ArH), 4.53 (1H, t, J = 8.3 Hz, OCH2), 4.43–4.36 
(1H, m, OCH2), 4.12–4.07 (1H, m, OCH2), 1.71–1.64 (1H, m, CH2), 1.63–1.55 (1H, m, CH2), 
1.48–1.40 (1H, m, CH(CH3)2), 1.30 (9H, s, C(CH3)3), 0.93 (3h, d, J = 6.5 Hz, CH(CH3)2), 
0.91 (2H, d, J = 6.6 Hz, CH(CH3)2). 13C NMR (126 MHz, CDCl3) δ 156.06 (NC(O)O), 148.32 
(ArC), 134.15 (ArC), 126.19 (ArC), 121.83 (ArC), 67.82 (OCH2), 55.29 (NCH), 41.36 (CH2), 
34.56, 31.46 (AlkylCH), 26.48 (AlkylCH), 24.83 (AlkylCH), 23.72 (AlkylCH), 21.79 (AlkylCH). 
HRMS (ESI): m/z calculated for C17H25N1O2 requires 276.1964 for [M+H]+, found 276.1947 
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General Procedure A was followed using the following compounds: ethyl(2-hydroxy 3-
(dimethyl-tert-butyl siloxy)propyl) carbamate (0.55 g, 2 mmol), copper iodide (0.038 g, 0.2 
mmol), 2,2,6,6-tetramethyl-3,5-heptanedione (0.083 mL, 0.074 g, 0.4 mmol), caesium 
carbonate (1.30 g, 4 mmol), iodobenzene (0.45 mL, 0.82 g, 4 mmol) and CH3CN (4 mL). 
Column chromatography (EtOAc:Hexanes 40:60) gave an off-white solid, 75, 86% (0.53 g). 
1H NMR (500 MHz, CDCl3) δ 7.58–7.54 (2H, m, ArH), 7.39–7.35 (2H, m, ArH), 7.15–7.10 
(1H, m, ArH), 4.70–4.63 (1H, m, OCH), 4.04 (1H, t, J = 8.7 Hz, OCH2), 3.99–3.93 (1H, m, 
OCH2), 3.89 (1H, dd, J = 11.2, 4.5 Hz, NCH2), 3.81 (1H, dd, J = 11.2, 3.5 Hz, NCH2), 0.86 
(9H, s, SiC(CH3)3), 0.09 (6H, s, SiCH3). 13C NMR (126 MHz, CDCl3) δ 154.74 (NC(O)O), 
138.36 (ArC), 128.99 (ArC), 123.85 (ArC), 118.17 (ArC), 72.36 (OCH), 63.52 (OCH2), 46.75 




6.1.4: Synthesis of Directing Group Analogues 
 




The procedure was adapted from a literature method.7 To a solution of N-(2-
Hydroxyethyl)aniline (1.25 mL, 1.37 g, 10 mmol), triethylamine (2.79 mL, 2.02 g, 20 mmol) 
and CH2Cl2 (30 mL) at 0 °C was slowly added thiophosgene (0.77 mL, 1.15 g, 10 mmol) in 
CH2Cl2 (10 mL) using a dropping funnel. After addition was complete the mixture was stirred 
at room temperature for 1 hour. The reaction mixture was concentrated in vacuo. The crude 
mixture was diluted in EtOAc and filtered using a silica plug, eluting with EtOAc. The solvent 
was again removed in vacuo and the crude mixture was purified using column 
chromatography (CH2Cl2:Hexanes 60:40) to yield off-white solid, 77% (1.38 g). 1H NMR 
(500 MHz, CDCl3) δ 7.58–7.52 (2H, m, ArH), 7.43–7.38 (2H, m, ArH), 7.31–7.25 (1H, m, 
ArH), 4.64–4.57 (2H, m, OCH2), 4.23–4.16 (2H, m, NCH2). 13C NMR (126 MHz, CDCl3) δ 
186.99 (NC(S)O), 138.54 (ArC), 129.13 (ArC), 127.46 (ArC), 124.40 (ArC), 66.33 (OCH2), 









The procedure was adapted from a literature method.7 To a solution of the compound above 
(0.72 g, 4 mmol) in toluene (16 mL) was added [RuCl2(p-cymene)]2 (0.024 g, 0.04 mmol) 
and 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (SPhos, 0.033 g, 0.08 mmol). The 
reaction was heated to 120 °C for 4 h. After the reaction was deemed complete by TLC the 
solvent was removed in vacuo and the crude mixture was purified using column 
chromatography (EtOAc:Hexanes 50:50) to yield an off-white solid, 5b, 66% (0.47 g). 1H 
NMR (500 MHz, CDCl3) δ 7.41–7.35 (4H, m, ArH), 7.21–7.17 (1H, m, ArH), 4.13 (2H, t, J = 
7.2 Hz, NCH2), 3.39 (2H, t, J = 7.1 Hz, SCH2). 13C NMR (126 MHz, CDCl3) δ 171.26 
(NC(O)S), 139.20 (ArC), 129.18 (ArC), 125.63 (ArC), 122.05 (ArC), 50.95 (NCH2), 25.80 
(SCH2). Data is line with literature precedent.7   
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To a solution of aniline (1.83 mL, 1.86 g, 20 mmol) in anhydrous toluene (100 mL) was 
added paraformaldehyde (0.60 g, 20 mmol) and the mixture was allowed to stir for 5 
minutes. Following this mercaptoacetic acid (1.39 mL, 1.84 g, 20 mmol) was added 
portionwise followed by para-toluenesulfonic acid (0.034 g, 1 mol%) and the mixture was 
heated to reflux overnight. The mixture was diluted in 100 mL EtOAc and washed with 
saturated NaHCO3 solution (3 x 100 mL) and 1M HCl (3 x 100 mL). The organic layer was 
dried over MgSO4 and concentrated in vacuo. The crude mixture was diluted in hot EtOH 
and the remaining precipitate was filtered and collected to give title compound, 28% (1.00 
g). 1H NMR (500 MHz, CDCl3) δ 7.46–7.38 (4H, m, ArH), 7.29–7.24 (1H, m, ArH), 4.83 (2H, 
t, J = 1.1 Hz, NCH2S), 3.75 (2H, t, J = 1.0 Hz, SCH2C=O). 13C NMR (126 MHz, CDCl3) δ 
170.58 (NC(O)CH2), 138.74 (ArC), 129.40 (ArC), 126.74 (ArC), 123.07 (ArC), 49.65 







6.1.5: Synthesis of C–H Alkenylated Products 
 




In an oven dried carousel tube, to a solution of aryloxazolidinone (1 eq), acrylate (3 eq) in 
2-MeTHF (1 mL) was added the combined solids: [RuCl2(p-cymene)]2 (2.5 mol%), AgSbF6 
(10 mol%) and Cu(OAc)2.H2O (1 eq). The carousel tube was sealed with a Teflon cap 
leaving the tap open and was heated to 120 °C for 18 h. The reaction mixture was diluted 
in EtOAc and filtered using a silica plug, eluting with EtOAc. The solvent was removed in 
vacuo and the crude mixture was purified using column chromatography (EtOAc:Hexanes 
50:50 to 60:40 unless otherwise stated) to give C–H alkenylated products. 
 




General Procedure C was followed using the following compounds: 3-phenyl-2-
oxazolidinone, 1a, (0.16 g, 1 mmol), ethyl acrylate (0.33 mL, 0.30 g, 3 mmol), [RuCl2(p-
cymene)]2 (0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 
mmol). Column chromatography gave amorphous solid, 3a, 76% (0.20 g). FT-IR (thin film): 
νmax (cm-1) = 1754.8, 1709.3. mp (from CHCl3) = 68-71 °C. 1H NMR (500 MHz, CDCl3) δ 
7.77 (1H, d, J = 16.0 Hz, ArCH=CHR), 7.66 (1H, dd, J = 7.8, 1.5 Hz, ArH), 7.44 (1H, td, J = 
7.7, 1.5 Hz, ArH), 7.38–7.32 (2H, m, ArH), 6.44 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.61–4.49 
(2H, m, OCH2), 4.25 (2H, q, J = 7.1 Hz, OCH2CH3), 3.96–3.91 (2H, m, NCH2), 1.32 (3H, t, 
J = 7.1 Hz, OCH2CH3). 13C NMR (126 MHz, CDCl3) δ 166.68 (C(O)O), 157.17 (NC(O)O), 
139.35 (ArCH=CHR), 137.12 (ArC), 132.36 (ArC), 131.26 (ArC), 128.52 (ArC), 127.77 
(ArC), 127.09 (ArC), 120.96 (ArCH=CHR), 62.48 (OCH2), 60.83 (OCH2CH3), 48.87 (NCH2), 
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14.43 (OCH2CH3). HRMS (ESI): m/z calculated for C14H15N1O4 requires 284.0899 for 
[M+Na]+, found 284.0867 
 




General Procedure C was followed using the following compounds: 3-phenyloxazolidinone, 
1a, (0.16 g, 1 mmol), methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 
g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column 
chromatography gave amorphous solid, 3b, 93% (0.23 g). mp (from CHCl3) = 81-84 °C. FT-
IR (thin film): νmax (cm-1) = 1746.1, 1708.7. 1H NMR (500 MHz, CDCl3) δ 7.76 (1H, d, J = 
16.0 Hz, ArCH=CHR), 7.65 (1H, dd, J = 7.8, 1.5 Hz, ArH), 7.43 (1H, td, J = 7.7, 1.5 Hz, 
ArH), 7.37–7.31 (2H, m, ArH), 6.44 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.57–4.51 (2H, m, 
OCH2), 3.96–3.91 (2H, m, NCH2), 3.79 (3H, s, OCH3). 13C NMR (126 MHz, CDCl3) δ 
167.07 (C(O)O), 157.12 (NC(O)O), 139.59 (ArCH=CHR), 137.12 (ArC), 132.22 (ArC), 
131.29 (ArC), 128.48 (ArC), 127.73 (ArC), 126.95 (ArC), 120.43 (ArCH=CHR), 62.47 
(OCH2), 51.95 (OCH3), 48.78 (NCH2). HRMS (ESI): m/z calculated for C13H13N1O4 requires 
270.0742 for [M+Na]+, found 270.0762 
 




General Procedure C was followed using the following compounds: 3-phenyl-2-
oxazolidinone, 1a, (0.16 g, 1 mmol), butyl acrylate (0.43 mL, 0.38 g, 3 mmol), [RuCl2(p-
cymene)]2 (0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 
mmol). Column chromatography gave amorphous solid (EtOAc:Hexanes 40:60 to 50:50), 
3c, 74% (0.21 g). FT-IR (thin film): νmax (cm-1) = 2959.7, 1749.1, 1706.2 1H NMR (500 MHz, 
CDCl3) δ 7.72 (1H, d, J = 16.0 Hz, ArCH=CHR), 7.62 (1H, dd, J = 7.8, 1.4 Hz, ArH), 7.38 
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(1H, td, J = 7.6, 1.5 Hz, ArH), 7.32–7.27 (2H, m, ArH), 6.40 (1H, d, J = 16.0 Hz, ArCH=CHR), 
4.50–4.43 (2H, m, OCH2), 4.15 (2H, t, J = 6.7 Hz, OCH2R), 3.88 (2H, dd, J = 8.5, 7.2 Hz, 
NCH2), 1.63 (2H, dt, J = 14.5, 6.7 Hz, OCH2CH2R), 1.38 (2H, dq, J = 14.8, 7.4 Hz, 
OCH2CH2CH2R), 0.91 (3H, t, J = 7.4 Hz, OCH2CH2CH2CH3). 13C NMR (126 MHz, CDCl3) 
δ 166.55 (C(O)O), 157.00 (NC(O)O), 139.18 (ArCH=CHR), 136.98 (ArC), 132.08 (ArC), 
131.04 (ArC), 128.26 (ArC), 127.48 (ArC), 126.84 (ArC), 120.61 (ArCH=CHR), 64.48 
(OCH2), 62.37 (OCH2R), 48.60 (NCH2), 30.63 (OCH2CH2R), 19.12 (OCH2CH2CH2R), 13.67 
(OCH2CH2CH2CH3). HRMS (ESI): m/z calculated for C16H19N1O4 requires 290.1392 for 
[M+H]+, found 290.1369 
 




General Procedure C was followed using the following compounds: 3-phenyl-2-
oxazolidinone, 1a, (0.16 g, 1 mmol), benzyl acrylate (0.46 mL, 3 mmol), [RuCl2(p-cymene)]2 
(0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). 
Column chromatography (EtOAc:Hexanes 40:60 to 50:50) gave amorphous solid, 3d, 94% 
(0.303 g). FTIR (thin film): νmax (cm-1) = 1749.3, 1709.9. 1H NMR (500 MHz, CDCl3) δ 7.83 
(1H, d, J = 16.0 Hz, ArCH=CHR), 7.65 (1H, app dd, ArH), 7.47–7.31 (8H, m, ArH), 6.50 (1H, 
d, J = 16.0 Hz, ArCH=CHR), 5.25 (2H, s, OCH2Ph), 4.52–4.47 (2H, m, OCH2), 3.94–3.88 
(2H, m, NCH2). 13C NMR (126 MHz, CDCl3) δ 166.41 (C(O)O), 157.10 (NC(O)O), 139.95 
(ArCH=CHR), 137.18 (ArC), 136.01 (ArC), 132.09 (ArC), 131.32 (ArC), 128.67 (ArC), 
128.42 (ArC), 128.36 (ArC), 128.28 (ArC), 127.66 (ArC), 126.93 (ArC), 120.32 
(ArCH=CHR), 66.54 (OCH2Ph), 62.44 (OCH2), 48.75 (NCH2). HRMS (ESI): m/z calculated 
for C19H17N1O4 requires 324.1236 for [M+H]+, found 324.1220 
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General Procedure C was followed using the following compounds: 1aa, (0.19 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), 
AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography 
gave a white solid, 3aa, 75% (0.21 g). mp (from CHCl3) = 150-157 °C. FT-IR (thin film): νmax 
(cm-1) = 1743.9, 1702.7. 1H NMR (500 MHz, CDCl3) δ 7.73 (1H, d, J = 16.0 Hz, ArCH=CHR), 
7.25 (1H, d, J = 8.4 Hz, ArH), 7.13 (1H, d, J = 2.9 Hz, ArH), 6.98 (1H, dd, J = 8.8, 2.9 Hz, 
ArH), 6.43 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.54 (2H, dd, J = 8.5, 7.3 Hz, OCH2), 3.89 (2H, 
dd, J = 8.5, 7.3 Hz, OCH2), 3.83 (3H, s, OCH3), 3.80 (3H, s, OCH3). 13C NMR (126 MHz, 
CDCl3) δ 167.04 (C(O)O), 159.40 (NC(O)O), 157.53 (ArCH=CHR), 139.50 (ArC), 133.59 
(ArC), 130.06 (ArC), 128.70 (ArC), 120.80 (ArC), 117.37 (ArC), 112.08 (ArCH=CHR), 62.41 
(OCH2), 55.80 (ArOCH3), 52.05 (OCH3), 49.17 (NCH2). HRMS (ESI): m/z calculated for 
C14H15N1O5 requires 278.1028 for [M+H]+, found 278.1006  
 




General Procedure C was followed using the following compounds: 1ab, (0.16 g, 0.9 mmol), 
methyl acrylate (0.24 mL, 0.23 g, 2.7 mmol), [RuCl2(p-cymene)]2 (0.014 g, 0.023 mmol), 
AgSbF6 (0.032 g, 0.09 mmol), Cu(OAc)2.H2O (0.18 g, 0.9 mmol). Column chromatography 
a gave white solid, 3ab, 81% (0.19 g). mp (from CHCl3) =  128-130 °C. FT-IR (thin film): 
νmax (cm-1) = 1746.9, 1711.7. 1H NMR (500 MHz, CDCl3) δ 7.75 (1H, d, J = 16.1 Hz, 
ArCH=CHR), 7.50–7.45 (1H, m, ArH), 7.30–7.19 (2H, m, ArH), 6.44 (1H, d, J = 16.0 Hz, 
ArCH=CHR), 4.54 (2H, dd, J = 8.3, 7.5 Hz, OCH2), 3.91 (2H, dd, J = 8.3, 7.5 Hz, NCH2), 
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3.80 (3H, s, OCH3), 2.37 (3H, s, ArCH3). 13C NMR (126 MHz, CDCl3) δ 167.20 (C(O)O), 
157.35 (NC(O)O), 139.74 (ArCH=CHR), 138.61 (ArC), 134.68 (ArC), 132.20 (ArC), 132.06 
(ArC), 128.20 (ArC), 127.02 (ArC), 120.31 (ArCH=CHR), 62.45 (OCH2), 51.99 (OCH3), 
48.98 (NCH2), 21.28 (ArCH3). HRMS (ESI): m/z calculated for C14H15N1O4 requires 
284.0899 for [M+Na]+, found 284.0901 
 




General Procedure C was followed using the following compounds: 1ac, (0.22 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), 
AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography 
gave a white solid, 3ac, 85% (0.26 g). mp (from CHCl3) = 145-147 °C. FT-IR (thin film): νmax 
(cm-1) = 1750.0, 1713.3. 1H NMR (500 MHz, CDCl3) δ 7.73 (1H, d, J = 16.1 Hz, ArCH=CHR), 
7.60 (1H, d, J = 2.3 Hz, ArH), 7.42 (1H, dd, J = 8.4, 2.3 Hz, ArH), 7.21 (1H, d, J = 8.4 Hz, 
ArH), 6.42 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.48–4.44 (2H, m, OCH2), 3.89 – 3.85 (2H, m, 
NCH2), 3.73 (3H, s, OCH3), 1.27 (9H, s, C(CH3)3). 13C NMR (126 MHz, CDCl3) δ 166.91 
(C(O)O), 157.13 (NC(O)O), 151.26 (ArCH=CHR), 140.01 (ArC), 134.41 (ArC), 131.31 
(ArC), 128.51 (ArC), 126.41 (ArC), 124.25 (ArC), 119.76 (ArCH=CHR), 62.34 (OCH2), 51.66 
(OCH3), 48.56 (NCH2), 34.64 (C(CH3)3), 31.07 (C(CH3)3). HRMS (ESI): m/z calculated for 
C17H21N1O4 requires 304.1549 for [M+H]+, found 304.1518 
 






General Procedure C was followed using the following compounds: 1ad, (0.18 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), 
AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography 
gave a white solid, 3ad, 80% (0.21 g). mp (from CHCl3) = 130-133 °C. FT-IR (thin film): νmax 
(cm-1) = 1746.3, 1713.1. 1H NMR (500 MHz, CDCl3) δ 7.70 (1H, dd, J = 16.0, 1.4 Hz, 
ArCH=CHR), 7.33 (2H, dt, J = 8.6, 4.4 Hz, ArH), 7.14 (1H, ddd, J = 8.8, 7.6, 2.9 Hz, ArH), 
6.43 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.59–4.52 (2H, m, OCH2), 3.94–3.88 (2H, m, NCH2), 
3.80 (3H, s, OCH3). 13C NMR (126 MHz, CDCl3) δ 166.78 (C(O)O), 162.04 (d, J = 248.9 
Hz, ArCF), 157.33 (NC(O)O), 138.47 (d, J = 2.2 Hz, ArCH=CHR), 134.59 (d, J = 8.3 Hz, 
ArC), 133.21 (d, J = 3.0 Hz, ArC), 129.23 (d, J = 9.0 Hz, ArC), 121.84 (ArCH=CHR), 118.39 
(d, J = 23.0 Hz, ArC), 114.17 (d, J = 23.6 Hz, ArC), 62.53 (OCH2), 52.16 (OCH3), 48.98 
(OCH2). 19F NMR (470 MHz, CDCl3) δ -112.14 (dd, J = 13.0, 8.1 Hz). HRMS (ESI): m/z 
calculated for C13H12N1O4F1 requires 266.0829 for [M+H]+, found 266.0800 
 




General Procedure C was followed using the following compounds: 1ae, (0.20 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), 
AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography 
gave a white solid, 3ae, 75% (0.21 g). mp (from CHCl3) = 156-160 °C. FT-IR (thin film): νmax 
(cm-1) = 1747.1, 1705.3. 1H NMR (500 MHz, CDCl3) δ 7.68 (1H, d, J = 16.0 Hz, ArCH=CHR), 
7.62 (1H, d, J = 2.4 Hz, ArH), 7.40 (1H, dd, J = 8.5, 2.4 Hz, ArH), 7.29 (1H, d, J = 8.6 Hz, 
ArH), 6.44 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.56 (2H, dd, J = 8.5, 7.2 Hz, OCH2), 3.92 (2H, 
dd, J = 8.4, 7.2 Hz, NCH2), 3.80 (3H, s, J = 2.7 Hz, OCH3). 13C NMR (126 MHz, CDCl3) δ 
166.74 (C(O)O), 156.97 (NC(O)O), 138.37 (ArCH=CHR), 135.62 (ArC), 134.32 (ArC), 
133.92 (ArC), 131.17 (ArC), 128.31 (ArC), 127.69 (ArC), 121.73 (ArCH=CHR), 62.53 
(OCH2), 52.16 (OCH3), 48.70 (NCH2). HRMS (ESI): m/z calculated for C13H12N1O4Cl1 









General Procedure C was followed using the following compounds: 1af, (0.24 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), 
AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography 
gave a white solid, 3af, 60% (0.20 g). mp (from CHCl3) = 174-176 °C. FT-IR (thin film): νmax 
(cm-1) = 1747.7, 1713.0. 1H NMR (500 MHz, CDCl3) δ 7.78 (1H, d, J = 2.3 Hz, ArCH=CHR), 
7.68 (1H, d, J = 16.0 Hz, ArH), 7.55 (1H, dd, J = 8.5, 2.3 Hz, ArH), 7.23 (1H, d, J = 8.5 Hz, 
ArH), 6.44 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.59–4.52 (2H, m, OCH2), 3.95–3.90 (2H, m, 
NCH2), 3.81 (3H, s, OCH3). 13C NMR (126 MHz, CDCl3) δ 166.74 (C(O)O), 156.92 
(NC(O)O), 138.32 (ArCH=CHR), 136.15 (ArC), 134.25 (ArC), 134.12 (ArC), 130.74 (ArC), 
128.52 (ArC), 122.21 (ArC), 121.79 (ArCH=CHR), 62.55 (OCH2), 52.16 (OCH3), 48.66 
(NCH2). HRMS (ESI): m/z calculated for C13H12N1O4Br1 requires 326.0028 for [M+H]+, found 
326.0016 
 




General Procedure C was followed using the following compounds: 1ag, (0.23 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), 
AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography 
gave a white solid, 3ag, 40% (0.13 g). mp (from CHCl3) = 158-161 °C. FT-IR (thin film): νmax 
(cm-1) = 1751.3, 1706.1. 1H NMR (500 MHz, CDCl3) δ 7.89 (1H, d, J = 1.5 Hz, ArCH=CHR), 
7.75 (1H, d, J = 16.0 Hz, ArH), 7.69 (1H, dd, J = 8.4, 1.8 Hz, ArH), 7.49 (1H, d, J = 8.3 Hz, 
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ArH), 6.52 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.59 (2H, dd, J = 8.4, 7.2 Hz, OCH2), 3.99 (2H, 
dd, J = 8.4, 7.2 Hz, NCH2), 3.82 (3H, s, J = 3.5 Hz, OCH3). 13C NMR (126 MHz, CDCl3) δ 
166.67 (C(O)O), 156.64 (NC(O)O), 140.34–139.70 (m, ArC), 138.52 (ArC), 132.80 (ArC), 
130.40 (ArC), 127.69 (q, J = 3.1 Hz, ArC), 127.04 (ArC), 125.09 (q, J = 3.8 Hz, ArC), 122.10 
(s, J = 20.4 Hz, ArC), 121.78 (app dd, ArCF3), 62.60 (CO2CH3), 52.19 (OCH2), 48.40 (NCH2). 
19F NMR (470 MHz, CDCl3) δ -62.89 (s, CF3). HRMS (ESI): m/z calculated for C14H12N1O4F3 
requires 338.0616 for [M+Na]+, found 338.0579 
 




General Procedure C was followed using the following compounds: 1ah, (0.12 g, 0.5 mmol), 
methyl acrylate (0.14 mL, 0.13 g, 1.5 mmol), [RuCl2(p-cymene)]2 (0.008 g, 0.013 mmol), 
AgSbF6 (0.018 g, 0.05 mmol), Cu(OAc)2.H2O (0.10 g, 0.5 mmol). Column chromatography 
(EtOAc:Hexanes 40:60 to 50:50) gave a white solid, 3ah, 31% (0.050 g). mp (from CHCl3) 
= 167-169 °C. FT-IR (thin film): νmax (cm-1) = 1750.3, 1701.8. 1H NMR (500 MHz, CDCl3) δ 
7.83 (2H, dd, J = 9.0, 6.8 Hz, ArH), 7.65 (1H, dd, J = 8.2, 2.1 Hz, ArH), 7.57–7.54 (2H, m, 
ArCH=CHR + ArH), 7.48–7.43 (2H, m, ArH), 7.43–7.37 (2H, m, ArH), 6.53 (1H, d, J = 16.0 
Hz, ArCH=CHR), 4.61–4.55 (2H, m, OCH2), 4.01–3.96 (2H, m, NCH2), 3.81 (3H, s, OCH3). 
13C NMR (126 MHz, CDCl3) δ 167.11 (C(O)O), 157.24 (NC(O)O), 141.68 (ArCH=CHR), 
139.80 (ArC), 139.74 (ArC), 136.23 (ArC), 132.54 (ArC), 130.06 (ArC), 129.14 (ArC), 128.17 
(ArC), 127.36 (ArC), 127.29 (ArC), 126.50 (ArC), 120.79 (ArCH=CHR), 62.57 (OCH2), 52.06 
(OCH3), 48.86 (NCH2). HRMS (ESI): m/z calculated for C19H17N1O4 requires 324.1200 for 









General Procedure C was followed using the following compounds: 1ai, (0.19 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), 
AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography 
gave a white solid, 3ai, 81% (0.22 g). mp (from CHCl3) = 120-123 °C. FT-IR (thin film): νmax 
(cm-1) = 1751.6, 1704.3. 1H NMR (500 MHz, CDCl3) δ 7.67 (1H, d, J = 16.0 Hz, ArCH=CHR), 
7.57 (1H, d, J = 8.8 Hz, ArH), 6.87 (1H, dd, J = 8.8, 1.6 Hz, ArH), 6.82 (1H, d, J = 1.9 Hz, 
ArH), 6.31 (1H, d, J = 15.9 Hz, ArCH=CHR), 4.51 (2H, t, J = 7.3 Hz, OCH2), 3.91 (2H, t, J = 
7.7 H, NCH2), 3.78 (3H, s, OCH3), 3.75 (3H, s, OCH3). 13C NMR (126 MHz, CDCl3) δ 167.35 
(C(O)O), 161.95 (NC(O)O), 157.03 (ArCH=CHR), 139.15 (ArC), 138.48 (ArC), 128.81 
(ArC), 124.44 (ArC), 117.75 (ArC), 114.76 (ArC), 112.06 (ArCH=CHR), 62.51 (OCH2), 55.71 
(OCH3), 51.73 (OCH3), 48.82 (NCH2). HRMS (ESI): m/z calculated for C14H15N1O5 requires 
278.1.028 for [M+H]+, found 278.1000 
 




General Procedure C was followed using the following compounds: 1aj, (0.18 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), 
AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography 
gave a light brown solid, 3aj, 83% (0.22 g). mp (from CHCl3) = 103-105 °C. FT-IR (thin film): 
νmax (cm-1) = 1746.0, 1709.3. 1H NMR (500 MHz, CDCl3) δ 7.74 (1H, d, J = 16.0 Hz, 
ArCH=CHR), 7.55 (1H, d, J = 7.9 Hz, ArH), 7.20–7.10 (2H, m, ArH), 6.41 (1H, d, J = 16.0 
Hz, ArCH=CHR), 4.54 (2H, dd, J = 8.5, 7.2 Hz, OCH2), 3.92 (2H, dd, J = 8.5, 7.3 Hz, NCH2), 
3.78 (3H, s, OCH3), 2.36 (3H, s, ArCH3). 13C NMR (126 MHz, CDCl3) δ 167.29 (C(O)O), 
157.25 (NC(O)O), 142.15 (ArCH=CHR), 139.50 (ArC), 137.03 (ArC), 129.51 (ArC), 129.35 
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(ArC), 127.65 (ArC), 127.57 (ArC), 119.42 (ArCH=CHR), 62.47 (OCH2), 51.92 (OCH3), 
48.95 (NCH2), 21.43 (ArCH3). HRMS (ESI): m/z calculated for C14H15N1O4 requires 
262.1079 for [M+H]+, found 262.1059 
 




General Procedure C was followed using the following compounds: 1ak, (0.25 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), 
AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography 
gave a light brown amorphous solid, 3ak, 50% (0.14 g). FTIR (thin film): νmax (cm-1) = 1749.8, 
1713.4. 1H NMR (500 MHz, CDCl3) δ 7.67 (1H, d, J = 16.0 Hz, ArCH=CHR), 7.57 (1H, d, J 
= 8.5 Hz, ArH), 7.34 (1H, d, J = 2.1 Hz, ArH), 7.31 (1H, ddd, J = 8.5, 2.2, 0.5 Hz, ArH), 6.41 
(1H, d, J = 16.0 Hz, ArCH=CHR), 4.58–4.50 (2H, m, OCH2), 3.96–3.91 (2H, m, NCH2), 3.77 
(3H, s, OCH3). 13C NMR (126 MHz, CDCl3) δ 166.87 (C(O)O), 156.77 (NC(O)O), 138.54 
(ArCH=CHR), 138.07 (ArC), 136.57 (ArC), 130.71 (ArC), 128.77 (ArC), 128.69 (ArC), 
126.99 (ArC), 120.72 (ArCH=CHR), 62.59 (OCH2), 52.01 (OCH3), 48.51 (NCH2). HRMS 
(ESI): m/z calculated for C13H12N1O4Cl1 requires 304.0500 for [M+Na]+, found 304.0342 
 




General Procedure C was followed using the following compounds: 1al, (0.096 g, 0.5 
mmol), methyl acrylate (0.14 mL, 0.13 g, 1.5 mmol), [RuCl2(p-cymene)]2 (0.008 g, 0.013 
mmol), AgSbF6 (0.018 g, 0.05 mmol), Cu(OAc)2.H2O (0.10 g, 0.5 mmol). Column 
chromatography gave a brown amorphous solid, 3al, 58% (0.080 g). FTIR (thin film): νmax 
(cm-1) = 1745.7, 1709.3. 1H NMR (500 MHz, CDCl3) δ 7.72 (1H, d, J = 16.0 Hz, ArCH=CHR), 
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7.42 (1H, s, ArH), 7.10 (1H, s, ArH), 6.40 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.53 (2H, dd, J 
= 8.5, 7.3 Hz, OCH2), 3.90 (2H, dd, J = 8.4, 7.3 Hz, NCH2), 3.78 (3H, s, OCH3), 2.27 (6H, s, 
ArCH3). 13C NMR (126 MHz, CDCl3) δ 167.36 (C(O)O), 157.44 (NC(O)O), 140.91 (ArC), 
139.59 (ArC), 137.45 (ArC), 134.84 (ArC), 129.61 (ArC), 128.56 (ArC), 128.23 (ArC), 119.26 
(ArCH=CHR), 62.46 (OCH2), 51.90 (OCH3), 49.10 (NCH2), 19.96 (ArCH3), 19.65 (ArCH3). 
HRMS (ESI): m/z calculated for C15H17N1O4 requires 276.1236 for [M+H]+, found 276.1221 
 




General Procedure C was followed using the following compounds: 1am, (0.21 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), 
AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography 
gave an off-white powdery solid, 3am, 60% (0.18 g). mp (from CHCl3) =  154-155 °C. FT-
IR (thin film): νmax (cm-1) = 1752.5, 1711.4. 1H NMR (500 MHz, CDCl3) δ 7.62 (1H, d, J = 
16.0 Hz, ArCH=CHR), 7.47 (1H, s, ArH), 7.30 (1H, s, ArH), 6.37 (1H, d, J = 16.0 Hz, 
ArCH=CHR), 4.52–4.46 (2H, m, OCH2), 3.88 (2H, dd, J = 8.5, 7.2 Hz, NCH2), 3.74 (3H, s, 
OCH3), 2.33 (3H, s, ArCH3). 13C NMR (126 MHz, CDCl3) δ 166.80 (C(O)O), 156.87 
(NC(O)O), 138.54 (ArCH=CHR), 136.55 (ArC), 136.49 (ArC), 135.59 (ArC), 130.52 (ArC), 
129.41 (ArC), 127.26 (ArC), 120.29 (ArCH=CHR), 62.48 (OCH2), 51.83 (OCH3), 48.49 
(NCH2), 19.75 (ArCH3). HRMS (ESI): m/z calculated for C14H14N1O4Cl1 requires 318.0509 
for [M+Na]+, found 318.0498 
 






General Procedure C was followed using the following compounds: 1an, (0.12 g, 0.5 mmol), 
methyl acrylate (0.14 mL, 0.13 g, 1.5 mmol), [RuCl2(p-cymene)]2 (0.008 g, 0.013 mmol), 
AgSbF6 (0.018 g, 0.05 mmol), Cu(OAc)2.H2O (0.10 g, 0.5 mmol). Column chromatography 
gave off-white solid 3an, 13% (0.021 g). mp (from CHCl3) = 124-128 °C. FT-IR (thin film): 
νmax (cm-1) = 1749.6, 1714.1. 1H NMR (500 MHz, CDCl3) δ 7.72 (1H, s, ArH), 7.63 (1H, d, J 
= 16.1 Hz, ArCH=CHR), 7.47 (1H, s, ArH), 6.43 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.57 (2H, 
dd, J = 8.1, 7.5 Hz, OCH2), 3.93 (2H, dd, J = 8.1, 7.5 Hz, NCH2), 3.81 (3H, s, OCH3). 13C 
NMR (126 MHz, CDCl3) δ 166.64 (C(O)O), 156.71 (NC(O)O), 137.59 (ArCH=CHR), 136.27 
(ArC), 134.86 (ArC), 132.86 (ArC), 132.27 (ArC), 129.17 (ArC), 128.81 (ArC), 121.95 
(ArCH=CHR), 62.65 (OCH2), 52.24 (OCH3), 48.57 (NCH2). HRMS (ESI): m/z calculated for 
C13H11N1O4Cl2 requires 316.0143 for [M+H]+, found 316.0129 
 




General Procedure C was followed using the following compounds: 1ao, (0.19 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), 
AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography 
gave an off-white powdery solid, 3ao, 23% (0.064 g). mp (from CHCl3) = 104-108 °C. FTIR 
(thin film): νmax (cm-1) = 1747.2, 1712.6. 1H NMR (500 MHz, CDCl3) δ 7.80 (1H, d, J = 16.0 
Hz, ArCH=CHR), 7.34 (1H, t, J = 8.0 Hz, ArH), 7.26–7.23 (1H, m, ArH), 7.00 (1H, dd, J = 
8.2, 1.0 Hz, ArH), 6.45 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.60–4.51 (2H, m, OCH2), 4.06–
3.96 (1H, m, NCH2), 3.86 (3H, s, OCH3), 3.79 (3H, s, OCH3), 3.71–3.66 (1H, m, NCH2). 13C 
NMR (126 MHz, CDCl3) δ 167.12 (C(O)O), 156.50 (NC(O)O), 139.45 (ArCH=CHR), 135.09 
(ArC), 129.85 (ArC), 129.02 (ArC), 128.56 (ArC), 125.63 (ArC), 121.21 (ArC), 118.95 
(ArCH=CHR), 113.52 (ArC), 62.98 (OCH2), 56.23 (OCH3), 51.98 (OCH3), 47.27 (NCH2). 










General Procedure C was followed using the following compounds: 1ap, (0.17 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), 
AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography 
gave an off-white solid, 3ap, 83% (0.21 g). mp (from CHCl3) = 120-123 °C. FT-IR (thin film): 
νmax (cm-1) = 1746.9, 1707.6. 1H NMR (500 MHz, CDCl3) δ 7.53 (1H, d, J = 15.9 Hz, 
ArCH=CHR), 7.17 (1H, dd, J = 5.8, 0.6 Hz, ArH), 7.15–7.12 (1H, m, ArH), 6.25 (1H, d, J = 
15.9 Hz, ArCH=CHR), 4.57–4.52 (2H, m, OCH2), 4.02–3.96 (2H, m, NCH2), 3.77 (3H, s, 
OCH3). 13C NMR (126 MHz, CDCl3) δ 167.41 (C(O)O), 156.44 (NC(O)O), 140.25 
(ArCH=CHR), 134.63 (ArC), 132.06 (ArC), 124.18 (ArC), 123.61 (ArC), 119.07 
(ArCH=CHR), 62.62 (OCH2), 51.88 (OCH3), 49.72 (NCH2). HRMS (ESI): m/z calculated for 
C11H11N1O4S1 requires 254.0487 for [M+H]+, found 254.0464 
 
Synthesis of 3aq1 and 3aq2 
 
General Procedure C was followed using the following compounds: 1aq, (0.20 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), 
AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography 
(EtOAc:Hexanes 30:70 to 40:60) gave two separable regioisomers 3aq1 and 3aq2 (ratio of 
36:64), combined yield 91% (0.25 g) 




mp (from CHCl3) =  128-130 °C. FT-IR (thin film): νmax (cm-1) = 1757.6, 1716.0. 1H NMR 
(500 MHz, CDCl3) δ 7.67 (1H, d, J = 16.0 Hz, ArCH=CHR), 7.48 (1H, d, J = 8.1 Hz, ArH), 
7.01 (1H, d, J = 9.7 Hz, ArH), 6.37 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.54 (2H, t, J = 7.7 Hz, 
 255 
 
OCH2), 3.94–3.88 (2H, m, NCH2), 3.78 (3H, s, OCH3), 2.28 (3H, d, J = 1.5 Hz, ArCH3). 13C 
NMR (126 MHz, CDCl3) δ 167.02 (C(O)O), 162.28 (d, J = 252.0 Hz, ArCF), 156.93 
(NC(O)O), 138.75 (d, J = 1.2 Hz, ArC), 136.17 (d, J = 9.7 Hz, ArC), 130.39 (d, J = 6.5 Hz, 
ArC), 128.05 (d, J = 3.8 Hz, ArC), 125.79 (d, J = 17.7 Hz, ArC), 119.70 (ArCH=CHR), 113.63 
(d, J = 24.0 Hz, ArC), 62.50 (OCH2), 51.88 (OCH3), 48.62 (NCH2), 14.44 (d, J = 2.9 Hz, 
ArCH3). 19F NMR (470 MHz, CDCl3) δ -111.38 – -111.44 (app t, ArF). HRMS (ESI): m/z 
calculated for C14H14N1O4F1 requires 302.0985 for [M+Na]+, found 302.0817 
 




mp (from CHCl3) = 125-127 °C. FT-IR (thin film): νmax (cm-1) = 1749.4, 1714.0. 1H NMR (500 
MHz, CDCl3) δ 7.56 (1H, d, J = 16.4 Hz, ArCH=CHR), 7.21 (1H, t, J = 8.2 Hz, ArH), 7.04 
(1H, d, J = 8.1 Hz, ArH), 6.65 (1H, d, J = 16.8 Hz, ArCH=CHR), 4.51 (2H, dd, J = 8.5, 7.3 
Hz, OCH2), 3.89 (2H, dd, J = 8.4, 7.3 Hz, NCH2), 3.77 (3H, s, OCH3), 2.27 (3H, d, J = 2.2 
Hz, ArCH3). 13C NMR (126 MHz, CDCl3) δ 167.41 (C(O)O), 160.15 (d, J = 253.9 Hz, ArCF), 
157.09 (NC(O)O), 136.22 (d, J = 5.3 Hz, ArC), 134.10 (ArCH=CHR), 132.80 (d, J = 7.2 Hz, 
ArC), 125.79 (d, J = 18.5 Hz, ArC), 124.35 (d, J = 13.8 Hz, ArC), 122.40 (d, J = 3.7 Hz, 
ArCH=CHR), 120.51 (d, J = 13.4 Hz, ArC), 62.52 (OCH2), 51.94 (OCH3), 48.68 (NCH2), 
14.60 (d, J = 4.7 Hz, ArCH3). 19F NMR (470 MHz, CDCl3) δ -112.40 (app d, ArF). HRMS: 
(ESI): m/z calculated for C14H14N1O4F1 requires 280.0985 for [M+H]+, found 280.0964 
 
Synthesis of 3ar1 and 3ar2 
 
General Procedure C was followed using the following compounds: 1ar, (0.10 g, 0.5 mmol), 
methyl acrylate (0.14 mL, 0.13 g, 1.5 mmol), [RuCl2(p-cymene)]2 (0.008 g, 0.013 mmol), 
AgSbF6 (0.018 g, 0.05 mmol), Cu(OAc)2.H2O (0.10 g, 0.5 mmol). Column chromatography 
(EtOAc:Hexanes 30:70 to 40:60) gave two separable regioisomers 3ar1 and 3ar2 (ratio of 
39:61), combined yield 46% (0.046 g) 






mp (from CHCl3) = 123-125 °C. FTIR (thin film): νmax (cm-1) = 1749.8, 1712.2. 1H NMR (500 
MHz, CDCl3) δ 7.65 (1H, dd, J = 16.0, 1.2 Hz, ArCH=CHR), 7.45 (1H, dd, J = 10.8, 8.4 Hz, 
ArH), 7.21 (1H, dd, J = 10.3, 7.2 Hz, ArH), 6.37 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.60–4.54 
(2H, m, OCH2), 3.92 (2H, dd, J = 8.4, 7.2 Hz, NCH2), 3.80 (3H, s, OCH3). 13C NMR (126 
MHz, CDCl3) δ 166.69 (C(O)O), 156.91 (NC(O)O), 151.79 (dd, J = 170.5, 13.5 Hz, ArC), 
149.77 (dd, J = 166.0, 13.4 Hz, ArC), 137.67 (ArC), 121.50 (ArCH=CHR), 116.53 (d, J = 
18.5 Hz, ArC), 115.98 (d, J = 19.0 Hz, ArC), 62.60 (OCH2), 52.21 (OCH3), 48.79 (NCH2). 
19F NMR (470 MHz, cdcl3) δ -131.22 (ddd, J = 21.7, 10.1, 8.8 Hz, ArF), -135.71–-136.03 
(m, ArF). HRMS (ESI): m/z calculated for C13H11N1O4F2 requires 284.0734 for [M+H]+, found 
284.0712 
 




mp (from CHCl3) = 128-130 °C. FTIR (thin film): νmax (cm-1) = 1748.8, 1717.1. 1H NMR (500 
MHz, CDCl3) δ 7.52 (1H, d, J = 16.4 Hz, ArCH=CHR), 7.25–7.20 (1H, m, ArH), 7.14 (1H, 
ddd, J = 8.9, 4.4, 1.9 Hz, ArH), 6.70 (1H, dd, J = 16.4, 0.6 Hz, ArCH=CHR), 4.57–4.54 (2H, 
m, OCH2), 3.93–3.89 (2H, m, NCH2), 3.82 (3H, s, OCH3). 13C NMR (126 MHz, CDCl3) δ 
167.02 (C(O)O), 157.02 (NC(O)O), 151.14 (dd, J = 48.3, 13.9 Hz, ArCF), 149.12 (dd, J = 
54.0, 13.8 Hz, ArCF), 133.69 (ArCH=CHR), 133.03 (ArCH=CHR), 125.99 (d, J = 12.9 Hz, 
ArC), 123.26 (dd, J = 6.9, 4.0 Hz, ArC), 118.49 (d, J = 18.5 Hz, ArC), 62.60 (OCH2), 52.24 
(OCH3), 48.76 (NCH2). 19F NMR (470 MHz, CDCl3) δ -133.86–-134.19 (m, ArF), -135.90 
(ddd, J = 20.4, 9.3, 4.4 Hz, ArF). HRMS (ESI): M/z calculated for C13H11N1O4F2 requires 
284.0700 for [M+H]+, found 284.0718 






General Procedure C was followed using the following compounds: 1ba, (0.077 g, 0.38 
mmol), methyl acrylate (0.10 mL, 0.098 g, 1.14 mmol), [RuCl2(p-cymene)]2 (0.006 g, 0.0095 
mmol), AgSbF6 (0.013 g, 0.014 mmol), Cu(OAc)2.H2O (0.076 g, 0.38 mmol). Column 
chromatography (EtOAc:Hexanes 40:60 to 50:50) gave a an off-white solid, 3ba, 74% 
(0.081 g). [α]D: (c 1, CHCl3) = +25. mp (from CHCl3) = 89-92 °C. FT-IR (thin film): νmax (cm-
1) = 2962.7, 1749.5, 1712.9. 1H NMR (500 MHz, CDCl3) δ 7.81 (1H, d, J = 16.0 Hz, 
ArCH=CHR), 7.65 (1H, d, J = 7.9 Hz, ArH), 7.43 (1H, td, J = 7.6, 1.5 Hz, ArH), 7.34 (2H, t, 
J = 7.6 Hz, ArH), 6.43 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.52 (1H, t, J = 8.8 Hz, OCH2), 4.27 
(1H, dd, J = 8.9, 5.8 Hz, OCH2), 4.20–4.12 (1H, m, NCH), 3.79 (3H, s, OCH3), 1.80 (1H, 
dtd, J = 13.8, 6.9, 3.9 Hz, CH(CH3)2), 0.89 (3H, d, J = 6.8 Hz, CH(CH3)2), 0.80 (3H, d, J = 
7.0 Hz, CH(CH3)2). 13C NMR (126 MHz, CDCl3) δ 167.05 (C(O)O), 157.06 (NC(O)O), 139.93 
(ArCH=CHR), 136.13 (ArC), 132.46 (ArC), 131.03 (ArC), 128.33 (ArC), 127.89 (ArC), 
120.41 (ArCH=CHR), 64.00 (OCH2), 63.43 (OCH3), 51.97 (NCH), 29.04 (CH(CH3)2), 18.22 
(CH(CH3)2), 15.40 (CH(CH3)2). HRMS (ESI): m/z calculated for C16H19N1O4 requires 
290.1392 for [M+H]+, found 290.1366 
 




General Procedure C was followed using the following compounds: 1bb, (0.24 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), 
AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography 
(EtOAc:Hexanes 40:60 to 50:50) gave a pale orange solid, 3bb, 65% (0.21 g). [α]D: (c 1, 
CHCl3) = +8. mp (from CHCl3) = 108-114 °C. FT-IR (thin film): νmax (cm-1) = 2964.1, 1749.9, 
1715.4. 1H NMR (500 MHz, CDCl3) δ 7.71 (1H, d, J = 16.0 Hz, ArCH=CHR), 7.60 (1H, d, J 
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= 2.4 Hz, ArH), 7.37 (1H, dd, J = 8.5, 2.4 Hz, ArH), 7.26 (1H, d, J = 8.5 Hz, ArH), 6.41 (1H, 
d, J = 16.0 Hz, ArCH=CHR), 4.50 (1H, t, J = 8.8 Hz, OCH2), 4.24 (1H, dd, J = 9.0, 6.0 Hz, 
OCH2), 4.17–4.10 (1H, m, NCH), 3.78 (3H, s, OCH3), 1.82–1.73 (1H, m, CH(CH3)2), 0.86 
(3H, d, J = 6.8 Hz, CH(CH3)2), 0.79 (3H, d, J = 7.0 Hz, CH(CH3)2). 13C NMR (126 MHz, 
CDCl3) δ 166.58 (C(O)O), 156.81 (NC(O)O), 138.59 (ArCH=CHR), 134.63 (ArC), 134.03 
(ArC), 133.98 (ArC), 130.81 (ArC), 128.87 (ArC), 127.68 (ArC), 121.53 (ArCH=CHR), 64.06 
(OCH2), 63.23 (OCH3), 52.03 (NCH), 29.03 (CH(CH3)2), 18.13 (CH(CH3)2), 15.39 (CH(CH3-
)2). HRMS (ESI): m/z calculated for C16H18N1O4Cl1 requires 324.1003 for [M+H]+, found 
324.0973 
 




General Procedure C was followed using the following compounds: 1bc, (0.16 g, 0.63 
mmol), methyl acrylate (0.17 mL, 0.16 g, 1.89 mmol), [RuCl2(p-cymene)]2 (0.0098 g, 0.0016 
mmol), AgSbF6 (0.022 g, 0.063 mmol), Cu(OAc)2.H2O (0.13 g, 0.63 mmol). Column 
chromatography (EtOAc:Hexanes 40:60 to 50:50) gave a pale orange solid, 3bc, 55% (0.12 
g). [α]D: (c 1, CHCl3) = +14. mp (from CHCl3) = 147-149 °C. FT-IR (thin film): νmax (cm-1) = 
2957.4, 1756.4, 1718.4. 1H NMR (500 MHz, CDCl3) δ 7.69 (1H, d, J = 16.0 Hz, ArCH=CHR), 
7.64 (1H, d, J = 2.4 Hz, ArH), 7.41 (1H, dd, J = 8.5, 2.4 Hz, ArH), 7.22 (1H, d, J = 8.5 Hz, 
ArH), 6.43 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.66 (1H, t, J = 8.1 Hz, OCH2), 4.27–4.19 (1H, 
m, OCH2), 4.18–4.13 (1H, m, NCH), 3.81 (3H, s, OCH3), 1.50–1.43 (1H, m, CH(CH3)2), 
1.43–1.36 (2H, m, CH2), 0.84 (3H, d, J = 6.4 Hz, CH(CH3)2), 0.80 (3H, d, J = 6.4 Hz, 
CH(CH3)2). 13C NMR (126 MHz, CDCl3) δ 166.71 (C(O)O), 156.66 (NC(O)O), 138.51 
(ArCH=CHR), 134.47 (ArC), 131.10 (ArC), 127.75 (ArC), 121.77 (ArCH=CHR), 68.93 
(OCH2), 57.78 (OCH3), 52.15 (NCH), 42.01 (CH2), 24.79 (CH(CH3)2), 23.42 (CH(CH3)2), 
21.99 (CH(CH3)2). HRMS (ESI): m/z calculated for C17H20N1O4Cl1 requires 338.1159 for 









General Procedure C was followed using the following compounds: 1bd, (0.056 g, 0.2 
mmol), methyl acrylate (0.054 mL, 0.052 g, 0.6 mmol), [RuCl2(p-cymene)]2 (0.0031 g, 0.005 
mmol), AgSbF6 (0.007 g, 0.02 mmol), Cu(OAc)2.H2O (0.04 g, 0.2 mmol). Column 
chromatography (EtOAc:Hexanes 40:60 to 50:50) gave a brown amorphous solid, 3bd, 
43% (0.073 g). [α]D: (c 1, CHCl3) = +19. FT-IR (thin film): νmax (cm-1) = 2957.8, 1757.9, 
1718.9. 1H NMR (500 MHz, CDCl3) δ 7.78 (1H, d, J = 16.0 Hz, ArCH=CHR), 7.66 (1H, d, J 
= 2.3 Hz, ArH), 7.47 (1H, dd, J = 8.4, 2.3 Hz, ArH), 7.17 (1H, d, J = 8.4 Hz, ArH), 6.45 (1H, 
d, J = 16.0 Hz, ArCH=CHR), 4.65 (1H, t, J = 8.1 Hz, OCH2), 4.23 (1H, dt, J = 14.7, 7.5 Hz, 
OCH2), 4.15 (1H, dd, J = 8.4, 7.4 Hz, NCH), 3.81 (3H, s, OCH3), 1.52–1.45 (1H, m, 
CH(CH3)2), 1.44–1.39 (2H, m, CH2), 1.34 (9H, s, C(CH3)3), 0.85 (3H, d, J = 6.4 Hz, 
CH(CH3)2), 0.80 (3H, d, J = 6.3 Hz, CH(CH3)2).  13C NMR (126 MHz, CDCl3) δ 167.23 
(C(O)O), 157.05 (NC(O)O), 151.60 (ArCH=CHR), 140.43 (ArC), 133.21 (ArC), 132.46 
(ArC), 128.67 (ArC), 124.58 (ArC), 120.03 (ArCH=CHR), 68.87 (OCH2), 57.90 (OCH3), 
51.98 (NCH), 41.95 (CH2), 34.96 (C(CH3)3), 31.37 (C(CH3)3), 24.82 (CH(CH3)2), 23.54 
(CH(CH3)2), 21.95 (CH(CH3)2). HRMS (ESI): m/z calculated for C21H29N1O4 requires 
360.2174 for [M+H]+, found 360.2162 
 




In an oven dried carousel tube, to a solution of 1ca (0.15 g, 0.5 mmol), methyl acrylate (0.14 
mL, 0.13 g, 1.5 mmol) in 2-MeTHF (1 mL) was added the combined solids: [RuCl2(p-
cymene)]2 (0.08 g, 0.013 mmol), AgSbF6 (0.018 g, 0.05 mmol) and Cu(OAc)2.H2O (0.10 g, 
 260 
 
0.5 mmol). The carousel tube was sealed with a Teflon cap leaving the tap open and was 
heated to 120 °C for 18 h. The reaction mixture was allowed to return to room temperature 
and was added tetrabutylammonium fluoride – 1 M solution in THF (2 mL) and was left to 
stir for 2 hours at room temperature. The reaction mixture was diluted in EtOAc and filtered 
using a silica plug, eluting with EtOAc. The solvent was removed in vacuo and the crude 
mixture was purified using column chromatography (EtOAc:Hexanes 60:40 to 80:20) to 
yield an amorphous solid, 3ca, 69% (0.095 g). mp (from CHCl3) = 114-116 °C. FT-IR (thin 
film): νmax (cm-1) = 3440.3, 1710.8 . 1H NMR (500 MHz, CDCl3) δ 7.82 (1H, d, J = 16.0 Hz, 
ArCH=CHR), 7.69–7.61 (1H, m, ArH), 7.45–7.38 (1H, m, ArH), 7.37–7.32 (2H, m, ArH), 6.44 
(1H, d, J = 16.0 Hz, ArCH=CHR), 4.78 (1H, td, J = 5.9, 3.0 Hz, OCH), 4.02–3.93 (2H, m, 
CH2OH), 3.92–3.87 (1H, m, NCH2), 3.77 (3H, s, OCH3), 3.70 (1H, dd, J = 12.6, 3.2 Hz, 
NCH2), 3.24 (1H, s, CH2OH). 13C NMR (126 MHz, CD3OD) δ 167.50 (C(O)O), 157.03 
(NC(O)O), 139.99 (ArCH=CHR), 137.01 (ArC), 132.42 (ArC), 131.37 (ArC), 128.66 (ArC), 
127.57 (ArC), 127.54 (ArC), 120.24 (ArCH=CHR), 74.31 (OCH), 62.81 (CH2OH), 52.07 
(OCH3), 49.84 (NCH2). HRMS (ESI): m/z calculated for C14H15N1O5 requires 278.1028 for 
[M+H]+, found 278.1000 
 
Coupling partners shown below were not tolerated in the alkenylation reaction due to either 





Compounds below were not tolerated under the alkenylation conditions discussed in the 
report. The nitrile example could be either electron deficient deactivation of the ring or nitrile 
catalyst binding and poisoning, or a combination of both. Pyridines are well documented 
directing groups in ruthenium catalysis9 therefore it is unsurprising that these motifs were 
not tolerated due to potential catalyst poisoning. Napthalene example was not tolerated due 
to most likely unfavourable steric interactions between C–Hoxazolidinone and C–Hnapthalene 
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In an oven dried carousel tube, to a solution of 1-phenyl-2-pyrrolidinone (0.16 g, 1 mmol), 
methyl acrylate (0.27 mL, 0.26 g, 3 mmol) in 2-MeTHF (1 mL) was added the combined 
solids: [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol) and 
Cu(OAc)2.H2O (0.20 g, 1 mmol). The carousel tube was sealed with a Teflon cap leaving 
the tap open and was heated to 120 °C for 18 h. The reaction mixture was diluted in EtOAc 
and filtered using a silica plug, eluting with EtOAc. The solvent was removed in vacuo and 
the crude mixture was purified using column chromatography (EtOAc:Hexanes 50:50) to 
yield an amorphous solid, 6a, 54% (0.13 g). FT-IR (thin film): νmax (cm-1) = 2951.1, 1691.2, 
1633.4. 1H NMR (500 MHz, CDCl3) δ 7.67–7.57 (2H, m, ArCH=CHR + ArH), 7.40 (1H, t, J 
= 7.0 Hz, ArH), 7.30 (1H, t, J = 7.6 Hz, ArH), 7.21 (1H, d, J = 7.8 Hz, ArH), 6.40 (1H, d, J = 
16.0 Hz, ArCH=CHR), 3.75 (3H, s, J = 3.8 Hz, OCH3), 3.71 (2H, t, J = 6.9 Hz, NCH2), 2.58 
(2H, t, J = 8.0 Hz, CH2C=O), 2.22 (2H, m, CH2CH2CH2). 13C NMR (126 MHz, CDCl3) δ 
175.27 (C(O)O), 167.13 (NC(O)C), 139.99 (ArCH=CHR), 138.36 (ArC), 131.83 (ArC), 
131.11 (ArC), 128.15 (ArC), 127.46 (ArC), 127.36 (ArC), 119.78 (ArCH=CHR), 51.79 
(OCH3), 51.60 (NCH2), 31.27 (CH2C=O), 19.05 (CH2CH2CH2). HRMS (ESI): m/z calculated 









In an oven dried carousel tube, to a solution of 3-phenylthiazolidin-2-one, 5b, (0.18 g, 1 
mmol), methyl acrylate (0.27 mL, 0.26 g, 3 mmol) in 2-MeTHF (1 mL) was added the 
combined solids: [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol) 
and Cu(OAc)2.H2O (0.20 g, 1 mmol). The carousel tube was sealed with a Teflon cap 
leaving the tap open and was heated to 120 °C for 18 h. The reaction mixture was diluted 
in EtOAc and filtered using a silica plug, eluting with EtOAc. The solvent was removed in 
vacuo and the crude mixture was purified using column chromatography (EtOAc:Hexanes 
40:60 to 50:50) to yield a white solid, 6b, 68% (0.1 g). mp (from CHCl3) = 108-109 °C. FT-
IR (thin film): νmax (cm-1) = 1710.6, 1667.9, 1634.9. 1H NMR (500 MHz, CDCl3) δ 7.74 (1H, 
d, J = 16.0 Hz, ArCH=CHR), 7.67 (1H, dd, J = 7.8, 1.5 Hz, ArH), 7.45 (1H, td, J = 7.7, 1.5 
Hz, ArH), 7.37 (1H, td, J = 7.5, 0.8 Hz, ArH), 7.29 (1H, d, J = 1.2 Hz, ArH), 6.46 (1H, d, J = 
16.0 Hz, ArCH=CHR), 3.95 (2H, t, J = 7.1 Hz, NCH2), 3.81 (3H, s, OCH3), 3.49 (2H, t, J = 
7.1 Hz, SCH2). 13C NMR (126 MHz, CDCl3) δ 172.26 (C(O)O), 167.14 (NC(O)S), 139.62 
(ArCH=CHR), 138.43 (ArC), 132.44 (ArC), 131.37 (ArC), 128.70 (ArC), 127.79 (ArC), 
127.61 (ArC), 120.57 (ArCH=CHR), 52.48 (OCH3), 52.02 (NCH2), 26.77 (SCH2). HRMS 









In an oven dried carousel tube, to a solution of 3-phenyl-1,3-thiazolidin-4-one (0.18 g, 1 
mmol), methyl acrylate (0.27 mL, 0.26 g, 3 mmol) in 2-MeTHF (1 mL) was added the 
combined solids: [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol) 
and Cu(OAc)2.H2O (0.20 g, 1 mmol). The carousel tube was sealed with a Teflon cap 
leaving the tap open and was heated to 120 °C for 18 h. The reaction mixture was diluted 
in EtOAc and filtered using a silica plug, eluting with EtOAc. The solvent was removed in 
vacuo and the crude mixture was purified using column chromatography (EtOAc:Hexanes 
50:50 to 60:40) to yield a cream powdery solid, 6c, 24% (0.063 g). mp (from CHCl3) = 122-
123 °C. FT-IR (thin film) νmax (cm-1) = 1710.9, 1683.7. 1H NMR (500 MHz, CDCl3) δ 7.69 
(1H, dd, J = 7.8, 1.0 Hz, ArH), 7.63 (1H, d, J = 16.0 Hz, ArCH=CHR), 7.46 (1H, td, J = 7.6, 
1.4 Hz, ArH), 7.40 (1H, t, J = 7.3 Hz, ArH), 7.26 (1H, dd, J = 7.9, 1.0 Hz, ArH), 6.46 (1H, d, 
J = 16.0 Hz, ArCH=CHR), 4.63 (2H, s, NCH2S), 3.80 (3H, s, OCH3), 3.76 (2H, s, 
SCH2C=O).13C NMR (126 MHz, CDCl3) δ 171.51 (C(O)O), 166.94 (NC(O)C), 139.08 
(ArCH=CHR), 137.63 (ArC), 132.46 (ArC), 131.48 (ArC), 129.27 (ArC), 128.20 (ArC), 
127.95 (ArC), 120.98 (ArCH=CHR), 51.99 (OCH3), 50.49 (NCH2S), 32.49 (SCH2C=O). 






6.1.6: Further Derivations 
 




To an oven dried carousel tube was added 3b (0.247 g, 1 mmol), palladium 10% on 
activated carbon (0.050 g) and MeOH (4 mL). Through the reaction mixture was bubbled 
hydrogen gas using a balloon. This was repeated twice before carousel tube was sealed 
and a balloon of hydrogen gas was placed through the septum. The reaction was left to stir 
overnight at room temperature. After TLC had deemed the reaction complete, the mixture 
was diluted in EtOAc and filtered through a plug of celite, eluting with EtOAc. The filtrate 
was concentrate in vacuo to give an amorphous solid, 4a, quantitative yield (0.248 g). FTIR 
(thin film): νmax (cm-1) = 1739.4. 1H NMR (500 MHz, CDCl3) δ 7.24–7.14 (4H, m, ArH), 4.42 
(2H, m, OCH2), 3.87 (2H, m, NCH2), 3.57 (3H, s, OCH3), 2.88 (2H, m, ArCH2), 2.60 (2H, m, 
CH2CO2Me). 13C NMR (126 MHz, CDCl3) δ 173.08 (C(O)O), 157.14 (NC(O)O), 138.46 
(ArC), 135.89 (ArC), 129.65 (ArC), 128.39 (ArC), 127.51 (ArC), 126.83 (ArC), 62.38 (OCH2), 
51.48 (OCH3), 48.35 (NCH2), 34.13 (ArCH2), 25.97 (CH2CO2Me). HRMS (ESI): m/z 









To a solution of 3b (0.247 g, 1 mmol) in H2O (2 mL) and MeOH (2 mL) was added KOH (1.1 
mmol, 0.074 g) and the reaction mixture was stirred at 50°C overnight. The mixture was 
brought to pH 1 and then extracted with 3 x 10 mL CH2Cl2. The organic phase was then 
washed with 1 x 30 mL brine and was dried over MgSO4. The resulting mixture was 
concentrated in vacuo to give a crude solid. This solid was triturated with 3 x 1 mL Et2O to 
give a crystalline solid, 4b, 81%. (0.19 g). mp (from CHCl3) = 172-174 °C. FT-IR (thin film): 
νmax (cm-1) = 2988.7, 1715.0. 1H NMR (500 MHz, CD3OD) δ 7.82 (1H, d, J = 7.9 Hz, ArH), 
7.78 (1H, d, J = 16.0 Hz, ArCH=CHR), 7.53–7.47 (1H, m, ArH), 7.42 (2H, dd, J = 11.7, 4.1 
Hz, ArH), 6.53 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.59 (2H, dd, J = 8.6, 7.3 Hz, OCH2), 4.06–
3.99 (2H, m, NCH2). 13C NMR (126 MHz, CD3OD) δ 168.58 (CO2H), 158.18 (NC(O)O), 
139.50 (ArCH=CHR), 136.93 (ArC), 132.14 (ArC), 130.89 (ArC), 128.24 (ArC), 127.18 
(ArC), 126.65 (ArC), 120.30 (ArCH=CHR), 62.94 (OCH2), 48.41 (NCH2). HRMS (ESI): m/z 









To a mixture of 3a (0.247 g, 1 mmol) and Na2CO3 (0.106 g, 1 mmol) in MeOH (1 mL) was 
added ethanolamine (0.301 mL, 5 mmol) portionwise. The reaction mixture was heated to 
reflux overnight before being allowed to return to room temperature. The reaction mixture 
was diluted with 10 mL MeOH and the remaining solids were filtered. The filtrate was 
concentrated and then purified using silica gel chromatography (EtOAc:Hexanes 60:40 to 
80:20) to give an amorphous white solid, 4c, 62% (0.171 g). FT-IR (thin film): νmax (cm-1) = 
3318.1, 1736.0, 1659.5. 1H NMR (500 MHz, CDCl3) δ 7.54 (1H, d, J = 15.7 Hz, ArCH=CHR), 
7.42 (1H, d, J = 7.5 Hz, ArH), 7.31 (1H, t, J = 7.5 Hz, ArH), 7.23 (1H, d, J = 7.9 Hz, ArH), 
7.14 (1H, t, J = 7.5 Hz, 1H), 6.42 (1H, d, J = 15.7 Hz, ArCH=CHR), 4.50 (2H, t, J = 7.7 Hz, 
OCH2), 4.45 (1H, s, NH), 3.89 (2H, t, J = 7.7 Hz, NCH2), 3.64 (2H, s, OCH2), 3.39–3.34 (2H, 
m, NCH2), 2.93 (1H, s, OH). 13C NMR (126 MHz, cdcl3) δ 166.90 (C(O)N), 158.00 (NC(O)O), 
136.47 (ArCH=CHR), 134.75 (ArC), 132.84 (ArC), 130.48 (ArC), 128.59 (ArC), 127.56 
(ArC), 126.77 (ArC), 123.78 (ArCH=CHR), 62.94 (OCH2), 61.24 (OCH2), 48.61 (NCH2), 





6.1.7: Deuterium Labelling and Kinetics Data 
 




Deuterated Analogue of 3-phenyl-2-oxazolidinone was synthesised using General 
Procedure B using the following compounds: 2-oxazolidinone (0.17 g, 2 mmol), copper 
iodide (0.019 g, 0.1 mmol), (±)-trans-1,2-diaminocyclohexane (0.024 mL, 0.023 g, 0.2 
mmol), potassium carbonate (0.55 g, 4 mmol), bromobenzene-d5 (0.21 mL, 0.32 g, 2 mmol) 
and dioxane (1 mL) Column chromatography gave an off-white solid, [D]5-1a, 70%, (0.24 
g). FT-IR (thin film): νmax (cm-1) = 1734.4 cm-1. 1H NMR (500 MHz, CDCl3) δ 4.50–4.45 (2H, 
m, OCH2), 4.08–4.03 (2H, m, NCH2).  13C NMR (126 MHz, CDCl3) δ 155.44 (NC(O)O), 
138.33 (ArC), 129.07–128.41 (ArCD), 124.11–123.36 (ArCD), 118.45–117.63 (ArCD), 
61.48 (OCH2), 45.38 (NCH2). HRMS (ESI): m/z calculated for C9H4N1O2D5 requires 
191.0845 for [M+Na]+, found 191.0867. 
 
 
Reaction of deuterated analogue under the reaction conditions (Scheme 12) 
 
General Procedure C was followed using the following compounds: [D]5-1a, (0.168 g, 1 
mmol), methyl acrylate (0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 
mmol), AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column 
chromatography (EtOAc:Hexanes) gave an amorphous white solid, [D]n-3b, 69% (0.17 g). 
FT-IR (thin film): νmax (cm-1) = 1745.2, 1710.4. 1H NMR (500 MHz, CDCl3) δ 7.73 (1H, d, J 
= 16.0 Hz, ArCH=CHR), 7.29 (1H, s, J = 7.3 Hz, ArH), 6.41 (1H, d, J = 16.0 Hz, ArCH=CHR), 
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4.52–4.46 (2H, m, OCH2), 3.93–3.87 (2H, m, NCH2), 3.75 (3H, s, CO2CH3). 13C NMR (126 
MHz, CDCl3) δ 167.01 (C(O)O), 157.10 (NC(O)O), 139.53 (ArCH=CHR), 136.99 (ArC), 
132.00 (ArC), 131.17–130.35 (m, ArC), 128.27–126.01 (ArC), 120.25 (ArCH=CHR), 62.45 
(OCH2), 51.84 (CO2CH3), 48.66 (NCH2). HRMS (ESI): m/z calculated for C13H9N1O4D4 




Kinetic Isotope Effect (KIE) Studies 
 
Parallel Reactions (Scheme 13a) 
 
Two parallel reactions were run using General Procedure C using the following compounds: 
1a (0.163 g, 1 mmol) or [D]5-1a, (0.168 g, 1 mmol), methyl acrylate (0.27 mL, 0.26 g, 3 
mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol), 
Cu(OAc)2.H2O (0.20 g, 1 mmol) and Naphthalene (0.128 g, 1 mmol). Column 
chromatography (EtOAc:Hexanes) gave an amorphous white solid, [D]n-3b, 69% (0.17 g). 
Aliquots were taken periodically and analysed via HPLC to provide the following 
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Intermolecular Competition (Scheme 13b) 
 
Two parallel reactions were run (Run 1 & Run 2) using General Procedure C using the 
following compounds: 1a (0.81 g, 0.5 mmol) and [D]5-1a, (0.84 g, 0.5 mmol), methyl acrylate 
(0.27 mL, 0.26 g, 3 mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 
mmol), Cu(OAc)2.H2O (0.20 g, 1 mmol). Column chromatography (EtOAc:Hexanes) gave a 
mixture of 3b and [D]n-3b, (average for 2 runs: 60% yield). The distribution was then 








Run 1 – H = 0.73. D = 0.27. KIE = 2.7 
 





6.1.8: Competition Experiments 
 
Crude 1H NMR spectra were taken after silica plug work-up and diagnostic peaks were 
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6.2: Data and Supporting Information for “Use of the Hydantoin Directing Group in 
Ruthenium(II)-Catalyzed C–H Functionalization 
 
In the interest of presentation in a thesis, NMR spectra have not been included. However, 
in the interest of the reader these are available online at:  
http://pubs.acs.org/doi/suppl/10.1021/acs.joc.6b02073/suppl_file/jo6b02073_si_001.pdf 
The supporting information has also been submitted to formatting and colour changes 




Proton, carbon and fluorine NMR spectra were recorded on Bruker 300 MHz or Agilent 
Technologies 500 MHz spectrometer (1H NMR at 300 MHz or 500 MHz, 13C{1H} NMR at 
126 MHz or 75 MHz and 19F NMR at 470 MHz). Chemical shifts for protons are reported in 
parts per million downfield from Si(CH3)4 and are referenced to residual protium in the 
deuterated solvent (CHCl3 at 7.26 ppm, D2O at 4.79 and CD3OD at 3.31). Chemical shifts 
for fluorine s are reported in parts per million downfield from CFCl3. NMR data are presented 
in the following format: chemical shift (number of equivalent nuclei by integration, multiplicity 
[app = apparent, br = broad, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, dt 
= doublet of triplets, dq = doublet of quartets, ddd = doublet of doublet of doublets, m = 
multiplet], coupling constant [in Hz], assignment). Electrospray ionisation ultrahigh 
resolution time-of-flight mass spectrometry (ESI–UHR–TOF–MS) was performed on a 
Bruker maXis mass spectrometer. Electrospray ionisation high resolution time-of-flight 
mass spectrometry (ESI–HR–TOF–MS) was performed on a Bruker micrOTOF 
spectrometer. Infrared (IR) spectra were recorded on a Perkin–Elmer 1600 FT (Fourier 
transform) IR spectrophotometer, with absorbencies quoted as wavelength (ν [in cm−1]). 
Melting points were obtained on a Bibby Sterilin SMP10 melting point machine and are 
uncorrected. 
 
Analytical thin-layer chromatography (TLC) was performed on aluminium-backed plates 
coated with Alugram® SIL G/UV254 purchased from Macherey–Nagel and visualised with 
UV light (254 or 365 nm) and/or KMnO4, 2,4-DNPH or I2/Silica staining. Silica gel column 
chromatography was performed using 60 Å, 200-400 mesh particle size silica gel purchased 





All reactions were performed using reagents obtained from Sigma-Aldrich, Acros Organics, 
Alfa Aesar, Fluorochem chemicals without further purification unless stated. [RuCl2(p-
cymene)]2 was purchased from STREM chemicals. All water used was purified through a 
Merck Millipore reverse osmosis purification system prior to use. Anhydrous acetonitrile 
(MeCN), anhydrous dichloromethane (CH2Cl2), anhydrous tetrahydrofuran (THF) and 
anhydrous toluene (PhMe) were dried and degassed by passing through anhydrous 
alumina columns using an Innovative Technology Inc. PS-400-7 solvent purification system 
(SPS) and stored under an atmosphere of N2 prior to use. 
Reactions were performed in oven-dried glassware and under a blanket of N2 if not stated. 













Entry Solvent Oxidant NMR Yield 
1 Dioxane Cu(OAc)2.H2O 35 
2 Bu2O Cu(OAc)2.H2O 19 
3 CPME Cu(OAc)2.H2O 59 
4 DME Cu(OAc)2.H2O 81 
5 DCE Cu(OAc)2.H2O 53 
6 DMA Cu(OAc)2.H2O 0 
7 tAmOH Cu(OAc)2.H2O 33 
8 2-Butanone Cu(OAc)2.H2O 38 
9 NMP Cu(OAc)2.H2O 0 
10 DMF Cu(OAc)2.H2O 0 
11 H2O Cu(OAc)2.H2O 0 
12 PhMe Cu(OAc)2.H2O 17 
13 PhCF3 Cu(OAc)2.H2O 46 
14 2-MeTHF (Repeat) Cu(OAc)2.H2O 85 
15 THF Cu(OAc)2.H2O 74 
16 AcOH Cu(OAc)2.H2O 0 
20 2-MeTHF AgOAc 39 
21 2-MeTHF Ag2CO3 8 
22 2-MeTHF AgTFA 0 
23 2-MeTHF AgOTf 0 
24 2-MeTHF Cu(OTf)2 0 
25 2-MeTHF Zn(OTf)2 0 
26b 2-MeTHF Cu(OAc)2.H2O 30 
27c 2-MeTHF Cu(OAc)2.H2O 95 (94) 
28c,d 2-MeTHF Cu(OAc)2.H2O 70 
 
Reaction general conditions. N-phenylhydantoin (0.25 mmol), methyl acrylate (0.75 mmol), [RuCl2(p-cymene)]2 
(0.0125 mmol), AbSbF6 (0.05 mmol) oxidant (1 eq) solvent (1 mL). 1,1,2,2-tetrachloroethane (0.25 mmol) as 
internal standard. 
b = Reaction performed at 80 °C 
c = Reaction performed at 100 °C 






6.2.3: Synthesis of Hydantoin Starting Materials 
 
Synthesis of 1a 
 
 
To a solution of 2-aminoisobutyric acid (4.12 g, 40 mmol) in MeOH (200 mL) was added 
thionyl chloride (3.20 mL, 5.30 g, 44 mmol) dropwise. The reaction mixture was heated to 
reflux and left to stir overnight. The resulting mixture was concentrated in vacuo affording a 
crystalline solid. This solid was re-dissolved in 160 mL anhydrous dichloromethane and 
triethylamine (6.12 mL, 4.44 g, 44 mmol). The flask was cooled to 0 °C and was added 
dropwise phenyl isocyanate (4.78 mL, 5.24 g, 44 mmol). After addition was complete the 
reaction mixture was allowed to return to room temperature and was stirred for two hours. 
The crude mixture was quenched with HCl (1M, 100 mL) and the organic phase extracted. 
The organic phase then washed with HCl (1M, 2 x 100 mL). The combined aqueous phases 
were re-extracted with 150 mL CH2Cl2. The organic phases were combined and dried over 
MgSO4 then concentrated in vacuo. The crude reaction mixture was then recrystallized from 
boiling ethanol to give pure urea intermediate. 1H NMR (500 MHz, CDCl3) δ 7.34–7.24 (4H, 
m, ArH), 7.10–7.00 (1H, m, ArH), 6.79 (1H, s, NH), 3.80–3.70 (3H, m, OCH3), 1.56 (6H, s, 
C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 176.18 (NC(O)C), 155.03 (NC(O)N), 138.71 (ArC), 
129.40 (ArC), 123.93 (ArC), 121.04 (ArC), 56.61 (OCH3), 52.90 (C(CH3)2), 25.73 (C(CH3)2). 
To a solution of the urea (6.74 g, 29 mmol) in THF (116 mL) was added potassium tert-
butoxide (3.58 g, 32 mmol). The reaction mixture was allowed to stir overnight at room 
temperature. The mixture was concentrated in vacuo and the crude residue was partitioned 
between EtOAc (100 mL) and Water (100 mL). The organic layer was separated and the 
aqueous layer was extracted with two further portions of EtOAc (2 x 100 mL). The combined 
organics were dried over MgSO4 and concentrated in vacuo to give a white crystalline solid, 
1a, 71% (4.21 g). 1H NMR (500 MHz, CDCl3) δ 7.50–7.33 (5H, m, ArH), 6.87 (1H, s, NH), 
1.49 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 176.43 (NC(O)C), 155.85 (NC(O)N), 
131.80 (ArC), 129.26 (ArC), 128.38 (ArC), 126.36 (ArC) 58.82 (C(CH3)2, 25.38 (C(CH3)2. 










To a solution of benzoic acid (10 mmol) in anhydrous CH2Cl2 (40 mL) was added DMF (0.1 
mL) and oxalyl chloride (15 mmol) dropwise at 0 °C. After addition was complete the 
reaction mixture was allowed to return to room temperature and stir for two hours. The 
mixture concentrated in vacuo. The mixture was re-dispersed in CH2Cl2 and was added 
tetrabutylammonium iodide (0.01 mmol). The mixture was cooled to 0 °C and was added 
sodium azide (15 mmol) solution in water (8 mL) portionwise. After addition was complete 
the reaction mixture was allowed to return to room temperature and stir overnight. The 
reaction mixture was diluted in water (32 mL) and the organic phase extracted. The aqueous 
phase was further extracted with dichloromethane (2 x 40 mL) and the combined organic 
phases were dried over MgSO4 and concentrated in vacuo. The crude mixture was purified 












Aryl acyl azide was dissolved in anhydrous toluene (8 mL) and heated to reflux for two 
hours. The reaction mixture was allowed to cool and concentrated in vacuo. The reaction 
mixture was then diluted in anhydrous CH2Cl2 (5 mL). In a separate flask, H-Aib-OMe 
hydrochloride salt (1 eq wrt. acyl azide) was diluted in anhydrous CH2Cl2 and was added 
triethylamine (1.1 eq) at 0 °C. The isocyanate mixture was then syringed into the amino acid 
mixture dropwise at 0 °C, allowing for mild effervescence. After the mixtures were 
completely combined the reaction mixture was allowed to return to room temperature and 
stir overnight. The reaction mixture was diluted with HCl (1M, 40 mL) and the organic phase 
was extracted. The organic phase was further washed with HCl (1M, 2 x 40 mL) and the 
organic phase was dried over MgSO4 and concentrated in vacuo. The crude residue was 
diluted in THF (40 mL) and was added potassium tert-butoxide (1.1 eq) and the reaction 
mixture was allowed to stir for two hours at room temperature. The mixture was 
concentrated in vacuo and dispersed in a mixture of CH2Cl2 (40 mL) and water (40 mL). 
The organic phase was extracted and the aqueous phase was further extracted with CH2Cl2 
(2 x 40 mL). The combined organic phases were dried with MgSO4 (if possible, often the 
hydantoin falls out of solution) and concentrated in vacuo to give N-arylhydantoin. The crude 
mixture was purified by silica gel column chromatography (EtOAc:Petroleum Ether 40-









The above compound was obtained from the appropriate acyl azide synthesized previously 
following General Procedure B using the following reagents: acyl azide (1.4 g, 8 mmol), H-
Aib-OMe.HCl (1.22 g, 8 mmol), triethylamine (1.22 mL, 8.8 mmol), potassium tert-butoxide 
(0.98 g, 8.8 mmol). The resulting crude mixture was purified via recrystallization using 
boiling ethanol to give a crystalline white solid, 1b, 64% from acyl azide, 52% from acid 
(1.19 g). mp (from CHCl3): 147-149 °C. FT-IR (thin film): νmax (cm-1) = 3224.8, 1780.5, 
1714.9. 1H NMR (500 MHz, CDCl3) δ 7.32–7.27 (2H, m, ArH), 7.00–6.94 (2H, m, ArH), 6.71 
(1H, s, NH), 3.82 (3H, s, ArOCH3), 1.50 (6H, s, C(CH3)2). 13C NMR (75 MHz, CDCl3) δ 176.62 
(NC(O)C), 159.39 (NC(O)N), 156.11 (ArCOCH3), 127.71 (ArC), 124.22 (ArC), 114.54 (ArC), 
58.74 (C(CH3)2), 55.61 (ArOCH3), 25.28 (C(CH3)2). HRMS (ESI): m/z calculated for 
C12H14N2O3 requires 257.0902 for [M+Na]+, found 257.0893. 
 




The above compound was obtained from the appropriate acyl azide synthesized previously 
following General Procedure B using the following reagents: acyl azide (1.45 g, 9 mmol), 
H-Aib-OMe.HCl (1.38 g, 9 mmol), triethylamine (1.38 mL, 9.9 mmol), potassium tert-
butoxide (1.01 g, 9.9 mmol). The resulting crude mixture did not require further purification 
as an off-white solid, 1c, 50% from acyl azide, 56% from acid (1.10 g). mp (from CHCl3): 
175-177 °C. FT-IR (thin film): νmax (cm-1) = 3385.3, 2979.9, 1773.8, 1714.6.  1H NMR (300 
MHz, CDCl3) δ 7.27 (4H, s, ArH), 2.38 (3H, s, ArCH3), 1.53 (6H, s, C(CH3)2). 13C NMR (75 
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MHz, CDCl3) δ 176.50 (NC(O)C), 156.00 (NC(O)N), 138.39 (ArC), 129.84 (ArC), 129.04 
(ArC), 126.22 (ArC), 58.75 (C(CH3)2), 25.28 (C(CH3)2), 21.29 (ArCH3). HRMS (ESI): m/z 
calculated for C12H14N2O2 requires 241.0955 for [M+Na]+, found 241.0973. 
 




The above compound was obtained from the appropriate acyl azide synthesized previously 
following General Procedure B using the following reagents: acyl azide (1.26 g, 8.2 mmol), 
H-Aib-OMe.HCl (1.26 g, 9 mmol), triethylamine (1.25 mL, 9 mmol), potassium tert-butoxide 
(0.92 g, 9 mmol). The resulting crude mixture was purified via silica gel chromatography to 
give a crystalline white solid, 1d, 38% from acyl azide, 31% from acid (0.82 g). mp (from 
CHCl3): 188-189 °C. FTIR (thin film): νmax (cm-1) = 2956.3, 1780.9, 1717.7. 1H NMR (500 
MHz, CDCl3) δ 7.50–7.45 (2H, m, ArH), 7.34–7.30 (2H, m, ArH), 5.77 (1H, s, NH), 1.54 (6H, 
s, C(CH3)2), 1.33 (9H, s, C(CH3)3). 13C NMR (126 MHz, CDCl3) δ 176.34 (NC(O)C), 151.44 
(NC(O)N), 129.03 (ArC), 128.80 (ArC), 126.33 (ArC), 125.82 (ArC), 58.80 (C(CH3)2), 34.92 
(C(CH3)3), 31.49 (C(CH3)3), 25.56 (C(CH3)2). HRMS (ESI): m/z calculated for C15H20N2O2 
requires 283.1422 for [M+Na]+, found 283.1390. 
 




The above compound was obtained from the appropriate acyl azide synthesized previously 
following General Procedure B using the following reagents: acyl azide (1.49 g, 8 mmol), 
H-Aib-OMe.HCl (1.22 g, 8 mmol), triethylamine (1.22 mL, 8.8 mmol), potassium tert-
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butoxide (0.98 g, 8.8 mmol). The resulting crude mixture was purified via recrystallization 
using boiling ethanol to give a crystalline white solid, 59% from acyl azide, 48% from acid 
(1.13 g). mp (from CHCl3): 139-141 °C. FT-IR (thin film): νmax (cm-1) = 3297.0, 2981.0, 
1780.0, 1707.3. 1H NMR (300 MHz, CDCl3) δ 7.48–7.35 (4H, m, ArH), 6.52 (1H, s, NH), 
1.53 (6H, s, C(CH3)2). 13C NMR (75 MHz, CDCl3) δ 176.11 (NC(O)C), 155.36 (NC(O)N), 
134.07 (ArC), 130.25 (ArC), 129.45 (ArC), 127.46 (ArC), 58.90 (C(CH3), 25.42 (C(CH3)2). 
HRMS (ESI): m/z calculated for C11H11N2O2Cl1 requires 21.0407 for [M+Na]+, found 
261.0385. 
 




The above compound was obtained from the appropriate acyl azide synthesized previously 
following General Procedure B using the following reagents: acyl azide (1.51 g, 6.7 mmol), 
H-Aib-OMe.HCl (1.03 g, 6.7 mmol), triethylamine (1.03 mL, 7.4 mmol), potassium tert-
butoxide (0.83 g, 7.4 mmol). The resulting crude mixture was purified via recrystallization 
using boiling ethanol to give a crystalline white solid, 63% from acyl azide, 42% from acid 
(1.20 g). mp (from CHCl3): 176-177 °C. FT-IR (thin film): νmax (cm-1) = 3295.7, 2979.9, 
1780.8 1708.4. 1H NMR (300 MHz, CDCl3) δ 7.59 (2H, d, J = 8.6 Hz, ArH), 7.33 (2H, d, J = 
8.6 Hz, ArH), 6.27 (1H, s, NH), 1.54 (6H, s, C(CH3)2). 13C NMR (75 MHz, CDCl3) δ 175.97 
(NC(O)C), 155.15 (NC(O)N), 132.43 (ArC), 130.82 (ArC), 127.71 (ArC), 122.09 (ArC), 58.90 
(C(CH3)2), 25.47 (C(CH3)2). HRMS (ESI): m/z calculated for C11H11N2O2Br1 requires 








The above compound was obtained from the appropriate acyl azide synthesized previously 
following General Procedure B using the following reagents: acyl azide (1.82 g, 8.5 mmol), 
H-Aib-OMe.HCl (1.31 g, 8.5 mmol), triethylamine (1.30 mL, 9.4 mmol), potassium tert-
butoxide (0.95 g, 9.4 mmol). The resulting crude mixture was purified via recrystallization 
using boiling ethanol to give a crystalline white solid, 66% from acyl azide, 56% from acid 
(1.53 g). FT-IR (thin film): νmax (cm-1) = 3328.1, 1779.8, 1719.2. 1H NMR (300 MHz, CDCl3) 
δ 7.74 (2H, d, J = 8.5 Hz, ArH), 7.63 (2H, d, J = 8.5 Hz, ArH), 6.26 (1H, s, NH), 1.56 (6H, s, 
C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 175.82 (NC(O)C)), 154.82 (NC(O)N)), 139.48 – 
114.06 (ArC) 135.05 (ArC), 130.15 (d, J = 32.9 Hz, ArC), 126.35 (q, J = 3.7 Hz, ArC), 126.16 
(ArC), 125.31 (q, J = 269.3 Hz, ArCF3), 58.93 (C(CH3)2), 25.53 (C(CH3)2). 19F NMR (470 
MHz, CDCl3) δ -62.71 (s, CF3). HRMS (ESI): m/z calculated for C12H11N2O3F3 requires 
295.0670 for [M+Na]+, found 295.0643. 
 




The above compound was obtained from the appropriate acyl azide synthesized previously 
following General Procedure B using the following reagents: acyl azide (1.19 g, 5.3 mmol), 
H-Aib-OMe.HCl (0.81 g, 5.3 mmol), triethylamine (0.81 mL, 5.83 mmol), potassium tert-
butoxide (0.65 g, 5.83 mmol). The resulting crude mixture was purified via recrystallization 
using boiling ethanol to give a crystalline off-white solid, 93% from acyl azide, 41% from 
acid (1.40 g). mp (from CHCl3): 196-198 °C FTIR (thin film): νmax (cm-1) = 3324.8, 2982.2, 
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1775.6, 1708.6. 1H NMR (300 MHz, CDCl3) δ 6.94 (2H, s, ArH), 6.88 (1H, s, ArH), 6.35 (1H, 
s, NH), 3.89 (6H, app d, ArOCH3), 1.53 (6H, s, C(CH3)2). 13C NMR (75 MHz, CDCl3) δ 176.60 
(NC(O)C), 155.96 (NC(O)N), 149.36 (ArCOCH3), 149.11 (ArCOCH3), 124.41 (ArC), 119.10 
(ArC), 111.22 (ArC), 110.03 (ArC), 58.82 (C(CH3)2), 56.23 (ArOCH3), 56.24 (ArOCH3), 
25.45 (C(CH3)2). HRMS (ESI): m/z calculated for C13H16N2O4 requires 287.1008 for [M+H]+, 
found 287.0976. 
 




The above compound was obtained from the appropriate acyl azide synthesized previously 
following General Procedure B using the following reagents: acyl azide (1.37 g, 7.8 mmol), 
H-Aib-OMe.HCl (1.20 g, 7.8 mmol), triethylamine (1.20 mL, 8.58 mmol), potassium tert-
butoxide (0.97 g, 8.58 mmol). The resulting crude mixture was purified via silica gel 
chromatography to give an off-white solid, 54% from acyl azide, 42% from acid (0.97 g). mp 
(from CHCl3): 181-183 °C FT-IR (thin film): νmax (cm-1) = 3292.6, 1778.1, 1713.6. 1H NMR 
(500 MHz, CDCl3) δ 7.22 (1H, d, J = 8.0 Hz, ArH), 7.14 (1H, d, J = 1.9 Hz, ArH), 7.09 (1H, 
dd, J = 8.0, 2.2 Hz, ArH), 6.06 (1H, s, NH), 2.29 (3H, s, ArCH3), 2.28 (3H, s, ArCH3), 1.53 
(6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 176.50 (NC(O)C), 155.88 (NC(O)N), 137.85 
(ArC), 137.36 (ArC), 130.45 (ArC), 129.24 (ArC), 127.59 (ArC), 124.00 (ArC), 58.85 
(C(CH3)2), 25.50 (C(CH3)2), 20.05 (ArCH3), 19.71 (ArCH3). HRMS (ESI): m/z calculated for 
C13H16N2O2 requires 233.1290 for [M+H]+, found 233.1272. 
 






The above compound was obtained from the appropriate acyl azide synthesized previously 
following General Procedure B using the following reagents: acyl azide (0.40 g, 2.6 mmol), 
H-Aib-OMe.HCl (0.4 g, 2.6 mmol), triethylamine (0.40 mL, 2.9 mmol), potassium tert-
butoxide (0.33 g, 2.9 mmol). The resulting crude mixture was purified via silica gel 
chromatography to give a light purple solid, 55% from acyl azide, 48% from acid (0.32 g). 
1H NMR (500 MHz, CDCl3) δ 7.50 (1H, dd, J = 3.9, 1.4 Hz, ArH), 7.17 (1H, dd, J = 5.5, 1.4 
Hz, ArH), 7.00 (1H, dd, J = 5.5, 3.8 Hz, ArH), 6.39 (1H, s, NH), 1.54 (6H, s, C(CH3)2). 13C 
NMR (126 MHz, CDCl3) δ 174.77 (NC(O)C), 154.39 (NC(O)N), 132.42 (ArC), 125.27 (ArC), 
121.87 (ArC), 120.19 (ArC), 58.68 (C(CH3)2), 25.52 (C(CH3)2). The data is in line with 
literature precedent.2 
  




The above compound was obtained from the appropriate acyl azide synthesized previously 
following General Procedure B using the following reagents: acyl azide (1.94 g, 7.4 mmol), 
H-Aib-OMe.HCl (1.14 g, 7.4 mmol), triethylamine (1.14 mL, 8.14 mmol), potassium tert-
butoxide (0.92 g, 8.14 mmol). The resulting crude mixture was purified via silica gel 
chromatography to give a crystalline yellow solid, 74% from acyl azide, 55% from acid (1.75 
g). 1H NMR (500 MHz, CDCl3) δ 8.14 (1H, s, ArH), 8.01 (2H, d, J = 1.6 Hz, ArH), 6.33 (1H, 
s, NH), 1.59 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 175.31 (NC(O)C), 153.84 
(NC(O)N), 146.32 (ArC), 136.09 (ArC), 129.11 (ArC), 124.61 (q, J = 5.5 Hz, CF3)., 122.83 










To a solution of glycine (2.25 g, 30 mmol) in NaOH (100 mL, 2M) was added phenyl 
isocyanate (3.25 mL, 30 mmol) dropwise at 0 °C. The solution was stirred at 0 °C for 15 
mins before allowing the mixture to return to room temperature and stirred overnight. A 
small precipitate fell out of solution and was filtered off and discarded. The filtrate was 
acidified using concentrated HCl to pH 1. A precipitate fell out of solution and was filtered 
using a Buchner funnel. The solid collected was redissolved in HCl (100 mL, 1M) and heated 
to reflux for 2 hours. The reaction mixture was then allowed to return to room temperature 
where a further precipitate fell out of solution. This precipitate was collected via Buchner 
funnel to give Gly-Hyd, 52% (2.72 g). 1H NMR (500 MHz, CDCl3) δ 7.55–7.45 (2H, m, ArH), 
7.40 (3H, dq, J = 3.1, 2.3 Hz, ArH), 6.71 (1H, s, NH), 4.10 (2H, s, CH2). 13C NMR (126 MHz, 
CDCl3) δ 170.34 (NC(O)CH2), 157.84 (NC(O)NH), 131.52 (ArC), 129.42 (ArC), 128.66 









In an oven dried round bottom flask was added appropriate amino acid hydrochloride salt 
(10 mmol). The solid was dispersed in anhydrous CH2Cl2 (40 mL) and cooled to 0 °C. To 
the slurry was added triethylamine (1.53 mL, 1.11 g, 11 mmol) allowing for effervescence 
and the reaction mixture was allowed to stir for 5 minutes. To the resulting mixture was 
added phenyl isocyanate (1.09 mL, 1.19 g, 10 mmol) portionwise and the reaction mixture 
was allowed to return to room temperature and stir overnight. The flask was quenched with 
HCl (1M, 40 mL) and the organic layer separated. The organic layer was further washed 
with HCl (1M, 2 x 40 mL), was dried over MgSO4 and concentrated in vacuo to give the 
crude urea. The resulting solid was dispersed in THF (40 mL) and was added potassium 
tert-butoxide (1.23 g, 11 mmol) and the mixture was stirred for ca. two hours, monitoring by 
TLC. The mixture was concentrated in vacuo and re-dispersed in a mixture of CH2Cl2 (40 
mL) and H2O (40 mL). The organic layer was separated and aqueous layer further extracted 
with CH2Cl2 (2 x 40 mL). The combined organics were dried over MgSO4 and concentrated 
in vacuo. The resulting crude hydantoin was purified via silica gel chromatography 









The above compound was obtained following General Procedure D from H-Val-OMe.HCl 
(1.68 g, 10 mmol). The resulting crude mixture was purified via recrystallization from boiling 
ethanol to give a crystalline white solid, 53% (1.16 g). mp (from CHCl3): 121-123 °C. FT-IR 
(thin film): νmax (cm-1) = 3294.8, 2964.9, 1776.2, 1704.6. 1H NMR (300 MHz, CDCl3) δ 7.53–
7.42 (2H, m, ArH), 7.38 (3H, m, ArH), 6.54 (1H, s, NH), 4.07 (1H, d, J = 3.5 Hz, CH(iPr), 
2.33 (1H, dtd, J = 13.7, 6.8, 3.6 Hz, CH(CH3)2), 1.09 (3H, d, J = 7.0 Hz, CH(CH3)2), 1.01 
(3H, d, J = 6.8 Hz, CH(CH3)2). 13C NMR (75 MHz, CDCl3) δ 172.63 (NC(O)C), 157.33 
(NC(O)N), 131.58 (ArC), 129.33 (ArC), 128.50 (ArC), 126.39 (ArC), 62.35 (CH(iPr)), 30.80 
(CH(CH3)2), 18.89 (CH(CH3)2), 16.19 (CH(CH3)2). HRMS (ESI): m/z calculated for 
C12H14N2O2 requires 241.0953 for [M+Na]+, found 241.0951. 
 




The above compound was obtained following General Procedure D from H-Leu-OMe.HCl 
(1.82 g, 10 mmol). The resulting crude mixture was purified via recrystallization from boiling 
ethanol to give a crystalline white solid, 80% (1.78 g). mp (from CHCl3): 119-121 °C. FT-IR 
(thin film): νmax (cm-1) =,3288.4, 2958.6, 1777.7, 1713.7. 1H NMR (500 MHz, CDCl3) δ 7.50–
7.42 (2H, m, ArH), 7.42–7.32 (3H, m, ArH), 7.12 (1H, s, NH), 4.14 (1H, ddd, J = 9.1, 4.0, 
1.3 Hz, NCHC=O), 1.89–1.75 (2H, m, CH2(CH(CH3)2)), 1.63 (1H, dd, J = 9.3, 8.1 Hz, 
CH2(CH(CH3)2)), 0.97 (3H, d, J = 6.2 Hz, CH(CH3)2), 0.94 (3H, d, J = 6.1 Hz, CH(CH3)2)). 
13C NMR (126 MHz, CDCl3) δ 173.61 (NC(O)C), 157.02 (NC(O)N), 131.65 (ArC), 129.11 
(ArC), 128.24 (ArC), 126.21 (ArC), 55.80 (NCC=O), 41.03 (CH2CH(CH3)2), 
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25.02(CH2CH(CH3)2), 23.08 (CH2CH(CH3)2), 21.75 (CH2CH(CH3)2). HRMS (ESI): m/z 
calculated for C13H16N2O2 requires 255.1109 for [M+Na]+, found 255.1095. 
 




The above compound was obtained following General Procedure D from H-Pro-OMe.HCl 
(1.66 g, 10 mmol). The resulting crude mixture was purified via recrystallization from boiling 
ethanol to give a crystalline white solid, 60% (1.30 g). mp (from CHCl3): 123-126 °C. FT-IR 
(thin film): νmax (cm-1) = 2980.6, 1774.6, 1707.5. 1H NMR (500 MHz, CDCl3) δ 7.48–7.42 
(2H, m, ArH), 7.40–7.32 (3H, m, ArH), 4.23 (1H, dd, J = 9.2, 7.5 Hz, NCH), 3.78 (1H, dt, J 
= 11.3, 7.8 Hz, NCH), 3.33 (1H, ddd, J = 11.3, 8.4, 4.6 Hz, NCH), 2.44–2.26 (1H, m, CH), 
2.21–2.04 (2H, m, CH), 1.92–1.75 (1H, m, CH). 13C NMR (126 MHz, CDCl3) δ 172.75 
(NC(O)C), 159.50 (NC(O)N), 132.01 (ArC), 129.21 (ArC), 128.28 (ArC), 126.06 (ArC), 63.39 
(NCH), 45.92 (NCH), 27.93 (CH2), 27.03 (CH2). HRMS (ESI): m/z calculated for C12H12N2O2 
requires 239.0796 for [M+Na]+, found 239.0798 
 




The above compound was obtained following General Procedure D from methyl 1-
aminocyclohexane-1-carboxylate hydrochloride salt (1.94 g, 10 mmol). The resulting crude 
mixture was purified via recrystallization from boiling ethanol to give a crystalline white solid, 
95% (2.32 g). mp (from CHCl3): 225-227 °C. FT-IR (thin film): νmax (cm-1) = 3251.3, 2981.0, 
1773.9, 1720.5 1H NMR (500 MHz, CDCl3) δ 7.48–7.44 (1H, m, ArH), 7.43–7.40 (1H, m, 
ArH), 7.39–7.33 (1H, m, ArH), 6.88 (1H, s, NH), 1.96 (2H, m, Cy-CH2), 1.78–1.65 (4H, m, 
 294 
 
Cy-CH2), 1.50–1.33 (2H, m, Cy-CH2). 13C NMR (126 MHz, CDCl3) δ 175.96 (NC(O)C), 
156.06 (NC(O)N), 131.85 (ArC), 129.19 (ArC), 128.23 (ArC), 126.32 (ArC), 61.78 (C(Cy)), 
33.85 (CyCH2), 24.68 (CyCH2), 21.89 (CyCH2). HRMS (ESI): m/z calculated for C14H16N2O2 
requires 267.1109 for [M+Na]+, found 267.1105. 
 




The above compound was obtained following General Procedure D from H-Sar-OMe.HCl 
(1.40 g, 10 mmol). The resulting crude mixture was purified via column chromatography to 
give a crystalline white solid, 38% (0.47 g). 1H NMR (500 MHz, CDCl3) δ 7.49–7.43 (2H, m, 
ArH), 7.42–7.33 (3H, m, ArH), 4.03 (2H, d, J = 1.9 Hz, CCH2N), 3.08 (3H, d, J = 1.9 Hz, 
NCH3). 13C NMR (126 MHz,CDCl3) δ 168.85 (NC(O)C), 155.96 (NC(O)N), 132.03 (ArC), 
129.27 (ArC), 128.34 (ArC), 126.24 (ArC), 51.83 (CCH2N), 30.09 (NCH3). Data is in line 









6.2.4: Synthesis of C–H Functionalized N-arylhydantoins 
 




To an oven dried carousel tube was added N-arylhydantoin (0.5 mmol), [RuCl2(p-cymene)]2 
(0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol) and Cu(OAc)2.H2O (0.10 g, 0.5 mmol). 
The carousel tube was sealed with a Teflon cap leaving the tap open. To the tube was 
added 2-MeTHF (2 mL, 0.25 M) followed by appropriate acrylate coupling partner (1.5 
mmol). The resulting mixture was stirred at 100 °C under reflux for 18 hours. The mixture 
was quenched with EtOAc (4 mL) and allowed to return to room temperature. The crude 
mixture was filtered using a short plug of silica, eluting with EtOAc. The filtrate was 
concentrated in vacuo. The crude mixture was purified using silica gel chromatography 
(EtOAc:Petroleum Spirit 40-60 °C) to give pure C–H alkenylated N-arylhydantoin. 
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1a, (0.10 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave an off-white solid, 94%, (0.135 g). mp (from CHCl3): 188-189 °C. FT-IR (thin film): νmax 
(cm-1) = 3311.0, 1782.6, 1712.9, 1638.4. 1H NMR (500 MHz, cdcl3) δ 7.73 (1H, d, J = 7.3 
Hz, ArH), 7.55–7.44 (3H, m, ArCH=CHR), 7.27 (1H, d, J = 7.6 Hz, ArH), 6.90 (1H, s, NH), 
6.43 (1H, d, J = 15.9 Hz, ArCH=CHR), 3.76 (3H, s,CO2CH3), 1.57 (3H, s, C(CH3)2), 1.50 
(3H, s, C(CH3)2). 13C NMR (126 MHz,CDCl3) δ 176.62 (NC(O)C), 166.97 (C(O)O), 155.58 
(NC(O)N), 139.01 (ArCH=CHR), 132.91 (ArC), 131.14 (ArC), 130.81 (ArC), 129.96 (ArC), 
129.49 (ArC), 127.58 (ArC), 120.85 (ArCH=CHR), 59.49 (C(CH3)2), 51.99 (CO2CH3), 25.76 
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(C(CH3)2), 24.89 (C(CH3)2). HRMS (ESI): m/z calculated for C15H16N2O4 requires 289.1110 
for [M+H]+, found 289.1163. 
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1a, (0.10 g, 0.5 mmol) and ethyl acrylate (0.17 mL, 1.5 mmol). Silica gel chromatography 
gave an amorphous solid, 73% (0.192 g). mp (from CHCl3): 105-107 °C. FT-IR (thin film): 
νmax (cm-1) = 3305.4, 2980.6, 1783.2, 1708.0, 1638.0. 1H NMR (500 MHz, CDCl3) δ 7.79–
7.68 (1H, m, ArH), 7.53–7.43 (3H, m, ArH & ArCH=CHR), 7.28 (1H, dd, J = 10.3, 8.8 Hz, 
ArH), 6.97 (1H, s, NH), 6.43 (1H, d, J = 15.9 Hz, ArCH=CHR), 4.22 (1H, qd, J = 7.1, 2.3 Hz, 
CO2CH2CH3), 1.56 (3H, s, C(CH3)2), 1.49 (3H, s, C(CH3)2), 1.29 (3H, t, J = 7.1 Hz, CO2CH3). 
13C NMR (126 MHz, CDCl3) δ 176.62 (NC(O)C), 166.48 (C(O)O), 155.59 (NC(O)N), 138.64 
(ArCH=CHR), 132.96 (ArC), 131.05 (ArC), 130.77 (ArC), 129.92 (ArC), 129.46 (ArC), 
127.51 (ArC), 121.32 (ArCH=CHR), 60.82 (C(CH3)2), 59.45 (CO2CH2CH3), 25.77 (C(CH3)2), 
24.81 (C(CH3)2), 14.38 (CO2CH2CH3). HRMS (ESI): m/z calculated for C16H18N2O4 requires 
303.1267 for [M+H]+, found 303.1312. 
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1a, (0.10 g, 0.5 mmol) and butyl acrylate (0.22 mL, 1.5 mmol). Silica gel chromatography 
gave a thick oil, 94%, (inseparable mixture of 6:1 3ac:1a) (0.154 g). 1H NMR (500 MHz, 
CDCl3) δ 7.73 (1H, dd, J = 7.6, 1.8 Hz, ArCH=CHR), 7.55–7.43 (3H, m, ArH), 7.28–7.24 
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(1H, m, ArH), 7.11 (1H, s, NH), 6.42 (1H, d, J = 15.9 Hz, ArCH=CHR), 4.16 (2H, td, J = 6.7, 
3.9 Hz, CO2CH2R), 1.69–1.58 (2H, m, CO2CH2CH2R), 1.54 (3H, s, C(CH3)2), 1.47 (3H, s, 
C(CH3)2), 1.44–1.34 (2H, m, CO2CH2CH2CH2CH3), 0.92 (3H, t, J = 7.4 Hz, 
CO2CH2CH2CH2CH3). 13C NMR (126 MHz, cdcl3) δ 176.57 (NC(O)C), 166.48 (C(O)O), 
155.50 (NC(O)N), 138.52 (ArCH=CHR), 132.86 (ArC), 130.93 (ArC), 130.69 (ArC), 129.79 
(ArC), 129.36 (ArC), 129.08 (ArC), 127.42 (ArC), 126.26 (ArC), 121.20 (ArCH=CHR), 64.63 
(CO2CH2R), 59.33 (C(CH3)2), 30.71 (CO2CH2CH2R), 25.60, (C(CH3)2), 24.69 (C(CH3)2), 
19.19 (CO2CH2CH2CH2R), 13.73 (CO2CH2CH2CH2CH3). 
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1a, (0.10 g, 0.5 mmol) and benzyl acrylate (0.20 mL, 1.5 mmol). Silica gel chromatography 
gave an amorphous solid, 79% (0.144 g). mp (from CHCl3): 143-145 °C. FT-IR (thin film): 
νmax (cm-1) = 3312.7, 2978.9, 1782.4, 1713.8, 1638.2. 1H NMR (300 MHz, CDCl3) δ 7.75 
(1H, dd, J = 7.3, 1.7 Hz, ArH), 7.56 (d, J = 15.9 Hz, ArCH=CHR), 7.53–7.24 (10H, m, ArH 
& NH), 7.21 (1H, s, ArH), 6.51 (1H, d, J = 15.9 Hz, ArCH=CHR), 5.30–5.11 (2H, m, 
CO2CH2Ph), 1.46 (3H, s, C(CH3)2), 1.45 (3H, s, C(CH3)2). 13C NMR (75 MHz, CDCl3) δ 
176.65 (NC(O)C), 166.22 (C(O)O), 155.59 (NC(O)N), 139.06 (ArCH=CHR), 135.76 (ArC), 
132.66 (ArC), 131.17 (ArC), 130.75 (ArC), 129.89 (ArC), 129.41 (ArC), 129.17 (ArC), 128.67 
(ArC), 128.39 (ArC), 127.43 (ArC), 126.33 (ArC), 120.77 (ArCH=CHR), 66.68 (CO2CH2Ph), 
59.36 (C(CH3)2), 25.54 (C(CH3)2), 24.66 (C(CH3)2). HRMS (ESI): m/z calculated for 









The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1b, (0.081 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave an off-white solid, 65% (0.101 g). mp (from CHCl3): 167-169 °C. FT-IR (thin film): νmax 
(cm-1) = 3317.2, 1779.2, 1711.1, 1642.8. 1H NMR (500 MHz, CDCl3) δ 7.45 (1H, d, J = 15.9 
Hz, ArCH=CHR), 7.19 (1H, d, J = 2.8 Hz, ArH), 7.17 (2H, d, J = 8.7 Hz, ArH), 7.02 (2H, m, 
ArH) 6.40 (1H, d, J = 15.9 Hz, ArCH=CHR), 3.83 (3H, s, CO2CH3), 3.76 (3H, s, ArOCH3), 
1.55 (3H, s, C(CH3)2), 1.48 (3H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 176.97 
(NC(O)C), 166.89 (C(O)O), 160.40 (ArCOMe), 155.99 (NC(O)N), 139.00 (ArCH=CHR), 
133.97 (ArC), 130.58 (ArC), 123.49 (ArC), 121.01 (ArC), 117.04 (ArC), 112.20 
(ArCH=CHR), 59.39 (C(CH3)2), 55.77 (ArOCH3), 51.99 (CO2CH3), 25.71 (C(CH3)2), 24.81 
(C(CH3)2). HRMS (ESI): m/z calculated for C16H18N2O5 requires 341.1112 for [M+Na]+, 
found 341.1099. 
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1c, (0.109 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave an off-white solid, 52% (0.079 g). mp (from CHCl3): 191-193 °C. FT-IR (thin film): νmax 
(cm-1) = 3313.6, 1778.9, 1707.6, 1641.8. 1H NMR (500 MHz, CDCl3) δ 7.53 (1H, s, ArH), 
7.49 (1H, d, J = 15.9 Hz, ArCH=CHR), 7.31 (1H, d, J = 7.5 Hz, ArH), 7.15 (1H, d, J = 8.0 
Hz, ArH), 6.99 (1H, s, NH), 6.41 (1H, d, J = 15.9 Hz, ArCH=CHR), 3.76 (3H, s, CO2CH3), 
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2.40 (3H, s, ArCH3), 1.56 (3H, s, C(CH3)2), 1.49 (3H, s, C(CH3)2). 13C NMR (126 MHz, 
CDCl3) δ 176.78 (NC(O)C), 167.00 (C(O)O), 155.83 (NC(O)N), 140.09 (ArCH=CHR), 
139.10 (ArC), 132.53 (ArC), 132.01 (ArC), 129.22 (ArC), 128.26 (ArC), 128.06 (ArC), 120.57 
(ArCH=CHR), 59.44 (C(CH3)2), 51.93 (CO2CH3), 25.73 (C(CH3)2), 24.85 (C(CH3)2), 21.40 
(ArCH3). HRMS (ESI): m/z calculated for C16H18N2O4 requires 325.1159 for [M+Na]+, found 
325.1154. 
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1d, (0.130 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave an off-white solid, 81% (0.140 g). mp (from CHCl3): 161-164 °C. FT-IR (thin film): νmax 
(cm-1) = 3310.5, 1780.0, 1709.9, 1640.9. 1H NMR (500 MHz, CDCl3) δ 7.71 (1H, s, ArH), 
7.59–7.47 (2H, m, ArCH=CHR & ArH), 7.19 (1H, d, J = 8.2 Hz, ArH), 7.08 (1H, s, NH), 6.43 
(1H, d, J = 15.9 Hz, ArCH=CHR), 3.76 (3H, s, CO2CH3), 1.54 (3H, s, C(CH3)2), 1.47 (3H, s, 
C(CH3)2), 1.33 (9H, s, C(CH3)3). 13C NMR (126 MHz, CDCl3) δ 176.82 (NC(O)C), 167.00 
(C(O)O), 155.81 (NC(O)N), 152.92 (ArCH=CHR), 139.62 (ArC), 132.07 (ArC), 128.89 
(ArC), 128.60 (ArC), 128.14 (ArC), 124.47 (ArC), 120.34 (ArCH=CHR), 59.37 (C(CH3)2), 
51.91 (CO2CH3), 35.02 (C(CH3)3), 31.29 (C(CH3)3), 25.67 (C(CH3)2), 24.79 (C(CH3)2). 









The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1e, (0.119 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave an off-white solid, 66% (0.106 g). mp (from CHCl3): 193-195 °C. FT-IR (thin film): νmax 
(cm-1) = 3317.3, 1782.8, 1714.0, 1641.6. 1H NMR (500 MHz, CDCl3) δ 7.69 (1H, d, J = 2.1 
Hz, ArH), 7.49–7.38 (2H. m, ArCH=CHR & ArH), 7.22 (1H, d, J = 8.5 Hz, ArH), 7.03 (1H, s, 
NH), 6.42 (1H, d, J = 15.9 Hz, ArCH=CHR), 3.76 (3H, s, CO2CH3), 1.56 (3H, s, C(CH3)2), 
1.49 (3H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 176.40 (NC(O)C), 166.59 (C(O)O), 
155.28 (NC(O)N), 137.76 (ArCH=CHR), 135.97 (ArC), 134.52 (ArC), 131.02 (ArC), 130.76 
(ArC), 129.18 (ArC), 127.56 (ArC), 122.05 (ArCH=CHR), 59.56 (C(CH3), 52.11 (CO2CH3), 
25.74 (C(CH3)2), 24.82 (C(CH3)2). HRMS (ESI): m/z calculated for C15H15N2O4Cl1 requires 
323.0799 for [M+H]+, found 323.0770.  
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1f, (0.142 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave an off-white solid, 66% (0.122 g). mp (from CHCl3): 181-183 °C. FT-IR (thin film): νmax 
(cm-1) = 3314.2, 1783.1, 1709.7, 1640.1. 1H NMR (500 MHz, CDCl3) δ 7.85 (1H, d, J = 2.2 
Hz, ArH), 7.60 (1H, dd, J = 8.4, 2.2 Hz, ArH), 7.41 (1H, d, J = 15.9 Hz, ArCH=CHR), 7.15 
(1H, d, J = 8.4 Hz, ArH), 7.06 (1H, s, NH), 6.42 (1H, d, J = 15.9 Hz, ArCH=CHR), 3.76 (3H, 
s, CO2CH3), 1.55 (3H, s, C(CH3)2), 1.48 (2H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 
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176.32 (NC(O)C), 166.59 (C(O)O), 155.26 (NC(O)N), 137.65 (ArCH=CHR), 134.77 (ArC), 
133.96 (ArC), 130.95 (ArC), 130.53 (ArC), 129.65 (ArC), 123.97 (ArC), 122.06 
(ArCH=CHR), 59.58 (C(CH3)2), 52.12 (CO2CH3), 25.69 (C(CH3)2), 24.78 (C(CH3)2). HRMS 
(ESI): m/z calculated for C15H15N2O4Br1 requires 367.0293 for [M+H]+, found 367.0275.  
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1g, (0.136 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave an off-white solid, 47% (0.084 g). mp (from CHCl3): 175-178 °C. FT-IR (thin film): νmax 
(cm-1) = 3300.5, 1785.6, 1713.4, 1644.4. 1H NMR (500 MHz, CDCl3) δ 7.97 (1H, s, ArH), 
7.75 (1H, d, J = 8.4 Hz, ArH), 7.51 (1H, d, J = 15.9 Hz, ArCH=CHR), 7.43 (1H, d, J = 8.2 
Hz, ArH), 6.89 (1H, s, NH), 6.50 (1H, d, J = 15.9 Hz, ArCH=CHR), 3.79 (3H, s, CO2CH3), 
1.60 (3H, s, C(CH3)2), 1.53 (3H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 176.09 
(NC(O)C), 166.54 (C(O)O), 154.94 (NC(O)N), 137.75 (ArCH=CHR), 133.77 (d, J = 26.9 Hz, 
ArC), 132.18 (q, J = 33.2 Hz, ArC), 130.22 (ArC), 127.58 (d, J = 3.5 Hz, ArC), 124.77 (d, J 
= 3.8 Hz, ArC), 123.29 (q, J = 272.7 Hz, ArCF3). 122.59 (ArC=CHR), 59.75 (C(CH3)2), 52.20 
(CO2CH3), 25.81 (C(CH3)2), 24.91 (C(CH3)2). 19F NMR (470 MHz, CDCl3) δ -63.03 (s). 
HRMS (ESI): m/z calculated for C16H15N2O4F3 requires 379.0882 for [M+Na]+, found 
379.0870. 
 






The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1h, (0.132 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave an off-white solid, 83% (0.145 g). mp (from CHCl3): 196-198 °C. FT-IR (thin film): νmax 
(cm-1) = 3328.4, 1779.6, 1712.5, 1634.3. 1H NMR (500 MHz, CDCl3) δ 7.41 (1H, d, J = 15.8 
Hz, ArCH=CHR), 7.15 (1H, s, ArH), 7.00 (1H, s, NH), 6.70 (1H, s, ArH), 6.33 (1H, d, J = 
15.8 Hz, ArCH=CHR), 3.92–3.88 (6H, m, ArOCH3), 3.74 (3H, s, CO2CH3), 1.58 (3H, s, 
C(CH3)2), 1.50 (3H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 176.86 (NC(O)C), 167.20 
(C(O)O), 155.84 (NC(O)N), 151.62 (ArCOCH3), 150.10 (ArCOCH3), 138.60 (ArCH=CHR), 
125.27 (ArC), 124.39 (ArC), 118.41 (ArCH=CHR), 111.74 (ArC), 108.74 (ArC), 59.43 
(C(CH3)2), 56.36 (ArOCH3), 56.26 (ArOCH3), 51.87 (CO2CH3), 25.83 (C(CH3)2), 24.82 
(C(CH3)2). HRMS (ESI): m/z calculated for C17H20N2O6 requires 349.1355 for [M+H]+, found 
349.1374. 
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1i, (0.116 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave an off-white solid, 89%, (0.141 g). mp (from CHCl3): 232-234 °C. FT-IR (thin film): νmax 
(cm-1) = 3327.5, 1783.6, 1728.0, 1636.1. 1H NMR (500 MHz, CDCl3) δ 7.51 (1H, s, ArH), 
7.46 (1H, d, J = 15.9 Hz, ArCH=CHR), 7.04 (1H, s, ArH), 6.79 (1H, s, NH), 6.39 (1H, d, J = 
15.9 Hz, ArCH=CHR), 3.76 (3H, s, CO2CH3), 2.31–2.29 (6H, m, ArCH3), 1.59 (3H, s, 
C(CH3)2), 1.52 (3H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 176.82 (NC(O)C), 167.21 
(C(O)O), 155.92 (NC(O)N), 140.80 (ArCH=CHR), 138.98 (ArC), 130.27 (ArC), 130.11 
(ArC), 128.50 (ArC), 128.40 (ArC), 119.59 (ArCH=CHR), 59.49 (C(CH3)2), 51.91 (CO2CH3), 
25.80 (C(CH3)2), 24.96 (C(CH3)2), 19.96 (ArCH3), 19.82 (ArCH3). HRMS (ESI): m/z 










The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1j, (0.105 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave an off-white solid, 92% (0.135 g). mp (from CHCl3): 172-174 °C. FT-IR (thin film): νmax 
(cm-1) = 3327.5, 1783.6, 1723.0, 1636.1. 1H NMR (500 MHz, CDCl3) δ 7.33 (1H, d, J = 5.8 
Hz, ArH), 7.24–7.14 (3H. m, ArCH=CHR & ArH & NH), 6.25 (1H, d, J = 15.9 Hz, 
ArCH=CHR), 3.72 (3H, s, CO2CH3), 1.48 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 
176.30 (NC(O)C), 167.30 (C(O)O), 154.59 (NC(O)N), 134.27 (ArCH=CHR), 134.21 (ArC), 
131.65 (ArC), 126.14 (ArC), 124.35 (ArC), 119.59 (ArCH=CHR), 59.46 (C(CH3)2), 51.91 
(CO2CH3), 25.24 (C(CH3)2). HRMS (ESI): m/z calculated for C13H14N2O4S1 requires 
295.0708 for [M+H]+, found 295.0706. 
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1j, (0.105 g, 0.5 mmol) and butyl acrylate (0.22 mL, 1.5 mmol). Silica gel chromatography 
gave an amorphous solid, 84%, (0.140 g). FT-IR (thin film): νmax (cm-1) = 3317.5, 1788.6, 
1728.0, 1634.1. 1H NMR (500 MHz, CDCl3) δ 7.37–7.22 (3H, m, ArCH=CHR & ArH), 6.99 
(1H, s, NH), 6.27 (1H, d, J = 15.9 Hz, ArCH=CHR), 4.15 (2H, t, J = 6.6 Hz, CO2CH2R), 1.63 
(2H, dt, J = 14.5, 6.7 Hz, CO2CH2CH2R), 1.52 (6H, s, C(CH3)2), 1.38 (2H, dd, J = 15.0, 7.5 
Hz, CO2CH2CH2CH2CH3), 0.92 (3H, t, J = 7.4 Hz, CO2CH2CH2CH2CH3). 13C NMR (126 MHz, 
CDCl3) δ 176.21 (NC(O)C), 166.97 (C(O)O), 154.67 (NC(O)N), 134.45 (ArCH=CHR), 
133.94 (ArC), 131.51 (ArC), 126.16 (ArC), 124.38 (ArC), 120.16 (ArCH=CHR), 64.71 
(CO2CH2R), 59.53 (C(CH3)2), 30.84 (CO2CH2CH2R), 25.37 (C(CH3)2), 19.32 
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(CO2CH2CH2CH2CH3), 13.86. (CO2CH2CH2CH2CH3). HRMS (ESI): m/z calculated for 
C16H20N2O4S1 requires 337.1177 for [M+H]+, found 337.1179. 
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1k, (0.088 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave a white solid, 35% (0.045 g). mp (from CHCl3): 154-157 °C FT-IR (thin film): νmax (cm-
1) = 3301.9, 1778.4, 1708.4, 1638.3. 1H NMR (500 MHz, CDCl3) δ 7.76 (1H, d, J = 7.5 Hz, 
ArH), 7.59–7.45 (3H, m, ArH & ArCH=CHR), 7.27 (1H, d, J = 7.9 Hz, ArH), 6.81 (1H, s, NH), 
6.47 (1H, d, J = 15.9 Hz, ArCH=CHR), 4.18 (1H, d, J = 17.8 Hz, CH2), 4.09 (1H, d, J = 17.8 
Hz, CH2), 3.78 (3H, s, CO2CH3). 13C NMR (126 MHz, CDCl3) δ 170.52 (NC(O)C), 167.11 
(C(O)O), 157.53 (NC(O)N), 139.06 (ArCH=CHR), 132.92 (ArC), 131.24 (ArC), 130.70 
(ArC), 130.05 (ArC), 129.36 (ArC), 127.66 (ArC), 121.00 (ArCH=CHR), 52.07 (CO2CH3), 
47.01 (CH2). HRMS (ESI): m/z calculated for C13H12N2O4 requires 283.0697 for [M+Na]+, 
found 283.0674. 
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1l, (0.109 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave a white solid, 67% (0.101 g). mp (from CHCl3): 178-180 °C. FT-IR (thin film): νmax (cm-
1) = 3301.9, 1778.4, 1708.4, 1638.3. 1H NMR (400 MHz, DMSO-d6, 368 K) δ 8.22 (1H, d, J 
= 25.3 Hz, ArCH=CHR), 7.93–7.86 (1H, m, ArH), 7.57–7.45 (3H, m, ArH), 7.28 (1H, s, NH), 
6.53 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.20 (1H, d, J = 2.7 Hz, CH(iPr)), 3.73 (3H, s, 
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CO2CH3), 2.20 (1H, dtd, J = 13.7, 6.9, 3.9 Hz, CH(CH3)2), 1.10 (3H, d, J = 7.0 Hz, CH(CH3)2), 
1.03 (3H, d, J = 6.8 Hz, CH(CH3)2). 13C NMR (101 MHz, DMSO-d6, 368 K) 172.16 (NC(O)C), 
165.5 (C(O)O), 155.32 (NC(O)N), 138.36 (ArCH=CHR), 132.04 (ArC), 131.14 (ArC), 130.14 
(ArC), 129.04 (ArC), 128.69 (ArC), 126.66 (ArC), 119.96 (ArCH=CHR), 50.75 (NCHC=O), 
29.46 (CH(CH3)2), 17.67 (CH(CH3)2), 15.76 (CH(CH3)2). HRMS (ESI): m/z calculated for 
C16H18N2O4 requires 325.1167 for [M+Na]+, found 325.1146. 
 




The above compound was synthesized using General Procedure E on half scale using N-
arylhydantoin, 1m, (0.63 g, 0.25 mmol) and methyl acrylate (0.07 mL, 0.75 mmol). Silica gel 
chromatography gave an white solid, 56% (0.044 g). FT-IR (thin film): νmax (cm-1) = 3298.62, 
2957.1, 1780.9, 1716.5, 1638.7. 1H NMR (400 MHz, DMSO-d6, 368 K) δ 8.41–8.29 (s, 1H, 
NH), 7.89 (1H, dd, J = 7.5, 1.9 Hz,ArH), 7.59–7.41 (3H, m, ArH & ArCH=CHR), 7.34–7.26 
(1H, m, ArH), 6.52 (1H, d, J = 16.0 Hz, ArCH=CHR), 4.31 (1H, app s, NCHC=O), 3.74 (3H, 
s, CO2CH3), 3.14–2.85 (2H, m, CH2iPr), 1.94 (1H, ddt, J = 14.6, 13.0, 6.6 Hz, CH(CH3)2), 
1.00 (6H, app d, CH(CH3)2). 13C NMR (101 MHz, DMSO-d6, 368 K) δ 173.17 (NC(O)C), 
165.51 (C(O)O), 154.92 (NC(O)N), 138.27 (ArCH=CHR), 132.01 (ArC), 131.05 (ArC), 
130.09 (ArC), 128.67 (ArC), 126.83 (ArC), 125.82 (ArC), 119.99 (ArCH=CHR), 55.13 
(NCHC=O), 50.78 (CO2CH3, 23.61 (CHiPr), 22.34 (CH(CH3)2), 21.30 (CH(CH3)2). HRMS 
(ESI): m/z calculated for C17H20N2O4 requires 317.1501 for [M+H]+, found 317.1493. 
 






The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1n, (0.108 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave an amorphous solid, 69% (0.103 g). FT-IR (thin film): νmax (cm-1) = 2953.6, 1777.9, 
1710.6, 1637.6. 1H NMR (500 MHz, DMSO-d6, 368 K) δ 7.90 (1H, dd, J = 7.6, 1.8 Hz, ArH), 
7.60–7.48 (2H, m, ArH & ArCH=CHR), 7.37 (1H, app s, ArH), 7.39–7.34 (1H, m, ArH), 6.53 
(1H, d, J = 15.9 Hz, ArCH=CHR), 4.44 (1H, t, J = 8.3 Hz, NCHC=O), 3.74 (3H, s, CO2CH3), 
3.69 (1H, q, J = 7.9 Hz, ProH), 3.27 (1H, ddd, J = 11.1, 7.5, 5.7 Hz, ProH), 2.50 (1H, p, J = 
1.9 Hz, ProH), 2.29 (1H, app s, ProH), 2.11 (2H, m, ProH), 1.89 (1H, app s, ProH). 13C NMR 
(126 MHz, DMSO) δ 172.30 (NC(O)C), 165.61 (C(O)O), 158.37 (NC(O)N), 138.01 
(ArCH=CHR), 131.83 (ArC), 130.88 (ArC), 130.24 (ArC), 128.98 (ArC), 126.93 (ArC), 
120.19 (ArCH=CHR), 62.61 (NCHC=O), 50.92 (CO2CH3), 45.24 (ProC), 26.66 (ProC), 
25.79 (ProC). HRMS (ESI): m/z calculated for C16H16N2O4 requires 323.1010 for [M+Na]+, 
found 323.1022.  
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1o, (0.122 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave a white solid, 82% (0.135 g). mp (from CHCl3): 228-229 °C FT-IR (thin film): νmax (cm-
1) = 3288.9, 1777.8, 1708.3, 1638.1. 1H NMR (500 MHz, CDCl3) δ 7.72 (1H, d, J = 7.4 Hz, 
ArH), 7.61–7.42 (4H, m, ArH & NH & ArCH=CHR), 7.25 (1H, d, J = 7.3 Hz, ArH), 6.42 (1H, 
d, J = 15.9 Hz, ArCH=CHR), 3.75 (3H, s, CO2CH3), 2.07–1.67 (6H, m, Alkyl-CH), 1.61–1.23 
(2H, m, Alkyl-CH). 13C NMR (126 MHz, CDCl3) δ 176.21 (NC(O)C), 166.94 (C(O)O), 155.97 
(NC(O)N), 139.15 (ArCH=CHR), 132.85 (ArC), 131.02 (ArC), 130.89 (ArC), 129.74 (ArC), 
129.47 (ArC), 127.42 (ArC), 120.60 (ArCH=CHR), 62.51 (C(Cyclohexyl)), 51.93 (CO2CH3), 
34.30 (AlkCH), 33.44 (AlkCH), 24.63 (AlkCH), 21.70 (AlkCH), 21.61 (AlkCH). HRMS (ESI): 










The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1o, (0.122 g, 0.5 mmol) and butyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave a white solid, 81% (0.150 g). mp (from CHCl3): 157-159 °C FT-IR (thin film): νmax (cm-
1) = 3284.3, 1778.3, 1707.8, 1638.0. 1H NMR (500 MHz, CDCl3) δ 7.72 (1H, d, J = 7.3 Hz, 
ArH), 7.68 (1H, s, ArH), 7.53–7.37 (4H, m, NH & ArH & ArCH=CHR), 7.25 (1H, d, J = 7.7 
Hz, ArH), 6.41 (1H, d, J = 15.9 Hz, ArCH=CHR), 4.22–4.09 (2H, m, CO2CH2R), 2.00–1.85 
(2H, m, CO2CH2CH2R), 1.83–1.53 (8H, m, Cyclohexyl-CH & n-Butyl-CH), 1.46–1.30 (5H, 
m, Cyclohexyl-CH & n-Butyl-CH), 0.92 (3H, t, J = 7.4 Hz, CO2CH2CH2CH2CH3). 13C NMR 
(126 MHz, CDCl3) δ 176.19 (NC(O)C), 166.53 (C(O)O), 156.00 (NC(O)N), 138.73 
(ArCH=CHR), 132.92 (ArC), 130.90 (ArC), 130.83 (ArC), 129.70 (ArC), 129.45 (ArC), 
129.05 (ArC), 127.39  (ArC), 126.31 (ArC), 121.09 (ArCH=CHR), 64.65 (C(Cyclohexyl)), 
62.49 (CO2CH2R), 34.34 (AlkC), 33.75 (AlkC), 33.39 (AlkC), 30.82 (AlkC), 24.62 (AlkC), 
21.67 (AlkC), 21.62 (AlkC), 21.57 (AlkC), 19.29 (AlkC), 13.85 (CO2CH2CH2CH2CH3). HRMS 
(ESI): m/z calculated for C21H26N2O4 requires 393.1793 for [M+Na]+, found 393.1825. 
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1p, (0.095 g, 0.5 mmol) and methyl acrylate (0.14 mL, 1.5 mmol). Silica gel chromatography 
gave an amorphous solid, 45% (0.062 g). FT-IR (thin film): νmax (cm-1) = 1778.0, 1710.0, 
1636.7. 1H NMR (500 MHz, CDCl3) δ 7.73 (1H, dd, J = 7.6, 1.8 Hz, ArH), 7.52 (1H, d, J = 
15.9, 7.0 Hz, ArCH=CHR), 7.25–7.20 (2H, m, ArH), 6.44 (1H. d, J = 15.9 Hz, ArCH=CHR), 
4.15 (1H, d, J = 17.7 Hz, CCH2N), 4.03 (1H, d, J = 17.7 Hz, CCH2N), 3.76 (3H, s, CO2CH3), 
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3.06 (3H, s, NCH3). 13C NMR (126 MHz,CDCl3) δ 168.92 (NC(O)C), 167.08 (C(O)O), 155.71 
(NC(O)N), 139.26 (ArCH=CHR), 132.86 (ArC), 131.17 (ArC), 131.11 (ArC), 129.81 (ArC), 
129.27 (ArC), 127.53 (ArC), 120.72 (ArCH=CHR), 52.03 (CO2CH3), 51.96 (CH2), 30.15 
(NCH3). HRMS (ESI): m/z calculated for C14H14N2O4 requires 275.1032 for [M+H]+, found 
275.1018. 
 




The above compound was synthesized using General Procedure E using N-arylhydantoin, 
1r, (0.159 g, 0.5 mmol) and butyl acrylate (0.22 mL, 1.5 mmol). Silica gel chromatography 
gave an off white anorphous solid, 14%, (0.030 g). FT-IR (thin film): νmax (cm-1) = 3310.8, 
2964.6, 1789.8, 1722.1, 1643.8, 1546.1, 1387.0. 1H NMR (500 MHz, CDCl3) δ 8.21 (1H, s, 
ArH), 7.77 (1H, s, ArH), 7.44 (1H, d, J = 15.9 Hz, ArCH=CHR), 6.57 (1H, d, J = 15.9 Hz, 
ArCH=CHR), 5.98 (1H, s, NH), 4.21 (2H, t, J = 6.6 Hz, CO2CH2R), 1.70–1.57 (8H, m, 
C(CH3)2 & CO2CH2CH2R), 1.42 (2H, dq, J = 14.5, 7.3 Hz, CO2CH2CH2CH2CH3), 0.95 (2H, 
t, J = 7.4 Hz, CO2CH2CH2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 175.22 (NC(O)C), 165.43 
(C(O)O), 153.49 (NC(O)N), 148.15 (ArCH=CHR), 138.41 (ArCNO2), 135.34 (ArC), 133.83 
(ArC), 129.65 (q, J = 5.3 Hz, ArCF3), 125.99 (ArC), 125.28 (d, J = 35.3 Hz, ArC), 124.45 
(ArC), 122.48 (ArC), 120.30 (ArC=CHR), 65.47 (C(CH3)2), 60.04 (CO2CH2R), 30.80 
(CO2CH2CH2R), 25.99 (C(CH3)2), 25.14 (C(CH3)2), 19.34 (CO2CH2CH2CH2CH3), 13.88 
(CO2CH2CH2CH2CH3). 19F NMR (470 MHz, CDCl3) δ -60.06 (s, CF3). HRMS (ESI): m/z 





6.2.5: Competition Experiments 
 



































1H NMR of crude mixture showing ratios between diagnostic protons showing ratio of 
















6.2.7: Synthesis of Succinimide Starting Materials 
 




In an oven dried carousel tube, to a solution of substituted aniline (1.3 eq) in pyridine (1 mL) 
was added succinic anhydride (1 eq). The carousel tube was sealed with a Teflon cap with 
the tap closed and heated to 125 °C for 1 hr. The reaction was allowed to return to room 
temperature before quenching with H2O (1 mL). HCl (1 M) was added until the aqueous 
solution was pH 3 and a crystalline solid falls out of solution. This solid was filtered and 
recrystallized from EtOH to give arylsuccinimide products. 
 
 




To a solution of freshly redistilled aniline (12 mL, 131.4 mmol) in pyridine (10 mL) was added 
succinic anhydride (10 g, 100 mmol) and the reaction was heated to reflux for 1 hr. The 
reaction was allowed to return to room temperature before quenching with H2O (20 mL). 
HCl (1 M) was added until the aqueous solution was pH 3 and a crystalline solid falls out of 
solution. This solid was filtered and was recrystallized from EtOH to give crystalline white 
solid, 5c, 56% (9.70 g). 1H NMR (500 MHz, CDCl3) δ 7.51–7.45 (2H, m, ArH), 7.42–7.37 
(1H, m, ArH), 7.30–7.27 (2H, m, ArH), 2.89 (4H, s, CH2). 13C NMR (126 MHz, CDCl3) δ 
176.32 (NC(O)CH2), 132.07 (ArC), 129.37 (ArC), 128.82 (ArC), 126.63 (ArC), 28.59 (ArC). 








General Procedure F was followed using the following compounds: 4-chloroaniline, (1.66 g, 
13 mmol), succinic anhydride (1 g, 10 mmol). Filtration gave a brown solid, 69% (1.45 g). 
1H NMR: (500 MHz, CDCl3 δ 7.46 – 7.43 (2H, d, J=8.6 Hz, ArH), 7.25 (2H, d, J=8.6 Hz, 
ArH), 2.89 (4H, s, CH2). 13C NMR: (126 MHz, CDCl3) δ 175.75 (NC(O)CH2), 135.41 (ArC), 









General Procedure F was followed using the following compounds: 4-bromoaniline, (2.33 
g, 13 mmol), succinic anhydride (1 g, 10 mmol). Filtration gave an off-white solid, 82% (2.09 
g). 1H NMR: (500 MHz, CDCl3) δ 7.59 (2H, app d, ArH), 7.19 (2H, app d, ArH), 2.88 (4H, d, 
J = 4.3 Hz, CH2). 13C NMR: (126 MHz, CDCl3) δ 175.71 (NC(O)CH2), 132.34 (ArC), 130.85 











The combined solids: N-phenylmaleimide, (0.346 g, 2 mmol), 4-methoxyphenylboronic acid 
(0.911 g, 6 mmol) and [RhCl(COD)]2 (0.049 g, 0.1 mmol) were added to an oven-dried 
carousel tube. The carousel tube was sealed with a Teflon cap ensuring the tap was closed. 
The solids were dissolved in de-oxygenated 1,4-dioxane (1.12 mL) and the solution stirred 
at room temperature for 15 minutes. To this solution was added KOH (50% in H2O) (0.112 
mL, 0.056 g, 1 mmol) and the solution heated to 50 °C for 18 h. The reaction mixture was 
diluted in EtOAc and filtered using a silica plug, eluting with EtOAc. The solvent was 
removed in vacuo and the crude mixture was purified using column chromatography 
(EtOAc:Hexanes) to yield a white solid, 4d, 71% (0.401 g).mp (from CHCl3) = 154-157 °C. 
FT-IR: (thin film): νmax (cm-1) = 3060.1, 2996.6, 1701.8, 1642.1, 1609.0. 1H NMR: (500 
MHz, CDCl3)  δ 7.48 (2H, t, J = 7.7 Hz, ArH), 7.41 (1H, d, J = 7.4 Hz, ArH), 7.34 – 7.31 (2H, 
m, ArH), 7.24 (2H, d, J = 8.6 Hz, ArH), 6.93 (2H, d, J = 8.7 Hz, ArH), 4.14 (1, dd, J = 9.7, 
4.8 Hz, CH), 3.81 (3H, s, OCH3), 3.36 (1H, dd, J = 18.5, 9.7 Hz, CH2), 2.97 (1 H, dd, J = 
18.5, 4.8 Hz, CH2). 13C NMR: (126 MHz, CDCl3) δ 176.85 (NC(O)CHAr), 175.16 
(NC(O)CH2), 159.34 (ArC), 131.95 (ArC), 129.16 (ArC), 129.04 (ArC), 128.64 (ArC), 128.43 
(ArC), 126.44 (ArC), 114.68 (ArC), 55.34 (OCH3), 45.22 (ArCHC(O)N), 37.31 (CH2C(O)N). 




6.2.8: Synthesis of C–H Functionalized N-arylsuccinimides 
 




To an oven dried carousel tube was added N-arylsuccinimide (0.5 mmol), [RuCl2(p-
cymene)]2 (0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol) and Cu(OAc)2.H2O (0.10 g, 
0.5 mmol). The carousel tube was sealed with a Teflon cap leaving the tap open. To the 
tube was added 2-MeTHF (2 mL, 0.25 M) followed by appropriate acrylate coupling partner 
(1.5 mmol). The resulting mixture was stirred at 100 °C under reflux for 18 hours. The 
mixture was quenched with EtOAc (4 mL) and allowed to return to room temperature. The 
crude mixture was filtered using a short plug of silica, eluting with EtOAc. The filtrate was 
concentrated in vacuo. The crude mixture was purified using silica gel chromatography 
(EtOAc:Petroleum Spirit 40-60 °C) to give pure C–H alkenylated N-arylsuccinimide. 
 




General Procedure G was followed using the following compounds: N-phenylsuccinimide, 
4a, (0.088 g, 0.5 mmol), methyl acrylate (0.14 mL, 0.13 g, 1.5 mmol), [RuCl2(p-cymene)]2 
(0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O (0.10 g, 0.5 mmol). The 
solvent was removed in vacuo and the crude mixture was purified using column 
chromatography (EtOAc:Hexanes) to yield a white solid, 5a, 54% (0.14 g). mp (from CHCl3) 
= 108-110 °C. FT-IR (thin film): νmax (cm-1) = 1708.6, 1638.1. 1H NMR (500 MHz, CDCl3) 
δ 7.75 (1H, dd, J = 7.5, 1.8 Hz, ArH), 7.53–7.47 (2H, m, ArH), 7.41 (1H, d, J = 15.9 Hz, 
ArCH=CHR), 7.16 (1H, dd, J = 7.6, 1.5 Hz, ArH), 6.44 (1H, d, J = 15.9 Hz, ArCH=CHR), 
3.78 (3H, s, OCH3), 3.07–2.91 (4H, m, CH2). 13C NMR (126 MHz, CDCl3) δ 176.21 (C(O)O), 
166.98 (NC(O)C), 138.88 (ArCH=CHR), 132.48 (ArC), 131.21 (ArC), 130.03 (ArC), 129.00 
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(ArC), 127.66 (ArC), 126.65 (ArC), 121.12 (ArCH=CHR), 52.04 (OCH3), 28.85 (CH2). HRMS 
(ESI): m/z calculated for C14H13N1O4 requires 282.0743 for [M+Na]+, found 282.0713 
 




General Procedure G was followed using the following compounds: N-(4-
chlorophenyl)succinimide, 4b, (0.105 g, 0.5 mmol), methyl acrylate (0.14 mL, 0.13 g, 1.5 
mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol), 
Cu(OAc)2.H2O (0.10 g, 0.5 mmol). Column chromatography gave a pale orange amorphous 
solid, 5c, 32% (0.047 g). mp (from CHCl3) = 101-103 °C. FT-IR: (thin film): νmax (cm-1) = 
3066.8, 2993.1, 1700.9, 1639.4, 1610.2. 1H NMR: (500 MHz, CDCl3)  δ 7.70 (1H, d, J = 2.1 
Hz, ArH), 7.45 (1H, dd, J = 8.4, 2.2 Hz, ArH), 7.31 (1H, d, J = 15.9 Hz, ArCH=CHR), 7.10 
(1H, d, J = 8.5 Hz, ArH), 6.42 (1H, d, J = 15.9 Hz, ArCH=CHR), 3.77 (3H, s, OCH3), 3.03 – 
2.86 (4H, m, CH2). 13C NMR: (126 MHz, CDCl3) δ 175.75 (NC(O)CH2), 166.40 (C(O)O), 
137.48 (ArCH=CHR), 135.84 (ArC), 133.94 (ArC), 130.87 (ArC), 130.09 (ArC), 129.77 
(ArC), 127.42 (ArC), 122.07 (ArCH=CHR), 51.94 (OCH3), 28.63 (CH2). HRMS: (ESI): m/z 
calculated for C14H12Cl1N1Na1O4 requires 316.0352 for [M+Na]+, found 316.0327 
 




General Procedure G was followed using the following compounds: N-(4-
bromophenyl)succinimide, 4c, (0.127 g, 0.5 mmol), methyl acrylate (0.14 mL, 0.13 g, 1.5 
mmol), [RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol), 
Cu(OAc)2.H2O (0.10 g, 0.5 mmol). Column chromatography gave an off-white amorphous 
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solid, 25, 26% (0.044 g). mp (from CHCl3) = 98-101 °C. FT-IR: (thin film): νmax (cm-1) = 
3073.5, 2996.4, 1701.3, 1643.4, 1609.1. 1H NMR: (500 MHz, CDCl3)  δ 7.86 (1H, d, J = 1.9 
Hz, ArH), 7.60 (1H, dd, J = 8.4, 2.0 Hz, ArH), 7.30 (1H, d,  J = 15.9 Hz, ArCH=CHR), 7.03 
(1H, d, J = 8.4 Hz, ArH), 6.42 (1H, d, J = 15.8 Hz, ArCH=CHR), 3.78 (3H, s, OCH3), 3.03 – 
2.87 (4H, m, CH2). 13C NMR: (126 MHz, CDCl3) δ 175.66 (NC(O)CH2), 166.38 (C(O)O), 
137.38 (ArCH=CHR), 134.23 (ArC), 133.83 (ArC), 130.43 (ArC), 130.28 (ArC), 123.86 
(ArC), 122.12 (ArCH=CHR), 51.95 (OCH3), 28.63 (CH2). HRMS: (ESI): m/z calculated for 
C14H12Br1N1O4 requires 338.0004 for [M+H]+, found 338.0028 
 




General Procedure A was followed using the following compounds: N-phenyl(4-
methoxy)succinimide, 4d, (0.141 g, 0.5 mmol), methyl acrylate (0.14 mL, 0.13 g, 1.5 mmol), 
[RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O 
(0.10 g, 0.5 mmol). Column chromatography gave an off-white amorphous solid, 33, 24% 
(0.043 g). mp (from CHCl3) = 92-94 °C. FT-IR: (thin film): νmax (cm-1) = 3065.1, 2995.1, 
2835.5, 1701.5, 1644.3, 1608.8. 1H NMR: (400 MHz, dmso-d6, 368K) δ 7.90 (1H, d, J = 7.8 
Hz, ArCH=CHR), 7.60 – 7.38 (4H, m, ArH), 7.37 – 7.26 (2H, m, ArH), 6.99 – 6.94 (2H, m, 
ArH), 6.53 (1H, d, J = 15.9 Hz, ArCH=CHR), 4.39 – 4.26 (1H, m, CH), 3.80 (3H, s, CH3), 
3.76 (3H, s, CH3), 3.02 – 2.96 (1H, m, CH2), 2.93 – 2.86 (1H, m, CH2). 13C NMR: (126 MHz, 
CDCl3) δ 176.82, 175.20, 175.11, 166.80, 166.49, 159.37, 138.74, 138.58, 132.47, 132.34, 
131.41, 130.97, 129.88, 129.86, 129.16, 128.93, 128.87, 128.81, 128.77, 128.67, 128.43, 
127.48, 127.42, 126.44, 121.26, 120.95, 114.88, 114.71, 114.67, 55.34, 55.33, 51.85, 
51.80, 45.86, 45.41, 45.22, 37.78, 37.42, 37.31, 28.41.(Mixture of peaks observed due to 
presence of rotamers). HRMS: (ESI): m/z calculated for C21H19N1O5 requires 388.1198 for 









General Procedure A was followed using the following compounds: N-phenyl(4-
methoxy)succinimide, 4d, (0.141 g, 0.5 mmol), benzyl acrylate (0.22 mL, 0.24 g, 1.5 mmol), 
[RuCl2(p-cymene)]2 (0.016 g, 0.025 mmol), AgSbF6 (0.035 g, 0.1 mmol), Cu(OAc)2.H2O 
(0.10 g, 0.5 mmol).  Column chromatography gave an off-white amorphous solid, 34, 28% 
(0.061 g). mp (from CHCl3) = 88-91 °C. FT-IR: (thin film): νmax (cm-1) = 3074.0, 2996.4, 
2837.5, 1700.9, 1643.4, 1608.8. 1H NMR: (400 MHz, dmso-d6, 368K) δ 7.93 (1H, d, J = 7.4 
Hz, ArCH-CHR), 7.62 – 7.45 (4H, m, ArH), 7.44 – 7.31 (7H, m, ArH), 6.96 (2H, dt, J = 9.8, 
5.4 Hz, ArH), 6.61 (1H, d, J = 15.9 Hz, ArCH=CHR), 5.26 (2H, d, J = 1.9 Hz, OCH2Bn), 4.33 
(1H, ddd, J = 27.2, 9.3, 5.1 Hz, CH), 3.77 (3H, s, CH3), 2.98 – 2.87 (2H, m, CH2). 13C NMR: 
(126 MHz, CDCl3) δ 138.94, 131.02, 129.86, 128.83, 128.64, 128.59, 128.42, 128.05, 
127.43, 126.44, 121.25, 114.91, 114.71, 77.25, 77.00, 76.75, 66.43, 55.34, 45.91, 45.39, 
37.75. (Mixture of peaks observed due to presence of rotamers.). HRMS: (ESI): m/z 
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6.3: Data and Supporting Information for “Remote C6-Selective Ruthenium-
Catalyzed C–H Alkylation of Indole Derivatives via σ-Activation” 
 
In the interest of presentation in a thesis, NMR spectra, computational data and 
crystallography data have not been included. However, in the interest of the reader these 
are available online at: 
http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b00038/suppl_file/cs7b00038_si_001.pdf 
This supporting information has also been modified with the inclusion of data for preliminary 
results not included in publication however presented in this thesis, and 1H and 13C NMR 




Proton, carbon and fluorine NMR spectra were recorded on Bruker 300 MHz, or Agilent 
Technologies 500 MHz, spectrometer (1H NMR at 500 MHz, or 300 MHz, 13C{1H} NMR at 
126 MHz, or 75 MHz, and 19F NMR at 470 MHz. Chemical shifts for protons are reported in 
parts per million downfield from Si(CH3)4 and are referenced to residual protium in the 
deuterated solvent (CHCl3 at 7.26 ppm, or CH3OH at 3.31 & 4.87 depending on solvent 
used). Chemical shifts for fluorines are reported in parts per million downfield from CFCl3. 
NMR data are presented in the following format: chemical shift (number of equivalent nuclei 
by integration, multiplicity [app = apparent, br = broad, d = doublet, t = triplet, q = quartet, 
dd = doublet of doublets), dt = doublet of triplets), dq = doublet of quartets), ddd = doublet 
of doublet of doublets), m = multiplet], coupling constant [in Hz], assignment). Electrospray 
ionisation ultrahigh resolution time-of-flight mass spectrometry (ESI–UHR–TOF–MS) was 
performed on a Bruker maXis mass spectrometer. Electrospray ionisation high resolution 
time-of-flight mass spectrometry (ESI–HR–TOF–MS) was performed on a Bruker 
micrOTOF spectrometer. Infrared (IR) spectra were recorded on a Perkin–Elmer 1600 FT 
(Fourier transform), IR spectrophotometer, with absorbencies quoted as wavelength (ν [in 
cm−1]). Melting points were obtained on a Bibby Sterilin SMP10 melting point machine and 
are uncorrected. 
 
Analytical thin-layer chromatography (TLC) was performed on aluminium-backed plates 
coated with Alugram® SIL G/UV254 purchased from Macherey–Nagel and visualised with 
UV light (254 or 365 nm), and/or KMnO4, 2,4-DNPH or I2/Silica staining. Silica gel column 
chromatography was performed using 60 Å, 200-400 mesh particle size silica gel purchased 
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from Sigma–Aldrich. Samples were loaded as saturated solutions in an appropriate solvent 
system. 
 
All reactions were performed using reagents obtained from Sigma-Aldrich, Acros Organics, 
Alfa Aesar, Fluorochem chemicals without further purification unless stated. [RuCl2(p-
cymene)]2 was purchased from STREM chemicals or Acros Organics. All water used was 
purified through a Merck Millipore reverse osmosis purification system prior to use. 
Anhydrous solvents were dried and degassed by passing through anhydrous alumina 
columns using an Innovative Technology Inc. PS-400-7 solvent purification system (SPS) 
and stored under an atmosphere of N2 prior to use. 
 
Reactions were performed in oven-dried glassware and under a blanket of N2 if not stated. 












1 KOAc - 1,4-dioxane 120 16 3 2 2 21 8 
2 KOAc AcOH 1,4-dioxane 120 16 3 2 2 49 47 
3 - AcOH 1,4-dioxane 120 16 3 2 2 26 0 
4 KOAc AcOH 2-MeTHF 120 16 3 2 2 62 32 
5 KOAc AcOH DME 120 16 3 2 2 48 45 
6 KOAc AcOH AcOH 120 16 3 2 2 91 5 
7 KOAc AcOH THF 120 16 3 2 2 39 57 
8 KOAc AcOH TBME 120 16 3 2 2 83 14 
9 KOAc AcOH DCE 120 16 3 2 2 65 33 
10 KOAc AcOH t-AmOH 120 16 3 2 2 12 6 
11 KOAc AcOH PhMe 120 16 3 2 2 59 37 
12 KOAc AcOH NMP 120 16 3 2 2 0 0 
13 NaOAc AcOH THF 120 16 3 2 2 35 9 
14 NBu4OAc AcOH THF 120 16 3 2 2 0 0 
15 K2CO3 AcOH THF 120 16 3 2 2 6 3 
16 K2CO3* AcOH THF 120 16 3 2 2 46 43 
17 Na2CO3 AcOH THF 120 16 3 2 2 0 0 
18 KOPiv AcOH THF 120 16 3 2 2 17 9 
19 KOAc PivOH THF 120 16 3 2 2 65 32 
20 KOAc AdCO2H THF 120 16 3 2 2 8 10 
21 KOAc MesCO2H THF 120 16 3 2 2 50 30 
22 KOAc Piv-Val-
OH 
THF 120 16 3 2 2 62 14 
23 KOAc TFA THF 120 16 3 2 2 31 3 
24 KOAc KOAc THF 120 16 3 2 2 55 40 
25 KOAc AcOH THF 120 16 1 2 2 70 30 
27 KOAc AcOH THF 120 16 5 2 2 36 26 
28 KOAc AcOH THF 120 16 10 2 2 37 28 
29 KOAc AcOH THF 100 16 3 2 2 55 43 
30 KOAc AcOH THF 120 16 3 2 1 27 14 
31 KOAc AcOH THF 120 16 3 2 3 56 46 
32 KOAc AcOH THF 120 16 3 2 10 69 31 
33 KOAc AcOH THF 120 16 3 1 2 71 17 
34 KOAc AcOH THF 120 16 3 3 2 26 74 
35** KOAc AcOH THF 120 Time 3 2 2 0 0 
Standard Conditions: Indole (0.25 mmol), ethyl α--bromoisobutyrate (0.75 mmol), [RuCl2(p-cymene)]2 (5 mol%), Base (2 eq), Additive (2 eq), 



















C7 selectivity was exclusively observed in the C4-F derivative in low yields. This shows that 
the electronic nature of the fluorine strongly influences the selectivity of the product. This 
was investigated using the computational methods used previously (Figure S1) and this 
showed that this functionalization is likely to take place on an organic non-cyclometalated 




Figure S1: Relative nucleophilicity Fukui indices for organic and inorganic computed structures. Calculations 
were performed at the BP86/6-31G**&SDD(Ru) level of theory. Fukui indices were calculated with NBO total 





6.3.3: Synthesis of Starting Materials 
 




To a solution of indole (2.34 g, 20 mmol) in DMF (50 mL) was added sodium hydride (60% 
wt. in mineral oil, 1.2 g, 30 mmol) portion-wise. The reaction mixture was allowed to stir at 
room temperature for 1 hour. To the solution was added 2-chloropyrimidine (3.43 g, 30 
mmol) and the reaction mixture was heated to 150 °C overnight. The reaction mixture was 
allowed to return to room temperature before being poured into brine (300 mL) and EtOAc 
(300 mL). The organic layer was separated and the aqueous layer was re-extracted with 
EtOAc (2 x 300 mL). The combined organic layers were dried over MgSO4 and concentrated 
in vacuo. The crude mixture was purified via silica gel column chromatography 
(EtOAc/Petroleum Ether 40-60 °C) to give a white solid, 99% (3.88 g). 1H NMR (300 MHz, 
CDCl3 δ 8.82 (1H, dq, J = 8.4, 0.9 Hz, InH), 8.71 (2H, d, J = 4.8 Hz, PmH), 8.28 (1H, d, J = 
3.7 Hz, InH), 7.69–7.58 (1H, m, InH), 7.35 (1H, ddd, J = 8.5, 7.1, 1.4 Hz, InH), 7.28–7.19 
(1H, m, InH), 7.06 (1H, t, J = 4.8 Hz, PmH), 6.71 (1H, dd, J = 3.7, 0.8 Hz, InH). 13C NMR 
(75 MHz, CDCl3) δ 158.3 (ArC), 154.9 (ArC), 147.6 (ArC), 131.4 (ArC), 125.9 (ArC), 123.8 










To a solution of 1H-indole (2.34 g, 20 mmol) and N,N-dimethylaminopyridine (0.244 g, 2 
mmol) in CH2Cl2 (40 mL) was added di-tert-butyl dicarbonate (4.8 g, 22 mmol). The reaction 
was allowed to stir at room temperature overnight. Brine (100 mL) and CH2Cl2 (60 mL) were 
added to the reaction mixture and the organic layer extracted. The aqueous layer was re-
extracted with CH2Cl2 (2 x 100 mL). The combined organic phases were dried over MgSO4 
and concentrated in vacuo to give a yellow oil, 90% (3.89 g). 1H NMR (500 MHz, CDCl3) δ 
8.21 (1H, d, J = 8.3 Hz, InH), 7.64 (1H, d, J = 3.8 Hz, InH), 7.60 (1H, ddd, J = 7.8, 1.3, 0.8 
Hz, InH), 7.36 (1H, ddd, J = 8.3, 7.2, 1.3 Hz, InH), 7.30–7.22 (1H, m, InH), 6.61 (1H, dd, J 
= 3.7, 0.8 Hz, InH), 1.72 (9H, s, CH3). 13C NMR (126 MHz, CDCl3) δ 149.9 (ArC), 135.3 
(ArC), 130.7 (ArC), 126.0 (ArC), 124.3 (ArC), 122.7 (ArC), 121.0 (ArC), 115.3 (ArC), 107.4 









To a solution of 1H-indole (2.34 g, 20 mmol), N’,N’-dimethylaminopyridine (244 mg, 0.2 
mmol), and triethylamine (4.2 mL, 30 mmol) in anhydrous CH2Cl2 (40 mL) was added 
trimethylacetyl chloride (2.96 mL, 24 mmol) dropwise at 0 °C. The reaction mixture was 
allowed to return to room temperature and allowed to stir overnight. The reaction was 
quenched with brine (100 mL), and the organic layer extracted. The aqueous layer was re-
extracted with CH2Cl2 (2 x 100 mL). The combined organics were dried over MgSO4 and 
concentrated in vacuo to give the title compound, quantitative yield (4.01 g). 1H NMR (500 
MHz, CDCl3) δ 8.52 (1H, dq, J = 8.4, 0.8 Hz, ArH), 7.74 (1H, dd, J = 3.9, 0.4 Hz, ArH), 7.56 
(1H, ddd, J = 7.7, 1.4, 0.8 Hz, ArH), 7.35 (1H, dddd, J = 8.5, 7.2, 1.4, 0.4 Hz, ArH), 7.29–
7.24 (2H, m, ArH), 6.62 (1H, dd, J = 3.8, 0.7 Hz, ArH), 1.53 (9H, s, C(CH3)2). 13C NMR (126 
MHz, CDCl3) δ 177.2 (COtBu), 136.9 (ArC), 129.5 (ArC), 125.7 (ArC), 125.2 (ArC), 123.6 
(ArC), 120.6 (ArC), 117.4 (ArC), 108.3 (ArC), 41.3 (C(CH3)2), 28.8 (C(CH3)2). Data is in line 








To a solution of indole (2.34 g, 20 mmol) in pyridine (5 mL) was added p-toluenesulfonyl 
chloride (4.58 g, 24 mmol) in CH2Cl2 (50 mL) dropwise. After addition was complete, the 
resulting mixture was allowed to stir at room temperature overnight. The mixture was 
quenched with 1M HCl (100 mL) and the organic phase extracted. The aqueous phase was 
re-extracted with CH2Cl2 (2 x 100 mL). The combine organic phases were dried over MgSO4 
and concentrated in vacuo to give the title compound, 2.99 g (55%). 1H NMR (500 MHz, 
CDCl3) δ 7.99 (1H, dd, J = 8.3, 0.9 Hz, ArH), 7.80–7.71 (2H, m, ArH), 7.56 (1H, d, J = 3.7 
Hz, ArH), 7.52 (1H, dt, J = 7.8, 1.0 Hz, ArH), 7.30 (1H, ddd, J = 8.4, 7.2, 1.3 Hz, ArH), 7.25–
7.19 (3H , m, ArH), 6.65 (1H, dd, J = 3.7, 0.8 Hz, ArH), 2.33 (3H, s, ArCH3). 13C NMR (126 
MHz, CDCl3) δ 145.0 (ArC), 135.5 (ArC), 135.0 (ArC), 130.9 (ArC), 130.0 (ArC), 127.0 (ArC), 
126.5 (ArC), 124.7 (ArC), 123.4 (ArC), 121.5 (ArC), 113.7 (ArC), 109.1 (ArC), 21.69 









To a solution of 1H-indole (2.34 g, 20 mmol) in DMF (20 mL) was added sodium hydride 
(60% wt. in mineral oil, 2.85 g, 24 mmol). The reaction mixture was left to stir at room 
temperature for 1 hour. To the resulting slurry was added benzyl bromide (3.6 mL, 30 mmol) 
at 0 °C. The reaction mixture was allowed to stir at room temperature overnight. The 
resulting mixture was quenched with water (200 mL) and EtOAc (200 mL) was added. The 
organic layer was extracted and the aqueous layer was re-extracted with EtOAc (2 x 200 
mL). The combined organic layers were dried over MgSO4 and concentrated in vacuo to a 
yellow oil 95%, (3.93 g). 1H NMR (500 MHz, CDCl3) δ 7.84 (1H, ddd, J = 7.7, 1.4, 0.8 Hz, 
ArH), 7.58–7.48 (1H, m, ArH), 7.46–7.38 (4H, m, ArH), 7.38–7.26 (2H, m, ArH), 7.27–7.19 
(3H, m, ArH), 5.39 (2H, d, J = 0.7 Hz, CH2Ph). 13C NMR (126 MHz, CDCl3) δ 137.6 (ArC), 
128.8 (ArC), 128.8 (ArC), 128.5 (ArC), 128.3 (ArC), 127.8 (ArC), 127.7 (ArC), 127.6 (ArC), 
126.8 (ArC), 121.8 (ArC), 121.1 (ArC), 119.6 (ArC), 109.8 (ArC), 101.8 (ArC), 50.1 (CH2Ph). 










To a solution of 3-methylindole (2.62 g, 20 mmol) in DMF (20 mL) was added sodium 
hydride (60% wt. in mineral oil, 1.2 g, 30 mmol) portion-wise. The reaction mixture was 
allowed to stir at room temperature for 1 hour. To the solution was added 2-chloropyrimidine 
(3.43 g, 30 mmol) and the reaction mixture was heated to 150 °C overnight. The reaction 
mixture was allowed to return to room temperature before being poured into brine (300 mL) 
and EtOAc (300 mL). The organic layer was separated and the aqueous layer was re-
extracted with EtOAc (2 x 300 mL). The combined organic layers were dried over MgSO4 
and concentrated in vacuo. The crude mixture was purified via silica gel column 
chromatography (EtOAc/Petroleum Ether 40-60 °C) to give a white solid, 24% (1.01 g). 1H 
NMR (500 MHz, CDCl3) δ 8.78 (1H, dd, J = 8.5, 3.1 Hz, InH), 8.66 (2H, t, J = 4.3 Hz, PmH), 
8.04 (1H, dt, J = 2.7, 1.4 Hz, InH), 7.57 (1H, dd, J = 8.0, 3.0 Hz, InH), 7.36 (1H, tdd, J = 8.4, 
3.9, 1.5 Hz, InH), 7.27 (1H, dt, J = 8.4, 3.4 Hz, InH), 6.98 (1H, q, J = 4.6 Hz, PmH), 2.39–
2.35 (3H, m, ArCH3). 13C NMR (126 MHz, CDCl3) δ 158.2 (ArC), 135.8 (ArC), 132.2 (ArC), 
123.8 (ArC), 123.0 (ArC), 121.9 (ArC), 118.9 (ArC), 116.3 (ArC), 116.2 (ArC), 115.7 (ArC), 








To a solution of 2-methylindole (0.65 g, 5 mmol) in DMF (5 mL) was added sodium hydride 
(60% wt. in mineral oil, 0.3 g, 7.5 mmol) portion-wise. The reaction mixture was allowed to 
stir at room temperature for 1 hour. To the solution was added 2-chloropyrimidine (0.84 g, 
7.5 mmol) and the reaction mixture was heated to 150 °C overnight. The reaction mixture 
was allowed to return to room temperature before being poured into brine (75 mL) and 
EtOAc (75 mL). The organic layer was separated and the aqueous layer was re-extracted 
with EtOAc (2 x 75 mL). The combined organic layers were dried over MgSO4 and 
concentrated in vacuo. The crude mixture was purified via silica gel column chromatography 
(CH2Cl2/Petroleum Ether 40-60 °C) to give a white solid, 5% (0.052 g). 1H NMR (500 MHz, 
CDCl3) δ 8.77 (2H, d, J = 4.9 Hz, PmH), 8.32 (1H, d, J = 8.1 Hz, InH), 7.54 (1H, d, J = 7.5 
Hz, InH), 7.23 (2H, dt, J = 19.7, 6.9 Hz, InH), 7.10 (1H, t, J = 4.8 Hz, PmH), 6.46 (1H, s, 
InH), 2.74 (3H, s, ArCH3). 13C NMR (126 MHz, CDCl3) δ 158.1 (ArC), 137.9 (ArC), 136.9 
(ArC), 129.5 (ArC), 122.4 (ArC), 121.9 (ArC), 119.6 (ArC), 117.0 (ArC), 114.1 (ArC), 106.8 









To a solution of indole-3-acetic acid (1.6 g, 9.1 mmol) in EtOH (40 mL) was added H2SO4 
(2 mL). The reaction mixture was refluxed overnight. The reaction mixture was allowed to 
return to room temperature and was diluted in H2O (100 mL) and EtOAc (100 mL). The 
organic layer was extracted, and the aqueous layer was re-extracted with EtOAc (100 mL). 
The combined organic layers were dried over MgSO4 and concentrated in vacuo. The 
resulting residue was purified via silica gel column chromatography (EtOAc:Petroleum Ether 
40-60 °C, 1:10 v:v) to afford a yellow oil. This yellow oil was diluted in DMF (7 mL) and 
sodium hydride (60% wt. in mineral oil, 0.39 g, 9.75 mmol) was added portionwise at 0 °C. 
The resulting slurry was allowed to stir for 1 hour. Following this 2-chloropyrimidine (1.12 g, 
9.75 mmol) was added and the reaction was allowed to stir at room temperature overnight. 
The reaction mixture was concentrated in vacuo. The resulting residue was diluted in EtOAc 
(200 mL) and brine (200 mL). The organic layer was extracted and the aqueous layer was 
re-extracted with EtOAc (2 x 200 mL). The combined organic phases were filtered through 
a pad of cotton wool before being dried over MgSO4 and concentrated in vacuo. The 
resulting residue was purified via silica gel column chromatography (EtOAc:Petroleum Ether 
40-60 °C, 1:20 v:v) to afford a yellow oil, 14% from free acid (0.388 g). 1H NMR (500 MHz, 
CDCl3) δ 8.80 (1H, dt, J = 8.4, 0.9 Hz, InH), 8.68 (2H, d, J = 4.8 Hz, PmH), 8.26 (1H, t, J = 
1.1 Hz, InH), 7.61 (1H, ddd, J = 7.8, 1.3, 0.7 Hz, InH), 7.36 (1H, ddd, J = 8.4, 7.1, 1.3 Hz, 
InH), 7.30–7.25 (1H, m, InH), 7.02 (1H, t, J = 4.8 Hz, PmH), 4.19 (2H, q, J = 7.1 Hz, 
CO2CH2R), 3.80 (2H, d, J = 1.1 Hz, ArCH2CO2Et), 1.27 (3H, t, J = 7.1 Hz, CO2CH2CH3). 13C 
NMR (126 MHz, CDCl3) δ 171.4 (CO2Et), 158.1 (ArC), 135.7 (ArC), 130.9 (ArC), 124.6 
(ArC), 124.0 (ArC), 122.1 (ArC), 119.7 (ArC), 119.0 (ArC), 116.5 (ArC), 116.1 (ArC), 113.0 
(ArC), 111.3 (ArC), 61.0 (CO2CH2CH3), 31.6 (ArCH2CO2Et), 14.3 (CO2CH2CH3). Data is in 









To an oven dried Schlenk flask was added 1-(pyrimidin-2-yl)-1H-indole (0.98 g, 5 mmol) 
and PhI(OAc)2 (1.77 g, 5.5 mmol). The flask was evacuated and refilled with argon three 
times. Degassed acetic acid (3.5 mL) and acetic anhydride (1.5 mL) were added via septum. 
The reaction mixture was then heated to 60 °C and left to stir overnight. The mixture was 
allowed to return to room temperature and was quenched with water (25 mL) and 
subsequently saturated NaHCO3 solution (75 mL). EtOAc (100 mL) was added and the 
organic layer was extracted. The aqueous layer was extracted with EtOAc (2 x 100 mL) and 
the combined organic phases were dried over MgSO4 and concentrated in vacuo. The crude 
residue was purified via silica gel column chromatography (EtOAc/Petroleum Spirit 40-60 
°C) to give a white solid, 61% (0.77 g). 1H NMR (500 MHz, CDCl3) δ 8.82 (1H, dt, J = 8.5, 
0.8 Hz, InH), 8.68 (2H, d, J = 4.7 Hz, PmH), 8.43 (1H, s, InH), 7.56 (1H, ddd, J = 7.9, 1.3, 
0.7 Hz, InH), 7.38 (1H, ddd, J = 8.5, 7.1, 1.3 Hz, InH), 7.30–7.21 (1H, m, InH), 7.02 (1H, t, 
J = 4.8 Hz, PmH), 2.40 (3H, s, COCH3). 13C NMR (126 MHz, CDCl3) δ 168.2 (C(O)Me), 
158.2 (ArC), 157.9 (ArC), 133.7 (ArC), 133.0 (ArC), 124.7 (ArC), 124.2 (ArC), 122.3 (ArC), 










To a solution of indole-3-carboxaldehyde (0.725 g, 5 mmol) in DMF (10 mL) was added 
sodium hydride (60% wt. in mineral oil, 0.3 g, 7.5 mmol) portion-wise. The reaction mixture 
was allowed to stir at room temperature for 1 hour. To the solution was added 2-
chloropyrimidine (0.863 g, 7.5 mmol) and the reaction mixture was heated to 150 °C 
overnight. The reaction mixture was allowed to return to room temperature before being 
poured into aqueous LiCl solution (5%, 100 mL) and EtOAc (100 mL). The organic layer 
was separated and the aqueous layer was re-extracted with EtOAc (2 x 100 mL). The 
combined organic layers were dried over MgSO4 and concentrated in vacuo. The crude 
mixture was purified via silica gel column chromatography (EtOAc/Petroleum Ether 40-60 
°C) and then recrystallized from EtOH to give a white fluffy solid, 22% (0.239 g). mp (from 
CHCl3): 159-164 °C. FT-IR (thin film): νmax (cm-1) = 3138.5, 1673.5, 1569.5, 1547.9. 1H NMR 
(500 MHz, CDCl3) δ 10.15 (1H, s, CHO), 8.91 (1H, s, InH), 8.79 (1H, dt, J = 8.4, 1.0 Hz, 
InH), 8.76 (2H, d, J = 4.8 Hz, PmH), 8.34 (1H, ddd, J = 7.7, 1.5, 0.8 Hz, InH), 7.43 (1H, ddd, 
J = 8.5, 7.2, 1.5 Hz, InH), 7.41–7.35 (1H, m, InH), 7.20 (1H, t, J = 4.8 Hz, PmH). 13C NMR 
(126 MHz, CDCl3) δ 186.0 (CHO), 158.5 (ArC), 157.1 (ArC), 136.9 (ArC), 136.5 (ArC), 127.0 
(ArC), 125.7 (ArC), 124.4 (ArC), 122.1 (ArC), 121.4 (ArC), 118.0 (ArC), 116.5 (ArC). HRMS 









To a solution of 5-methoxyindole (0.735 g, 5 mmol) in DMF (10 mL) was added sodium 
hydride (60% wt. in mineral oil, 0.3 g, 7.5 mmol) portion-wise. The reaction mixture was 
allowed to stir at room temperature for 1 hour. To the solution was added 2-chloropyrimidine 
(0.863 g, 7.5 mmol) and the reaction mixture was heated to 150 °C over the weekend. The 
reaction mixture was allowed to return to room temperature before being poured into brine 
(100 mL) and EtOAc (100 mL). The organic layer was separated and the aqueous layer 
was re-extracted with EtOAc (2 x 100 mL). The combined organic layers were dried over 
MgSO4 and concentrated in vacuo. The crude mixture was purified via silica gel column 
chromatography (EtOAc/Petroleum Ether 40-60 °C) to give a powdery white solid, 60% 
(0.670 g). 1H NMR (500 MHz, CDCl3) δ 8.73–8.68 (1H, m, InH), 8.67 (2H, d, J = 4.8 Hz, 
PmH), 8.25 (1H, d, J = 3.6 Hz, InH), 7.10 (1H, dd, J = 2.6, 0.5 Hz, InH), 7.00 (1H, t, J = 4.8 
Hz, PmH), 6.97 (1H, ddd, J = 9.1, 2.6, 0.5 Hz, InH), 6.63 (1H, dd, J = 3.7, 0.8 Hz, InH), 3.89 
(3H, s, OCH3). 13C NMR (126 MHz, CDCl3) δ 158.2 (ArC), 157.8 (ArC), 155.6 (ArC), 132.2 
(ArC), 130.4 (ArC), 126.5 (ArC), 117.2 (ArC), 116.0 (ArC), 112.7 (ArC), 106.9 (ArC), 103.3 











To a solution of 5-fluoroindole (0.675 g, 5 mmol) in DMF (10 mL) was added sodium hydride 
(60% wt. in mineral oil, 0.3 g, 7.5 mmol) portion-wise. The reaction mixture was allowed to 
stir at room temperature for 1 hour. To the solution was added 2-chloropyrimidine (0.863 g, 
7.5 mmol) and the reaction mixture was heated to 150 °C over the weekend. The reaction 
mixture was allowed to return to room temperature before being poured into brine (100 mL) 
and EtOAc (100 mL). The organic layer was separated and the aqueous layer was re-
extracted with EtOAc (2 x 100 mL). The combined organic layers were dried over MgSO4 
and concentrated in vacuo. The crude mixture was purified via silica gel column 
chromatography (EtOAc/Petroleum Ether 40-60 °C) to give a powdery white solid, 85% 
(0.897 g). 1H NMR (500 MHz, CDCl3) δ 8.76 (1H, ddt, J = 9.1, 4.8, 0.6 Hz, InH), 8.69 (2H, 
d, J = 4.8 Hz, PmH), 8.31 (1H, dd, J = 3.7, 0.5 Hz, InH), 7.32–7.20 (1H, m, InH), 7.10–7.02 
(2H, m, PmH & InH), 6.65 (1H, dd, J = 3.7, 0.8 Hz, InH). 13C NMR (126 MHz, CDCl3) δ 159.1 
(d, J = 237.8 Hz, ArC), 158.3 (ArC), 132.2 (d, J = 10.0 Hz, ArC), 127.5 (ArC), 117.4 (d, J = 
8.6 Hz, ArC), 116.4 (ArC), 111.5 (d, J = 25.0 Hz, ArC), 106.7 (d, J = 3.9 Hz, ArC), 106.2 (d, 
J = 23.4 Hz, ArC). 19F NMR (470 MHz, CDCl3) δ -122.0 (td, J = 9.1, 4.9 Hz, ArF). Data is in 








To a solution of 5-bromoindole (0.980 g, 5 mmol) in DMF (10 mL) was added sodium hydride 
(60% wt. in mineral oil, 0.3 g, 7.5 mmol) portion-wise. The reaction mixture was allowed to 
stir at room temperature for 1 hour. To the solution was added 2-chloropyrimidine (0.863 g, 
7.5 mmol) and the reaction mixture was heated to 150 °C overnight. The reaction mixture 
was allowed to return to room temperature before being poured into aqueous LiCl solution 
(5%, 100 mL) and EtOAc (100 mL). The organic layer was separated and the aqueous layer 
was re-extracted with EtOAc (2 x 100 mL). The combined organic layers were dried over 
MgSO4 and concentrated in vacuo. The crude mixture was purified via silica gel column 
chromatography (EtOAc/Petroleum Ether 40-60 °C) to give a powdery white solid, 86% 
(1.18 g). 1H NMR (500 MHz, CDCl3) δ 8.73–8.66 (3H, m, PmH & InH), 8.28 (1H, dd, J = 3.7, 
0.4 Hz, InH), 7.74 (1H, dd, J = 2.1, 0.5 Hz, InH), 7.41 (1H, ddd, J = 8.8, 2.0, 0.4 Hz, InH), 
7.07 (1H, t, J = 4.8 Hz, PmH), 6.63 (1H, dd, J = 3.7, 0.8 Hz, InH). 13C NMR (126 MHz, 
CDCl3) δ 158.3 (ArC), 157.6 (ArC), 134.2 (ArC), 133.2 (ArC), 127.1 (ArC), 126.5 (ArC), 
123.5 (ArC), 117.9 (ArC), 116.6 (ArC), 115.6 (ArC), 110.2 (ArC), 106.2 (ArC). Data is in line 









To a solution of indole (1.17 g, 10 mmol) in DMF (15 mL) was added sodium hydride (60% 
wt. in mineral oil, 0.6 g, 15 mmol) portion-wise. The reaction mixture was allowed to stir at 
room temperature for 1 hour. To the solution was added 2-bromopyridine (1.14 mL, 1.90 g, 
12 mmol) and the reaction mixture was heated to 150 °C overnight. The reaction mixture 
was allowed to return to room temperature before being poured into brine (100 mL) and 
EtOAc (100 mL). The organic layer was separated and the aqueous layer was re-extracted 
with EtOAc (2 x 100 mL). The combined organic layers were dried over MgSO4 and 
concentrated in vacuo. The crude mixture was purified via silica gel column chromatography 
(EtOAc/Petroleum Ether 40-60 °C) to give a light brown oil, 56% (1.08 g). 1H NMR (500 
MHz, CDCl3) δ 8.64–8.48 (1H, m, ArH), 8.22 (1H, dd, J = 8.4, 0.9 Hz, ArH), 7.82 (1H, ddd, 
J = 8.2, 7.4, 2.0 Hz, ArH), 7.74 (1H, d, J = 3.4 Hz, ArH), 7.68 (1H, ddd, J = 7.8, 1.3, 0.8 Hz, 
ArH), 7.50 (1H, dt, J = 8.2, 0.9 Hz, ArH), 7.31 (1H, dd, J = 8.4, 7.1, 1.3 Hz, ArH), 7.22 (1H, 
ddd, J = 8.1, 7.1, 1.0 Hz, ArH), 7.17 (1H, ddd, J = 7.4, 4.9, 0.9 Hz, ArH), 6.73 (1H, dd, J = 
3.5, 0.8 Hz, ArH). 13C NMR (126 MHz, CDCl3) δ 152.6 (ArC), 149.1 (ArC), 138.5 (ArC), 
135.2 (ArC), 130.6 (ArC), 126.1 (ArC), 123.2 (ArC), 121.4 (ArC), 121.2 (ArC), 120.2 (ArC), 









To a solution of indole (0.585 g, 5 mmol) in DMF (5 mL) was added sodium hydride (60% 
wt. in mineral oil, 0.3 g, 7.5 mmol) portion-wise. The reaction mixture was allowed to stir at 
room temperature for 1 hour. To the solution was added 2,5-dichloropyrimidine (1.39 g, 7.5 
mmol) and the reaction mixture was heated to 150 °C overnight. The reaction mixture was 
allowed to return to room temperature before being poured into brine (100 mL) and EtOAc 
(100 mL). The organic layer was separated and the aqueous layer was re-extracted with 
EtOAc (2 x 100 mL). The combined organic layers were dried over MgSO4 and concentrated 
in vacuo. The crude mixture was purified via silica gel column chromatography 
(EtOAc/Petroleum Ether 40-60 °C) to give a powdery white solid, 36% (0.416 g). mp (from 
CHCl3) = 115-117 °C. FT-IR (thin film): νmax (cm-1) = 3051.4, 727.5 (C-Cl). 1H NMR (500 
MHz, CDCl3) δ 8.71 (1H, dt, J = 8.4, 0.9 Hz, InH), 8.62 (2H, d, J = 1.0 Hz, PmH), 8.19 (1H, 
dd, J = 3.7, 1.0 Hz, InH), 7.62 (1H, ddd, J = 7.8, 1.3, 0.8 Hz, InH), 7.35 (1H, ddd, J = 8.5, 
7.3, 1.3 Hz, InH), 7.30–7.18 (1H, m, InH), 6.71 (1H, dd, J = 3.7, 0.8 Hz, InH). 13C NMR (126 
MHz, CDCl3) δ 156.4 (ArC), 155.7 (ArC), 135.2 (ArC), 131.3 (ArC), 125.8 (ArC), 125.0 (ArC), 
123.8 (ArC), 122.4 (ArC), 120.9 (ArC), 116.1 (ArC), 107.5 (ArC). HRMS (ESI): m/z 




6.3.4: Synthesis of C3 Functionalized Materials 
 




To an oven dried flask was charged relevant indole (2 mmol), ethyl α-bromo isobutyrate 
(0.95 L, 6 mmol), [RuCl2(p-cymene)]2 (0.061 g, 0.1 mmol), potassium acetate (0.392 g, 4 
mmol), and 1,4-dioxane (8 mL). The vessel was evacuated and refilled with argon three 
times. The reaction mixture was heated to 120 °C and left to stir for 16 h. The reaction 
mixture was allowed to return to room temperature and diluted with EtOAc (80 mL) and sat. 
NaHCO3 solution (80 mL). The organic layer was extracted and the aqueous layer was re-
extracted with EtOAc (2 x 20 mL). The combined organic layers were dried over MgSO4 
and concentrated in vacuo. The crude residue was purified via silica gel column 










To a solution of C-3 alkylated indole (1 eq) in DMF (0.5-1 M), was added sodium hydride 
(60% wt. in mineral oil, 1.5 eq) portion-wise. The reaction mixture was allowed to stir at 
room temperature for 1 hour. To the solution was added 2-chloropyrimidine/2,5-
dichloropyrimidine/2-bromopyridine (1.5 eq) and the reaction mixture was heated to 150 °C 
overnight. The reaction mixture was allowed to return to room temperature before being 
poured into aqueous LiCl solution (5%, 100 mL) and EtOAc (100 mL). The organic layer 
was separated and the aqueous layer was re-extracted with EtOAc (2 x 100 mL). The 
combined organic layers were dried over MgSO4 and concentrated in vacuo. The crude 
mixture was purified via silica gel column chromatography (EtOAc/Petroleum Ether 40-60 
°C, 10-20:90-80 v:v) to give N-substituted products.  
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To an oven-dried carousel tube was charged with 1-(pyrimidin-2-yl)-1H-indole (49 mg, 0.25 
mmol), potassium acetate (49 mg, 0.25 mmol), and [RuCl2(p-cymene)]2 (8 mg, 0.0125 
mmol, 5 mol%). The flask was sealed with a Teflon cap, evacuated and refilled with argon 
three times. 1,4-dioxane (1 mL) and 2-bromo-2-methylpropane (0.084 mL, 103 mg, 0.75 
mmol) were added via septum and the reaction flask was heated to 120 °C for 16 h. The 
reaction mixture was allowed to return to room temperature and was diluted with EtOAc (30 
mL) and sat. NaHCO3 solution (30 mL). The organic phase was extracted and the aqueous 
phase re-extracted with EtOAc (2 x 30 mL). The combined organics were dried over MgSO4 
and concentrated in vacuo. The crude residue was purified via silica gel column 
chromatography (EtOAc:Petroleum Spirit 40-60 °C – 10:90 v:v) to give an amorphous off-
white solid, 13% (8 mg). FT-IR (thin film): νmax (cm-1) = 2961.0, 1580.0, 1560.4. 1H NMR 
(500 MHz, CDCl3) δ 8.86 (1H, dt, J = 8.4, 1.0 Hz, ArH), 8.68 (2H, d, J = 4.8 Hz, ArH), 8.01 
(1H, s, ArH), 7.89–7.77 (1H, m, ArH), 7.33 (1H, ddd, J = 8.4, 7.1, 1.3 Hz, ArH), 7.28–7.18 
(1H, m, ArH), 6.99 (1H, t, J = 4.8 Hz, ArH), 1.52 (9H, s, C(CH3)3). 13C NMR (126 MHz, 
CDCl3) δ 158.1 (ArC), 158.1 (ArC), 136.8 (ArC), 130.5 (ArC), 130.0 (ArC), 123.3 (ArC), 
121.5 (ArC), 121.4 (ArC), 120.9 (ArC), 116.6 (ArC), 115.7 (ArC), 31.9 (C(CH3)3), 30.5 









The above compound was synthesized using General Procedure B using ethyl 2-(1H-indol-
3-yl)-2-methylpropanoate (1.16 g, 5 mmol), sodium hydride (60% wt. dispersion in mineral 
oil, 0.3 g, 7.5 mmol), 2-chloropyrimidine (0.863 g, 7.5 mmol) and DMF (5 mL) Silica gel 
chromatography gave a white solid, 89% (0.412 g). mp (from CHCl3): 113-117 °C. FT-IR 
(thin film): νmax (cm-1) = 2981.1, 1725.6, 1579.3, 1562.7. 1H NMR (500 MHz, CDCl3) δ 8.82 
(1H, dt, J = 8.4, 0.9 Hz, InH), 8.69 (2H, d, J = 4.8 Hz, PmH), 8.17 (1H, s, InH), 7.60 (1H, 
ddd, J = 7.9, 1.3, 0.7 Hz, InH), 7.33 (1H, ddd, J = 8.4, 7.1, 1.3 Hz, InH), 7.21 (1H, ddd, J = 
8.1, 7.1, 1.1 Hz, InH), 7.02 (1H, t, J = 4.8 Hz, PmH), 4.13 (2H, q, J = 7.1 Hz, CO2CH2R), 
1.73 (6H, s, C(CH3)2), 1.13 (3H, t, J = 7.1 Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 
176.8 (CO2Et), 158.2 (ArC), 157.8 (ArC), 136.3 (ArC), 129.5 (ArC), 123.8 (ArC), 122.1 
(ArC), 122.0 (ArC), 120.3 (ArC), 116.6 (ArC), 116.0 (ArC), 61.1 (CO2CH2R, 42.2 (C(CH3)2), 
26.1 (C(CH3)2), 14.3 (CO2CH2CH3). HRMS (ESI): m/z calculated for C18H19N3O2 requires 
310.1556 for [M+H]+, found 310.1554. 
 




The above compound was synthesized using General Procedure A using 1H-indole (1c), 
0.234 g). Silica gel chromatography gave a white solid, 89% (0.412 g). mp (from CHCl3): 
106-110 °C. FT-IR (thin film): νmax (cm-1) = 3409.7, 2979.5, 1709.6. 1H NMR (500 MHz, 
CDCl3) δ 8.02 (1H, s, NH), 7.68 (1H, dq, J = 8.0, 0.9 Hz, InH), 7.34 (1H, dt, J = 8.2, 1.0 Hz, 
InH), 7.18 (1H, ddd, J = 8.2, 7.0, 1.1 Hz, InH), 7.09 (1H, ddd, J = 8.1, 7.1, 1.1 Hz, InH), 7.04 
(1H, d, J = 2.5 Hz, InH), 4.13 (2H, q, J = 7.1 Hz, CO2CH2R), 1.70 (6H, s, C(CH3)2), 1.16 (3H, 
t, J = 7.1 Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 177.2 (CO2Et), 137.0 (ArC), 125.8 
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(ArC), 122.0 (ArC), 121.1 (ArC), 120.6 (ArC), 120.6 (ArC), 119.5 (ArC), 111.4 (ArC), 60.9 
(CO2CH2R), 42.2 (C(CH3)2), 26.3 (C(CH3)2), 14.3 (CO2CH2CH3). HRMS (ESI): m/z 
calculated for C14H17N1O2 requires 232.1338 for [M+H]+, found 232.1317. 
 




The above compound was synthesized using General Procedure B using ethyl 2-(1H-indol-
3-yl)-2-methylpropanoate (0.231 g, 1 mmol), sodium hydride (60% wt. dispersion in mineral 
oil, 0.06 g, 1.5 mmol), 2-bromopyridine (0.143 mL, 1.5 mmol, 0.237 g) and DMF (2 mL) 
Silica gel chromatography gave an amorphous oil, 19% (0.060 g). FT-IR (thin film): νmax (cm-
1) = 2980.0, 1723.0, 1591.1. 1H NMR (500 MHz, CDCl3) δ 8.56 (1H, ddd, J = 4.9, 1.9, 0.9 
Hz, ArH), 8.13 (1H, dt, J = 8.3, 0.9 Hz, ArH), 7.81 (1H, ddd, J = 8.2, 7.4, 1.9 Hz, ArH), 7.71–
7.63 (2H, m, ArH), 7.52 (1H, dt, J = 8.3, 0.9 Hz, ArH), 7.33–7.24 (1H, m, ArH), 7.21–7.13 
(2H, m, ArH), 4.13 (2H, q, J = 7.1 Hz, CO2CH2R), 1.74 (6H, s, C(CH3)2), 1.15 (3H, t, J = 7.1 
Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 176.9 (CO2Et), 152.4 (ArC), 149.1 (ArC), 
138.4 (ArC), 135.9 (ArC), 128.5 (ArC), 123.7 (ArC), 123.2 (ArC), 122.6 (ArC), 121.0 (ArC), 
120.7 (ArC), 120.1 (ArC), 114.8 (ArC), 112.9 (ArC), 61.0 (CO2CH2R), 42.2 (C(CH3)2), 26.2 
(C(CH3)2), 14.3 (CO2CH2CH3). HRMS (ESI): m/z calculated for C19H20N2O2 requires 
309.1603 for [M+H]+, found 309.1610. 
 






The above compound was synthesized using General Procedure B using ethyl 2-(1H-indol-
3-yl)-2-methylpropanoate (0.231 g, 1 mmol), sodium hydride (60% wt. dispersion in mineral 
oil, 0.06 g, 1.5 mmol), 2,5-dichloropyrimidine (0.22 g, 1.5 mmol) and DMF (5 mL) Silica gel 
chromatography gave a white solid, 66% (0.225 g). mp (from CHCl3): 120-124 °C.  FT-IR 
(thin film): νmax (cm-1) = 2980.3, 1725.00, 1573.4, 1543.1. 1H NMR (500 MHz, CDCl3) δ 8.72 
(1H, dt, J = 8.5, 0.9 Hz, InH), 8.61 (2H, s, PmH), 8.09 (1H, s), 7.60 (1H, ddd, J = 8.0, 1.2, 
0.7 Hz, InH), 7.33 (1H, ddd, J = 8.4, 7.1, 1.3 Hz, InH), 7.22 (1H, ddd, J = 8.1, 7.2, 1.1 Hz, 
InH), 4.14 (2H, q, J = 7.1 Hz, CO2CH2R), 1.73 (6H, s, C(CH3)2), 1.14 (3H, t, J = 7.1 Hz, 
CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 176.7 (CO2Et), 156.5 (ArC), 155.7 (ArC), 136.2 
(ArC), 129.6 (ArC), 125.6 (ArC), 124.9 (ArC), 124.0 (ArC), 122.3 (ArC), 122.1 (ArC), 120.4 
(ArC), 116.4 (ArC), 61.1 (CO2CH2R), 42.2 (C(CH3)2), 26.1 (C(CH3)2), 14.3 (CO2CH2CH3). 
HRMS (ESI): m/z calculated for C18H18Cl1N3O2 requires 344.1166 for [M+H]+, found 
344.1159. 
 




The above compound was synthesized using General Procedure A using 5-methoxyindole, 
0.294 g). Silica gel chromatography gave a white solid, 69% (0.362 g). mp (from CHCl3): 
121-126 °C. FT-IR (thin film): νmax (cm-1) = 3412.9, 2981.9, 1715.8, 1624.8, 1582.5. 1H NMR 
(500 MHz, CDCl3) δ 7.99 (1H, s, NH), 7.21 (1H, dd, J = 8.8, 0.6 Hz, InH), 7.13 (1H, dd, J = 
2.5, 0.7 Hz, InH), 7.01 (1H, dd, J = 2.7, 0.4 Hz, InH), 6.85 (1H, ddd, J = 8.8, 2.5, 0.5 Hz, 
InH), 4.13 (2H, q, J = 7.1 Hz, CO2CH2R), 3.84 (3H, s, OCH3), 1.68 (6H, s, C(CH3)2), 1.17 
(3H, t, J = 7.1 Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 177.2 (CO2Et), 153.8 (ArC), 
132.1 (ArC), 126.1 (ArC), 121.4 (ArC), 120.6 (ArC), 112.2 (ArC), 112.1 (ArC), 102.5 (ArC), 
60.9 (CO2CH2R), 56.0 (ArOCH3), 42.1 (C(CH3)2), 26.1 (C(CH3)2), 14.3 (CO2CH2CH3). 












The above compound was synthesized using General Procedure B using ethyl 2-(5-
methoxy-1H-indol-3-yl)-2-methylpropanoate (0.342 g, 1.3 mmol), sodium hydride (60% wt. 
dispersion in mineral oil, 0.078 g, 1.95 mmol) and 2-chloropyrimidine (0.224 g, 1.95 mmol). 
Silica gel column chromatography gave a white solid, 82% (0.361 g). mp (from CHCl3): 71-
75 °C. FT-IR (thin film): νmax (cm-1) = 2981.2, 1725.5, 1578.8, 1561.6. 1H NMR (500 MHz, 
CDCl3) δ 8.71 (1H, d, J = 9.0 Hz, InH), 8.65 (2H, d, J = 4.8 Hz, PmH), 8.14 (1H, s, InH), 
7.06 (1H, d, J = 2.5 Hz, InH), 6.99 (1H, t, J = 4.8 Hz, PmH), 6.95 (1H, dd, J = 9.1, 2.6 Hz, 
InH), 4.14 (2H, q, J = 7.1 Hz, CO2CH2R), 3.86 (3H, s, ArOCH3), 1.72 (6H, s, C(CH3)2), 1.15 
(3H, t, J = 7.1 Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 176.8 (CO2Et), 158.1 (ArC), 
157.7 (ArC), 155.3 (ArC), 131.2 (ArC), 130.3 (ArC), 124.8 (ArC), 122.6 (ArC), 117.35 (ArC), 
115.8 (ArC), 112.5 (ArC), 103.0 (ArC), 61.1 (CO2CH2R), 55.8 (ArOCH3), 42.1 (C(CH3)2), 
26.0 (C(CH3)2), 14.3 (CO2CH2CH3). HRMS (ESI): m/z calculated for C19H21N3O3 requires 
340.1661 for [M+H]+, found 340.1670. 
 
Synthesis of ethyl 2-(5-fluoro-1H-indol-3-yl)-2-methylpropanoate (S3c) 
 
 
The above compound was synthesized using General Procedure A using 5-fluoroindole, 
0.270 g). Silica gel chromatography gave an off-white solid, 74% (0.366 g). mp (from CHCl-
3): 97-102 °C. FT-IR (thin film): νmax (cm-1) = 3370.7, 2980.0, 1705.3, 1630.2, 1580.5. 1H 
NMR (500 MHz, CDCl3) δ 8.08 (1H, s, NH), 7.34 (1H, ddt, J = 10.3, 2.6, 0.6 Hz, InH), 7.23 
(1H, ddd, J = 8.8, 4.5, 0.5 Hz, InH), 7.07 (1H, d, J = 2.5 Hz, InH), 6.92 (1H, td, J = 9.0, 2.5 
Hz, InH), 4.14 (2H, q, J = 7.1 Hz, CO2CH2R), 1.67 (6H, s, C(CH3)2), 1.18 (3H, t, J = 7.1 Hz, 
CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 176.9 (CO2Et), 157.6 (d, J = 234.1 Hz, ArC), 
133.5 (ArC), 126.1 (d, J = 10.0 Hz, ArC), 122.5 (ArC), 121.1 (d, J = 4.9 Hz, ArC), 111.9 (d, 
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J = 9.8 Hz, ArC), 110.5 (d, J = 26.3 Hz, ArC), 105.6 (d, J = 24.0 Hz, ArC), 61.0 (CO2CH2R), 
42.1 (C(CH3)2), 26.1 (C(CH3)2), 14.3 (CO2CH2CH3). 19F NMR (470 MHz, CDCl3) δ -124.5 
(td, J = 9.8, 4.6 Hz). HRMS (ESI): m/z calculated for C14H16N1O2F1 requires 250.1243 for 
[M+H]+, found 250.1243. 
 




The above compound was synthesized using General Procedure B using ethyl 2-(5-fluoro-
1H-indol-3-yl)-2-methylpropanoate (0.349 g, 1.4 mmol), sodium hydride (60% wt. dispersion 
in mineral oil, 0.084 g, 2.1 mmol) and 2-chloropyrimidine (0.242 g, 2.1 mmol). Silica gel 
column chromatography gave a white solid, 66% (0.302 g). mp (from CHCl3): 110-114 °C. 
FT-IR (thin film): νmax (cm-1) = 2980.2, 1727.2, 1580.0, 1564.4. 1H NMR (500 MHz, CDCl3) 
δ 8.84–8.74 (1H, m, InH), 8.67 (2H, d, J = 4.8 Hz, PmH), 8.21 (1H, s, InH), 7.31–7.22 (1H, 
m, InH), 7.10–6.97 (2H, m, InH & PmH), 4.14 (2H, q, J = 7.1 Hz, CO2CH2R), 1.71 (6H, s, 
C(CH3)2), 1.16 (3H, t, J = 7.1 Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 176.5 (CO2Et), 
158.8 (d, J = 238.0 Hz, ArC), 158.2 (ArC), 157.6 (ArC), 132.7 (ArC), 130.3 (d, J = 9.6 Hz, 
ArC), 124.7 (d, J = 4.2 Hz, ArC), 123.6 (ArC), 117.5 (d, J = 9.0 Hz, ArC), 116.2 (ArC), 111.5 
(d, J = 24.8 Hz, ArC), 105.9 (d, J = 24.2 Hz, ArC), 61.2 (CO2CH2R), 42.1 (C(CH3)2), 26.0 
(C(CH3)2), 14.3 (CO2CH2CH3). 19F NMR (470 MHz, CDCl3) δ -121.4 (td, J = 9.6, 5.1 Hz, 
ArF). HRMS (ESI): m/z calculated for C18H18N3O2F1 requires 328.1461 for [M+H]+, found 
328.1453. 
 






The above compound was synthesized using General Procedure A using 5-bromoindole, 
(0.392 g). Silica gel chromatography gave a light brown solid, 79% (0.490 g). FT-IR (thin 
film): νmax (cm-1) = 3352.4, 2979.1, 1703.4. 1H NMR (500 MHz, CDCl3) δ 8.15 (1H, s, NH), 
7.82 (1H, dd, J = 1.9, 0.6 Hz, ArH), 7.24 (1H, dd, J = 8.6, 1.9 Hz, ArH), 7.19–7.15 (1H, m, 
ArH), 4.20–4.09 (2H, m, CO2CH2CH3), 1.67 (6H, s, C(CH3)2), 1.20 (3H, t, J = 7.1 Hz, 
CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 176.92 (CO2Et), 135.59 (ArC), 127.48 (ArC), 
124.89 (ArC), 123.12 (ArC), 121.99 (ArC), 120.62 (ArC), 112.82 (ArC), 112.78 (ArC), 61.14 
(CO2CH2CH3), 42.14 (C(CH3)2), 26.25 (C(CH3)2), 14.27 (CO2CH2CH3). HRMS (ESI): m/z 
calculated for C14H16N1O2Br1 requires 310.0443 for [M+H]+, found 310.0430. 
 




The above compound was synthesized using General Procedure B using ethyl 2-(5-bromo-
1H-indol-3-yl)-2-methylpropanoate (0.440 g, 1.4 mmol), sodium hydride (60% wt. dispersion 
in mineral oil, 0.084 g, 2.1 mmol) and 2-chloropyrimidine (0.242 g, 2.1 mmol). Silica gel 
column chromatography gave a white solid, 43% (0.215 g). mp (from CHCl3): 113-118 °C. 
FT-IR (thin film): νmax (cm-1) = 2981.2, 1723.9, 1575.5, 1563.5. 1H NMR (500 MHz, CDCl3) 
δ 8.70 (1H, dd, J = 8.9, 0.5 Hz, InH), 8.68 (2H, d, J = 4.8 Hz, PmH), 8.17 (1H, s, InH), 7.74 
(1H, dd, J = 2.0, 0.5 Hz, InH), 7.40 (1H, dd, J = 8.9, 2.0 Hz, InH), 7.04 (1H, t, J = 4.8 Hz, 
PmH), 4.16 (2H, q, J = 7.1 Hz, CO2CH2CH3), 1.71 (6H, s, C(CH3)2), 1.18 (3H, t, J = 7.1 Hz, 
CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 176.39 (CO2Et), 158.23 (ArC), 157.51 (ArC), 
135.00 (ArC), 131.19 (ArC), 126.58 (ArC), 124.28 (ArC), 123.29 (ArC), 122.98 (ArC), 118.06 
(ArC), 116.40 (ArC), 115.42 (ArC), 61.24 (CO2CH2CH3), 42.14 (C(CH3)2), 26.07 (C(CH3)2), 
14.25 (CO2CH2CH3). HMRS (ESI): m/z calculated for C18H18N3O2Br1 requires 388.0661 for 












The above compound was synthesized using General Procedure A using 4-fluoroindole 
(0.405 g, 3 mmol) and other reagents scaled respectively. Silica gel chromatography gave 
a white solid which was immediately submitted to General Procedure B without analysis. 
This procedure was followed using sodium hydride (60% wt. dispersion in mineral oil, 0.072 
g, 1.8 mmol), 2-chloropyrimidine (0.344 g, 3 mmol) and DMF (5 mL). Silica gel column 
chromatography gave a white solid, 40% over two steps (0.360 g). mp (from CHCl3): 119-
121 °C. FT-IR (thin film): νmax (cm-1) = 2979.9, 2923.8, 1727.0, 1578.6, 1563.2, 1445.3. 1H 
NMR (300 MHz, CDCl3) δ 8.69 (2H, d, J = 4.8 Hz, PmH), 8.64 (1H, d, J = 8.4 Hz, InH), 8.13 
(1H, s, InH), 7.33–7.15 (1H, m, InH), 7.05 (1H, t, J = 4.8 Hz, PmH), 6.89 (1H, ddd, J = 11.0, 
8.0, 0.8 Hz, InH), 4.16 (2H, q, J = 7.1 Hz, CO2CH2CH3), 1.72 (6H, s, C(CH3)2), 1.16 (2H, t, 
J = 7.1 Hz, CO2CH2CH3). 13C NMR (75 MHz, CDCl3) δ 177.1 (CO2R), 158.2 (ArC), 157.6 
(d, J = 5.8 Hz, ArC), 154.3 (ArC), 138.5 (d, J = 10.5 Hz, ArC), 124.6 (d, J = 8.0 Hz, ArC), 
124.2 (d, J = 3.5 Hz, ArC), 122.2 (ArC), 118.2 (d, J = 19.9 Hz, ArC), 116.4 (ArC), 112.6 (d, 
J = 3.6 Hz, ArC), 107.9 (d, J = 20.6 Hz, ArC), 61.0 (CO2CH2CH3), 42.5 (C(CH3)2), 26.9 
(C(CH3)2), 26.9 (C(CH3)2), 14.2 (CO2CH2CH3). 19F NMR (470 MHz, CDCl3) δ -123.66 (dd, J 





6.3.5: Synthesis of C6 Functionalized Materials 
 





To an oven dried carousel tube was charged relevant C-3 functionalized material (0.25 
mmol), α-bromo ester (0.75 mmol), [RuCl2(p-cymene)]2 (0.0077 g), potassium acetate 
(0.049 g, 0.5 mmol), acetic acid (0.029 mL, 0.5 mmol, 0.030 g) and 1,4-dioxane (1 mL). The 
vessel was evacuated and refilled with argon three times. The reaction mixture was heated 
to 120 °C and left to stir for 16 h. The reaction mixture was allowed to return to room 
temperature and diluted with EtOAc (20 mL) and sat. NaHCO3 solution (20 mL). The organic 
layer was extracted and the aqueous layer was re-extracted with EtOAc (2 x 20 mL). The 
combined organic layers were dried over MgSO4 and concentrated in vacuo. The crude 
residue was purified via silica gel column chromatography using EtOAc/Petroleum Ether 









To an oven dried carousel tube was charged relevant indole derivative (0.25 mmol), α-
bromo ester (0.75 mmol), [RuCl2(p-cymene)]2 (0.0077 g), potassium acetate (0.049 g, 0.5 
mmol), acetic acid (0.029 mL, 0.5 mmol, 0.030 g) and THF (1 mL). The vessel was 
evacuated and refilled with argon three times. The reaction mixture was heated to 120 °C 
and left to stir for 16 h. The reaction mixture was allowed to return to room temperature and 
diluted with EtOAc (20 mL) and sat. NaHCO3 solution (20 mL). The organic layer was 
extracted and the aqueous layer was re-extracted with EtOAc (2 x 20 mL). The combined 
organic layers were dried over MgSO4 and concentrated in vacuo. The crude residue was 
purified via silica gel column chromatography using EtOAc/Petroleum Ether 40-60 °C (1:20-








The above compound was synthesized using General Procedure C using 3a (0.077 g) and 
ethyl α-bromoisobutyrate (0.12 mL, 0.75 mmol) as coupling partner. Silica gel 
chromatography gave a white solid, 80% (0.085 g). mp (from CHCl3): 94-99 °C. FT-IR (thin 
film): νmax (cm-1) = 2978.7, 1725.1, 1578.1, 1562.8. 1H NMR (500 MHz, CDCl3) δ 8.88 (1H, 
dd, J = 1.8, 0.6 Hz, InH), 8.68 (2H, d, J = 4.8 Hz, PmH), 8.14 (1H, s, InH), 7.54 (1H, dd, J = 
8.4, 0.6 Hz, InH), 7.19 (1H, dd, J = 8.4, 1.8 Hz, InH), 7.01 (1H, t, J = 4.8 Hz, PmH), 4.14 
(4H, m, CO2CH2CH3), 1.71 (6H, s, C(CH3)2), 1.67 (6H, s, C(CH3)2), 1.20 (3H, t, J = 7.1 Hz, 
CO2CH2CH3), 1.15 (3H, t, J = 7.1 Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 177.4 
(CO2Et), 176.7 (CO2Et), 158.2 (ArC), 157.8 (ArC), 140.9 (ArC), 136.5 (ArC), 128.1 (ArC), 
124.8 (ArC), 122.4 (ArC), 120.0 (ArC), 116.0 (ArC), 113.7 (ArC), 61.0 (CO2CH2R), 60.9 
(CO2CH2R), 47.0 (C(CH3)2), 42.2 (C(CH3)2), 27.2 (C(CH3)2), 26.1 (C(CH3)2), 14.2 
(CO2CH2CH3), 14.2 (CO2CH2CH3). HRMS (ESI): m/z calculated for C24H29N3O4 requires 
424.2236 for [M+H]+, found 424.2254. 
 




The above compound was synthesized using General Procedure C using 3a (0.070 g) and 
ethyl α-bromoisobutyrate (0.12 mL, 0.75 mmol) as coupling partner. Silica gel 
chromatography gave an off white amorphous solid, 40% (0.040 g). FT-IR (thin film): νmax 
(cm-1) = 2979.5, 1727.6, 1577.8, 1567.6. 1H NMR (500 MHz, CDCl3) δ 8.87 (1H, d, J = 1.8 
Hz, InH), 8.68 (2H, d, J = 4.8 Hz, PmH), 8.28 (1H, s, InH), 7.54 (1H, d, J = 8.4 Hz, InH), 
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7.28–7.22 (2H, m, InH), 7.03 (1H, t, J = 4.8 Hz, PmH), 4.45 (2H, d, J = 1.4 Hz, CH2CO2Et), 
4.24–4.09 (4H, m, CO2CH2CH3), 1.68 (6H, s, C(CH3)2), 1.17-1.13 (3H, m, CO2CH2CH3), 
0.95–0.85 (3H, m, CO2CH2CH3).13C NMR (126 MHz, CDCl3) δ 177.3 (CO2Et), 172.7 
(CO2Et), 158.2 (ArC), 141.0 (ArC), 135.5 (ArC), 130.1 (ArC), 126.4 (ArC), 120.3 (ArC), 
119.2 (ArC), 116.3 (ArC), 113.78 (ArC), 113.6 (ArC), 61.0 (CO2CH2R), 60.9 (CO2CH2R), 
48.9, 45.6, 27.2 (C(CH3)2), 14.3 (CO2CH2CH3), 14.2 (CO2CH2CH3). HRMS (ESI): m/z 
calculated for C22H25N3O4 requires 418.1745 for [M+Na]+, found 418.1775. 
 




The above compound was synthesized using General Procedure C and using 1-(pyridinyl-
1-yl)-1H-indole (0.049 g) and ethyl α-bromoisobutyrate (0.12 mL, 0.75 mmol) as coupling 
partner. Silica gel chromatography gave an amorphous solid, 55% (0.058 g). FT-IR (thin 
film): νmax (cm-1) = 2979.7, 1723.2, 1589.8, 1555.1. 1H NMR (500 MHz, CDCl3) δ 8.56 (1H, 
ddd, J = 4.9, 2.0, 0.9 Hz, ArH), 8.14 (1H, dd, J = 1.7, 0.7 Hz, ArH), 7.82 (1H, ddd, J = 8.2, 
7.4, 2.0 Hz, ArH), 7.60 (2H, d, J = 8.9 Hz, ArH), 7.48 (1H, dt, J = 8.2, 0.9 Hz, ArH), 7.22–
7.12 (2H, m, ArH), 4.17–4.08 (4H, m, CO2CH2CH3), 1.71 (6H, s, C(CH3)2), 1.64 (6H, s, 
C(CH3)2), 1.22–1.14 (6H, m, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 177.2 (CO2Et), 
176.8 (CO2Et), 152.4 (ArC), 149.2 (ArC), 140.2 (ArC), 138.5 (ArC), 136.0 (ArC), 127.1 
(ArC), 123.4 (ArC), 122.9 (ArC), 120.5 (ArC), 120.1 (ArC), 119.3 (ArC), 114.9 (ArC), 109.8 
(ArC), 61.0 (CO2CH2R), 60.9 (CO2CH2R), 46.8 (C(CH3)2), 42.2 (C(CH3)2), 27.1 (C(CH3)2), 
26.2 (C(CH3)2), 14.3 (CO2CH2CH3), 14.2 (CO2CH2CH3). HRMS (ESI): m/z calculated for 








The above compound was synthesized using General Procedure C using 1-(5-
chloropyrimidin-2yl)-1H-indole (0.057 g, 0.25 mmol) and ethyl α-bromoisobutyrate (0.12 mL, 
0.75 mmol) as coupling partner. Silica gel chromatography gave a white solid, 40% (0.046 
g). mp (from CHCl3): 129-133 °C. FT-IR (thin film): νmax (cm-1) = 2980.0, 1725.6, 1573.3. 1H 
NMR (500 MHz, CDCl3) δ 8.77 (1H, dd, J = 1.9, 0.6 Hz, InH), 8.62 (2H, s, PmH), 8.06 (1H, 
s), 7.53 (1H, dd, J = 8.4, 0.6 Hz, InH), 7.21 (1H, dd, J = 8.4, 1.8 Hz, InH), 4.18-4.10 (4H, m, 
CO2CH2R), 1.71 (6H, s, C(CH3)2), 1.66 (6H, s, C(CH3)2), 1.20 (3H, t, J = 7.1 Hz, 
CO2CH2CH3), 1.15 (3H, t, J = 7.1 Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 177.2 
(CO2Et), 176.6 (CO2Et), 156.5 (ArC), 155.7 (ArC), 141.1 (ArC), 136.3 (ArC), 128.16 (ArC), 
125.4 (ArC), 124.9 (ArC), 122.4 (ArC), 120.4 (ArC), 120.2 (ArC), 113.6 (ArC), 61.1 
(CO2CH2R), 60.9 (CO2CH2R), 47.0 (C(CH3)2), 42.2 (C(CH3)2), 27.1 (C(CH3)2), 26.0 
(C(CH3)2), 14.2 (CO2CH2CH3), 14.1 (CO2CH2CH3). HRMS (ESI): m/z calculated for C24H28-
Cl1N3O4 requires 458.1847 for [M+H]+, found 458.1855. 
 




The above compound was synthesized using General Procedure C using 3a (0.077 g) and 
ethyl α-bromoisobutyrate (0.12 mL, 0.75 mmol) as coupling partner. Silica gel 
chromatography gave a white solid, 65% (0.066 g). mp (from CHCl3): 81-85 °C. FT-IR (thin 
film): νmax (cm-1) = 2977.6, 1727.5, 1578.0, 1562.7. 1H NMR (500 MHz, CDCl3) δ 8.88 (1H, 
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dd, J = 1.9, 0.6 Hz, InH), 8.68 (2H, d, J = 4.8 Hz, PmH), 8.14 (1H, s, InH), 7.54 (1H, dd, J = 
8.4, 0.6 Hz, InH), 7.18 (1H, dd, J = 8.4, 1.9 Hz, InH), 7.01 (1H, t, J = 4.8 Hz, PmH), 4.12 
(2H, q, J = 7.1 Hz, CO2CH2R), 3.67 (3H, s, CO2CH3), 1.71 (6H, s, C(CH3)2), 1.68 (6H, s, 
C(CH3)2), 1.15 (3H, t, J = 7.1 Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 177.9 (CO2R), 
176.7 (CO2R), 158.2 (ArC), 157.8 (ArC), 140.6 (ArC), 136.5 (ArC), 128.2 (ArC), 124.8 (ArC), 
122.4 (ArC), 120.1 (ArC), 120.1 (ArC), 116.0 (ArC), 113.6 (ArC), 61.0 (CO2CH2R), 52.3 
(CO2CH2R), 47.0 (C(CH3)2), 42.2 (C(CH3)2), 27.1 (C(CH3)2), 26.1 (C(CH3)2), 14.2 
(CO2CH2CH3). HRMS (ESI): m/z calculated for C23H27N3O4 requires 432.1902 for [M+Na]+, 
found 432.1947. 
 




The above compound was synthesized using General Procedure C using 3a (0.077 g) and 
2-bromo isobutyrophenone (0.15 mL, 0.75 mmol) as coupling partner. Silica gel 
chromatography gave an amorphous solid, 26% (0.030 g). FT-IR (thin film): νmax (cm-1) = 
2980.8, 1727.3, 1676.5, 1577.8, 1565.8. 1H NMR (500 MHz, CD3OD) δ 8.94 (1H, dd, J = 
1.8, 0.6 Hz, InH), 8.72 (2H, d, J = 4.8 Hz, PmH), 8.20 (1H, s, InH), 7.52 (1H, dd, J = 8.4, 0.6 
Hz, ArH), 7.50–7.47 (2H, m, ArH), 7.36–7.28 (1H, m, ArH), 7.20–7.16 (2H, m), 7.14 (1H, t, 
J = 4.8 Hz, PmH), 7.11 (1H, dd, J = 8.3, 1.8 Hz, ArH), 4.10 (2H, q, J = 7.1 Hz, CO2CH2R), 
1.69 (6H, s, C(CH3)2), 1.66 (6H, s, C(CH3)2), 1.08 (3H, t, J = 7.1 Hz, CO2CH2CH3). 13C NMR 
(126 MHz, CD3OD) δ 178.2 (CO), 159.62 (CO), 158.8 (ArC), 142.2 (ArC), 138.1 (ArC), 137.9 
(ArC), 132.8 (ArC), 130.7 (ArC), 129.4 (ArC), 129.0 (ArC), 125.7 (ArC), 123.7 (ArC), 121.5 
(ArC), 121.1 (ArC), 117.7 (ArC), 114.7 (ArC), 62.1 (CO2CH2R), 52.8 (C(CH3)2), 43.2 
(C(CH3)2), 28.7 (C(CH3)2), 26.3 (C(CH3)2), 14.4 (CO2CH2CH3). HRMS (ESI): m/z calculated 








The above compound was synthesized using General Procedure C using 3a (0.077 g) and 
methyl 1-bromo-1-cyclohexanecarboxylate (0.12 mL, 0.75 mmol) as coupling partner. Silica 
gel chromatography gave an amorphous solid, 14% (0.016 g). FT-IR (thin film): νmax (cm-1) 
= 2924.8, 2854.9, 1726.0, 1578.0, 1562.6, 1438.7. 1H NMR (300 MHz, CDCl3) δ 8.93 (1H, 
dd, J = 1.8, 0.6 Hz, InH), 8.70 (2H, d, J = 4.8 Hz, PmH), 8.13 (1H, s, InH), 7.52 (1H, dd, J = 
8.5, 0.6 Hz, InH), 7.37–7.13 (1H, m, InH), 7.03 (1H, t, J = 4.8 Hz, PmH), 4.12 (2H, q, J = 
7.1 Hz, CO2CH2CH3), 3.65 (3H, s, CO2CH3).2.61 (2H, d, J = 13.0 Hz, CyH), 1.96–1.55 (10H, 
m, CyH & C(CH3)2), 1.55–1.47 (2H, m, CyH), 1.37–1.28 (2H, m, CyH), 1.15 (3H, t, J = 7.1 
Hz, CO2CH2CH3), 0.94–0.79 (2H, m, CyH). 13C NMR (75 MHz, CDCl3) δ 176.8 (CO2R), 
176.3 (CO2R), 158.2 (ArC), 157.8 (ArC), 139.9 (ArC), 136.6 (ArC), 128.2 (ArC), 124.7 (ArC), 
122.4 (ArC), 120.10 (ArC), 116.0 (ArC), 114.0 (ArC), 67.9 (CO2CH2R), 66.2 (CO2CH2R), 
61.1 (C(CH3)2), 52.1 (C(Cy)), 51.4 (AlkCH), 42.2 (AlkCH), 35.4 (AlkCH), 29.8 (AlkCH), 26.1 
(AlkCH), 24.0 (AlkCH), 14.3 (AlkCH). HRMS (ESI): m/z calculated for C27H33N3O4 requires 
472.2215 for [M+Na]+, found 472.2216. 
 




The above compound was synthesized using General Procedure C using 3a (0.077 g) ethyl 
bromodifluoroacetate (0.096 mL, 0.75 mmol) as coupling partner. Silica gel chromatography 
gave an amorphous solid, 16% (0.017 g). FT-IR (thin film): νmax (cm-1) = 2983.7, 2922.8, 
1764.4, 1727.4, 1578.2, 1566.7, 1452.9. 1H NMR (300 MHz, CDCl3) δ 9.15 (1H, dd, J = 1.7, 
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0.8 Hz, InH), 8.73 (2H, d, J = 4.8 Hz, PmH), 8.28 (1H, s, InH), 7.66 (1H, dd, J = 8.4, 0.8 Hz, 
InH), 7.44 (1H, dd, J = 8.4, 1.7 Hz, InH), 7.09 (1H, t, J = 4.8 Hz, PmH), 4.32 (2H, q, J = 7.1 
Hz, CO2CH2CH3), 4.12 (2H, q, J = 7.1 Hz, CO2CH2CH3), 1.72 (6H, s, C(CH3)2), 1.32 (3H, t, 
J = 7.2 Hz, CO2CH2CH3), 1.14 (3H, t, J = 7.1 Hz, CO2CH2CH3). 13C NMR (75 MHz, CDCl3) 
δ 176.6 (CO2R), 158.3 (CO2R), 157.5 (ArC), 135.6 (ArC), 124.7 (ArC), 124.2 (ArC), 120.5 
(ArC), 119.0 (ArC), 116.6 (ArC), 114.3 (ArC), 63.2 (CO2CH2CH3), 61.2 (CO2CH2CH3), 42.1 
(C(CH3)2), 28.0 (d, J = 285.6 Hz, C(F2)), 14.3 (CO2CH2CH3), 14.1 (CO2CH2CH3). 19F NMR 
(470 MHz, CDCl3) δ -101.51. HRMS (ESI): m/z calculated for C22H23N3O4F2 requires 
432.1758 for [M+H]+, found 432.1735. 
 




The above compound was synthesized using General Procedure C, using ethyl 2-(5-
methoxy-1-(pyrimidin-2-yl)-1H-indol-3-yl)-2-methylpropanoate (0.085 g, 0.25 mmol), and 
ethyl α-bromoisobutyrate (0.12 mL, 0.75 mmol). Silica gel column chromatography gave a 
white solid, 92% (0.104 g). mp (from CHCl3): 122-128 °C. FT-IR (thin film): νmax (cm-1) = 
2980.9, 1726.2, 1578.5, 1562.7.  1H NMR (500 MHz, CDCl3) δ 8.84 (1H, s, InH), 8.66 (2H, 
d, J = 4.7 Hz, PmH), 8.11 (1H, s, InH), 7.01 (1H, s, InH), 6.98 (1H, t, J = 4.8 Hz, PmH), 4.12 
(4H, app qd, J = 7.1, 2.4 Hz, CO2CH2CH3), 3.80 (3H, s, ArOCH3), 1.71 (6H, s, C(CH3)2), 
1.62 (6H, s, C(CH3)2), 1.15 (6H, app td, J = 7.1, 1.8 Hz, CO2CH2CH3). 13C NMR (126 MHz, 
CDCl3) δ 178.42 (CO2Et), 176.81 (CO2Et), 158.14 (ArC), 157.73 (ArC), 152.87 (ArC), 
131.40 (ArC), 130.93 (ArC), 128.58 (ArC), 124.54 (ArC), 122.11 (ArC), 115.76 (ArC), 113.89 
(ArC), 101.38 (ArC), 61.01 (CO2CH2CH3), 60.36 (CO2CH3), 55.40 (ArOCH3), 44.91 
(C(CH3)2), 42.13 (C(CH3)2), 26.21 (C(CH3)2), 25.96 (C(CH3)2), 14.34 (CO2CH2CH3), 14.30 













The above compound was synthesized using General Procedure C, using ethyl 2-(5-fluoro-
1-(pyrimidin-2-yl)-1H-indol-3-yl)-2-methylpropanoate (0.082 g, 0.25 mmol), and ethyl α-
bromoisobutyrate (0.12 mL, 0.75 mmol). Silica gel column chromatography gave a white 
solid, 87% (0.096 g). mp (from CHCl3): 117-121 °C. FT-IR (thin film): νmax (cm-1) = 2981.0, 
1729.3, 1579.0, 1565.0. 1H NMR (500 MHz, CDCl3) δ 8.88 (1H, d, J = 7.2 Hz), 8.68 (2H, d, 
J = 4.8 Hz), 8.18 (1H, s), 7.25 (1H, d, J = 12.0 Hz), 7.04 (1H, t, J = 4.8 Hz), 4.15 (4H, app 
dq, J = 15.5, 7.1 Hz, CO2CH2CH3), 1.70 (6H, s, C(CH3)2), 1.66 (6H, s, C(CH3)2), 1.17 (6H, 
app dt, J = 8.6, 7.1 Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 177.32 (CO2Et), 176.40 
(CO2Et), 158.21 (ArC), 157.87 (ArC), 156.79 (d, J = 207.0 Hz, ArCF), 132.67 (ArC), 129.14 
(d, J = 16.2 Hz, ArC), 128.79 (d, J = 10.1 Hz, ArC), 124.48 (d, J = 3.9 Hz, ArC), 123.37 
(ArC), 116.17 (ArC), 114.27 (d, J = 5.1 Hz, ArC), 106.24 (d, J = 25.8 Hz, ArC), 61.04 (d, J 
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= 25.7 Hz, ArC), 44.73 (C(CH3)2), 42.16 (C(CH3)2), 26.25 (C(CH3)2), 25.96 (C(CH3)2), 14.23 
(CO2CH2CH3), 14.19 (CO2CH3CH3). 19F NMR (470 MHz, CDCl3) δ -120.99 (dd, J = 12.0, 7.2 









The above compound was synthesized using General Procedure C, using ethyl 2-(5-bromo-
1-(pyrimidin-2-yl)-1H-indol-3-yl)-2-methylpropanoate (0.097 g, 0.25 mmol), and ethyl α-
bromoisobutyrate (0.12 mL, 0.75 mmol). Silica gel column chromatography gave a white 
solid, 55% (0.069 g). mp (from CHCl3): 130-134 °C. FT-IR (thin film): νmax (cm-1) = 2989.2, 
1723.3, 1576.4, 1563.4, 1461.9, 1435.5.  1H NMR (500 MHz, CDCl3) δ 9.03 (1H, s, InH), 
8.67 (2H, d, J = 4.8 Hz, PmH), 8.16 (1H, s, InH), 7.82 (1H, s, InH), 7.02 (1H, t, J = 4.8 Hz, 
PmH), 4.16 (4H, dq, J = 11.0, 7.1 Hz, CO2CH2CH3), 1.74 (6H, s, C(CH3)2), 1.71 (6H, s, 
C(CH3)2), 1.19 (6H, td, J = 7.1, 4.1 Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 177.54 
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(CO2Et), 176.29 (CO2Et), 158.20 (ArC), 157.52 (ArC), 138.88 (ArC), 135.54 (ArC), 129.48 
(ArC), 125.53 (ArC), 123.89 (ArC), 123.40 (ArC), 117.04 (ArC), 116.28 (ArC), 115.45 (ArC), 
61.19 (CO2CH2CH3), 61.17 (CO2CH2CH3), 48.53 (C(CH3)2), 42.14 (C(CH3)2), 27.05 
(C(CH3)2), 26.07 (C(CH3)2), 14.22 (CO2CH2CH3), 14.12 (CO2CH2CH3). HRMS (ESI): m/z 








The above compound was synthesized using General Procedure C, using ethyl 2-(4-fluoro-
1-(pyrimidin-2-yl)-1H-indol-3-yl)-2-methylpropanoate (0.082 g, 0.25 mmol), and ethyl α-
bromoisobutyrate (0.12 mL, 0.75 mmol). Silica gel column chromatography gave an 
amorphous solid, 14% (0.015 g). 1H NMR (300 MHz, Chloroform-d) δ 8.76 – 8.60 (m, 3H), 
8.10 (d, J = 0.6 Hz, 1H), 7.06 (t, J = 4.8 Hz, 1H), 6.90 (dd, J = 12.6, 1.5 Hz, 1H), 4.21 – 4.10 
(m, 4H), 1.69 (s, 6H), 1.65 (s, 6H), 1.22 (d, J = 7.1 Hz, 2H), 1.22 – 1.11 (m, 4H). 13C NMR 
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(75 MHz, CDCl3) δ 177.0 (CO2R), 176.9 (CO2R), 158.2 (ArC), 157.4 (d, J = 41.5 Hz, ArC), 
153.9 (ArC), 142.4 (d, J = 7.0 Hz, ArC), 138.4 (d, J = 11.0 Hz, ArC), 124.0 (d, J = 3.4 Hz, 
ArC), 122.4 (ArC), 116.8 (d, J = 20.5 Hz, ArC), 116.4 (ArC), 109.9 (d, J = 3.5 Hz, ArC), 
106.2 (d, J = 21.6 Hz, ArC), 61.02 (CO2CH2CH3) 61.00 (CO2CH2CH3), 46.9 (d, J = 1.6 Hz, 
(C(CH3)2), 42.5 (C(CH3)2), 29.9 (C(CH3)2), 27.0 (C(CH3)2), 26.8 (CO2CH2CH3), 14.2 









Synthesis of 3s and 4s 
 
The above compounds were synthesized using General Procedure D using methyl α-
bromoisobutyrate (0.10 mL, 0.75 mmol) as coupling partner. Silica gel chromatography 




3s. mp (from CHCl3): 110-114 °C. FT-IR (thin film): νmax (cm-1) = 2980.4, 1727.2, 1578.8, 
1562.5. 1H NMR (500 MHz, CDCl3) δ 8.84 (1H, d, J = 8.4 Hz, C-7H), 8.67 (2H, d, J = 4.8 
Hz, PmH), 8.19 (1H, s, C-2H), 7.58 (1H, d, J = 7.9 Hz, InH), 7.34 (1H, ddd, J = 8.4, 7.1, 1.3 
Hz, InH), 7.23 (1H, ddd, J = 8.1, 7.1, 1.1 Hz, InH), 7.00 (1H, t, J = 4.8 Hz, PmH), 3.66 (3H, 
s, CO2CH3), 1.75 (6H, s, C(CH3)2).13C NMR (126 MHz,CDCl3) δ 177.38 (CO2R), 158.14 
(ArC), 158.13 (ArC), 157.76 (ArC), 136.29 (ArC), 129.44 (ArC), 124.85 (ArC), 123.81 (ArC), 
122.10 (ArC), 122.05 (ArC), 120.02 (ArC), 116.63 (ArC), 116.04 (ArC), 52.39 (CO2CH3), 
42.13 (C(CH3)2), 26.10 (C(CH3)2). HRMS (ESI): m/z calculated for C17H17N3O2 requires 




4s. mp (from CHCl3): 108-112 °C. FT-IR (thin film): νmax (cm-1) = 2980.9, 1726.2, 1578.0, 
1562.6 1H NMR (500 MHz, CDCl3) δ 8.89 (1H, dd, J = 1.8, 0.6 Hz, C-7H), 8.68 (2H, d, J = 
4.8 Hz, PmH), 8.15 (1H, s, C-2H), 7.52 (1H, dd, J = 8.4, 0.6 Hz, InH), 7.19 (1H, dd, J = 
8.4, 1.8 Hz, InH), 7.01 (1H, t, J = 4.8 Hz, PmH), 3.67 (3H, s, CO2CH3), 3.65 (3H, s, 
CO2CH3), 1.72 (6H, s, C(CH3)2), 1.69 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 
177.85 (CO2R), 177.27 (CO2R), 158.16 (ArC), 157.77 (ArC), 140.64 (ArC), 136.46 (ArC), 
128.13 (ArC), 124.58 (ArC), 122.44 (ArC), 120.17 (ArC), 119.91 (ArC), 116.03 (ArC), 
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113.72 (ArC), 52.39 (CO2CH3), 52.29 (CO2CH3), 47.01 (C(CH3)2), 42.13 (C(CH3)2), 27.13 
(C(CH3)2), 26.09 (C(CH3)2). HRMS (ESI): m/z calculated for C22H25N3O4 requires 418.1800 
for [M+Na]+, found 418.1816. 
 
Synthesis of 3t and 4t 
 
The above compounds were synthesized using General Procedure D using benzyl α-
bromoisobutyrate (0.13 mL, 0.75 mmol) as coupling partner. Silica gel chromatography 




3t. FT-IR (thin film): νmax (cm-1) = 2980.9, 1726.2, 1578.7, 1562.0. 1H NMR (500 MHz, CDCl3) 
δ 8.83 (1H, dt, J = 8.4, 0.9 Hz, C-7H), 8.67 (2H, d, J = 4.8 Hz, PmH), 8.18 (1H, s, C-2H), 
7.54 (1H, dt, J = 8.0, 0.9 Hz, InH), 7.33 (1H, ddd, J = 8.4, 7.1, 1.2 Hz, InH), 7.30–7.21 (2H, 
m, ArH), 7.21–7.11 (3H, m, ArH), 7.00 (1H, t, J = 4.8 Hz, PmH), 5.12 (2H, s, CH2Ph), 1.77 
(6H, s, C(CH3)2). 13C NMR (126 MHz,CDCl3) δ 176.62 (CO2R), 158.15 (ArC), 157.78 (ArC), 
136.28 (ArC), 136.18 (ArC), 129.42 (ArC), 128.45 (ArC), 128.01 (ArC), 127.98 (ArC), 127.97 
(ArC), 124.78 (ArC), 123.78 (ArC), 122.12 (ArC), 122.04 (ArC), 120.26 (ArC), 116.54 (ArC), 
116.03 (ArC), 66.70 (CH2Ph), 42.31 (C(CH3)2), 26.07 (C(CH3)2). HRMS (ESI): m/z 




4t. FT-IR (thin film): νmax (cm-1) = 2978.1, 1725.8, 1577.5, 1562.4. 1H NMR (500 MHz, CDCl3) 
δ 8.91 (1H, d, J = 1.7 Hz, C-7H), 8.65 (2H, d, J = 4.8 Hz, PmH), 8.17 (1H, s, C-2H), 7.44 
(1H, d, J = 8.4 Hz, InH), 7.30–7.19 (7H, m, ArH), 7.18–7.10 (3H, m, ArH), 7.00 (1H, t, J = 
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4.8 Hz, PmH), 5.15 (2H, s, CH2Ph), 5.12 (2H, s, CH2Ph), 1.75 (6H, s, C(CH3)2), 1.73 (6H, 
s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 177.03 (CO2R), 176.52 (CO2R), 158.14 (ArC), 
157.76 (ArC), 140.45 (ArC), 136.45 (ArC), 136.41 (ArC), 136.16 (ArC), 128.43 (ArC), 128.10 
(ArC), 128.00 (ArC), 127.97 (ArC), 127.92 (ArC), 127.75 (ArC), 127.74 (ArC), 124.51 (ArC), 
122.46 (ArC), 120.15 (ArC), 120.00 (ArC), 115.97 (ArC), 113.84 (ArC), 66.66 (CH2Ph), 
66.46 (CH2Ph), 47.08 (C(CH3)2), 42.30 (C(CH3)2), 27.08 (C(CH3)2), 26.04 (C(CH3)2). HRMS 
(ESI): m/z calculated for C34H33N3O4 requires 548.2549 for [M+H]+, found 548.2539 
 
Synthesis of 3u and 4u 
 
The above compounds were synthesized using General Procedure D using 2-
bromoisobutyrophenone (0.15 mL, 0.75 mmol) as coupling partner. Silica gel 




3u. mp (from CHCl3): 120-128 °C. FT-IR (thin film): νmax (cm-1) = 2980.8, 1673.4, 1577.9, 
1562.5.  1H NMR (500 MHz, CDCl3) δ 8.82 (1H, dt, J = 8.4, 0.9 Hz, InH), 8.74 (2H, d, J = 
4.8 Hz, PmH), 8.34 (1H, s, InH), 7.79–7.71 (2H, m, ArH), 7.45 (1H, ddd, J = 8.0, 1.2, 0.7 
Hz, ArH), 7.35–7.26 (2H, m, ArH), 7.21–7.15 (2H, m, ArH), 7.14–7.07 (2H, m, ArH), 1.78 
(6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 204.54 (COPh), 158.32 (ArC), 137.29 (ArC), 
136.42 (ArC), 131.90 (ArC), 129.52 (ArC), 129.09 (ArC), 128.12 (ArC), 125.78 (ArC), 124.17 
(ArC), 122.39 (ArC), 121.39 (ArC), 120.39 (ArC), 116.48 (ArC), 116.26 (ArC), 47.32 
(C(CH3)2), 27.25 (C(CH3)2). HRMS (ESI): m/z calculated for C22H19N3O requires 364.1426 






4u. mp (from CHCl3): 106-110 °C. FT-IR (thin film): νmax (cm-1) = 2980.7, 1674.4, 1577.1, 
1562.8. 1H NMR (500 MHz, CDCl3) δ 8.86 (1H, dd, J = 1.8, 0.6 Hz, C-7H), 8.72 (2H, d, J = 
4.8 Hz, PmH), 8.33 (1H, s, C-2H), 7.72 (2H, dd, J = 8.5, 1.2 Hz, ArH), 7.46–7.37 (3H, m, 
ArH), 7.35–7.31 (1H, m, ArH), 7.31–7.24 (2H, m, ArH), 7.21–7.16 (2H, m, ArH), 7.13–7.08 
(2H, m, ArH), 7.08–7.05 (2H, m, ArH & PmH), 1.77 (6H, s, C(CH3)2), 1.65 (6H, s, C(CH3)2). 
13C NMR (126 MHz, CDCl3) δ 204.58 (COPh), 204.20 (COPh), 158.35 (ArC), 157.82 (ArC), 
141.35 (ArC), 137.43 (ArC), 136.98 (ArC), 136.70 (ArC), 131.80 (ArC), 131.50 (ArC), 129.83 
(ArC), 129.03 (ArC), 128.33 (ArC), 128.08 (ArC), 127.94 (ArC), 125.46 (ArC), 121.88 (ArC), 
120.73 (ArC), 120.45 (ArC), 116.29 (ArC), 113.84 (ArC), 51.85 (C(CH3)2), 47.28 (C(CH3)2), 
28.30 (C(CH3)2), 27.21 (C(CH3)2). HRMS (ESI): m/z calculated for C32H29N3O2 requires 
488.2338 for [M+H]+, found 488.2360 
 
Synthesis of 3v and 4v 
   
The above compounds were synthesized using General Procedure A using 1-(5-
chloropyrimidin-2yl)-1H-indole (0.057 g, 0.25 mmol) and methyl α-bromoisobutyrate (0.10 
mL, 0.75 mmol) as coupling partner. Silica gel chromatography gave two white solids), 3t 




3v. mp (from CHCl3): 151-153 °C. FT-IR (thin film): νmax (cm-1) = 2981.5, 1729.4, 1573.5, 
1544.3. 1H NMR (500 MHz, Chloroform-d) δ 8.72 (1H, dd, J = 8.4, 0.9 Hz, C-7H), 8.60 (2H, 
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d, J = 0.7 Hz, PmH), 8.10 (1H, d, J = 0.8 Hz, InH), 7.57 (1H, dd, J = 7.9, 1.1 Hz, InH), 7.34 
(1H, dd, J = 8.3, 7.2 Hz, InH), 7.26–7.19 (1H, m, InH), 3.66 (3H, s, CO2CH3), 1.74 (6H, s, 
C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 177.23 (CO2R), 156.44 (ArC), 155.68 (ArC), 136.15 
(ArC), 129.50 (ArC), 125.45 (ArC), 124.94 (ArC), 124.05 (ArC), 122.42 (ArC), 122.06 (ArC), 
120.16 (ArC), 116.50 (ArC), 52.44 (CO2CH3), 42.14 (C(CH3)2), 26.06 (C(CH3)2). HRMS 




4v. mp (from CHCl3): 142-148 °C. FT-IR (thin film): νmax (cm-1) = 2979.6, 1728.3, 1573.5, 
1545.1. 1H NMR (500 MHz, CDCl3) δ 8.78 (1H, dd, J = 1.8, 0.6 Hz, C-7H), 8.63 (2H, s, 
PmH), 8.07 (1H, s, C-2H), 7.51 (1H, dd, J = 8.4, 0.6 Hz, InH), 7.20 (1H, dd, J = 8.4, 1.8 
Hz, InH), 3.67 (3H, s, CO2CH3), 3.65 (3H, s, CO2CH3), 1.71 (6H, s, C(CH3)2), 1.68 (6H, s, 
C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 177.75 (CO2R), 177.13 (CO2R), 156.50 (ArC), 
155.71 (ArC), 140.94 (ArC), 136.35 (ArC), 128.19 (ArC), 125.20 (ArC), 124.95 (ArC), 
122.45 (ArC), 120.49 (ArC), 120.06 (ArC), 113.59 (ArC), 52.45 (CO2CH3), 52.33 
(CO2CH3), 47.01 (C(CH3)2), 42.14 (C(CH3)2), 27.11 (C(CH3)2), 26.06 (C(CH3)2). HRMS 




6.3.6: Deuterium Experiments 
 





  Regular Spectra     Deuterium Incorpoation Spectra 
       C2: 1.00           C2: 0.67 
       C7: 0.96           C7: 0.91 
 
Deuterium incorporation at C2 = 33% 








3a - Mono 
 
  Regular Spectra               Deuterium Incorporation Spectra 
        C-2: 1.00        C-2: 0.66 
        C-7: 0.95        C-7: 0.94 
 
Deuterium incorporation at C-2 = 34% 








4a - Di 
 
  Regular Spectra   Deuterium Incorporation Spectra 
        C-2: 1.00        C-2: 0.61 
        C-7: 0.96        C-7: 0.94 
 
Deuterium incorporation at C-2 = 39% 




6.3.7: Organometallic Work 
 




To an oven dried Schlenk flask was added [RuCl2(p-cymene)]2 (0.239 g, 0.39 mmol), 1a 
(0.150 g, 0.77 mmol) and potassium acetate (0.153 g, 1.56 mmol). The flask was evacuated 
and refilled with argon three times. Anhydrous methanol (5 mL) was then added via septum 
and the reaction mixture was stirred at 40 °C for 24 h. The mixture was filtered under a 
blanket of N2, eluting with anhydrous methanol. The filtrate was then kept in the freezer for 
7 days. The deep red crystals that formed in the filtrate were collected via vacuum filtration, 
giving 1a-[Ru]-OAc, 32% (0.120 g). 1H NMR (500 MHz, CDCl3) δ 9.10 (1H, dd, J = 5.6, 2.3 
Hz), 8.61 (1H, dd, J = 4.6, 2.3 Hz), 8.37 (1H, dq, J = 8.0, 0.9 Hz), 7.40 (1H, ddd, J = 7.7, 
1.2, 0.7 Hz), 7.19–7.09 (1H, m), 7.03 (1H, ddd, J = 8.3, 7.2, 1.2 Hz), 6.89–6.81 (2H, m), 
5.72 (1H, dd, J = 6.0, 1.2 Hz), 5.54 (1H, dd, J = 6.0, 1.2 Hz), 5.28 (1H, dd, J = 6.0, 1.2 Hz), 
5.12 (1H, dd, J = 6.0, 1.2 Hz), 3.47 (3H, s), AcH), 2.62 (1H, hept, J = 6.9 Hz), CH(CH3)2), 
2.07 (3H, s), ArCH3), 1.11 (3H, d, J = 7.0 Hz), CH(CH3)2), 0.97 (3H, d, J = 6.9 Hz), 
CH(CH3)2). 13C NMR (126 MHz, CDCl3) δ 165.59 (C=O), 162.47, 158.97, 136.45, 135.09, 
122.55, 120.29, 117.67, 113.71, 113.65, 113.32, 103.17, 101.27, 89.67, 88.80, 83.29, 
82.77, 50.84 (AcCH3), 30.67 (CH(CH3)2), 22.74 (ArCH3), 21.73 (CH(CH3)2), 18.75 
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6.4: Data and Supporting Information for “Ruthenium-Catalyzed Remote C4-
Functionalization of Carbazoles via σ-Activation” 
 
In the interest of presentation in a thesis, NMR spectra and crystallography data have not 
been included. However, in the interest of the reader these are available online at: 
http://www.rsc.org/suppdata/c7/cc/c7cc07606a/c7cc07606a1.pdf 
The supporting information has also been submitted to formatting and colour changes, 




Proton, carbon and fluorine NMR spectra were recorded on Bruker 300 MHz, or Agilent 
Technologies 500 MHz, spectrometer (1H NMR at 500 MHz, or 300 MHz, 13C NMR at 126 
MHz, or 75 MHz, and 19F NMR at 470 MHz. Chemical shifts for protons are reported in parts 
per million downfield from Si(CH3)4 and are referenced to residual protium in the deuterated 
solvent (CHCl3 at 7.26 ppm, or CH3OH at 3.31 & 4.87 depending on solvent used). Chemical 
shifts for fluorines are reported in parts per million downfield from CFCl3. NMR data are 
presented in the following format: chemical shift (number of equivalent nuclei by integration, 
multiplicity [app = apparent, br = broad, d = doublet, t = triplet, q = quartet, dd = doublet of 
doublets), dt = doublet of triplets), dq = doublet of quartets), ddd = doublet of doublet of 
doublets), m = multiplet], coupling constant [in Hz], assignment). Electrospray ionisation 
ultrahigh resolution time-of-flight mass spectrometry (ESI–UHR–TOF–MS) was performed 
on a Bruker maXis mass spectrometer. Electrospray ionisation high resolution time-of-flight 
mass spectrometry (ESI–HR–TOF–MS) was performed on a Bruker micrOTOF 
spectrometer. Infrared (IR) spectra were recorded on a Perkin–Elmer 1600 FT (Fourier 
transform), IR spectrophotometer, with absorbencies quoted as wavelength (ν [in cm−1]). 
Melting points were obtained on a Bibby Sterilin SMP10 melting point machine and are 
uncorrected. 
Analytical thin-layer chromatography (TLC) was performed on aluminium-backed plates 
coated with Alugram® SIL G/UV254 purchased from Macherey–Nagel and visualised with 
UV light (254 or 365 nm), and/or KMnO4, 2,4-DNPH or I2/Silica staining. Silica gel column 
chromatography was performed using 60 Å, 200-400 mesh particle size silica gel purchased 
from Sigma–Aldrich. Samples were loaded as saturated solutions in an appropriate solvent 
system. 
All reactions were performed using reagents obtained from Sigma-Aldrich, Acros Organics, 
Alfa Aesar, Fluorochem chemicals without further purification unless stated. [RuCl2(p-
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cymene)]2 was purchased from STREM chemicals or Acros Organics. All water used was 
purified through a Merck Millipore reverse osmosis purification system prior to use. 
Anhydrous solvents were dried and degassed by passing through anhydrous alumina 
columns using an Innovative Technology Inc. PS-400-7 solvent purification system (SPS) 
and stored under an atmosphere of N2 prior to use. 
Reactions were performed in oven-dried glassware and under a blanket of N2 if not stated.  
 










Entry Base Acid Acid eq Solvent C4 % (IY) 
1 KOAc - - 1,4-dioxane 53 
2 KOAc AcOH 2 1,4-dioxane 68 (48) 
3 K2CO3 (+ MesCO2H 30%) - - 1,4-dioxane 7 
4 K2CO3 (+ Piv-Val-OH 30%) - - 1,4-dioxane 7 
5 K2CO3 AcOH 2 1,4-dioxane - 
6 K3Citrate AcOH 2 1.4-dioxane 45 
7 K2Oxalate AcOH 2 1,4-dioxane - 
8 K2Tartrate AcOH 2 1,4-dioxane 56 
9 KO2CH AcOH 2 1,4-dioxane 25 
10 - Piv-Val-OH 2 1,4-dioxane Trace 
11 AdCO2Na AcOH 2 1,4-dioxane 58 
12 MesCO2K AcOH 2 1,4-dioxane 80 (61) 
13 MesCO2K MesCO2H 2 1,4-dioxane 64 
14 MesCO2K AdCO2H 2 1,4-dioxane 66 
15 MesCO2K TFA 2 1,4-dioxane 15 
16 MesCO2K HO2CH 2 1,4-dioxane 34 
17 MesCO2K conc. HCl(aq) 2 1,4-dioxane 17 
18 MesCO2K AcOH 2 2-MeTHF 55 
19 MesCO2K AcOH 2 PhMe - 
20 MesCO2K AcOH 2 MeCN 72 
21 MesCO2K AcOH 2 C6H6 39 
22 MesCO2K AcOH 2 2-butanone 55 
23 MesCO2K AcOH 2 AcOH 31 
24 MesCO2K AcOH 2 DCE 38 
25 MesCO2K AcOH 2 DME 49 
26 MesCO2K AcOH 0.5 1,4-dioxane 80 
27 MesCO2K AcOH 1 1,4-dioxane 84 (68) 
28 MesCO2K AcOH 4 1,4-dioxane 68 
29a MesCO2K AcOH 1 1,4-dioxane 61 
30b MesCO2K AcOH 1 1,4-dioxane 76 
31c MesCO2K AcOH 1 1,4-dioxane - 
32d MesCO2K AcOH 1 1,4-dioxane 90 (76) 
General Conditions: 5CP-A (0.25-0.5 mmol), methyl α-bromoisobutyrate (0.75-1.5 mmol), [RuCl2(p-cymene)]2 (5 mol%, 
0.0125-0.025 mmol), solvent (1-2 mL), 120 °C, 16 h. a : Reaction carried out at 100 °C. b : Reaction carried out under air. c : 
Without [RuCl2(p-cymene)]2. 






We carried out further experiments to elucidate whether secondary and primary alkyl esters 
were amenable to the reaction methodology. Unfortunately, on using both the chloro and 
bromo ester coupling partners, no conversion to any product was observed. 
 





We were intrigued to investigate whether carbazole templates could be applied to other σ-
activation protocols. To that end, we identified meta-sulfonation and meta-bromination 
methodologies as potentially the most amenable to this template. Unfortunately using the 
original conditions, the carbazole conditions from this report, and amalgamations, no C4-
functionalised products were observed. 
 













6.4.3: Synthesis of Starting Materials 
 




To a stirred solution of 9H-carbazole (1.67 g, 10 mmol) in DMF (10 mL) was added sodium 
hydride (60% wt. in mineral oil, 0.43 g, 11 mmol) at 0 °C. The reaction mixture was stirred 
at 0 °C for 1 hour. The reaction mixture was allowed to return to room temperature and 2-
chloropyrimidine (1.38 g, 12 mmol) was added. The reaction mixture was heated to 150 °C 
overnight. After returning to room temperature the solution was poured into a separating 
funnel containing brine (150 mL). EtOAc (150 mL) was added and the organics were 
extracted. The resulting aqueous mixture was reextracted with EtOAc (2 x 150 mL). The 
combined organics were dried over MgSO4 and concentrated in vacuo. The crude residue 
was purified via silica gel column chromatography (EtOAc:Petroleum Spirit 40-60 °C, 10:90 
v:v) to give a white powdery solid, 1a, 32% (790 mg). 1H NMR (500 MHz, CDCl3) δ 8.93–
8.80 (4H, m, ArH), 8.21–7.76 (2H, m, ArH), 7.51 (2H, ddd, J = 8.5, 7.2, 1.3 Hz, ArH), 7.38 
(2H, ddd, J = 8.1, 7.2, 1.0 Hz, ArH), 7.13 (1H, t, J = 4.7 Hz, ArH). 13C NMR (126 MHz, 
CDCl3) δ 159.3 (ArC), 158.0 (ArC), 139.3 (ArC), 126.7 (ArC), 125.9 (ArC), 122.4 (ArC), 








To a solution of 9H-carbazole (4 g, 24 mmol) in CH2Cl2 (75 mL) was added N-
bromosuccinimide (4.25 g, 24 mmol) in DMF (8 mL) dropwise at room temperature. The 
reaction mixture was stirred for 4 hours before H2O (100 mL) was added. The organic phase 
extracted, dried over MgSO4, and concentrated in vacuo. The crude residue was purified 
via recrystallization from EtOH to give a crystalline white solid, 55% (3.26 g). 1H NMR (500 
MHz, DMSO-d6) δ 11.43 (1H, s, NH), 8.35 (1H, dd, J = 2.0, 0.6 Hz, ArH), 8.16 (1H, dt, J = 
7.9, 1.1 Hz, ArH), 7.53–7.45 (3H, m, ArH), 7.42 (1H, ddd, J = 8.2, 7.1, 1.2 Hz, ArH), 7.17 
(1H,ddd, J = 8.0, 7.1, 1.0 Hz, ArH). 13C NMR (126 MHz, DMSO-d6) δ 140.1 (ArC), 138.4 
(ArC), 127.8 (ArC), 126.3 (ArC), 124.4 (ArC), 122.7 (ArC), 121.4 (ArC), 120.7 (ArC), 118.9 









To a solution of 9H-carbazole (2 g, 12 mmol) in CH2Cl2 (20 mL) was added SO2Cl2 (1.0 mL, 
800 mg, 12 mmol) dropwise at 0 °C. After addition was complete the reaction mixture was 
allowed to return to room temperature and stir overnight. The mixture was then diluted in 
CH2Cl2 (80 mL) and sat. NaHCO3 solution (100 mL). The organic layer was separated and 
washed with aq. NaHSO3 solution (100 mL), and brine (100 mL). The organic phase was 
dried over MgSO4 and concentrated in vacuo. The crude residue was purified via silica gel 
column chromatography (EtOAc:Petroleum Spirit 40-60 °C, 10:90 v:v) to give mono-
chlorinated product as a powdery white solid, 37% (900 mg). 1H NMR (500 MHz, DMSO-
d6) δ 11.41 (1H, s, NH), 8.22 (1H, d, J = 2.1 Hz, ArH), 8.16 (1H, d, J = 7.8 Hz, ArH), 7.50 
(2H, dd, J = 8.4, 2.2 Hz, ArH), 7.44–7.37 (2H, m, ArH), 7.21–7.11 (1H, m, ArH). 13C NMR 
(126 MHz, DMSO-d6) δ 140.3 (ArC), 138.1 (ArC), 126.3 (ArC), 125.2 (ArC), 123.7 (ArC), 
122.8 (ArC), 121.5 (ArC), 120.7 (ArC), 119.7 (ArC), 118.8 (ArC), 112.4 (ArC), 111.2 (ArC). 










To a solution of 9H-carbazole (4 g, 24 mmol) in CH2Cl2 (40 mL) was added SO2Cl2 (4.0 mL, 
6.4 g, 48 mmol) dropwise at 0 °C. After addition was complete the reaction mixture was 
allowed to return to room temperature and stir overnight. A further portion of SO2Cl2 (2.0 
mL, 3.2 g, 24 mmol) was added at room temperature and allowed to stir for a further 4 
hours. The mixture was then diluted in CH2Cl2 (80 mL) and sat. NaHCO3 solution (200 mL). 
The organic layer was separated and washed with aq. NaHSO3 solution (200 mL), and brine 
(200 mL). The organic phase was dried over MgSO4 and concentrated in vacuo. The crude 
residue was purified via silica gel column chromatography (EtOAc:Petroleum Spirit 40-60 
°C, 10:90 v:v) to give di-chlorinated product as a powdery white solid, 42% (2.7 g). 1H NMR 
(500 MHz, DMSO-d6) δ 11.91 (1H, s, NH), 8.32 (2H, dd, J = 8.1, 2.0 Hz, ArH), 7.61 (1H, d, 
J = 1.9 Hz, ArH), 7.56 (1H, d, J = 8.6 Hz, ArH), 7.48 (1H, dd, J = 8.7, 2.1 Hz, ArH). 13C NMR 
(126 MHz, DMSO-d6) δ 138.9 (ArC), 135.9 (ArC), 127.0 (ArC), 125.0 (ArC), 124.1 (ArC), 
124.0 (ArC), 123.3 (ArC), 123.0 (ArC), 120.8 (ArC), 119.5 (ArC), 116.1 (ArC), 113.3 (ArC). 









To an oven-dried carousel tube was charged relevant carbazole derivative (2 mmol), copper 
iodide (38 mg, 0.2 mmol, 20 mol%), caesium carbonate (1.3 g, 4 mmol) and 2-
iodopyrimidine (824 mg, 4 mmol). The tube was sealed with a Teflon cap and anhydrous 
DMF (6 mL) was added via syringe. The reaction mixture was heated to 100 °C for 16 h. 
After this time the reaction mixture was allowed to return to room temperature. The mixture 
was diluted in EtOAc and filtered through a plug of celite, eluting with EtOAc. The filtrate 
was then concentrated in vacuo. The resulting crude residue was purified via silica gel 
column chromatography (EtOAc:Petroleum Spirit 40-60 °C, 10:90 v:v) to give desired 
arylated carbazole derivative. Note: The efficiency of this Ullmann reaction is directly 
affected by the quality of the 2-iodopyrimidine. 
 




General Procedure A was followed using 3-bromo-9H-carbazole (492 mg, 2 mmol). Silica 
gel column chromatography gave a powdery white solid, 34% (220 mg). mp (from CHCl3): 
167-170 °C. FT-IR (thin film): νmax (cm-1) = 1581.7, 1558.2. 1H NMR (500 MHz, DMSO-d6) 
δ 8.96 (2H, d, J = 4.8 Hz, ArH), 8.77 (1H, d, J = 8.5 Hz, ArH), 8.70 (1H, d, J = 8.9 Hz, ArH), 
8.45 (1H, d, J = 2.1 Hz, ArH), 8.25 (1H, d, J = 7.7 Hz, ArH), 7.62 (1H, dd, J = 8.9, 2.1 Hz, 
ArH), 7.53 (1H, ddd, J = 8.4, 7.2, 1.3 Hz, ArH), 7.43–7.34 (2H, m, ArH). 13C NMR (126 MHz, 
DMSO-d6) δ 158.6 (ArC), 157.9 (ArC), 138.7 (ArC), 137.1 (ArC), 129.0 (ArC), 127.4 (ArC), 
127.0 (ArC), 123.7 (ArC), 122.5 (ArC), 122.5 (ArC), 120.4 (ArC), 117.9 (ArC), 117.2 (ArC), 
116.1 (ArC), 114.60 (ArC). HRMS (ESI): m/z calculated for C16H10Br1N3 requires 345.9950 
for [M+Na]+, found 345.9968. 
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General Procedure A was followed using 3-chloro-9H-carbazole (403 mg, 2 mmol). Silica 
gel column chromatography gave a powdery white solid, 88% (492 mg). mp (from CHCl3): 
156-159 °C. FT-IR (thin film): νmax (cm-1) = 2980.9, 1582.9, 1558.1. 1H NMR (500 MHz, 
DMSO-d6) δ 8.98 (2H, d, J = 4.8 Hz, ArH), 8.78 (2H, dd, J = 8.7, 7.4 Hz, ArH), 8.34 (1H, d, 
J = 2.2 Hz, ArH), 8.30–8.25 (1H, m, ArH), 7.61–7.49 (2H, m, ArH), 7.47–7.33 (2H, m, ArH). 
13C NMR (126 MHz, DMSO-d6) δ 158.7 (ArC), 157.9 (ArC), 138.8 (ArC), 136.8 (ArC), 127.5 
(ArC), 126.7 (ArC), 126.5 (ArC), 126.3 (ArC), 123.9 (ArC), 122.6 (ArC), 120.4 (ArC), 119.6 
(ArC), 117.5 (ArC), 117.3 (ArC), 116.2 (ArC). HRMS (ESI): m/z calculated for C16H10N3Cl1 
requires 280.0636 for [M+H]+, found 280.0652. 
 




General Procedure A was followed using 1,3,6-trichloro-9H-carbazole (540 mg, 2 mmol). 
Silica gel column chromatography gave a powdery white solid, 41% (289 mg). mp (from 
CHCl3): 175-179 °C. FT-IR (thin film): νmax (cm-1) = 2981.1, 1565.3. 1H NMR (500 MHz, 
CDCl3) δ 8.90 (2H, d, J = 4.8 Hz, ArH), 7.94 (1H, dd, J = 19.7, 2.0 Hz, ArH), 7.88 (1H, d, J 
= 8.8 Hz, ArH), 7.48 (1H,d, J = 1.9 Hz, ArH), 7.42 (1H, dd, J = 8.8, 2.1 Hz, ArH), 7.33 (1H, 
t, J = 4.8 Hz, ArH). 13C NMR (126 MHz,CDCl3) δ 158.7 (ArC), 157.3 (ArC), 140.4 (ArC), 
135.7 (ArC), 128.5 (ArC), 128.3 (ArC), 128.12 (ArC), 128.08 (ArC), 127.9 (ArC), 124.9 
(ArC), 120.3 (ArC), 120.2 (ArC), 119.1 (ArC), 118.9 (ArC), 113.8 (ArC). HRMS (ESI): m/z 









To a solution of 9H-carbazole (3 g, 18 mmol) in toluene (20 mL) was added sodium 
hydroxide (12 M in H2O, 23 mL) and the reaction mixture allowed to stir at room temperature 
for 10 mins. After this time, tetebutylammonium iodide (650 mg, cat.) and subsequently 
benzyl bromide (2.6 mL, 3.69 g, 21.6 mmol) were added in one portion. The reaction mixture 
was left to stir overnight. The organic and aqueous phases were then separated and 
aqueous layer re-extracted with CH2Cl2 (2 x 50 mL). The combined organics were dried 
over MgSO4 and concentrated in vacuo. The crude residue was purified via recrystallization 
from EtOH to give a crystalline white solid, 81% (3.76 g). 1H NMR (500 MHz, CDCl3) δ 8.15 
(2H, dt, J = 7.8, 1.0 Hz, ArH), 7.44 (2H, ddd, J = 8.3, 7.1, 1.2 Hz, ArH), 7.38 (2H, dt, J = 8.2, 
0.9 Hz, ArH), 7.31–7.23 (4H, m, ArH), 7.16 (2H, ddd, J = 7.6, 2.0, 1.0 Hz, ArH), 5.52 (2H, 
s, CH2Ph). 13C NMR (126 MHz, CDCl3) δ 140.8 (ArC), 137.3 (ArC), 128.9 (ArC), 127.6 (ArC), 
126.5 (ArC), 126.0 (ArC), 123.2 (ArC), 120.5 (ArC), 119.3 (ArC), 109.0 (ArC), 46.68 









To a stirred solution of 9H-carbazole (1.67 g, 10 mmol), triethylamine (2.1 mL, 1.52 g, 15 
mmol), and N’,N’-dimethylaminopyridine (DMAP, 122 mg, 1 mmol) in anhydrous CH2Cl2 (30 
mL) was added trimethylacetyl chloride (pivaloyl chloride, 1.5 mL, 1.45 g, 12 mmol) 
dropwise at 0 °C. After addition was complete, the reaction mixture was allowed to return 
to room temperature and stirred overnight. The reaction mixture was concentrate in vacuo, 
and the resulting residue was partitioned between EtOAc (100 mL) and brine (100 mL). The 
organic layer was extracted and the aqueous phase was re-extracted with EtOAc (2 x 100 
mL). The combined organics were dried over MgSO4 and concentrated in vacuo. The 
resulting residue was purified via silica gel column chromatography (EtOAc:Petroleum 
Spirit, 5:95 v:v) to give (on standing at 4 °C overnight) a crystalline white solid, 65% (1.62 
g). 1H NMR (500 MHz, CDCl3) δ 8.04 (2H, dd, J = 7.6, 1.4 Hz, ArH), 7.75–7.63 (2H, m, ArH), 
7.45 (2H, ddq, J = 8.3, 7.1, 1.3 Hz, ArH), 7.37–7.29 (2H, m, ArH), 1.54 (6H, app d, PivH). 
13C NMR (126 MHz, CDCl3) δ 184.2 (COtBu), 139.4 (ArC), 126.5 (ArC), 124.9 (ArC), 122.0 










To an oven dried carousel tube was charged N-(2-bromophenyl)pyrimidin-2-amine (62.5 
mg, 0.25 mmol), palladium(II) acetate (5.6 mg, 0.025 mmol), lithium chloride (1.1 mg, 0.025 
mmol) and sodium carbonate (132 mg, 1.25 mmol). The reactor tube was evacuated and 
refilled with argon three times. Dimethylformamide (1 mL) and hex-3-yne (0.085 mL, 0.75 
mmol) were then added via septum. The vessel was heated to 100 oC for 16 hours. Then 
the reaction mixture was cooled to room temperature, and EtOAc and 5 % LiCl solution 
(100 mL) were added. The organic layer was separated and the aqueous was washed with 
further EtOAc (3 × 100 mL). The organic layer was dried over MgSO4 and the solvents were 
removed under vacuum. The resulting residue was purified by silica gel column 
chromatography (EtOAc:Petroleum Ether 40-60 °C, 5:95 v:v) to give  as an orange oil in 56 
% yield (35 mg). FT-IR: (thin film): νmax (cm-1) = 3044, 2963, 2929, 2871, 2160, 2008, 1694, 
1560, 1455, 1422. 1H NMR: (500 MHz, CDCl3) δ 8.79 (2H, d, J = 4.8 Hz, ArH), 8.22 (1H, d, 
J = 7.1 Hz, ArH), 7.54 (1H, d, J = 6.7 Hz, ArH), 7.24–7.16 (2H, m, ArH), 7.12 (1H, t, J = 4.8 
Hz, ArH), 3.19 (2H, q, J = 7.4 Hz, CH2CH3), 2.78 (2H, q, J = 7.6 Hz, CH2CH3), 1.28 (3H, t, 
J = 7.5 Hz, CH2CH3), 1.11 (3H, t, J = 7.4 Hz, CH2CH3). 13C NMR: (126 MHz, CDCl3) δ 165.8 
(ArC), 158.1 (ArC), 138.3 (ArC), 136.4 (ArC), 129.6 (ArC), 122.5 (ArC), 121.3 (ArC), 118.8 
(ArC), 118.0 (ArC), 116.7 (ArC), 113.5 (ArC), 19.3 (CH2CH3) , 17.4 (CH2CH3), 15.4 
(CH2CH3), 15.0 (CH2CH3). HRMS: (ESI): m/z calculated for C16H17N4 required 274.1315 for 








To a solution of indoline (0.56 mL, 5 mmol) and 2-chloropyrimidine (0.69 g, 5 mmol) in EtOH 
(40 mL) and water (20 mL) was added conc. HCl (1 mL). The reaction mixture was then 
refluxed overnight. The EtOH and water were then removed in vacuo. The crude residue 
was partitioned between water (100 mL) and CH2Cl2 (100 mL) and the organic layer 
extracted. The aqueous layer was re-extracted with CH2Cl2 (2 x 100 mL). The combined 
organic phases were dried over MgSO4 and concentrated in vacuo. The crude residue was 
purified via silica gel column chromatography to give a bronze oil, 65% (0.632 g). FT-IR 
(thin film): νmax (cm-1) = 3041.9, 2955.9, 1557.0, 1548.0. 1H NMR (500 MHz, CDCl3) δ 8.49 
(2H, d, J = 4.7 Hz, ArH), 8.40 (1H, d, J = 8.1 Hz, ArH), 7.25–7.18 (2H, m, ArH), 6.94 (1H, 
td, J = 7.4, 1.1 Hz, ArH), 6.68 (1H, t, J = 4.8 Hz, ArH), 4.24 (2H, dd, J = 9.2, 8.2 Hz, CH2), 
3.31–3.13 (2H, m, CH2). 13C NMR (126 MHz, CDCl3) δ 157.57 (ArC), 143.74 (ArC), 132.31 
(ArC), 127.38 (ArC), 124.74 (ArC), 121.63 (ArC), 115.46 (ArC), 111.52 (ArC), 48.87 (CH2), 








6.4.4: Synthesis of C4-Functionalized Carbazoles 
 




To an oven dried carousel tube was charged with relevant carbazole derivative (0.25 mmol), 
[RuCl2(p-cymene)]2 (8 mg, 0.0125 mmol, 5 mol%) or [Ru(O2CMes)2(p-cymene)] (14 mg, 
0.025 mmol, 10 mol%), and potassium 2,4,6-trimethylbenzoate (MesCO2K, 102 mg, 0.5 
mmol). The reaction vessel was then sealed with a Teflon cap, and then evacuated and 
refilled with Argon three times. 1,4-dioxane (1 mL), acetic acid (0.015 mL, 15 mg, 0.25 
mmol) and relevant coupling partner (0.75 mmol) were added via syringe. The flask was 
then heated at 120 °C for 16 h. The reaction mixture was allowed to return to room 
temperature and was then diluted in EtOAc (20 mL) and sat. NaHCO3 solution (20 mL). The 
organic layer was extracted and the aqueous layer was re-extracted with EtOAc (2 x 20 
mL). The combined organics were dried over MgSO4 and concentrated in vacuo. The crude 
residue was then purified via silica gel column chromatography (EtOAc:Petroleum Spirit 40-








General Procedure B was followed using 1a (61 mg, 0.25 mmol) and ethyl α-
bromoisobutyrate (0.12 mL, 146 mg, 0.75 mmol). Silica gel column chromatography gave 
a white solid. [RuCl2(p-cymene)]2 as catalyst: 68% (61 mg). [Ru(O2CMes)2(p-cymene)] as 
catalyst: 76% (68 mg). mp (from CHCl3): 127-129 oC. mp (from CHCl3): 130-133 °C. FT-IR: 
(thin film): νmax (cm-1) = 3040, 2983, 2874, 2164, 1725, 1580, 1564, 1427. 1H NMR: (500 
MHz, CDCl3) δ 8.87 (2H, d, J = 4.78 Hz, ArH), 8.69 (2H, d, J = 8.37 Hz, ArH), 8.02 (1H, d, 
J = 8.11 Hz, ArH), 7.46 (3H, m, ArH), 7.32 (1H, t, J = 7.63 Hz, ArH), 7.17 (1H, t, J = 4.77 
Hz, ArH), 4.04 (2H, q, J = 7.10 Hz, CO2CH2CH3), 1.88 (6H, s, C(CH3)2), 0.95 (3H, t, J = 7.11 
Hz, CO2CH2CH3). 13C NMR: (126 MHz, CDCl3) δ 178.3 (CO2Et), 158.7 (ArC), 158.0 (ArC), 
140.0 (ArC), 139.5 (ArC), 139.0 (ArC), 126.0 (ArC), 125.7 (ArC), 124.5 (ArC), 123.5 (ArC), 
123.2 (ArC), 121.8 (ArC), 119.5 (ArC), 116.7 (ArC), 114.4 (ArC), 113.7 (ArC), 61.1 
(CO2CH2CH3), 47.0 (C(CH3)2), 27.0 (C(CH3)2), 13.9 (CO2CH2CH3). HRMS: (ESI): found m/z 
calculated for C22H21N3O2 required 360.1707 for [M+H]+, found 360.1715. 
 




General Procedure B was followed using 1a (61 mg, 0.25 mmol) and methyl α-
bromoisobutyrate (0.10 mL, 136 mg, 0.75 mmol). Silica gel column chromatography gave 
a white solid, [RuCl2(p-cymene)]2 as catalyst: 70% (60 mg). [Ru(O2CMes)2(p-cymene)] as 
catalyst: 65% (56 mg). FT-IR (thin film): νmax (cm-1) = 2981.1, 1726.1, 1561.3. mp (from 
CHCl3): 162-165 °C. 1H NMR (500 MHz, CDCl3) δ 8.85 (2H, d, J = 4.8 Hz, ArH), 8.74–8.66 
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(2H, m, ArH), 7.54–7.45 (1H, m, ArH), 7.45–7.41 (2H, m, ArH), 7.38–7.32 (1H, m, ArH), 
7.14 (1H, t, J = 4.8 Hz, ArH), 3.53 (3H, s, CO2CH3), 1.91 (6H, s, C(CH3)2). 13C NMR (126 
MHz, CDCl3) δ 179.1 (CO2Me), 158.8 (ArC), 158.2 (ArC), 140.1 (ArC), 139.5 (ArC), 139.1 
(ArC), 126.1 (ArC), 125.9 (ArC), 124.6 (ArC), 123.3 (ArC), 123.2 (ArC), 122.1 (ArC), 119.5 
(ArC), 116.9 (ArC), 114.6 (ArC), 114.0 (ArC), 52.65 (CO2CH3), 47.1 (C(CH3)2), 27.2 
(C(CH3)2). HRMS (ESI): m/z calculated for C21H19N3O2 requires 346.1550 for [M+H]+, found 
346.1583. 
 




General Procedure B was followed using 1a (61 mg, 0.25 mmol) and tert-butyl α-
bromoisobutyrate (0.14 mL, 167 mg, 0.75 mmol). Silica gel column chromatography gave 
a white solid, [RuCl2(p-cymene)]2 as catalyst: 72% (69 mg). [Ru(O2CMes)2(p-cymene)] as 
catalyst: 92% (89 mg). mp (from CHCl3): 180-183 °C. FT-IR (thin film): νmax (cm-1) = 2980.8, 
1717.2, 1561.2 1H NMR (500 MHz, CDCl3) δ 8.84 (2H, d, J = 4.8 Hz, ArH), 8.72–8.63 (2H, 
m, ArH), 8.18–8.15 (1H, m, ArH), 7.50–7.43 (1H, m, ArH), 7.40 (1H, dd, J = 7.7, 1.0 Hz, 
ArH), 7.36–7.31 (1H, m, ArH), 7.13 (1H, t, J = 4.8 Hz, ArH), 1.86 (6H, s, C(CH3)2), 1.27 (9H, 
s, C(CH3)3). 13C NMR (126 MHz, CDCl3) δ 177.2 (CO2R), 158.8 (ArC), 158.1 (ArC), 140.1 
(ArC), 140.1 (ArC), 139.1 (ArC), 126.0 (ArC), 125.8 (ArC), 124.6 (ArC), 124.5 (ArC), 123.3 
(ArC), 121.7 (ArC), 119.7 (ArC), 116.7 (ArC), 114.4 (ArC), 113.6 (ArC), 80.9 (AlkC), 47.8 
(AlkC) , 27.8 (AlkC), 26.9 (AlkC). HRMS (ESI): m/z calculated for C24H25N3O2 requires 









General Procedure B was followed using 1a (61 mg, 0.25 mmol) and benzyl α-
bromoisobutyrate (0.13 mL, 178 mg, 0.75 mmol). Silica gel column chromatography gave 
a white solid, [RuCl2(p-cymene)]2 as catalyst: 51% (54 mg). [Ru(O2CMes)2(p-cymene)] as 
catalyst: 74% (78 mg). mp (from CHCl3): 112-116 oC. FTIR (thin film): νmax = 2968, 1718, 
1583, 1563. 1H NMR (500 MHz, CDCl3): δ 8.88 (2H, d, J = 4.8 Hz, ArH), 8.69 (2H, dd, J = 
8.3, 1.1 Hz, ArH), 7.96 (1H, ddd, J = 8.2, 1.2, 0.6 Hz, ArH), 7.48 (1H, dd, J = 8.4, 7.6 Hz, 
ArH), 7.43-7.40 (2H, m, ArH), 7.22-7.15 (5H, m, ArH), 7.02-6.99 (2H, m, ArH), 5.02 (2H, s, 
CH2Ph), 1.90 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3): δ 178.4 (CO2Bn), 163.5 (ArC), 
158.4  (ArC), 139.6 (ArC), 139.1 (ArC), 128.6  (ArC), 128.2  (ArC), 126.4  (ArC), 126.0 (ArC), 
125.9 (ArC), 124.8 (ArC), 123.6 (ArC), 123.5 (ArC), 122.3 (ArC), 119.9 (ArC), 117.1  (ArC), 
114.8 (ArC), 114.2 (ArC), 67.2 CO2CH2Ph), 47.4 (C(CH3)2), 27.4 (C(CH3)2). HRMS (ESI): 
m/z calculated for C27H23N3O2 requires 422.1870 for [M+H]+ found 422.1943.  
 




General Procedure B was followed using 1a (61 mg, 0.25 mmol) and cyclohexyl α-
bromoisobutyrate (147 mg, 0.75 mmol). Silica gel column chromatography gave an 
amorphous solid, [RuCl2(p-cymene)]2 as catalyst: 54% (56 mg). [Ru(O2CMes)2(p-cymene)] 
as catalyst: 74% (76 mg). FTIR (thin film): νmax = 2929, 2855, 1718, 1570. 1H NMR (500 
MHz, CDCl3): δ 8.88 (2H, d, J = 4.8 Hz,ArH), 8.68 (2H, ddd, J = 8.4, 3.4, 1.0 Hz, ArH), 8.05 
(1H, dd, J = 8.2, 1.1 Hz, ArH), 7.49-7.44 (2H, m, ArH), 7.43-7.39 (1H, m, ArH), 7.30 (1H, 
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ddd, J = 8.2, 7.2, 1.1 Hz, ArH), 7.14 (1H, m, ArH), 4.81-4.73 (1H, m, CO2CH), 1.87 (6H, s, 
C(CH3)2), 1.56 (3H, broad s, CyH), 1.45-1.32 (3H, m, CyH), 1.22-1.00 (4H, m, CyH). 13C 
NMR (126 MHz, CDCl3): δ 178.2 (CO2Cy), 163.3 (ArC), 158.2 (ArC), 139.4 (ArC), 135.9 
(ArC), 128.4 (ArC), 128.0 (ArC), 126.2 (ArC), 125.8 (ArC), 124.6 (ArC), 123.4  (ArC), 122.1 
(ArC), 119.7 (ArC), 116.9 (ArC), 114.6 (ArC), 114.0 (ArC), 67.0 (CO2CH), 47.2 (C(CH3)2), 
27.2 (C(CH3)2), 27.1 (CyC), 25.3  (CyC), 24.6  (CyC). HRMS (ESI): m/z calculated for 
C26H27N3O2 requires 436.1995 for [M+Na]+ found 436.2027.  
 




General Procedure B was followed using 1a (61 mg, 0.25 mmol) and methyl 1-
bromocyclohexane-1-carboxylate (0.12 mL, 166 mg, 0.75 mmol). Silica gel column 
chromatography gave a white solid, [RuCl2(p-cymene)]2 as catalyst: 35% (34 mg). 
[Ru(O2CMes)2(p-cymene)] as catalyst: 42% (40 mg). mp (from CHCl3): 182-185 °C. FTIR 
(thin film): νmax = 2955, 2932, 2362, 2165, 2034, 1718, 1560. 1H NMR (500 MHz, CDCl3): δ 
8.89 (d, J = 4.8 Hz, 2H), 8.66–8.61 (2H, m, ArH), 8.10–8.06 (1H, m, ArH), 7.52–7.46 (2H, 
m, ArH), 7.45 (1H, ddd, J = 8.4, 7.1, 1.2 Hz, ArH), 7.45 (1H, ddd, J = 8.3, 7.1, 1.2 Hz, ArH), 
7.20 (1H, t, J = 4.8 Hz, ArH), 3.49 (3H, s, CO2CH3), 2.48 (5H, s, CyH), 1.81 (3H, s, CyH), 
1.26 (2H, s, CyH). 13C NMR (126 MHz, CDCl3) δ 178.6 (CO2Me), 158.3 (ArC), 140.5 (ArC), 
139.1 (ArC), 138.5 (ArC), 125.9 (ArC), 125.8 (ArC), 124.7 (ArC), 124.2 (ArC), 123.4 (ArC), 
122.0 (ArC), 121.9 (ArC), 117.0 (ArC), 114.3 (ArC), 113.5 (ArC), 52.5 (CO2CH3), 50.9 
(C(Cy)), 34.0 (CyC), 25.9 (CyC), 22.8 (CyC). HRMS (ESI): m/z calculated for C24H23N3O2 








General Procedure B was followed using 1a (61 mg, 0.25 mmol) and 
(perfluorophenyl)methyl-2-bromo-2-methylpropanoate (260 mg, 0.75 mmol),. Silica gel 
column chromatography gave a white solid, [RuCl2(p-cymene)]2 as catalyst: 41% (52 mg). 
[Ru(O2CMes)2(p-cymene)] as catalyst: 39% (50 mg). mp (from CHCl3): 165-168 oC. FTIR 
(thin film): νmax = 2959, 1742, 1661, 1570, 1509. 1H NMR (500 MHz, CDCl3): δ 8.88 (2H, d, 
J = 4.8 Hz, ArH), 8.69 (2H, dd, J = 10.8, 8.4 Hz, ArH), 7.78 (1H, d, J = 8.1 Hz, ArH), 7.49 
(1H, t, J = 8.0 Hz, ArH), 7.43-7.38 (2H, m, ArH), 7.18 (1H, t, J = 4.8 Hz, ArH), 7.12 (1H, t, J 
= 7.6 Hz, ArH), 5.06 (2H, s, CH2Ar), 1.89 (6H, s, (C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 
177.8 (CO2R), 158.8 (ArC), 158.2 (ArC), 145.5 (dddd, J = 251.3, 11.3, 7.7, 4.0 Hz, ArFC), 
143.0–140.2 (m, ArFC), 140.1 (ArC), 139.0 (ArC), 138.8 (ArC), 138.4–135.7 (ArFC), 126.3 
(ArC), 125.6 (ArC), 124.1 (ArC), 123.0 (ArC), 122.9 (ArC), 121.5 (ArC), 119.5 (ArC), 116.9 
(ArC), 114.7 (ArC), 114.2 (ArC), 109.2 (td, J = 17.5, 3.7 Hz, ArFC), 53.9 (CH2R), 47.1 (C(CH-
3)2), 29.8 (C(CH3)2). 19F NMR (470 MHz, CDCl3): δ -141.85 (2F, dd, J = 22.4, 8.3 Hz, o-F), -
153.06 (1F, s, p-F), -161.99 (2F, m, m-F). HRMS (ESI): m/z calculated for C27H18F5N3O2 
requires 512.1392 for [M+H]+ found 512.1426.  
 




General Procedure B was followed using 1b (81 mg, 0.25 mmol) and methyl α-
bromoisobutyrate (0.1 mL, 136 mg, 0.75 mmol). Silica gel column chromatography gave a 
white solid, 54% (57 mg). FT-IR (thin film): νmax (cm-1) = 2981.2, 1727.8, 1567.3. mp (from 
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CHCl3): 183-185 °C. 1H NMR (500 MHz, CDCl3) δ 8.81 (2H, d, J = 4.8 Hz, ArH), 8.71 (1H, 
dd, J = 8.4, 1.0 Hz, ArH), 8.62 (1H, d, J = 8.9 Hz, ArH), 8.09 (1H, d, J = 1.9 Hz, ArH), 7.55 
(1H, dd, J = 9.0, 1.9 Hz, ArH), 7.52 (1H, dd, J = 8.5, 7.6 Hz, ArH), 7.43 (1H, dd, J = 7.7, 1.0 
Hz, ArH), 7.14 (1H, t, J = 4.8 Hz, ArH), 3.68 (3H, s, CO2CH3), 1.89 (6H, s, C(CH3)2). 13C 
NMR (126 MHz, CDCl3) δ 178.3 (CO2Me), 158.5 (ArC), 158.2 (ArC), 140.5 (ArC), 139.8 
(ArC), 137.8 (ArC), 128.4 (ArC), 126.9 (ArC), 126.4 (ArC), 125.7 (ArC), 122.1 (ArC), 119.8 
(ArC), 117.0 (ArC), 116.4 (ArC), 115.0 (ArC), 114.4 (ArC), 52.6 (CO2CH3), 47.1 (C(CH3)2), 
27.1 (C(CH3)2). HRMS (ESI): m/z calculated for C21H18N3O2Br1 requires 446.0482 for 
[M+Na]+, found 446.0554.  
 




General Procedure B was followed using 1c (70 mg, 0.25 mmol) and methyl α-
bromoisobutyrate (0.1 mL, 136 mg, 0.75 mmol). Silica gel column chromatography gave a 
white solid, 60% (57 mg). mp (from CHCl3): 200-203 °C. FT-IR (thin film): νmax (cm-1) = 
2981.2, 1727.8, 1567.3. 1H NMR (500 MHz, CDCl3) δ 8.82 (2H, d, J = 4.8 Hz, ArH), 8.69 
(2H, dd, J = 23.7, 8.9 Hz, ArH), 7.95 (1H, s, ArH), 7.51 (1H, d, J = 8.3 Hz, ArH), 7.47–7.37 
(2H, m, ArH), 7.14 (1H, d, J = 4.9 Hz, ArH), 3.66 (3H, s, CO2CH3), 1.89 (6H, s, C(CH3)2). 
13C NMR (126 MHz, CDCl3) δ 178.3 (CO2Me), 158.5 (ArC), 158.2 (ArC), 140.6 (ArC), 139.7 
(ArC), 137.5 (ArC), 127.4 (ArC), 126.9 (ArC), 125.8 (ArC), 125.7 (ArC), 122.7 (ArC), 122.3 
(ArC), 119.8 (ArC), 117.0 (ArC), 116.0 (ArC), 114.4 (ArC), 52.6 (CO2CH3), 47.1 (C(CH3)2), 
27.1 (C(CH3)2). HRMS (ESI): m/z calculated for C21H18N3O2Cl1 requires 402.0988 for 









General Procedure B was followed using 1d (87 mg, 0.25 mmol) and methyl α-
bromoisobutyrate (0.1 mL, 136 mg, 0.75 mmol). Silica gel column chromatography gave a 
white solid, 10% (11 mg). FT-IR (thin film): νmax (cm-1) = 2950.9, 1731.1, 1566.7. 1H NMR 
(500 MHz, CDCl3) δ 8.92 (2H, d, J = 4.9 Hz, ArH), 8.03 (1H, d, J = 1.8 Hz, ArH), 7.59 (1H, 
d, J = 8.9 Hz, ArH), 7.45–7.41 (2H, m, ArH), 7.38 (1H, t, J = 4.9 Hz, ArH), 3.63 (3H, s, 
CO2CH3), 2.08 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 178.2 (CO2Me), 158.9 (ArC), 
137.0 (ArC), 131.7 (ArC), 127.7 (ArC), 127.4 (ArC), 126.8 (ArC), 123.9 (ArC), 122.8 (ArC), 
119.8 (ArC), 119.2 (ArC), 111.8 (ArC), 52.69 (CO2CH3), 50.0 (C(CH3)2), 27.8 (C(CH3)2). 
HRMS (ESI): m/z calculated for C21H16N3O2Cl3 requires 470.0200 for [M+Na]+, found 
470.0162.  
 




General Procedure B was followed using 9H-carbazole, 16 (87 mg, 0.25 mmol) and ethyl 
α-bromoisobutyrate (0.11 mL, 146 mg, 0.75 mmol). Silica gel column chromatography gave 
an amorphous solid, 14% (10 mg). FT-IR (thin film): νmax (cm-1) = 3419.2, 2928.7, 1715.5. 
1H NMR (500 MHz, CDCl3) δ 8.11–8.05 (2H, m, ArH), 8.03 (1H, s, NH), 7.45–7.33 (4H, m, 
ArH), 7.23 (1H, ddd, J = 8.0, 4.8, 3.4 Hz, ArH), 4.14 (2H, q, J = 7.1 Hz, CO2CH2CH3), 1.70 
(6H, s, C(CH3)2), 1.18 (3H, t, J = 7.1 Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 177.5 
(CO2Et), 140.1 (ArC), 138.4 (ArC), 136.3 (ArC), 126.0 (ArC), 124.1 (ArC), 123.6 (ArC), 
123.4 (ArC), 120.4 (ArC), 119.6 (ArC), 117.2 (ArC), 110.78 (ArC), 110.5 (ArC), 60.9 
(CO2CH2CH3), 46.5 (C(CH3)2), 27.2 (C(CH3)2), 14.2 (CO2CH2CH3). HRMS (ESI) m/z 
calculated for C18H19N1O2 requires 304.1316 for [M+Na]+, found 304.1340. 
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Bromo and chloro disubstituted compounds were not amenable to the Ullmann coupling 
proceeding in low yields, due to perceived lack of solubility under the conditions. The small 
amounts brought through from these reactions were also not amenable to the C4-alkylation 

















   
     Product from D-Experiment    NMR 3a 




   
            Product from D-Experiment    NMR 1a 





6.5: Data and Supporting Information for “Ruthenium-Catalyzed para-Selective C–
H Alkylation of Aniline Derivatives” 
 
In the interest of presentation in a thesis, NMR spectra, crystallography data and 
computational data have not been included. However, in the interest of the reader these are 
available online at: 
http://onlinelibrary.wiley.com/store/10.1002/anie.201708961/asset/supinfo/anie201708961
-sup-0001-misc_information.pdf?v=1&s=f0fb5197df43fdbf5d975a9d52a1791e941ecc6a 
The supporting information has also been submitted to formatting and colour changes, 





Proton, carbon and fluorine NMR spectra were recorded on Bruker 300 MHz, 400 MHZ or 
500 MHz, or Agilent Technologies 500 MHz, spectrometer (1H NMR at 500 MHz, 400 MHz, 
or 300 MHz, 13C NMR at 126 MHz, 100 MHz, or 75 MHz, and 19F NMR at 470 or 376 MHz. 
Chemical shifts for protons are reported in parts per million downfield from Si(CH3)4 and are 
referenced to residual protium in the deuterated solvent (CHCl3 at 7.26 ppm). Chemical 
shifts for fluorines are reported in parts per million downfield from CFCl3. NMR data are 
presented in the following format: chemical shift (number of equivalent nuclei by integration, 
multiplicity [app = apparent, br = broad, d = doublet, t = triplet, q = quartet, dd = doublet of 
doublets), dt = doublet of triplets), dq = doublet of quartets), ddd = doublet of doublet of 
doublets), m = multiplet], coupling constant [in Hz], assignment). Electrospray ionisation 
ultrahigh resolution time-of-flight mass spectrometry (ESI–UHR–TOF–MS) was performed 
on a Bruker maXis mass spectrometer. Electrospray ionisation high resolution time-of-flight 
mass spectrometry (ESI–HR–TOF–MS) was performed on a Bruker micrOTOF 
spectrometer. Infrared (IR) spectra were recorded on a Perkin–Elmer 1600 FT (Fourier 
transform), IR spectrophotometer, with absorbencies quoted as wavelength (ν [in cm−1]). 
Melting points were obtained on a Bibby Sterilin SMP10 melting point machine and are 
uncorrected. 
 
Analytical thin-layer chromatography (TLC) was performed on aluminium-backed plates 
coated with Alugram® SIL G/UV254 purchased from Macherey–Nagel and visualised with 
UV light (254 or 365 nm), and/or KMnO4, 2,4-DNPH or I2/Silica staining. Silica gel column 
chromatography was performed using 60 Å, 200-400 mesh particle size silica gel purchased 
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from Sigma–Aldrich. Samples were loaded as saturated solutions in an appropriate solvent 
system. 
 
All reactions were performed using reagents obtained from Sigma-Aldrich, Acros Organics, 
Alfa Aesar, Fluorochem chemicals without further purification unless stated. [RuCl2(p-
cymene)]2 was purchased from STREM chemicals or Acros Organics. All water used was 
purified through a Merck Millipore reverse osmosis purification system prior to use. 
Anhydrous solvents were dried and degassed by passing through anhydrous alumina 
columns using an Innovative Technology Inc. PS-400-7 solvent purification system (SPS) 
and stored under an atmosphere of N2 prior to use. 
 
Reactions were performed in oven-dried glassware and under a blanket of N2 if not stated. 






6.5.2: Optimization and Further Experiments 
 




a = 1H NMR Conversions of Product Formation. b = Isolated Yield. 
 
The use of dichloropyrimidine derivative (1d) led to increased ratio of formation of the di-
substituted structure. This could be due to increased acidity at this position or the chloro 
substituents promoting radical interaction via ortho/para-direction. 
The use of phenylpyridine under the exact same conditions leads to exclusively meta-
selective products (S5a). This manifests the importance of the aniline substrate in enabling 
the para-C–H functionalisation.   
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Entry Ligand Base Solvent Temp 
(°C) 




1 NaOAc K2CO3 1,4-dioxane 120 16 39 - 
2 NaOAc K2CO3 PhMe 120 16 56 - 
3 NaOAc K2CO3 2-MeTHF 120 16 56 - 
4 NaOAc K2CO3 DME 120 16 28 - 
5 NaOAc K2CO3 CPME 120 16 35 - 
6 NaOAc K2CO3 TBME 120 16 81 (50) - 
7 NaOAc K2CO3 DCE 120 16 59 - 
8 NaOAc K2CO3 MeCN 120 16 56 - 
9 NaOAc K2CO3 AcOH 120 16 Trace - 
10 NaOAc K2CO3 DMA 120 16 - - 
11 NaOAc K2CO3 tAmOH 120 16 41 - 
12 NaOAc K2CO3 tBuOH 120 16 24 - 
13 KOAc K2CO3 TBME 120 16 59 - 
14 MesCO2H K2CO3 TBME 120 16 77 - 
15 Piv-Val-OH K2CO3 TBME 120 16 70 - 
16 DMEDA K2CO3 TBME 120 16 85 - 
17 EN K2CO3 TBME 120 16 28 - 
18 TMEDA K2CO3 TBME 120 16 7 - 
19 Ac-Gly-OH K2CO3 TBME 120 16 71 - 
20 HCO2K K2CO3 TBME 120 16 52 - 
21 tBu Acac K2CO3 TBME 120 16 4 - 
22 DMEDA+NaOAc K2CO3 TBME 120 16 72 - 
23 - K2CO3 TBME 120 16 86 (55) - 
24 - Na2CO3 TBME 120 16 78 - 
25 - NaH TBME 120 16 27 22 
26 - DIPEA TBME 120 16 - - 
27 - KOAc TBME 120 16 57 43 
28 - Cs2CO3 TBME 120 16 69 - 
29 - Ag2CO3 TBME 120 16 - - 
30 - - TBME 120 16 - - 
31 - K2CO3 TBME 60 16 - - 
32 - K2CO3 TBME 100 16 63 - 
33 - K2CO3 TBME 110 16 80 - 
34 - K2CO3 TBME 130 16 80 10 
35 - K2CO3 TBME 140 16 55 38 
36 - K2CO3 TBME 120 16 - - 
40 - K2CO3 TBME 120 2 32 - 
41 - K2CO3 TBME 120 4 66 - 
42 - K2CO3 TBME 120 6 59 - 
43a - K2CO3 TBME 120 16 73 - 
43b - K2CO3 TBME 120 16 71 - 
General Conditions: Aniline Derivative (0.25-0.5 mmol), methyl α-bromoisobutyrate (0.75-1.5 mmol), [RuCl2(p-cymene)]2 (5 
mol%, 0.0125-0.025 mmol), solvent (1-2 mL), 120 °C, 16 h. a : K2CO3 (3 eq). b : Reaction carried out under air. CPME = 
cyclopentyl methyl ether. TBME = tert-butyl methyl ether tAmOH = 2-methyl-2-butanol. MesCO2H = 2,4,6-trimethylbenzoic 
acid. DMEDA = N,N’-dimethylethylenediamine, EN = ethylenediamine. TMEDA = N,N’-tetramethylethylenediamine. tBu Acac 
= 2,2,6,6-tetramethylheptane-3,5-dione. DIPEA = N,N-diisoproylethylamine. 
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Disappointingly, the reaction conversions that were observed via crude NMR analysis were 
not readily converted in high isolated yields. We isolated polymer by-products out of the 
reaction mixture, which were contributing to the NMR conversion. These polymers were 
suggested to be formed via the trace formation of the methyl methacrylate in situ, via base 
elimination or in the protodemetalation mechanism. Interaction of the tertiary alkyl radical 
formed via single electron transfer with this alkene forms a secondary radical which can 
then interact in the para position. The dimeric radical products were isolated and fully 
characterised, and presence of trimeric products was observed via LC-MS however were 
not able to be characterised effectively enough to report. These observations are in line with 
our previous studies on meta-functionalisation using alpha halo carbonyl coupling partners.1 
This reaction methodology has also had issues with ruthenium leeching which has led to 

























These investigations demonstrate that substitution of the N–H on the aniline structure with 
either a methyl (S1e), or boc (S1f) completely shuts down the reaction. N-methylaniline 
(S1g) and N,N-dimethylaniline were (S1h) unsuccessful substrates despite the 
demonstrated reactivity of free aniline previously. The use of pivanilide (S1i) and 
brominated derivative (S1j) were shown to incompatible with this methodology. The second 
of these results is of paramount importance as it suggests that the formation of the oxindoles 
do not proceed via an amidation reaction at the ester followed by radical ring closure. This 
demonstrates that these anilide derivatives are not capable of forming tertiary alkyl radicals. 
Exchange of the NH with a S linker (S1k) also are not tolerated. This manifests the 
importance of the free NH and that other electron rich anilines apart from aniline have any 
activity. This suggests that a general electron rich aniline C–H functionalisation protocol is 
not possible, and aniline is an outlier in this methodology due to innate reactivity via 




6.5.3: Synthesis of Starting Materials 
 




To a mixture of the relevant 2-chloropyrimidine derivative (1-1.5 eq) was added AcOH and 
1,4-dioxane (1:3 solvent mixture at 0.25 M) and subsequently relevant aniline (1-1.5 eq). 
The reaction mixture was heated to reflux for 16 h. The flask was allowed to return to room 
temperature and diluted in EtOAc. To the solution was slowly added sat NaHCO3 solution 
to quench the acetic acid, allowing for effervescence. The mixture was left to quench for 30 
mins. After this time the mixture was poured into a separating funnel and the organic layer 
extracted. The organic layer was further washed with sat NaHCO3 solution (2x) and brine 
(1x) and was then dried over MgSO4 and concentrated in vacuo. The crude residue was 
purified using silica gel chromatography (EtOAc:Hexanes, 5:95-10:90 v:v) to give pure 
substituted aniline. 
 




General Procedure A was followed using 2-chloropyrimidine (5.73 g, 50 mmol) and aniline 
(6.83 mL, 6.98 g, 75 mmol). Silica gel column chromatography gave a white solid, 69% 
(3.69 g). 1H NMR (500 MHz, CDCl3) δ 8.42 (2H, d, J = 4.8 Hz, ArH), 7.67 (1H, s, NH), 7.65–
7.60 (2H, m, ArH), 7.39–7.31 (2H, m, ArH), 7.11–6.95 (1H, m, ArH), 6.75–6.59 (1H, m, ArH). 
13C NMR (126 MHz, CDCl3) δ 160.2 (ArC), 158.1 (ArC), 139.4 (ArC), 129.1 (ArC), 122.9 








General Procedure A was followed using 2,5-dichloropyrimidine (17.88 g, 120 mmol) and 
aniline (7.29 mL, 7.44 g, 80 mmol). Silica gel column chromatography gave a white solid, 
8.72 g (53%). mp (from CHCl3): 129-132 °C. FT-IR: νmax (cm-1) = 3255.7, 3107.4. 1H NMR 
(500 MHz, CDCl3) δ 8.36 (2H, s, ArH), 7.66–7.47 (2H, m, ArH), 7.42 (1H, s, NH), 7.38–7.33 
(2H, m, ArH), 7.08 (1H, tt, J = 7.5, 1.1 Hz, ArH). 13C NMR (126 MHz, cdcl3) δ 158.4 (ArC), 
156.3 (ArC), 139.04 (ArC), 129.15 (ArC), 123.30 (ArC), 121.00 (ArC), 119.69 (ArC). HRMS 









To a round bottom flask containing charged with 2,4,6-tichloropyrimidine (1.15 mL, 10 
mmol) and THF 30 mL) was added aniline (1.37 mL, 1.40 g, 15 mmol) dropwise. Following 
this addition triethylamine (2.09 mL, 1.52 g, 15 mmol) was added in one portion. The 
reaction mixture was stirred at rt for 16 h. The mixture was poured into water (100 mL) and 
extracted with EtOAc (3 x 100 mL). The combined organics were washed with brine (100 
mL), dried over MgSO4 and concentrated in vacuo. The crude residue was purified via silica 
gel column chromatography (EtOAc/Hexanes - 5:95 v:v) to give a solid containing desired 
product and regioisomer (2,6-dichloro-N-phenylpyrimidin-4-amine). Trituration of the solid 
with hexane gave desired product, 19% (460 mg) 1H NMR (500 MHz, CDCl3) δ 7.56 (2H, 
ddd, J = 4.0, 3.1, 1.7 Hz, ArH), 7.36 (2H, dd, J = 8.5, 7.5 Hz, ArH), 7.30 (1H, s, NH), 7.12 
(1H, tt, J = 7.6, 1.1 Hz, ArH), 6.79 (1H, s, J = 1.9 Hz, ArH). 13C NMR (126 MHz, CDCl3) δ 
161.9 (ArC), 159.1 (ArC), 137.8 (ArC), 129.1 (ArC), 124.0 (ArC), 119.9 (ArC), 111.3 (ArC). 
Recrystallization of the triturate from EtOH gave the pure regioisomer, 20%, (500 mg). 1H 
NMR (500 MHz, CDCl3) δ 7.49–7.38 (3H, m, ArH), 7.34–7.27 (3H, m, ArH), 6.55 (1H, s, 
ArH). 13C NMR (126 MHz, CDCl3) δ 163.5 (ArC), 161.3 (ArC), 160.2 (ArC), 136.4 (ArC), 










A mixture of aniline (2.73 mL, 2.79 g, 30 mmol) and 2-bromopyridine (2.86 mL, 4.75 g, 30 
mmol) was heated to 160 °C for 16 h. The reaction mixture was allowed to cool and 
quenched with sat. NaHCO3 solution (200 mL). The mixture was extracted with EtOAc (200 
mL). The organic phase was washed with brine (200 mL) and dried over MgSO4. The 
mixture was concentrated in vacuo to give a crude residue which was purified via silica gel 
column chromatography (EtOAc/Hexanes) to give an off-white solid, 3.15 g (62%). 1H NMR 
(500 MHz, CDCl3) δ 8.21 (1H, dd, J = 4.9, 1.0 Hz, ArH), 7.52–7.44 (1H, m, ArH), 7.34 (2H, 
dd, J = 2.3, 0.6 Hz, ArH), 7.33 (2H, d, J = 1.9 Hz, ArH), 7.07–7.02 (1H, m, ArH), 6.91–6.86 
(1H, m, ArH), 6.83 (1H, s, ArH), 6.76–6.68 (1H, m, ArH). 13C NMR (126 MHz, CDCl3) δ 
156.2 (ArC), 148.6 (ArC), 140.7 (ArC), 137.8 (ArC), 129.4 (ArC), 122.9 (ArC), 120.5 (ArC), 










To a stirred solution of aniline (457 μL, 466 mg, 5 mmol) in anhydrous THF (10 mL) was 
added sequentially triethylamine (2.09 mL, 1.52 g, 15 mmol) and pyridine-2-carbonyl 
chloride hydrochloride (1.33 g, 7.5 mmol). The reaction mixture was stirred at rt for 2 h. After 
this time the reaction was concentrated in vacuo, diluted in EtOAc (100 mL) and washed 
with brine (100 mL) and sat. NaHCO3 solution (100 mL). The aqueous layer was re-
extracted with EtOAc (2 x 100 mL). The combined organic layers were dried over MgSO4 
and passed through a pad of silica using EtOAc as eluent. The solvent was concentrated in 
vacuo to give desired compound, 18% (171 mg). 1H NMR (400 MHz, CDCl3) δ 10.03 (1H, 
s, NH), 8.62 (1H, ddd, J = 4.8, 1.6, 0.9 Hz, ArH), 8.31 (1H, dt, J = 7.8, 1.0 Hz, ArH), 7.91 
(1H, td, J = 7.7, 1.7 Hz, ArH), 7.79 (2H, dt, J = 8.7, 1.6 Hz, ArH), 7.52–7.45 (1H, m, ArH), 
7.43–7.35 (2H, m, ArH), 7.18–7.13 (1H, m, ArH). 13C NMR (101 MHz, CDCl3) δ 162.1 (ArC), 
150.0 (ArC), 148.1 (ArC), 137.9 (ArC), 137.8 (ArC), 129.23 (ArC), 126.6 (ArC), 124.5 (ArC), 









General Procedure A was followed using 2,5-dichloropyrimidine (4.47 g, 30 mmol) and 3-
(methylthio)-aniline (2.46 mL, 2.78 g, 20 mmol). Silica gel column chromatography and 
subsequent recrystallization from EtOH gave a golden solid, 53% (2.67 g). mp (from CHCl3): 
121-123 °C. FT-IR (thin film): νmax (cm-1) = 3277.8, 2987.8, 2920.0. 1H NMR (400 MHz, 
CDCl3) δ 8.39 (2H, s, ArH), 7.61 (1H, t, J = 1.9 Hz, Ar), 7.33 (1H, ddd, J = 8.1, 2.0, 1.2 Hz, 
ArH), 7.31-7.27 (2H, m, ArH & NH), 7.01–6.95 (1H, m, ArH), 2.53 (3H, s, SCH3). 13C NMR 
(126 MHz, CDCl3) δ 158.2 (ArC), 156.3 (ArC), 139.6 (ArC), 129.4 (ArC), 121.2 (ArC), 121.1 
(ArC), 117.4 (ArC), 116.3 (ArC), 15.9 (SCH3). HRMS (ESI): m/z calculated for C11H10Cl1S1 
requires 252.0284 for [M+H]+, found 252.0306. 
 




General Procedure A was followed using 2,5-dichloropyrimidine (4.47 g, 30 mmol) and m-
toluidine (2.15 mL, 2.14 g, 20 mmol). Silica gel column chromatography gave a white solid, 
53% (2.31 g). mp (from CHCl3): 95-96 °C. FT-IR (thin film): νmax (cm-1) = 3351.2, 3048.4, 
2922.0. 1H NMR (400 MHz, CDCl3) δ 8.35 (2H, s, ArH & NH), 7.43–7.36 (1H, m, ArH), 7.26–
7.18 (1H, m, ArH), 6.90 (1H, d, J = 7.5 Hz, ArH), 2.37 (3H, s, ArCH3). 13C NMR (101 MHz, 
CDCl3) δ 158.5 (ArC), 156.4 (ArC), 139.1 (ArC), 138.9 (ArC), 129.0 (ArC), 124.2 (ArC), 
120.9 (ArC), 120.3 (ArC), 116.9 (ArC), 21.7 (ArCH3). HRMS (ESI): m/z calculated for 










General Procedure A was followed using 2,5-dichloropyrimidine (4.47 g, 30 mmol) and 3-
fluoroaniline (1.92 mL, 2.22 g, 20 mmol). Silica gel column chromatography gave a white 
solid 58% (2.58 g). mp (from CHCl3): 112-114 °C. FT-IR (thin film): νmax (cm-1) = 3275.5. 1H 
NMR (400 MHz, CDCl3) δ 8.38 (2H, s, ArH), 7.65 (1H, dt, J = 11.5, 2.3 Hz, ArH), 7.48 (1H, 
s, NH), 7.30–7.21 (1H, m, ArH), 7.14 (1H, ddd, J = 8.1, 2.0, 0.7 Hz, ArH), 6.76 (1H, tdd, J = 
8.3, 2.5, 0.8 Hz, ArH). 13C NMR (101 MHz, CDCl3) δ 163.4 (d, J = 243.9 Hz, ArCF), 162.1 
(ArC), 158.0 (ArC), 156.4 (ArC), 140.7 (d, J = 11.2 Hz, ArC), 130.1 (d, J = 9.6 Hz, ArC), 
121.6 (ArC), 114.6 (d, J = 2.8 Hz, ArC), 109.6 (d, J = 21.5 Hz, ArC), 106.5 (d, J = 26.8 Hz, 
ArC). 19F NMR (376 MHz, CDCl3) δ -106.60 – -114.82 (m, ArF). HRMS (ESI): m/z calculated 
for C10H7Cl1F1N3 requires 224.0385 for [M+H]+, found 224.0384 
 




General Procedure A was followed using 2,5-dichloropyrimidine (4.47 g, 30 mmol) and 3-
chloroaniline (2.12 mL, 2.55 g, 20 mmol). Silica gel column chromatography gave a white 
solid 57% (2.72 g). mp (from CHCl3): 3286.9. FT-IR (thin film): νmax (cm-1) = 3286.9. 1H NMR 
(400 MHz, CDCl3) δ 8.38 (2H, s, ArH), 7.79 (1H, t, J = 2.0 Hz, ArH), 7.43–7.31 (2H, m, ArH 
& NH), 7.25 (1H, t, J = 8.0 Hz, ArH), 7.03 (1H, ddd, J = 7.9, 1.9, 0.9 Hz, ArH).  13C NMR 
(101 MHz, CDCl3) δ 157.94, 156.39, 140.30, 134.83, 130.05, 123.01, 121.68, 119.21, 
117.27, 77.48, 77.36, 77.16, 76.84. HRMS (ESI): m/z calculated for C10H7Cl2N3 requires 








General Procedure A was followed using 2,5-dichloropyrimidine (2.24 g, 15 mmol) and 3-
bromoaniline (1.09 mL, 1.72 g, 10 mmol). Silica gel column chromatography gave a pale 
pink solid, 44% (1.26 g). mp (from CHCl3): 132-134 °C. FT-IR (thin film): νmax (cm-1) = 
3311.2, 2977.8. 1H NMR (500 MHz, CDCl3) δ 8.38 (2H, s, ArH), 7.92 (1H, d, J = 1.0 Hz, 
ArH), 7.47–7.37 (2H, m, ArH & NH), 7.21–7.15 (2H, m, ArH). 13C NMR (126 MHz, CDCl3) δ 
157.9 (ArC), 156.4 (ArC), 140.5 (ArC), 130.3 (ArC), 125.9 (ArC), 122.9 (ArC), 122.1 (ArC), 
121.7 (ArC), 117.8 (ArC). HRMS (ESI): m/z calculated for C10H7Br1Cl1N3 requires 283.9512 
for [M+H]+, found 283.9566.  
 




General Procedure A was followed using 2,5-dichloropyrimidine (2.24 g, 15 mmol) and 3,5-
difluoroaniline (1.29 g, 10 mmol). Silica gel column chromatography gave a pale pink solid, 
22% (530 mg). mp (from CHCl3): 134-136 °C. FT-IR (thin film): νmax (cm-1) = 3296.9, 3167.5, 
3127.5. 1H NMR (500 MHz, CDCl3) δ 8.41 (2H, s, ArH), 7.39 (1H, s, NH), 7.23 (2H, dd, J = 
9.5, 2.2 Hz, ArH), 6.49 (1H, tt, J = 8.9, 2.3 Hz, ArH). 13C NMR (126 MHz, CDCl3) δ 163.5 (d, 
J = 245.4 Hz, ArCF), 163.4 (d, J = 245.4 Hz, ArCF), 157.7 (ArC), 156.4 (ArC), 143.3–139.2 
(m, ArC), 122.3 (ArC), 103.2–99.8 (m, ArC), 98.0 (t, J = 25.8 Hz, ArC). 19F NMR (471 MHz, 
CDCl3) δ -109.20 (t, J = 8.7 Hz, ArF). HRMS (ESI): m/z calculated for C10H6Cl1F2N3 requires 
242.0291 for [M+H]+, found 242.0298. 
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General Procedure A was followed using 2-chloroquinazoline (1.23 g, 7.5 mmol) and aniline 
(457 μL, 465 mg, 5 mmol). Silica gel column chromatography a yellow solid, 46% (513 mg). 
1H NMR (500 MHz, Chloroform) δ 9.08 (1H, s, ArH), 7.86–7.80 (2H, m, ArH), 7.77–7.70 
(3H, m, ArH), 7.50 (1H, s, NH), 7.41–7.36 (2H, m, ArH), 7.33 (1H, ddd, J = 8.0, 4.8, 3.2 Hz, 
ArH), 7.07 (1H, t, J = 7.4 Hz, ArH). 13C NMR (126 MHz, CDCl3) δ 162.0 (ArC), 157.0 (ArC), 
151.7 (ArC), 139.8 (ArC), 134.5 (ArC), 129.1 (ArC), 127.6 (ArC), 126.5 (ArC), 123.9 (ArC), 
122.7 (ArC), 121.0 (ArC), 119.2 (ArC). Data is in line with literature precedent.6 
 




General Procedure A was followed using 2,5-dichloropyrimidine (4.47 g, 30 mmol) and m-
anisidine (2.25 mL, 2.46 g, 20 mmol). Silica gel column chromatography and subsequent 
recrystallization from EtOH gave a white solid, 45% (2.15 g). mp (from CHCl3): 133.136 °C. 
FT-IR (thin film) νmax (cm-1) = 3286.3, 2971.0. 1H NMR (400 MHz, CDCl3) δ 8.36 (2H, s, 
ArH), 7.35 (1H, t, J = 2.2 Hz, ArH), 7.29 (1H, s, NH), 7.24 (1H, t, J = 8.3 Hz, ArH), 7.05 (1H, 
dd, J = 8.0, 1.5 Hz, ArH), 6.63 (1H, dd, J = 8.2, 1.9 Hz, ArH), 3.83 (3H, s, OCH3).13C NMR 
(101 MHz, CDCl3) δ 160.4 (ArC), 158.3 (ArC), 156.3 (ArC), 140.3 (ArC), 129.8 (ArC), 121.1 
(ArC), 111.9 (ArC), 108.3 (ArC), 105.7 (ArC), 55.44 (OCH3). HRMS (ESI): m/z calculated 










General Procedure A was followed using 2,5-dichloropyrimidine (2.24 g, 15 mmol) and 3,5-
dimethoxyaniline (1.53 g, 10 mmol). Silica gel column chromatography gave a white solid, 
33% (880 mg). mp (from CHCl3): 121-124 °C. FT-IR (thin film): νmax (cm-1) = 3288.0, 3126.2, 
2936.2, 2838.8. 1H NMR (500 MHz, CDCl3) δ 8.35 (2H, s, ArH), 7.43 (1H, s, NH), 6.83 (2H, 
d, J = 2.2 Hz, ArH), 6.20 (1H, t, J = 2.2 Hz, ArH), 3.80 (6H, s, ArOCH3). 13C NMR (126 MHz, 
CDCl3) δ 161.3 (ArC), 158.3 (ArC), 156.3 (ArC), 140.8 (ArC), 121.1 (ArC), 98.0 (ArC), 95.1 
(ArC), 55.5 (ArOCH3). HRMS (ESI): m/z calculated for C12H12Cl1N3O2 requires 266.0691 for 
[M+H]+, found 266.0681. 
 
 




General Procedure A was followed using 2-chloropyrimidine (580 mg, 5 mmol) and N-
methylaniline (810 μL, 800 mg, 7.5 mmol). Silica gel column chromatography gave a pale 
orange solid, 74% (685 mg). 1H NMR (500 MHz, CDCl3) δ 8.34 (2H, d, J = 4.8 Hz, ArH), 
7.48–7.39 (2H, m, ArH), 7.39–7.30 (2H, m, ArH), 7.25 (1H, d, J = 7.3 Hz, ArH), 6.56 (1H, t, 
J = 4.8 Hz, ArH), 3.55 (3H, d, J = 0.5 Hz, NCH3). 13C NMR (126 MHz, CDCl3) δ 161.86 
(ArC), 157.54 (ArC), 157.52 (ArC), 145.46 (ArC), 129.06 (ArC), 126.48 (ArC), 125.72 (ArC), 











To a solution of N-phenylpyrimidin-2-amine (1a, 513 mg, 3 mmol) in DMF (20 mL) was 
added sodium hydride (60% wt. in mineral oil, 132 mg, 3.3 mmol) at 0 °C. After this addition 
the reaction mixture was allowed to return to room temperature and stir for 1 hour. After this 
time di-tert-butyldicarbonate (Boc2O, 719 mg, 3.3 mmol) was added in one portion. The 
mixture was allowed to stir for a further hour. The solution was diluted with water (100 mL) 
and extracted with EtOAc (3 x 100 mL). The combined organic phases were dried over 
MgSO4 and concentrated in vacuo. The crude residue was purified via silica gel column 
chromatography to give a white solid, 19% (156 mg). 1H NMR (500 MHz, CDCl3) δ 8.65 
(2H, d, J = 4.8 Hz, ArH), 7.42–7.34 (2H, m, ArH), 7.28 (2H, dt, J = 3.6, 1.5 Hz, ArH), 7.22 
(1H, dd, J = 8.5, 1.2 Hz, ArH), 7.04 (1H, t, J = 4.8 Hz, ArH), 1.45 (9H, s, C(CH3)3). 13C NMR 
(126 MHz, CDCl3) δ 161.5 (ArC), 158.35 (ArC), 153.31 (ArC), 141.41 (ArC), 129.09 (ArC), 
127.83 (ArC), 126.97 (ArC), 117.29 (ArC), 82.16 (C(CH3)3), 28.20 (C(CH3)2). Data is in line 










To a solution of aniline (0.91 mL, 930 mg, 10 mmol) and triethylamine (1.67 mL, 1.21 g, 12 
mmol) in anhydrous CH2Cl2 (10 mL) was added trimethylacetyl chloride (1.24 mL, 1.21 g, 
10 mmol) in anhydrous CH2Cl2 (10 mL) dropwise at 0 °C. After the addition was finished the 
reaction was stirred at 0 °C for 1 hour before being allowed to return to room temperature 
and stir overnight. The reaction mixture was quenched with 1M HCl (50 mL) and diluted in 
CH2Cl2 (30 mL). The organic layer was extracted and then washed with sat. NaHCO3 
solution (50 mL), brine (50 mL), dried over MgSO4 and concentrated in vacuo. Petroleum 
Ether 40-60 °C (100 mL) was added and the mixture was allowed to crystallise at 0 °C for 
two hours. The pure product was collected via filtration to give a white solid, 84% (1.49 g). 
1H NMR (500 MHz, CDCl3) δ 7.57–7.47 (2H, m, ArH), 7.36–7.28 (2H, m, ArH), 7.10 (1H, td, 
J = 7.5, 0.8 Hz, ArH), 1.32 (9H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 176.7 (NC(O)C), 
138.2 (ArC), 129.0 (ArC), 129.0 (ArC), 124.3 (ArC), 120.1 (ArC), 39.7 (C(CH3)3), 27.8 









To a well stirred solution of aniline (0.91 mL, 930 mg, 10 mmol) and triethylamine (4.17 mL, 
3.03 g, 30 mmol) in anhydrous CH2Cl2 (100 mL) was added 2-bromoisobutyryl bromide 
(1.23 mL, 2.29 g, 10 mmol) dropwise at 0 °C. After addition was complete the reaction was 
allowed to return to room temperature and stir overnight. The reaction mixture was 
concentrated and partitioned between EtOAc (100 mL) and H2O (100 mL). The organic 
layer was extracted, dried over MgSO4 and concentrated in vacuo, to give a light brown 
solid, 83% (2.01 g). 1H NMR (500 MHz, CDCl3) δ 8.54–8.35 (1H, s, NH), 7.54 (2H, dt, J = 
8.0, 1.1 Hz, ArH), 7.41–7.30 (2H, m, ArH), 7.15 (1H, t, J = 7.4 Hz, ArH), 2.05 (6H, s, 
C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 170.1 (NC(O)C), 137.5 (ArC), 129.2 (ArC), 125.0 










To a solution of thiophenol (8.15 mL, 8.80 g, 80 mmol) in acetic acid (20 mL) and 1,4-
dioxane (40 mL) was added 2-chloropyrimidine (2.29 g, 20 mmol). The reaction mixture was 
heated to 120 °C overnight. After the reaction had returned to room temperature, saturated 
NaHCO3 solution (20 mL) was added and the reaction was allowed to quench for 30 
minutes. After this time, EtOAc (100 mL) and saturated NaHCO3 solution (80 mL) were 
added. The organic layer was separated and the aqueous layer was extracted with EtOAc 
(2 x 100 mL). The combined organic layers were dried over MgSO4 and concentrated in 
vacuo. The crude residue was purified via silica gel column chromatography 
(EtOAc/Petroleum Ether 40-60 °C) to give an off-white solid, 47% (1.77 g). 1H NMR (500 
MHz, CDCl3) δ 8.48 (2H, d, J = 4.9 Hz), 7.67–7.59 (2H, m), 7.47–7.37 (3H, m), 6.96 (1H, t, 
J = 4.8 Hz). 13C NMR (126 MHz, CDCl3) δ 172.99, 157.68, 135.39, 129.54, 129.45, 129.35, 




6.5.4: Synthesis of para-C–H Functionalized Materials 
 
Synthesis of 3a and 4a 
 
An oven-dried carousel tube was charged with N-phenylpyrimidin-2-amine (1a, 42 mg, 0.25 
mmol), potassium carbonate (69 mg, 0.5 mmol), sodium acetate (6 mg, 0.075 mmol) and 
[RuCl2(p-cymene)]2 (8 mg, 0.0125 mmol, 5 mol%) then sealed with a Teflon cap. The tube 
was evacuated and refilled three times with argon. 1,4-dioxane (1 mL) and methyl α-
bromoisobutyrate (97 μL, 136 mg, 0.75 mmol) were added via septum and the reaction 
mixture heated to 120 °C for 16 h. After this time, the mixture was allowed to return to room 
temperature and was diluted in EtOAc (20 mL) filtered through a plug of celite. The filtrate 
was concentrated in vacuo. The crude residue was purified via silica gel column 
chromatography to give two products, 3a (37%, 24 mg) and 4a (6%, 5 mg) among a 




3a. Amorphous solid, 37% (24 mg). FT-IR (thin film): νmax (cm-1) = 3240.0, 2971.4, 1709.0, 
1625.1. 1H NMR (500 MHz, CDCl3) δ 8.79 (1H, s, NH), 7.17 (1H, dd, J = 8.1, 2.0 Hz, ArH), 
7.14 (1H, d, J = 1.9 Hz, ArH), 6.88 (1H, d, J = 8.0 Hz, ArH), 3.65 (3H, s, CO2CH3), 1.57 (6H, 
s, C(CH3)2), 1.38 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 184.3 (C(O)N), 177.5 
(C(O)O), 139.2 (ArC), 138.7 (ArC), 136.5 (ArC), 125.1 (ArC), 120.1 (ArC), 109.7 (ArC), 52.4 
(CO2CH3), 46.4 (C(CH3)2), 45.0 (C(CH3)2), 26.9 (C(CH3)2) , 24.5 (C(CH3)2). HRMS (ESI): 







4a. Light yellow oil, 6% (5 mg). FT-IR (thin film): νmax (cm-1) = 3364.7, 2970.1, 1721.0, 
1619.6, 1517.5. 1H NMR (500 MHz, CDCl3) δ 7.97 (1H, s, NH), 7.23–7.17 (2H, m, ArH), 
7.16–7.09 (2H, m, ArH), 7.04 (1H, td, J = 7.5, 1.1 Hz, ArH), 6.90 (1H, dd, J = 8.1, 1.1 Hz, 
ArH), 6.71–6.63 (2H, m, ArH), 3.63 (3H, s, CO2CH3), 1.53 (6H, s, C(CH3)2), 1.40 (6H, s, 
C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 176.6 (C=O), 154.7 (C=O), 139.7 (ArC), 136.4 
(ArC), 127.8 (ArC), 126.7 (ArC), 122.8 (ArC), 122.6 (ArC), 115.4 (ArC), 109.8 (ArC), 52.3 









An oven-dried carousel tube was charged with N-phenylpyrimidin-2-amine (1b, 42 mg, 0.25 
mmol), potassium carbonate (69 mg, 0.5 mmol), sodium acetate (6 mg, 0.075 mmol) and 
[RuCl2(p-cymene)]2 (8 mg, 0.0125 mmol, 5 mol%) then sealed with a Teflon cap. The tube 
was evacuated and refilled three times with argon. 1,4-dioxane (1 mL) and methyl α-
bromoisobutyrate (97 μL, 136 mg, 0.75 mmol) were added via septum and the reaction 
mixture heated to 120 °C for 16 h. After this time, the mixture was allowed to return to room 
temperature and was diluted in EtOAc (20 mL) and 5% ethylenediamine solution (20 mL). 
The organic layer was extracted and the aqueous phase we re-extracted with EtOAc (2 x 
20 mL). The combined organic phases were dried over MgSO4 and concentrated in vacuo. 
The crude residue was purified via silica gel column chromatography to give an inseparable 
mixture of 3b and 4b, 41% combined yield (Mixture of 85:15 3b:4b). FT-IR (thin film): νmax 
(cm-1) = 1730.3. 1H NMR (500 MHz, CDCl3) δ 8.42 (2H, s, ArH), 7.59 (1H, s, NH), 7.58–
7.55 (2H, m, ArH), 7.34–7.28 (2H, m, ArH), 6.71 (1H, t, J = 4.7 Hz, ArH), 3.64 (3H, s, 
CO2CH3), 1.57 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 177.4 (CO2Et), 160.3 (ArC), 
158.1 (ArC), 156.1 (ArC), 139.0 (ArC), 138.1 (ArC), 126.4 (ArC), 119.7 (ArC), 120.0 (ArC), 
112.6 (ArC), 52.3 (CO2CH3), 46.1 (C(CH3)2), 26.7 (C(CH3)2). HRMS (ESI): m/z calculated 
for C15H17N3O2 (3a) requires 272.1394 for [M+H]+, found 272.1382, C20H25N3O4 (4a) 
requires 394.1745 for [M+Na]+, found 394.1759.  
 









To a two-necked 25 mL round bottomed flask was added relevant aniline derivative (0.5 
mmol), [RuCl2(p-cymene)]2 (15.5 mg 0.025 mmol, 5 mol%), potassium carbonate (139 mg, 
1 mmol) with stirring. The reaction vessel was sealed with a septum, a condenser equipped, 
and evacuated and refilled three times with nitrogen. To this mixture was added tert-
butylmethyl ether (2 mL) and releveant coupling partner (1.5 mmol). The reaction mixture 
was heated to 120 °C for 16 h. After allowing the flask to return to room temperature, the 
mixture was diluted with EtOAc (20 mL) and filtered through a pad of cotton wool, rinsing 
with EtOAc. The resulting brown/green solution was concentrated in vacuo. The crude 
residue was loaded onto silica and purified via silica gel column chromatography 
(EtOAc:Hexanes, gradient to 10:90) to give pure para-alkylated product. 
 




General Procedure B was followed using 5-chloro-N-phenylpyrimidin-2-amine (1c, 103 mg, 
0.5 mmol) and methyl α-bromoisobutyrate (194 μL, 272 mg, 1.5 mmol). Silica gel column 
chromatography gave a white solid, 55% (84 mg). mp (from CHCl3): 116-118 °C. FT-IR (thin 
film): νmax (cm-1) = 3269.8, 2950.5, 1726.1. 1H NMR (500 MHz, CDCl3) δ 8.34 (2H, s, ArH), 
7.58–7.49 (2H, m, ArH), 7.41 (1H, s, NH), 7.35–7.29 (2H, m, ArH), 3.65 (3H, s, CO2CH3), 
1.58 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 177.4 (CO2Me), 158.3 (ArC), 156.3 
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(ArC), 139.5 (ArC), 137.6 (ArC), 126.5 (ArC), 121.0 (ArC), 119.6 (ArC), 52.33 (CO2CH3), 
46.13 (C(CH3)2), 26.66 (C(CH3)2). HRMS (ESI): m/z calculated for C15H16Cl1N3O2 requires 
306.1004 for [M+H]+, found 306.0984. 
 
Synthesis of 3d and 4d 
 
An oven-dried carousel tube was charged with 4,6-dichloro-N-phenylpyrimidin-2-amine (1d, 
60 mg, 0.25 mmol), potassium carbonate (69 mg, 0.5 mmol), sodium acetate (6 mg, 0.075 
mmol) and [RuCl2(p-cymene)]2 (8 mg, 0.0125 mmol, 5 mol%) then sealed with a Teflon cap. 
The tube was evacuated and refilled three times with argon. 1,4-dioxane (1 mL) and methyl 
α-bromoisobutyrate (97 μL, 136 mg, 0.75 mmol) were added via septum and the reaction 
mixture heated to 120 °C for 16 h. After this time, the mixture was allowed to return to room 
temperature and was diluted in EtOAc (20 mL) and 5% ethylenediamine solution (20 mL). 
The organic layer was extracted and the aqueous phase we re-extracted with EtOAc (2 x 
20 mL). The combined organic phases were dried over MgSO4 and concentrated in vacuo. 
The crude residue was purified via silica gel column chromatography to give separable 
mono and di-functionalized materials, 3d and 4d, 25% combined yield (62:38 - 3d:4d). 
 
   
 
3d. Off-white amorphous solid. FT-IR (thin film): νmax (cm-1) = 3321.7, 2929.9, 1731.2. 1H 
NMR (500 MHz, CDCl3) δ 7.57–7.46 (2H, m, ArH), 7.36–7.31 (2H, m, ArH), 7.28 (1H, s, 
NH), 6.78 (1H, s, ArH), 3.65 (3H, s, CO2CH3), 1.58 (6H, s, C(CH3)2). 13C NMR (126 MHz, 
CDCl3) δ 177.3 (CO2Me), 162.0 (ArC), 159.0 (ArC), 140.4 (ArC), 136.5 (ArC), 126.6 (ArC), 
119.8 (ArC), 111.4 (ArC), 52.4 (CO2CH3), 46.2 (C(CH3)2), 26.66 (C(CH3)2). HRMS (ESI): 







4d. Amorphous solid. FT-IR (thin film): νmax (cm-1) = 2978.7, 1732.4. 1H NMR (500 MHz, 
CDCl3) δ 7.53–7.49 (2H, m, ArH), 7.35–7.30 (2H, m, ArH), 7.12 (1H, s, NH), 3.72 (3H, s, 
CO2CH3), 3.65 (3H, s, CO2CH3), 1.75 (6H, s, C(CH3)2), 1.57 (6H, s, C(CH3)2). 13C NMR (126 
MHz, CDCl3) δ 177.3 (CO2Me), 177.2 (CO2Me), 161.2 (ArC), 155.6 (ArC), 140.1 (ArC), 
136.6 (ArC), 126.6 (ArC), 119.44 (ArC), 52.9 (CO2CH3), 52.4 (CO2CH3), 47.6 (C(CH3)2), 
47.2 (C(CH3)2), 26.7 (C(CH3)2), 26.6 (C(CH3)2). HRMS (ESI): m/z calculated for 
C20H23Cl2N3O4 requires 440.1138 for [M+H]+, found 440.1113. 
 




General Procedure B was followed using 5-chloro-N-phenylpyrimidin-2-amine (1c, 103 mg, 
0.5 mmol) and ethyl α-bromoisobutyrate (220 μL, 293 mg, 1.5 mmol). Silica gel column 
chromatography gave a white solid, 39% (62 mg). mp (from CHCl3): 93-96 °C. FT-IR (thin 
film): νmax (cm-1) = 2981.6, 1727.5. 1H NMR (500 MHz, CDCl3) δ 8.34 (2H, s, ArH), 7.59 (1H, 
s, NH), 7.56–7.46 (2H, m, ArH), 7.38–7.29 (2H, m, ArH), 4.12 (2H, q, J = 7.1 Hz, 
CO2CH2CH3), 1.57 (6H, s, C(CH3)2), 1.19 (3H, t, J = 7.1 Hz, CO2CH2CH3). 13C NMR (126 
MHz, CDCl3) δ 176.8 (CO2Et), 158.4 (ArC), 156.3 (ArC), 139.6 (ArC), 137.5 (ArC), 126.5 
(ArC), 120.9 (ArC), 119.5 (ArC), 60.91 (CO2CH2CH3), 46.06 (C(CH3)2), 26.62 (C(CH3)2), 
14.18 CO2CH2CH3). HRMS (ESI): m/z calculated for C16H18Cl1N3O2 requires 342.0988 for 
[M+Na]+, found 342.0981. 
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General Procedure B was followed using 5-chloro-N-phenylpyrimidin-2-amine (1c, 103 mg, 
0.5 mmol) and tert-butyl α-bromoisobutyrate (280 μL, 335 mg, 1.5 mmol). Silica gel column 
chromatography gave a brown amorphous solid, 40% (70 mg). FT-IR (thin film): νmax (cm-1) 
= 2978.5, 1723.6. 1H NMR (500 MHz, CDCl3) δ 8.33 (2H, s, ArH), 7.60 (1H, s, NH), 7.54–
7.49 (2H, m, ArH), 7.35–7.29 (2H, m, ArH), 1.52 (6H, s, C(CH3)2), 1.38 (9H, s, C(CH3)3). 13C 
NMR (126 MHz, CDCl3) δ 176.0 (CO2tBu), 158.4 (ArC), 156.3 (ArC), 140.1 (ArC), 137.3 
(ArC), 126.4 (ArC), 120.8 (ArC), 119.3 (ArC), 80.38 (CO2C(CH3)3), 46.65 (C(CH3)2), 27.94 
(C(CH3)3), 26.64 (C(CH3)2). HRMS (ESI): m/z calculated for C18H22Cl1N3O2 requires 
370.1301 for [M+Na]+, found 370.1314. 
 




General Procedure B was followed using 5-chloro-N-phenylpyrimidin-2-amine (1c, 103 mg, 
0.5 mmol) and cyclohexyl α-bromoisobutyrate (374 mg, 1.5 mmol). Silica gel column 
chromatography gave a white solid, 25% (46 mg). mp (from CHCl3): 158-160 °C. FT-IR (thin 
film): νmax (cm-1) = 2935.1, 1722.8. 1H NMR (500 MHz, Chloroform) δ 8.34 (2H, s, ArH), 
7.55–7.47 (2H, m, ArH), 7.44 (1H, s, NH), 7.36–7.29 (2H, m, ArH), 4.82–4.73 (1H, m, OCH), 
1.72 (2H, dt, J = 13.1, 7.2 Hz, CyH), 1.65–1.58 (2H, m, CyH), 1.56 (6H, s, C(CH3)2), 1.51–
1.26 (6H, m, CyH). 13C NMR (126 MHz, CDCl3) δ 176.2 (CO2Cy), 158.4 (ArC), 156.3 (ArC), 
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139.9 (ArC), 137.4 (ArC), 126.5 (ArC), 120.9 (ArC), 119.4 (ArC), 72.6 (CO2CH), 46.2 
(C(CH3)2), 31.3 (CyC), 26.6 (C(CH3)2), 25.5 (CyC), 23.5 (CyC). HRMS (ESI): m/z calculated 
for C20H24Cl1N3O2 requires 396.1449 for [M+Na]+, found 396.1468. 
 




General Procedure B was followed using 5-chloro-N-phenylpyrimidin-2-amine (1c, 103 mg, 
0.5 mmol) and perfluorobenzyl α-bromoisobutyrate (521 mg, 1.5 mmol). Silica gel column 
chromatography gave a white solid, 40% (93 mg). mp (from CHCl3): 134-138 °C. FT-IR (thin 
film): νmax (cm-1) = 2975.9, 1736.9. 1H NMR (500 MHz, CDCl3) δ 8.34 (2H, s, ArH), 7.53 (1H, 
s, NH), 7.52–7.48 (2H, m, ArH), 7.29–7.25 (2H, m, ArH), 5.17 (2H, s, CH2PhF), 1.57 (6H, s, 
C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 176.12 (CO2BnF), 158.3 (ArC), 156.3 (ArC), 147.1–
144.1 (m, ArFC), 143.3–140.4 (m, ArFC), 138.6 (ArC), 137.8 (ArC), 138.9–135.9 (m, ArFC), 
126.4 (ArC), 121.0 (ArC), 119.5 (ArC), 109.6 (td, J = 17.3, 3.7 Hz, ArFC), 54.0 (CH2PhF), 
46.2 (C(CH3)2), 26.4 (C(CH3)2). 19F NMR (471 MHz, Chloroform) δ -141.82 (dd, J = 21.9, 
8.0 Hz, ArF), -152.77 (t, J = 20.8 Hz, ArF), -161.68 (td, J = 21.3, 7.8 Hz, ArF). HRMS (ESI): 
m/z calculated for C21H15Cl1F5N3O2 requires 494.0673 for [M+Na]+, found 494.0681. 
 






General Procedure B was followed using 5-chloro-N-phenylpyrimidin-2-amine (1c, 103 mg, 
0.5 mmol) and 3,4-dimethoxybenzyl α-bromoisobutyrate (476 mg, 1.5 mmol). Silica gel 
column chromatography gave a golden oil, 43% (96 mg). FT-IR (thin film): νmax (cm-1) = 
3344.0, 2936.9, 1781.3, 1726.9. 1H NMR (500 MHz, CDCl3) δ 8.32 (2H, s, ArH), 7.62 (1H, 
s, NH), 7.54–7.44 (2H, m, ArH), 7.34–7.27 (2H, m, ArH), 6.83–6.74 (2H, m, ArH), 6.69 (1H, 
d, J = 2.0 Hz, ArH), 5.04 (2H, s, CH2Ar), 3.83 (3H, s, ArOCH3), 3.76 (3, s, ArOCH3), 1.58 
(6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 176.5 (CO2Ar), 158.3 (ArC), 156.2 (ArC), 
148.9 (ArC), 148.9 (ArC), 139.2 (ArC), 137.6 (ArC), 128.8 (ArC), 126.5 (ArC), 120.9 (ArC), 
120.6 (ArC), 119.4 (ArC), 111.1 (ArC), 110.9 (ArC), 66.47 (CH2Ar), 55.9 (ArOCH3), 55.8 
(ArOCH3), 46.1 (C(CH3)2), 26.5 (C(CH3)2). HRMS (ESI): m/z calculated for C23H24N3O4Cl1 
requires 464.1355 for [M+Na]+, found 464.1350. 
 




General Procedure B was followed using 5-chloro-N-phenylpyrimidin-2-amine (1c, 103 mg, 
0.5 mmol) and methyl 1-bromo-1-cyclohexanecarboxylate (238 μL, 332 mg, 1.5 mmol). 
Silica gel column chromatography gave an amorphous white solid, 38% (66 mg). mp (from 
CHCl3): 154-157 °C. FT-IR (thin film): νmax (cm-1) = 2937.4, 1726.8. 1H NMR (500 MHz, 
CDCl3) δ 8.35 (2H, s, ArH), 7.52 (2H, d, J = 8.7 Hz, ArH), 7.37 (2H, d, J = 8.7 Hz, ArH), 7.26 
(1H, s, NH), 3.63 (3H, s, CO2CH3), 2.48 (2H, d, J = 12.9 Hz, CyH), 1.75–1.61 (4H, m, CyH), 
1.51–1.42 (2H, m, CyH), 1.32–1.23 (2H, m, CyH). 13C NMR (126 MHz, CDCl3) δ 175.9 
(CO2Me), 158.3 (ArC), 156.4 (ArC), 138.6 (ArC), 137.6 (ArC), 126.8 (ArC), 121.1 (ArC), 
119.5 (ArC), 119.5 (ArC), 52.1 (CO2CH3), 50.5 (CCy), 34.8 (CyC), 25.7 (CyC), 23.8 (CyC). 









General Procedure B was followed using 5-chloro-N-phenylpyrimidin-2-amine (1c, 103 mg, 
0.5 mmol) and 2-bromoisobutyrophenone (252 μL, 341 mg, 1.5 mmol). Silica gel column 
chromatography gave an amorphous white solid, 9% (16 mg). FT-IR (thin film): νmax (cm-1) 
= 1676.5. 1H NMR (500 MHz, CDCl3) δ 8.35 (2H, s, ArH), 7.58 (2H, d, J = 8.7 Hz, ArH), 7.52 
(2H, dd, J = 8.3, 1.1 Hz, ArH), 7.36 (1H, t, J = 7.4 Hz, ArH), 7.32–7.28 (3H, m, ArH & NH), 
7.23 (2H, t, J = 7.8 Hz, ArH), 1.60 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 203.9 
(COPh), 158.2 (ArC), 156.4 (ArC), 156.1 (ArC), 139.8 (ArC), 137.8 (ArC), 136.5 (ArC), 131.8 
(ArC), 129.9 (ArC), 128.1 (ArC), 126.5 (ArC), 121.13 (ArC), 119.8 (ArC), 51.08 (C(CH3)2), 
27.98 (C(CH3)2). HRMS (ESI): m/z calculated for C20H18Cl1N3O1 requires 374.1038 for 
[M+Na]+, found 374.1027. 
 




General Procedure B was followed using 5-chloro-N-phenylpyrimidin-2-amine (1c, 103 mg, 
0.5 mmol) and ethyl bromodifluoroacetate (192 μL, 304 mg, 1.5 mmol). Silica gel column 
chromatography gave a white solid, 6% (10 mg). mp (from CHCl3): 110-114 °C. FT-IR (thin 
film): νmax (cm-1) = 1755.2. 1H NMR (500 MHz, CDCl3) δ 8.39 (2H, s, ArH), 7.69 (2H, d, J = 
8.7 Hz, ArH), 7.58 (2H, d, J = 8.7 Hz, ArH), 7.39 (1H, s, NH), 4.30 (2H, q, J = 7.1 Hz, 
CO2CH2CH3), 1.31 (3H, t, J = 7.1 Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 165.9–
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162.3 (m, CF2), 157.9 (ArC), 156.4 (ArC), 141.46 (ArC), 126.7 (t, J = 6.0 Hz, ArC), 122.0 
(ArC), 118.7 (ArC), 113.6 (ArC), 63.2 (s, CO2CH2CH3), 14.1 (s, CO2CH2CH3). 19F NMR (471 
MHz, CDCl3) δ -103.05 (CF2). HRMS (ESI): m/z calculated for C14H12Cl1F2N3O2 requires 
350.0486 for [M+Na]+, found 350.0480. 
 




General Procedure B was followed using 5-chloro-N-phenylpyrimidin-2-amine (1c, 103 mg, 
0.5 mmol) and ethyl 2-bromopropionate (195 μL, 272 mg, 1.5 mmol). Silica gel column 
chromatography gave an amorphous white solid, 8% (12 mg). mp (from CHCl3): 113-116 
°C. FT-IR (thin film): νmax (cm-1) = 1730.2. 1H NMR (500 MHz, CDCl3) δ 8.34 (2H, s, ArH), 
7.54–7.47 (2H, m, ArH), 7.34–7.27 (3H, m, ArH & NH), 4.18–4.05 (2H, m, CO2CH2CH3), 
3.68 (1H, q, J = 7.2 Hz, CH(CH3)), 1.49 (2H, d, J = 7.2 Hz, CH(CH3)), 1.21 (3H, t, J = 7.1 
Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 174.7 (CO2Et), 158.4 (ArC), 156.4 (ArC), 
137.9 (ArC), 135.6 (ArC), 128.2 (ArC), 121.0 (ArC), 119.8 (ArC), 60.87 (CO2CH2CH3), 45.10 
(CH(CH3), 18.72 (CH(CH3), 14.27 (CO2CH2CH3). HRMS (ESI): m/z calculated for 
C15H16Cl1N3O2 requires 306.1004 for [M+H]+, found 306.0989. 
 






General Procedure B was followed using 5-chloro-N-(3-(methylthio)phenyl)pyrimidin-2-
amine (1h, 126 mg, 0.5 mmol) and methyl α-bromoisobutyrate (194 μL, 272 mg, 1.5 mmol). 
Silica gel column chromatography gave an amorphous white solid, 38% (67 mg). FT-IR (thin 
film): νmax (cm-1) = 3327.4, 2978.8, 1729.5. 1H NMR (500 MHz, CDCl3) δ 8.35 (2H, s, ArH), 
7.72 (1H, d, J = 2.3 Hz, ArH), 7.42 (1H, s, NH), 7.39 (1H, dd, J = 8.6, 2.3 Hz, ArH), 7.32 
(1H, d, J = 8.6 Hz, ArH), 3.68 (3H, s, CO2CH3), 2.44 (3H, s, SCH3), 1.60 (6H, s, C(CH3)2). 
13C NMR (126 MHz, CDCl3) δ 178.5 (CO2Me), 158.2 (ArC), 156.4 (ArC), 139.9 (ArC), 138.2 
(ArC), 138.0 (ArC), 126.2 (ArC), 122.2 (ArC), 121.2 (ArC), 117.5 (ArC), 52.4 (CO2CH3), 46.8 
(C(CH3)2), 27.3 (SCH3), 19.1 (C(CH3)2). HRMS (ESI): m/z calculated for C16H18Cl1N3O2S1 
requires 374.0708 for [M+Na]+, found 374.0717. 
 




General Procedure B was followed using 5-chloro-N-(m-tolyl)pyrimidin-2-amine (1i, 110 
mg, 0.5 mmol) and methyl α-bromoisobutyrate (194 μL, 272 mg, 1.5 mmol). Silica gel 
column chromatography gave an amorphous white solid, 21% (34 mg). FT-IR (thin film): 
νmax (cm-1) = 2970.6, 1731.7. 1H NMR (500 MHz, Chloroform) δ 8.34 (2H, s, ArH), 7.45 (1H, 
dd, J = 8.5, 2.4 Hz, ArH), 7.33 (1H, d, J = 8.6 Hz, ArH), 7.31–7.28 (2H, m, ArH & NH), 3.67 
(3H, s, CO2CH3), 2.21 (3H, s, ArCH3), 1.57 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 
178.9 (CO2Me), 158.4 (ArC), 156.3 (ArC), 137.9 (ArC), 137.5 (ArC), 136.9 (ArC), 125.9 
(ArC), 122.7 (ArC), 120.9 (ArC), 117.1 (ArC), 52.4 (CO2CH3), 46.1 (C(CH3)2), 27.1 (ArCH3), 
20.3 (C(CH3)2). HRMS (ESI): m/z calculated for C16H18Cl1N3O2 requires 342.0988 for 









General Procedure B was followed using 5-chloro-N-(3-fluorophenyl)pyrimidin-2-amine (1j, 
112 mg, 0.5 mmol) and methyl α-bromoisobutyrate (194 μL, 272 mg, 1.5 mmol). Silica gel 
column chromatography gave an amorphous white solid, 55% (89 mg). mp (from CHCl3): 
142-144 °C. FT-IR (thin film): νmax (cm-1) = 3338.3, 2981.2, 2951.1, 1726.9. 1H NMR (500 
MHz, CDCl3) δ 8.36 (2H, s, ArH), 7.71 (1H, s, NH), 7.59 (1H, dd, J = 13.6, 2.2 Hz, ArH), 
7.24 (1H, t, J = 9.5 Hz, ArH), 7.14 (1H, dd, J = 8.5, 2.2 Hz, ArH), 3.68 (3H, s, CO2CH3), 1.56 
(6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 177.4 (CO2Me), 160.8 (d, J = 245.2 Hz, 
ArCF), 158.0 (ArC), 156.3 (ArC), 139.4 (d, J = 11.7 Hz, ArC), 126.8 (d, J = 14.1 Hz, ArC), 
126.6 (d, J = 6.3 Hz, ArC), 114.4 (d, J = 2.5 Hz, ArC), 107.0 (d, J = 28.2 Hz, ArC), 52.4 
(CO2CH3), 43.8 (C(CH3)2), 25.9 (C(CH3)2). 19F NMR (471 MHz, CDCl3) δ -111.88 (dd, J = 
13.4, 8.9 Hz, ArF). HRMS (ESI): m/z calculated for C15H15Cl1F1N3O2 requires 346.0737 for 
[M+Na]+, found 346.0737. 
 




General Procedure B was followed using 5-chloro-N-(3-chlorophenyl)pyrimidin-2-amine 
(1k, 120 mg, 0.5 mmol) and methyl α-bromoisobutyrate (194 μL, 272 mg, 1.5 mmol). Silica 
gel column chromatography gave an amorphous white solid, 35% (60 mg). mp (from 
CHCl3): 160-166 °C. FT-IR (thin film): νmax (cm-1) = 3345.2, 2923.2, 1733.2. 1H NMR (500 
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MHz, CDCl3) δ 8.37 (2H, s, ArH), 7.76 (1H, d, J = 2.3 Hz, ArH), 7.42 (1H, s, NH), 7.40 (1H, 
dd, J = 8.6, 2.3 Hz, ArH), 7.35 (1H, d, J = 8.6 Hz, ArH), 3.68 (3H, s, CO2CH3), 1.61 (6H, s, 
C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 177.7 (CO2Me), 158.0 (ArC), 156.4 (ArC), 138.8 
(ArC), 136.7 (ArC), 134.1 (ArC), 127.1 (ArC), 121.6 (ArC), 121.1 (ArC), 117.5 (ArC), 52.6 
(CO2CH3), 46.3 (C(CH3)2), 26.3 (C(CH3)2). HRMS (ESI): m/z calculated for C15H15Cl2N3O2 
requires 362.0441 for [M+Na]+, found 362.0439. 
 




General Procedure B was followed using N-(3-bromophenyl)-5-chloropyrimidin-2-amine (1l, 
137 mg, 0.5 mmol) and methyl α-bromoisobutyrate (194 μL, 272 mg, 1.5 mmol). Silica gel 
column chromatography gave an amorphous white solid, 29% (56 mg). mp (from CHCl3): 
150-155 °C. FT-IR (thin film): νmax (cm-1) = 2987.9, 1732.8. 1H NMR (500 MHz, CDCl3) δ 
8.37 (2H, s, ArH), 7.92 (1H, d, J = 2.4 Hz, ArH), 7.52 (1H, s, NH), 7.48 (1H, dd, J = 8.6, 2.4 
Hz, ArH), 7.35 (1H, d, J = 8.6 Hz, ArH), 3.68 (3H, s, CO2CH3), 1.63 (6H, s, C(CH3)2). 13C 
NMR (126 MHz, CDCl3) δ 177.7 (CO2Me), 157.9 (ArC), 156.4 (ArC), 138.8 (ArC), 138.1 
(ArC), 127.4 (ArC), 124.6 (ArC), 123.9 (ArC), 121.6 (ArC), 118.1 (ArC), 52.6 (CO2CH3), 47.7 
(C(CH3)2), 26.6 (C(CH3)2). HRMS (ESI): m/z calculated for C15H15N3O2Br1Cl1 requires 
405.9936 for [M+Na]+, found 405.9955. 
 





General Procedure B was followed using 5-chloro-N-(3,5-difluorophenyl)pyrimidin-2-amine 
(1m, 121 mg, 0.5 mmol) and methyl α-bromoisobutyrate (194 μL, 272 mg, 1.5 mmol). Silica 
gel column chromatography gave an amorphous white solid, 33% (57 mg). mp (from 
CHCl3): 138-142 °C. FT-IR (thin film): νmax (cm-1) = 3293.7, 2988.4, 1734.3. 1H NMR (500 
MHz, CDCl3) δ 8.38 (2H, s, ArH), 7.56 (1H, s, NH), 7.22–7.18 (1H, m, ArH), 7.18–7.15 (1H, 
m, ArH), 3.71 (3H, s, CO2CH3), 1.63 (6H, app t, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 
177.3 (CO2Me), 161.3 (dd, J = 245.6, 11.7 Hz, ArCF), 157.6 (ArC), 156.3 (ArC), 139.1 (t, J 
= 15.1 Hz, ArC), 122.00 (ArC), 114.5 (t, J = 16.3 Hz, ArC), 103.4 – 101.5 (ArC), 52.4 
(CO2CH3), 44.1 (C(CH3)2), 26.4 (app t, J = 3.6 Hz, C(CH3)2). 19F NMR (471 MHz, CDCl3) δ 
-109.37 (d, J = 12.3 Hz). HRMS (ESI): m/z calculated for C15H14Cl1F2N3O2 requires 
342.0815 for [M+H]+, found 342.0834. 
 




General Procedure B was followed using N-phenylquinazolin-2-amine (1n, 110 mg, 0.5 
mmol) and methyl α-bromoisobutyrate (194 μL, 272 mg, 1.5 mmol). Silica gel column 
chromatography gave a white solid, 48% (77 mg). mp (from CHCl3): 136-138 °C. FT-IR (thin 
film): νmax (cm-1) = 2978.3, 1729.0. 1H NMR (500 MHz, CDCl3) δ 9.07 (1H, s, ArH), 7.81–
7.77 (2H, m, ArH), 7.75–7.69 (4H, m, ArH & NH), 7.38–7.34 (2H, m, ArH), 7.32 (1H, ddd, J 
= 8.0, 5.0, 3.0 Hz, ArH), 3.66 (3H, s, CO2CH3), 1.60 (6H, s, C(CH3)2). 13C NMR (126 MHz, 
CDCl3) δ 177.5 (CO2Me), 161.9 (ArC), 156.9 (ArC), 151.6 (ArC), 138.8 (ArC), 138.4 (ArC), 
134.5 (ArC), 127.6 (ArC), 126.4 (ArC), 126.4 (ArC), 123.9 (ArC), 121.0 (ArC), 119.1 (ArC), 
52.29 (CO2CH3), 46.09 (C(CH3)2), 26.66 (C(CH3)2). HRMS (ESI): m/z calculated for 









General Procedure B was followed using N-phenylquinazolin-2-amine (1n, 110 mg, 0.5 
mmol) and ethyl α-bromoisobutyrate (220 μL, 293 mg, 1.5 mmol). Silica gel column 
chromatography gave a white solid, 28% (47 mg). mp (from CHCl3): 100-102 °C. FT-IR (thin 
film): νmax (cm-1) = 3269.9, 2977.6, 1771.7. 1H NMR (500 MHz, CDCl3) δ 9.08 (1H, s, ArH), 
7.81–7.77 (2H, m, ArH), 7.75–7.68 (4H, m, ArH & NH), 7.39–7.35 (2H, m, ArH), 7.32 (1H, 
ddd, J = 8.0, 4.8, 3.2 Hz, ArH), 4.13 (2H, q, J = 7.1 Hz, CO2CH2CH3), 1.60 (6H, s, C(CH3)2), 
1.20 (3H, t, J = 7.1 Hz, CO2CH2CH3). 13C NMR (126 MHz, CDCl3) δ 177.0 (CO2Et), 161.9 
(ArC), 156.9 (ArC), 151.6 (ArC), 139.0 (ArC), 138.2 (ArC), 134.5 (ArC), 127.6 (ArC), 126.4 
(ArC), 123.8 (ArC), 120.9 (ArC), 119.0 (ArC), 60.87 (CO2CH2CH3), 46.05 (C(CH3)2), 26.66 
(C(CH3)2), 14.19 (CO2CH2CH3). HRMS (ESI): m/z calculated for C20H21N3O2 requires 
336.1707 for [M+H]+, found 336.1727. 
 




General Procedure B was followed using N-phenylquinazolin-2-amine (1n, 110 mg, 0.5 
mmol) and benzyl α-bromoisobutyrate (386 mg, 1.5 mmol). Silica gel column 
chromatography gave a white solid, 53% (105 mg). mp (from CHCl3): 98-102 °C. FT-IR (thin 
film): νmax (cm-1) = 3273.9, 2973.9, 1727.4. 1H NMR (500 MHz, CDCl3) δ 9.09 (1H, s, ArH), 
7.81–7.76 (2H, m, ArH), 7.76–7.72 (3H, m, ArH), 7.59 (1H, s, NH), 7.39–7.35 (2H, m, ArH), 
7.35–7.23 (6H, m, ArH), 5.13 (2H, s, CH2Ph), 1.64 (6H, s, C(CH3)2). 13C NMR (126 MHz, 
 437 
 
CDCl3) δ 176.7 (CO2Bn), 162.0 (ArC), 156.9 (ArC), 151.7 (ArC), 138.6 (ArC), 138.3 (ArC), 
136.4 (ArC), 134.5 (ArC), 128.5 (ArC), 128.0 (ArC), 127.8 (ArC), 127.6 (ArC), 126.5 (ArC), 
126.4 (ArC), 123.9 (ArC), 121.0 (ArC), 119.1 (ArC), 66.5 (CO2CH2Ph), 46.2 (C(CH3)2), 26.6 
(C(CH3)2). HRMS (ESI): m/z calculated for C25H23N3O2 requires 398.1863 for [M+H]+, found 
398.1896. 
  




General Procedure B was followed using N-phenylquinazolin-2-amine (1n, 110 mg, 0.5 
mmol) and methyl 1-bromo-1-cyclohexanecarboxylate (238 μL, 332 mg, 1.5 mmol). Silica 
gel column chromatography gave a white solid, 38% (69 mg). mp (from CHCl3): 196-198 
°C. FT-IR (thin film): νmax (cm-1) = 2988.6, 1720.6. 1H NMR (500 MHz, CDCl3) δ 9.08 (1H, s, 
ArH), 7.81–7.76 (2H, m, ArH), 7.76–7.70 (3H, m, ArH), 7.43 (1H, s, NH), 7.43–7.39 (2H, m, 
ArH), 7.34 (1H, ddd, J = 8.1, 5.7, 2.4 Hz, ArH), 3.65 (3H, s, CO2CH3), 2.50 (2H, d, J = 12.0 
Hz, CyH), 1.82–1.58 (6H, m, CyH), 1.53–1.42 (2H, m, CyH). 13C NMR (126 MHz, CDCl3) δ 
176.0 (CO2Me), 162.0 (ArC), 156.9 (ArC), 151.7 (ArC), 138.3 (ArC), 137.9 (ArC), 134.5 
(ArC), 127.6 (ArC), 126.7 (ArC), 126.5 (ArC), 123.9 (ArC), 121.0 (ArC), 119.1 (ArC), 52.1 
(CO2CH3), 50.5 (CCy), 34.8 (CyC), 25.8 (CyC), 23.8 (CyC). HRMS (ESI): m/z calculated for 
C22H23N3O2 requires 362.1863 for [M+H]+, found 362.1888.
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Synthesis of S3imono and S3idi 
 
General Procedure B was followed using 5-chloro-N-(3-methoxyphenyl)pyrimidin-2-amine 
(S1a, 118 mg, 0.5 mmol) and methyl α-bromoisobutyrate (194 μL, 272 mg, 1.5 mmol). Silica 
gel column chromatography gave two separable products, para-C–H-alkylated S3imono, 




S3imono. White Solid. mp (from CHCl3): 132-134 °C. FT-IR (thin film): νmax (cm-1) = 2969.0, 
1745.1. 1H NMR (500 MHz, CDCl3) δ 8.35 (2H, s, ArH), 7.35–7.31 (2H, m, NH & ArH), 7.23 
(1H, d, J = 8.3 Hz, ArH), 7.04 (1H, dd, J = 8.3, 2.2 Hz, ArH), 3.80 (3H, s, ArOCH3), 3.62 
(3H, s, CO2CH3), 1.51 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 178.7 (CO2Me), 158.3 
(ArC), 157.3 (ArC), 156.4 (ArC), 138.9 (ArC), 129.1 (ArC), 125.8 (ArC), 121.0 (ArC), 111.3 
(ArC), 103.2 (ArC), 55.5 (CO2CH3), 52.0 (ArOCH3), 44.0 (C(CH3)2), 25.9 (C(CH3)2). HRMS 
(ESI): m/z calculated for C16H18Cl1N3O3 requires 336.1109 for [M+H]+, found 336.1110. 
 
 
S3idi. Amorphous Solid. FT-IR (thin film): νmax (cm-1) = 2975.8, 1735.8. 1H NMR (500 MHz, 
CDCl3) δ 7.29 (2H, s, ArH), 7.15 (1H, s, ArH), 3.77 (3H, s, ArOCH3), 3.62 (3H, s, CO2CH3), 
1.52 (6H, s, C(CH3)2), 1.49 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 180.9 (CO2Me), 
178.4 (CON), 157.0 (ArC), 156.4 (ArC), 154.1 (ArC), 138.9 (ArC), 130.5 (ArC), 128.0 (ArC), 
126.4 (ArC), 119.4 (ArC), 97.6 (ArC), 55.8 (ArOCH3), 52.0 (CO2CH3), 44.6 (C(CH3)2), 44.28 
(C(CH3)2), 26.0 (C(CH3)2), 25.5 (C(CH3)2). HRMS (ESI): m/z calculated for C20H22N3O4Cl1 
requires 426.1199 for [M+Na]+, found 426.1200. 
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Synthesis of S3jpara and S3jortho 
 
General Procedure B was followed using 5-chloro-N-(3,5-dimethoxyphenyl)pyrimidin-2-
amine (S1b, 133 mg, 0.5 mmol) and methyl α-bromoisobutyrate (194 μL, 272 mg, 1.5 
mmol). Silica gel column chromatography gave two separable products, para-C–H-




S3jpara. Amorphous Solid. FT-IR (thin film): νmax (cm-1) = 3330.3, 2938.8, 1732.8. 1H NMR 
(500 MHz, Chloroform) δ 8.36 (2H, s, ArH), 7.29 (1H, s, NH), 6.87 (2H, s, ArH), 3.77 (6H, 
s, ArOCH3), 3.65 (3H, s, CO2CH3), 1.57 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 179.6 
(CO2Me), 158.8 (ArC), 158.3 (ArC), 156.3 (ArC), 138.8 (ArC), 121.1 (ArC), 116.6 (ArC), 
97.0 (ArC), 55.9 (ArOCH3), 51.8 (CO2CH3), 44.8 (C(CH3)2), 26.6 (C(CH3)2). HRMS (ESI): 




S3jortho. Amorphous Solid. FT-IR (thin film): νmax (cm-1) = 2988.4, 1734.8. 1H NMR (500 MHz, 
CDCl3) δ 8.80 (2H, s, ArH), 6.84 (1H, d, J = 2.0 Hz, ArH), 6.27 (1H, d, J = 2.0 Hz, ArH), 3.86 
(3H, s, ArOCH3), 3.80 (3H, s, ArOCH3), 1.54 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) 
δ 179.6 (CON), 158.8 (ArC), 158.3 (ArC), 156.3 (ArC), 138.8 (ArC), 121.1 (ArC), 116.6 
(ArC), 97.0 (ArC), 55.9 (ArOCH3), 51.8 (ArOCH3), 44.8 (C(CH3)2), 26.6 (C(CH3)2). HRMS 










Amorphous Solid. FT-IR (thin film): νmax (cm-1) = 1734.3. 1H NMR (500 MHz, CDCl3) δ 8.34 
(2H, s, ArH), 7.54–7.49 (2H, m, ArH), 7.38–7.32 (2H, m, ArH), 7.18 (1H, s, NH), 3.64 (3H, 
s, CO2CH3), 3.64 (3H, s, CO2CH3), 2.56 (1H, d, J = 14.5 Hz, CH2), 2.48 (1H, d, J = 14.5 Hz, 
CH2), 1.48 (3H, s, CH3), 1.17 (3H, s, CH3), 1.12 (3H, s, CH3). 13C NMR (126 MHz, CDCl3) δ 
178.9 (CO2Me), 176.7 (CO2Me), 158.3 (ArC), 156.4 (ArC), 139.1 (ArC), 137.7 (ArC), 126.7 
(ArC), 121.1 (ArC), 119.3 (ArC), 52.3 (CO2CH3), 52.0 (CO2CH3), 48.9 (C(CH2R)2), 48.2 
(C(CH2R)2), 41.8 (CH2), 29.2 (CH3), 24.0 (CH3), 20.9 (CH3). HRMS (ESI): m/z calculated for 





6.5.5: Synthesis of meta-C–H Functionalized Materials 
 




An oven-dried carousel tube was charged with phenylpyridine (36 μL, 39 mg, 0.25 mmol), 
potassium carbonate (69 mg, 0.5 mmol), sodium acetate (6 mg, 0.075 mmol) and [RuCl2(p-
cymene)]2 (8 mg, 0.0125 mmol, 5 mol%) then sealed with a Teflon cap. The tube was 
evacuated and refilled three times with argon. 1,4-dioxane (1 mL) and methyl α-
bromoisobutyrate (97 μL, 136 mg, 0.75 mmol) were added via septum and the reaction 
mixture heated to 120 °C for 16 h. After this time, the mixture was allowed to return to room 
temperature and was diluted in EtOAc (20 mL) and 5% ethylenediamine solution (20 mL). 
The organic layer was extracted and the aqueous phase we re-extracted with EtOAc (2 x 
20 mL). The combined organic phases were dried over MgSO4 and concentrated in vacuo. 
The crude residue was purified via silica gel column chromatography to give meta-
substituted structure, 36% (23 mg). FT-IR (thin film): νmax (cm-1) = 2978.2, 1782.0, 1731.6. 
1H NMR (500 MHz, CDCl3) δ 8.73–8.65 (1H, m, ArH), 7.98 (1H, t, J = 1.8 Hz, ArH), 7.90–
7.80 (1H, m, ArH), 7.77–7.66 (2H, m, ArH), 7.42 (1H, t, J = 7.7 Hz, ArH), 7.38 (1H, ddd, J = 
7.8, 1.8, 1.3 Hz, ArH), 7.22 (1H, ddd, J = 7.2, 4.8, 1.3 Hz, ArH), 3.65 (3H, s, J = 8.9 Hz, 
CO2CH3), 1.65 (6H, s, J = 1.1 Hz, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 177.2 (CO2Me), 
173.1 (ArC), 157.5 (ArC), 149.6 (ArC), 145.2 (ArC), 139.56 (ArC), 136.7 (ArC), 128.8 (ArC), 
126.4 (ArC), 125.4 (ArC), 124.2 (ArC), 122.1 (ArC), 120.7 (ArC), 52.3 (CO2CH3), 46.6 
(C(CH3)2), 26.6 (C(CH3)2)). HRMS (ESI): m/z calculated for C16H17N1O2 requires 256.1332 









To an oven dried carousel tube was charged 5-chloro-N-phenylpyrimidin-2-amine (1c, 52 
mg, 0.25 mmol), [RuCl2(p-cymene)]2 (15.5 mg, 0.025 mmol, 10 mol%) and potassium 
acetate (49 mg, 0.5 mmol). The reaction vessel was sealed with a Teflon cap and evacuated 
and refilled three times with argon. To the carousel tube was then added DME (1 mL), acetic 
acid (29 μL, 30 mg, 0.5 mmol) and methyl α-bromoisobutyrate (97 μL, 136 mg, 0.75 mmol) 
were added via septum and the reaction mixture heated to 120 °C for 16 h. After this time, 
the mixture was allowed to return to room temperature and was diluted in EtOAc (20 mL) 
and sat. NaHCO3 solution (20 mL). The organic layer was extracted and the aqueous phase 
we re-extracted with EtOAc (2 x 20 mL). The combined organic phases were dried over 
MgSO4 and concentrated in vacuo. The crude residue was purified via silica gel column 
chromatography to give meta-substituted structure, 47% (36 mg, mixture of meta:para of 
99:1. FT-IR (thin film): νmax (cm-1) = 3348.3, 2978.1, 1731.4.  1H NMR (500 MHz, CDCl3) δ 
8.35 (2H, s, ArH), 7.55 (1H, ddd, J = 8.1, 2.2, 0.9 Hz, ArH), 7.49 (1H, t, J = 2.0 Hz, ArH), 
7.31 (1H, t, J = 8.0 Hz, ArH), 7.05 (1H, ddd, J = 7.8, 1.9, 0.9 Hz, ArH), 3.67 (3H, s, CO2CH3), 
1.59 (6H, s, C(CH3)2). 13C NMR (126 MHz, CDCl3) δ 177.2 (CO2Me), 158.4 (ArC), 156.3 
(ArC), 145.8 (ArC), 139.1 (ArC), 129.1 (ArC), 121.0 (ArC), 120.6 (ArC), 118.1 (ArC), 117.2 
(ArC), 52.4 (CO2CH3), 46.7 (C(CH3)2), 26.6 (C(CH3)2). HRMS (ESI): m/z calculated for 






6.5.6: Deuterium Experiments 
 




To a 250 mL three-necked round bottomed flask was charged 2-amino-4-
chloroaminopyrimidine (1.42 g, 11 mmol), copper iodide (952 mg, 5 mmol, 50 mol%) and 
potassium carbonate (2.76 g, 20 mmol). A condenser was equipped and the flask was 
evacuated and refilled with nitrogen three times. d5-bromobenzene (1.05 mL, 1.62 mL, 10 
mmol), N,N’-dimethylethylenediamine (538 μL, 441 mg, 5 mmol, 50 mol%) and 1,4-dioxane 
(40 mL) were then added via septum. The reaction mixture was heated to 100 °C for 72 h. 
After this time, the reaction mixture was allowed to cool to room temperature and 
concentrated ammonia solution (20 mL) and brine (80 mL) were added and extracted with 
EtOAc (3 x 100 mL). The combined organic phases were dried over MgSO4 and 
concentrated in vacuo. The crude residue was purified via silica gel column chromatography 
(EtOAc/Hexanes, 5:95 v:v) to give pure white solid, 35% (706 mg). *Note: The 
corresponding palladium-catalyzed Buchwald amination did not give any conversion to 
product. 1H NMR (400 MHz, CDCl3) δ 8.36 (2H, s, ArH), 7.63 (1H, s, NH). 13C NMR (101 
MHz, CDCl3) δ 158.4 (ArC), 156.3 (ArC), 138.9 (ArC), 129.2–128.2 (m, ArC), 123.2–122.0 




1c-d5 – 1H NMR (400 MHz, CDCl3) 
  

































6.5.7: KIE Experiments 
 





























6.5.9: DFT Discussion 
 
With a potential inner sphere ruthenium dictating the selectivity of functionalization, further 
Density Functional Theory (DFT) computations were employed to map the contrasting H-
activation (cyclometalation) mechanisms for 1c that result in complementary para or meta 
selectivity. 
 
Using the same computational methodology we employed previously,12 geometries were 
optimized in the gas phase with the BP86 functional using the basis set SDD for Ru and Cl, 
and 6-31G** on all other atoms. Additional single point corrections were applied for solvation 
(dioxane, ε = 2.2099), dispersion (Grimme’s D3-BJ parameter set) and an extended basis-
set (cc-pVTZ for Ru and 6-311++G** for all other atoms).  
 
Initial coordination of the substrate 1c to the in situ catalytically active cationic Ru 
intermediate (A), [Ru(η6-p-cymene)(κ2-O2CR)(1c)]+, occurs through one of the nitrogen 
atoms in the pyrimidine ring and affords two isomers; AC and AN. The former (AC) has the 
phenyl group orientated towards the Ru centre and leads to X–H-activation occurring at the 
ortho carbon via a two-step concerted metalation deprotonation (CMD) mechanism and 
eventually forming the meta product. The latter, AN, is the more stable geometry with the 
phenyl group orientated away from Ru, positioning the N–H for activation and forming a 
four-membered ruthenacycle that ultimately leads to the para product. This intermediate 
(AN) has been chosen as the relative energy zero reference for both H-activation pathways.  
 
Focusing first on acetate as the activating carboxylate base (see Figure S1, R = Me, bold), 
despite the preferred N–H orientation of 1c by 3.3 kcal mol-1, the barrier for reversible one-
step N–H activation (TS(A-B)N) is 4.6 kcal mol-1 higher in free energy than the irreversible 
two-step CMD pathway. From AC (ΔGcorr = +3.3 kcal mol-1), the first C–H activation step 
(TS(A-B)1C) is the higher of the two CMD transition states (ΔGcorr = +10.9 kcal mol-1), which 
involves the κ2-κ1 displacement of the base at Ru as the C–H bond of 1c approaches the 
metal centre to form an agostic intermediate (INT(A-B)C; ΔGcorr = +7.0 kcal mol-1), 
elongating the C–H bond from 1.091 Å to 1.151 Å. The lower second step, TS(A-B)2C, 
involves the cleavage of the C–H bond (ΔGcorr = +8.4 kcal mol-1) and then exergonically 
forms a six-membered ruthenacycle acetic acid adduct, BC (ΔGcorr = +2.0 kcal mol-1). The 
preference for C–H activation over N–H activation agrees with our experimental 




Comparison of the acetate pathways with the carbonate equivalent structures was achieved 
by using bicarbonate (HCO3-, R = OH) in our computational model instead of the dianionic 
carbonate, CO32-. This approach has been used in previous studies13 and is not a perfect 
solution.14 As shown in Figure S1 (R = OH, dashed / italic, ʹ), the barrier to N–H activation 
is smaller for the bicarbonate pathway by 1.7 kcal mol-1, (TS(A-B)Nʹ; ΔGcorr = +12.8 kcal mol-
1) and remains reversible with the four-membered ruthenacycle adduct BNʹ endergonic by 
2.6 kcal mol-1. In fact, this barrier is now lower than the C–H activation pathway by 3.9 kcal 
mol-1, with the N–H product, BNʹ, 0.5 kcal mol-1 lower in energy than the C–H product 
complex BCʹ. Despite ACʹ being relatively more stable to ANʹ for R = OH by 1.4 kcal mol-1 
(ACʹ; ΔGcorr = +1.9 kcal mol-1), the first step in the CMD pathway (TS(A-B)1Cʹ) has increased 
significantly to ΔGcorr = +16.7 kcal mol-1. The displacement of the distal oxygen in TS(A-
B)1Cʹ leading to the loss of a Ru-O bond as the bicarbonate base at Ru changes from κ2 to 
κ1 raises the barrier by 5.8 kcal mol-1. A shorter elongation of the C–H bond (1.122 Å) is 
observed in the agostic intermediate, INT(A-B) Cʹ; ΔGcorr = +3.1 kcal mol-1, which after a 
small barrier to C–H cleavage in the second CMD step (TS(A-B)2Cʹ; ΔGcorr = +6.6 kcal mol-
1) endergonically forms the six-membered ruthenacycle adduct BCʹ (ΔGcorr = +3.1 kcal mol-
1).  
Therefore, by changing the base used to assist in the X–H-activation, we have mirrored 
computationally that which is seen experimentally - a change in mechanism and product 
selectivity is observed. When acetate is the base (R = Me), C–H activation is the lower 
pathway and forms the more stable product adduct BC. However, when bicarbonate is the 
base (R = OH), the lower pathway involves N–H activation, and the more stable product 





Figure S1. DFT calculated free energies (kcal mol-1) relative to the most stable 
intermediate, AN, for the competing C–H and N–H activations of 1c at [Ru(p-
cymene)(O2CR)]+ in dioxane, when R = Me (acetate) or OH (carbonate). 
 
Exchange of the coordinated acid in adduct B post X–H-activation for another carboxylate 
anion affords complex C, [Ru(η6-p-cymene)(κ1-O2CR)(1c*)], when 1c* is the H-activated 1c. 
For both carboxylates, the N–H activated intermediate (CN/CNʹ) is more stable; ΔΔG = 1.9 
kcal mol-1 for acetate (R = Me) and 1.1 kcal mol-1 for bicarbonate (R = OH). Subsequently, 
the relative Fukui indices for the proposed N–H and C–H activated complexes were 
calculated (Figure S2). The N–H activated complex (CN’) was shown to have C3 (para-
position) as the most activated position by a considerable amount. When the position of 
cyclometalation was switched to ortho C–H activation (CC) a complete shift in the electronic 
nature of 1c’s phenyl group is observed. Here the C2 (meta) position has increased relative 
nucleophilicity due the presence of the Ru-C σ-bond para to the C2 position. Likewise, an 
increase in the reactivity of the two ortho sites to the metal center (C4 and C6) reinforces 
the concept of the ruthenium behaving as a transient electronic ortho/para director. It is also 
worth noting that the nature of the ligand (R = OH vs Me) was shown to have negligible 





Figure S3.  Relative nucleophilicity Fukui indices for inorganic computed structures CNʹ (L 
= O2C(OH)) and CC (L = OAc) for (BP86/6-31G**&SDD(Ru,Cl); optimization and NBO), ball-
and-stick figures of CNʹ and CC have the η6-p-cymene and base ligands (L) omitted for clarity. 
The most reactive C–H position is highlighted in red 
 
Varying the nature of the oxygen bound ligand to the ruthenium showed negligible influence 
in the electronic nature of the phenyl group of 1c. This suggests that the complementary 
selectivity observed is not related to the different ligand set present in the reaction conditions 
(i.e. which base is used) but moreover on the position of cyclometalation and how these 
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